penicillamine has been researched along with Hepatolenticular Degeneration in 956 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Hepatolenticular Degeneration: A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.
| Excerpt | Relevance | Reference |
|---|---|---|
| "d-penicillamine; myasthenia gravis; pyridostigmine; Wilson's disease." | 8.12 | D-penicillamine Induced Myasthenia Gravis in Wilson's Disease: A Case Report. ( Bhattarai, S; Paudel, R; Pokharel, M; Rai, N; Sharma, N; Shrestha, AM; Thapa, L; Thapa, M, 2022) |
| "Two siblings born to a mother with Wilson's disease, who was taking D-penicillamine, developed transient goitrous hypothyroidism." | 7.74 | Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease. ( Berkowitz, D; Curiel, B; Hanukoglu, A; Levine, A; Lorberboym, M; Sack, J, 2008) |
| "To report a case of early-decompensated liver cirrhosis secondary to discontinuation of penicillamine therapy in a patient with Wilson's disease." | 7.74 | Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease. ( Awaisu, A; Aziz, NA; Ghazali, R; Hassan, Y; Ping, CC, 2007) |
| "To summarize the long-term effect of combined treatment with large-dose zinc sulfate and low-dose penicillamine in children with hepatolenticular degeneration (HLD)." | 7.70 | [Long-term follow-up of combined therapy with large-dose zinc sulfate and low-dose penicillamine in children with hepatolenticular degeneration]. ( Du, S; Li, T; Lin, R; Qu, Z, 1999) |
| "A case of successful pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate is presented." | 7.69 | Pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate. A case report and review of the literature. ( Hartard, C; Kunze, K, 1994) |
| "A patient with Wilson's disease who developed elastosis perforans serpiginosa and localized cutis laxa during prolonged treatment with D-penicillamine is described." | 7.69 | D-penicillamine-induced elastosis perforans serpiginosa and localized cutis laxa in a patient with Wilson's disease. ( Amichai, B; Metzker, A; Rotem, A, 1994) |
| "This case report illustrates the occurrence of a large pleural effusion associated with long-term D-penicillamine therapy." | 7.69 | Pleural effusion associated with D-penicillamine therapy: a case report. ( Karkos, C; Manche, A; Moore, A; Thorpe, JA, 1996) |
| "The occurrence of a neurologic syndrome that severely impaired a child's usual daily activities and his health-related quality of life after the institution of penicillamine therapy." | 7.69 | Penicillamine-related neurologic syndrome in a child affected by Wilson disease with hepatic presentation. ( Iorio, R; Pensati, P; Porzio, S; Vajro, P; Vegnente, A, 1997) |
| " A regimen of d-penicillamine was started at this time and continued, although irregularly for the 10 months prior to her 9th week of pregnancy." | 7.67 | Pregnancy and penicillamine treatment in a patient with Wilson's disease. ( Komatsu, K; Morimoto, I; Ninomiya, H; Satho, M, 1986) |
| "A patient with Wilson's disease on long-term penicillamine therapy was seen for evaluation and management of chronic persistent debilitating stomatitis, which was subsequently determined to be cytologically and histologically consistent with pemphigus vulgaris." | 7.66 | Pemphigus-like mucosal lesions: a side effect of penicillamine therapy. ( Ballow, M; Eisenberg, E; Krutchkoff, DJ; Tanzer, JM; Wolfe, SH, 1981) |
| "The action of D-penicillamine on collagen can cause undesired side-effects in the treatment of cystinuria and Wilson's disease, it is on the other hand essential to the therapy of rheumatoid arthritis and scleroderma." | 7.66 | D-penicillamine in pregnancy--to ban or not to ban? ( Endres, W, 1981) |
| "A large air cyst was removed from the right lung of a 29-year-old female patient with Wilson's disease and penicillamine-induced perforating elastosis, the cyst first appearing after 9 years of treatment with penicillamine." | 7.66 | [Penicillamine-induced elastosis perforans serpiginosa and pulmonary cyst in Wilson's disease (author's transl)]. ( Bardach, G; Bardach, H; Gebhart, W; Niebauer, G, 1981) |
| "In a 33-year-old man with Wilson's disease a nephrotic syndrome appeared as a severe complication under penicillamine therapy." | 7.65 | [Nephrotic syndrome after treatment with penicillamine in Wilson's disease]. ( Hampel, R; Kallwellis, G; Meng, W, 1976) |
| "We describe a 14-year-old boy with Wilson disease (WD) who first developed pseudo-pseudoxanthoma elasticum (PPXE) after 4." | 5.56 | Pediatric Pseudo-pseudoxanthoma Elasticum Resulting From D-Penicillamine Treatment for Wilson Disease. ( Corey, K; Hawryluk, EB; Schmidt, B; Sheu Song, J; Yu, Z, 2020) |
| " Our patient is one of three siblings on Penicillamine, she was the only one who developed massive breast enlargement four months after commencing Penicillamine therapy, as well as dermatological adverse reactions and myasthenia gravis three more months later." | 5.38 | Concurrent massive breast enlargement, myasthenia gravis and dermopathy as manifestations of penicillamine toxicity in a Wilson's disease patient. ( Latif, SA; Poh, WY; Tan, SS, 2012) |
| "We report a 47-year-old man with Wilson disease who developed bullous lesions on the trunk and extremities after 20 years of penicillamine treatment." | 5.35 | Bullous pemphigoid induced by penicillamine in a patient with Wilson disease. ( Medenica, L; Popadic, S; Skiljevic, D, 2009) |
| "Because Wilson disease was never associated with ANCA-related nephritis, this case strongly supports that d-penicillamine can induce ANCA-vasculitis." | 5.34 | D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease. ( Bienaimé, F; Clerbaux, G; Mougenot, B; Plaisier, E; Ronco, P; Rougier, JP, 2007) |
| "These patients had been treated for Wilson's disease since 14 and 16 years, respectively." | 5.33 | Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson's disease with penicillamine. ( Balme, B; Bécuwe, C; Dalle, S; Kanitakis, J; Ronger-Savlé, S; Skowron, F; Thomas, L, 2005) |
| "The mother we present is a Wilson's disease patient who had been compliant with D-penicillamine for the preceding 13 years." | 5.32 | Transient fetal myelosuppressive effect of D-penicillamine when used in pregnancy. ( Akisu, M; Aydogdu, S; Kultursay, N; Ozgenc, F; Yagci, RV; Yalaz, M, 2003) |
| "The generalized dystonia improved in the following 3 months and 3 years respectively in 2 patients." | 5.30 | Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease. ( Chu, NS; Huang, CC, 1998) |
| "Nephrotic syndrome is a late complication of D-penicillamine treatment." | 5.30 | Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease. ( Alexander, S; Furuta, GT; Herrin, J; Jonas, MM; Siafakas, CG, 1998) |
| "In this report, we describe a case of Wilson's disease with pancytopenia and liver cirrhosis for over 4 years, without any specific treatment." | 5.28 | Successful pregnancy after D-penicillamine therapy in a patient with Wilson's disease. ( Chu, NS; Huang, CC; Huang, HY; Soong, YK, 1991) |
| "Penicillamine is the drug of choice in Wilson's disease and a therapeutic alternative in rheumatoid arthritis." | 5.27 | Penicillamine associated pulmonary hemorrhage. ( Cross, CE; Gamble, CN; Louie, S, 1986) |
| " A 20-year-old man with hepatolenticular degeneration, under prolonged treatment with D-penicillamine, presented with a circular or serpiginous arrangement of nuchal papules." | 4.79 | Penicillamine-induced degenerative dermatoses: report of a case and brief review of such dermatoses. ( Iozumi, K; Nakagawa, H; Tamaki, K, 1997) |
| "Penicillamine is a chelator that has been used in Wilson's disease, cystinuria, rheumatoid arthritis and heavy metal intoxication." | 4.31 | Penicillamine-induced degenerative dermopathy in a patient with Wilson's disease. ( Chen, M; Chen, Y; Gao, L; Jiang, Y; Qiu, X; Qiu, Y, 2023) |
| " The first pregnant woman had a 16-year history of WD, stopped taking penicillamine 1 year before pregnancy." | 4.31 | Wilson disease in pregnancy: A case series. ( Chen, Q; Wei, H; Xiong, X; Zhao, Z; Zhou, X; Zhu, Y, 2023) |
| "d-penicillamine; myasthenia gravis; pyridostigmine; Wilson's disease." | 4.12 | D-penicillamine Induced Myasthenia Gravis in Wilson's Disease: A Case Report. ( Bhattarai, S; Paudel, R; Pokharel, M; Rai, N; Sharma, N; Shrestha, AM; Thapa, L; Thapa, M, 2022) |
| "D-penicillamine has been reported to cause antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis presenting as rapidly progressive glomerulonephritis or pulmonary-renal syndrome mostly in adults." | 3.91 | A Pediatric Case of a D-Penicillamine Induced ANCA-associated Vasculitis Manifesting a Pulmonary-Renal Syndrome. ( Cheong, HI; Cho, MH; Ha, IS; Hyun, H; Kang, HG; Kang, S; Kim, JH; Kim, WS; Ko, JS; Moon, KC, 2019) |
| "She was at 38 weeks and 4 days of gestation with a 15-year history of WD, controlled with penicillamine in the past and replaced by zinc preparations from three months before pregnancy." | 3.88 | Anesthetic management of cesarean delivery for a parturient with Wilson's disease: A case report. ( Jiang, X; Lin, X; Wan, Y, 2018) |
| "Two siblings born to a mother with Wilson's disease, who was taking D-penicillamine, developed transient goitrous hypothyroidism." | 3.74 | Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease. ( Berkowitz, D; Curiel, B; Hanukoglu, A; Levine, A; Lorberboym, M; Sack, J, 2008) |
| "To report a case of early-decompensated liver cirrhosis secondary to discontinuation of penicillamine therapy in a patient with Wilson's disease." | 3.74 | Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease. ( Awaisu, A; Aziz, NA; Ghazali, R; Hassan, Y; Ping, CC, 2007) |
| " Bilirubin levels and hepatic encephalopathy improved under MARS therapy." | 3.72 | Liver support--a task for nephrologists? Extracorporeal treatment of a patient with fulminant Wilson crisis. ( Bisse, E; Grotz, W; Manz, T; Ochs, A; Strey, C, 2003) |
| "We report a chromosomally normal infant boy with congenital diffuse cutis laxa, severe micrognathia, contractures of all limbs, and central nervous system abnormalities including agenesis of the corpus callosum, born to a woman taking D-penicillamine (DP) for Wilson disease (WD) throughout her pregnancy." | 3.72 | Infant with severe penicillamine embryopathy born to a woman with Wilson disease. ( Hogge, WA; McPherson, E; Pinter, R, 2004) |
| "To summarize the long-term effect of combined treatment with large-dose zinc sulfate and low-dose penicillamine in children with hepatolenticular degeneration (HLD)." | 3.70 | [Long-term follow-up of combined therapy with large-dose zinc sulfate and low-dose penicillamine in children with hepatolenticular degeneration]. ( Du, S; Li, T; Lin, R; Qu, Z, 1999) |
| " Through the formation of copper and protein metal complexes D-penicillamine impoverishes copper deposits causing the reduction or disappearance of hepatic and neurological symptoms; a small percentage of patients treated develops a nephrotic syndrome requiring the compulsory suspension of the drug." | 3.69 | [Wilson's disease: physiopathology, therapeutic approach and case report]. ( Bisbocci, D; Gallo, V; Riva, P; Sidoli, L, 1994) |
| "A case of successful pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate is presented." | 3.69 | Pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate. A case report and review of the literature. ( Hartard, C; Kunze, K, 1994) |
| "Elastosis perforans serpiginosa (EPS) and the elastotic changes of pseudoxanthoma elasticum (PXE) are rare but well-recognized side-effects of long-term penicillamine therapy." | 3.69 | Penicillamine-induced elastosis perforans serpiginosa treated successfully with isotretinoin. ( Norris, PG; Ratnavel, RC, 1994) |
| "A patient with Wilson's disease who developed elastosis perforans serpiginosa and localized cutis laxa during prolonged treatment with D-penicillamine is described." | 3.69 | D-penicillamine-induced elastosis perforans serpiginosa and localized cutis laxa in a patient with Wilson's disease. ( Amichai, B; Metzker, A; Rotem, A, 1994) |
| "This case report illustrates the occurrence of a large pleural effusion associated with long-term D-penicillamine therapy." | 3.69 | Pleural effusion associated with D-penicillamine therapy: a case report. ( Karkos, C; Manche, A; Moore, A; Thorpe, JA, 1996) |
| "The occurrence of a neurologic syndrome that severely impaired a child's usual daily activities and his health-related quality of life after the institution of penicillamine therapy." | 3.69 | Penicillamine-related neurologic syndrome in a child affected by Wilson disease with hepatic presentation. ( Iorio, R; Pensati, P; Porzio, S; Vajro, P; Vegnente, A, 1997) |
| "Three patients with symptoms and signs of hepatolenticular degeneration (HLD) who developed serious renal side effects of D-penicillamine (DP) had their therapeutic schedule changed to zinc." | 3.68 | [Zinc in the treatment of hepatolenticular degeneration: report of 3 cases]. ( Barbosa, ER; Burdmann, Ede A; Cançado, ER; Canelas, HM; Haddad, MS; Scaff, M, 1992) |
| "A patient with Wilson's disease treated with penicillamine developed severe hirsutism." | 3.68 | Macromastia in a woman treated with penicillamine and oral contraceptives. A case report. ( Jeffers, LJ; LeMaire, WJ; Rose, BI, 1990) |
| " The drug was applied to 3 patients, 18 to 25 years of age, with Wilson-Konovalov disease (hepatolenticular degeneration) who in the course of chronic D-penicillamine treatment developed drug intolerance with signs of nephrotoxicity (in one patient) and myelotoxicity with leucopenia and thrombocytopenia (in two patients)." | 3.67 | [New possibilities in the treatment of Wilson-Konovalov disease (hepatolenticular degeneration)]. ( Kolarski, V, 1987) |
| " The patient was treated with Penicillamine, a copper-chelating agent, for 7 months, with notable improvement in her dementia and in her motor signs." | 3.67 | Wilson's disease, a reversible dementia: case report. ( Lorenzana, P; Rosselli, A; Rosselli, M; Vergara, I, 1987) |
| " A regimen of d-penicillamine was started at this time and continued, although irregularly for the 10 months prior to her 9th week of pregnancy." | 3.67 | Pregnancy and penicillamine treatment in a patient with Wilson's disease. ( Komatsu, K; Morimoto, I; Ninomiya, H; Satho, M, 1986) |
| "A patient with Wilson's disease on long-term penicillamine therapy was seen for evaluation and management of chronic persistent debilitating stomatitis, which was subsequently determined to be cytologically and histologically consistent with pemphigus vulgaris." | 3.66 | Pemphigus-like mucosal lesions: a side effect of penicillamine therapy. ( Ballow, M; Eisenberg, E; Krutchkoff, DJ; Tanzer, JM; Wolfe, SH, 1981) |
| "The action of D-penicillamine on collagen can cause undesired side-effects in the treatment of cystinuria and Wilson's disease, it is on the other hand essential to the therapy of rheumatoid arthritis and scleroderma." | 3.66 | D-penicillamine in pregnancy--to ban or not to ban? ( Endres, W, 1981) |
| "A large air cyst was removed from the right lung of a 29-year-old female patient with Wilson's disease and penicillamine-induced perforating elastosis, the cyst first appearing after 9 years of treatment with penicillamine." | 3.66 | [Penicillamine-induced elastosis perforans serpiginosa and pulmonary cyst in Wilson's disease (author's transl)]. ( Bardach, G; Bardach, H; Gebhart, W; Niebauer, G, 1981) |
| " In 9 of these patients a slight (4 patients) or a strong proteinuria (5 patients) appeared during the therapy with D-penicillamine." | 3.66 | [immunohistologic findings of kidney biopsies in Wilson's disease]. ( Ditscherlein, G; Lange, E; Lössner, J; Storch, W, 1980) |
| "18 patients with Wilson's disease with and without proteinuria and 19 test persons without Wilson's disease were examined for a disturbance of the transformation on account of phythemagglutinin, streptolysin-O and several D-penicillamine preparations by means of the lymphocyte transformation test." | 3.66 | [Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease]. ( Berger, H; Storch, W, 1980) |
| "Liver biopsy specimens from 7 patients with Wilson's disease (hepatolenticular degeneration), obtained before and after 3 to 5 years of D-penicillamine therapy, were studied by electron microscopy and stereology." | 3.65 | Effects of anticopper therapy on hepatocellular mitochondria in patients with Wilson's disease: an ultrastructural and stereological study. ( Feldmann, G; Sternlieb, I, 1976) |
| "In a 33-year-old man with Wilson's disease a nephrotic syndrome appeared as a severe complication under penicillamine therapy." | 3.65 | [Nephrotic syndrome after treatment with penicillamine in Wilson's disease]. ( Hampel, R; Kallwellis, G; Meng, W, 1976) |
| "Fatal pulmonary hemorrhages and rapidly progressive glomerulonephritis occurred in three patients with Wilson's disease (hepatolenticular degeneration) who had been treated with penicillamine for 2 to 31/2 years." | 3.65 | D-penicillamine induced Goodpasture's syndrome in Wilson's disease. ( Bennett, B; Scheinberg, IH; Sternlieb, I, 1975) |
| "Wilson disease is an inherited disorder of copper transport." | 3.11 | Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial. ( Ala, A; Cassiman, D; Couchonnal-Bedoya, E; Cury, RG; Czlonkowska, A; D'Hollander, K; D'Inca, R; Denk, G; Dubois, N; Gondim, FAA; Kamlin, COF; Moore, J; Ott, P; Poujois, A; Schilsky, ML; Twardowschy, C; Weiss, KH; Zuin, M, 2022) |
| "The diagnosis of MS preceded that of Wilson's disease and was relatively mild in course." | 2.82 | Rare co-occurrence of multiple sclerosis and Wilson's disease - case report. ( Despotov, K; Klivényi, P; Nagy, I; Pálvölgyi, A; Rajda, C; Vécsei, L, 2022) |
| "Wilson disease is multisystemic and the hepatic manifestations are seen more frequently in childhood, whereas neurologic manifestations are more common in adults; presentation may range from subtle changes to end-stage liver disease with or without encephalopathy as well as neuropsychiatric manifestations." | 2.82 | Wilson Disease in Children. ( Kerkar, N; Rana, A, 2022) |
| "The most frequent diagnostic clues to Wilson's disease in patients with SLE included unexplained liver damage despite well-controlled SLE, extrapyramidal symptoms and signs, hyper-intense signals of the basal ganglia bilaterally on T2-weighted and fluid-attenuated inversion recovery (FLAIR) MRI images, and Kayser-Fleischer (K-F) rings on physical examination." | 2.72 | Co-occurring Wilson's disease and non-penicillamine-induced systematic lupus erythematosus: a case report and literature review. ( Huang, X; Jiao, Y; Shi, W; Zhang, S, 2021) |
| "This article reviews the treatment of Wilson Disease, focusing on penicillamine, sodium dimercaptopropane sulfonate, ammonium tetrathiomolybdate and zinc, liver transplantation and gene therapy." | 2.72 | [Advances in the treatment of Wilson Disease]. ( Fan, JG; Xiao, QQ, 2021) |
| "In patients with Wilson's disease, the concentration of reduced glutathione was lower than that in patients with viral hepatitis and as high as that in subjects with alcoholic liver damage." | 2.71 | Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease. ( Cardin, R; D'inca, R; Farinati, F; Naccarato, R; Sturniolo, GC, 2003) |
| "LMW proteinuria was elevated almost exclusively in the first 2 years after the start of treatment, indicating early tubular damage." | 2.68 | Proteinuria and other renal functions in Wilson's disease. ( Feist, D; Ruder, H; Schärer, K; Sözeri, E, 1997) |
| "Wilson disease is an autosomal recessive disorder based on inborn error of copper metabolism." | 2.61 | [Diagnosis and treatment of Wilson disease in Japan]. ( Shimizu, N, 2019) |
| "Consideration of a diagnosis of Wilson disease is still the critical factor in testing for and establishing disease diagnosis." | 2.55 | Wilson Disease: Diagnosis, Treatment, and Follow-up. ( Schilsky, ML, 2017) |
| "Hereditary hemochromatosis and Wilson disease are autosomal recessive storage disorders of iron and copper overload, respectively." | 2.50 | Metal storage disorders: Wilson disease and hemochromatosis. ( Kanwar, P; Kowdley, KV, 2014) |
| " Standardized dosage strategies that address changes in copper pools might improve adherence and reduce side effects." | 2.50 | Clinical considerations for an effective medical therapy in Wilson's disease. ( Stremmel, W; Weiss, KH, 2014) |
| "Excellent treatment options exist for Wilson disease, based on copper chelation." | 2.49 | Inborn errors of copper metabolism. ( Kaler, SG, 2013) |
| "Copper overload in patients with Wilson's disease is caused by impairment to the biliary route for excretion of dietary copper A combination of neurological, psychiatric and hepatic symptoms can make the diagnosis of Wilson's disease challenging." | 2.49 | The treatment of Wilson's disease, a rare genetic disorder of copper metabolism. ( Purchase, R, 2013) |
| "Wilson's disease is an orphan disease due to copper homeostasis dysfunction." | 2.48 | Chelation therapy in Wilson's disease: from D-penicillamine to the design of selective bioinspired intracellular Cu(I) chelators. ( Delangle, P; Mintz, E, 2012) |
| "Some of the implications are that Alzheimer's disease and other diseases of neurodegeneration and fibrotic, inflammatory, and autoimmune diseases may be treatable by lowering the availability of free copper." | 2.44 | The risks of free copper in the body and the development of useful anticopper drugs. ( Brewer, GJ, 2008) |
| "The discovery of the Wilson's disease gene has opened up a new molecular diagnostic approach, and could form the basis of future gene therapy." | 2.44 | Wilson's disease. ( Ala, A; Ashkan, K; Dooley, JS; Schilsky, ML; Walker, AP, 2007) |
| "Wilson disease is an inherited, autosomal recessive, copper accumulation and toxicity disorder that affects about 30 individuals per million." | 2.44 | Wilson disease--a practical approach to diagnosis, treatment and follow-up. ( Medici, V; Rossaro, L; Sturniolo, GC, 2007) |
| "Wilson disease is caused by disease-specific mutations of the copper transporting ATPase, ATP7B." | 2.43 | Wilson disease: new insights into pathogenesis, diagnosis, and future therapy. ( Schilsky, ML, 2005) |
| "Wilson's disease is a rare autosomal recessive disease of copper accumulation and copper toxicity, due to mutations in the ATP7B gene, which leads to a failure of copper excretion in the bile." | 2.43 | Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment. ( Brewer, GJ, 2005) |
| "To present a case of Wilson's disease that presented with fatigue, nausea, abdominal pain, and splenomegaly." | 2.43 | A case study: identifying a new case of Wilson's disease. ( Noble, JA, 2005) |
| "The treatment of Wilson's disease has changed considerably in recent times, from the use of penicillamine (Cuprimine, Merck) for all stages and types of disease, to the use of three other anticopper drugs at appropriate times for appropriate patients." | 2.43 | Novel therapeutic approaches to the treatment of Wilson's disease. ( Brewer, GJ, 2006) |
| "The myriad manifestations of Wilson disease make its diagnosis dependent on a high index of suspicion, and determination of its genetic background is helping to elucidate the genotype-phenotype correlation and the diversity of presentations." | 2.42 | Wilson disease. ( El-Youssef, M, 2003) |
| "Wilson's disease is an inherited copper toxicosis caused by defective putative copper transporting ATPase in the liver." | 2.42 | [Wilson's disease and its pharmacological treatment]. ( Hayashi, H; Suzuki, R; Wakusawa, S, 2004) |
| "Most patients with Wilson disease become symptomatic between the ages of 6 and 15." | 2.41 | [Rare, but important chronic liver diseases]. ( Maier, KP, 2002) |
| "Wilson's disease is a relatively rare inherited disorder of copper accumulation and toxicity, caused by a defect in an enzyme that is part of the pathway of biliary excretion of excess copper." | 2.41 | Recognition, diagnosis, and management of Wilson's disease. ( Brewer, GJ, 2000) |
| "The laboratory diagnosis of Wilson's disease is confirmed by decreased serum ceruloplasmin, increased urinary copper content, and elevated hepatic copper concentration." | 2.41 | Wilson's disease. ( Gitlin, JD; Loudianos, G, 2000) |
| "The diagnosis of Wilson's disease is based on clinical findings and laboratory abnormalities and can be made if two of the following symptoms are present: Kayser-Fleischer rings; topical neurologic symptoms; and low serum ceruloplasmin levels." | 2.40 | Wilson's disease. ( Ferenci, P, 1998) |
| "Wilson disease is a copper storage disease with autosomal-recessive trait that is predominantly a disorder of the adolescent and young adult." | 2.40 | [Therapy of Wilson disease]. ( Smolarek, C; Stremmel, W, 1999) |
| "Wilson's disease is an autosomal recessive disorder related to the copper metabolism." | 2.40 | Treatment and management of Wilson's disease. ( Aoki, T; Shimizu, N; Yamaguchi, Y, 1999) |
| "It is important to consider Wilson's disease in patients with psychiatric signs and symptoms who also have abnormal liver function test results or neurologic findings, or both." | 2.39 | Wilson's disease. Psychiatric manifestations may be the clinical presentation. ( Jackson, GH; Lippmann, S; Meyer, A, 1994) |
| "Because the manifestations of Wilson's disease are so protean, and the disease masquerades so well as something else, recognition of the possibility of Wilson's disease is a major problem, leading to serious underdiagnosis of the disease." | 2.39 | Practical recommendations and new therapies for Wilson's disease. ( Brewer, GJ, 1995) |
| "The discovery that the gene for Wilson disease encodes a copper-transporting ATPase has greatly improved our understanding of the pathophysiology of this disorder and of copper metabolism in humans." | 2.39 | Wilson disease: genetic basis of copper toxicity and natural history. ( Schilsky, ML, 1996) |
| "Certain features of Wilson's disease (WD) in Asia have been found to be different from those in other continents." | 2.38 | Geographic variations in Wilson's disease. ( Chu, NS; Hung, TP, 1993) |
| "Hepatocellular carcinoma has rarely been reported in Wilson's disease, particularly in women." | 2.38 | Hepatocellular carcinoma in a case of Wilson's disease. ( Cheng, WS; Govindarajan, S; Redeker, AG, 1992) |
| "Beside, once the diagnosis is made, Wilson's disease can be effectively treated." | 2.38 | [Wilson's disease]. ( Cramarossa, L; D'Angelo, D; D'Ascanio, I; Ferri, GB; Piane, E, 1992) |
| "The gene for Wilson's disease has been mapped to chromosome 13, but the function of its gene product has not yet been determined." | 2.38 | Wilson's disease: current status. ( Friedman, LS; Martin, P; Muñoz, SJ; Yarze, JC, 1992) |
| "If untreated, Wilson's disease is fatal." | 2.38 | Wilson's disease. ( Colón, VF; Woods, SE, 1989) |
| " Reduction in dosage is recommended when surgery is planned to increase collagen formation and, thus, healing." | 2.37 | Management of an oroantral fistula in a patient with Wilson's disease: case report and review of the literature. ( Alley, RS; Greene, MW; King, RC, 1988) |
| "This article presents a case report of Wilson's disease in pregnancy and a review of this entity during gestation." | 2.36 | Hepatolenticular degeneration (Wilson's disease) and pregnancy. A review and report of a case. ( Peyser, MR; Streifler, M; Toaff, ME; Toaff, R, 1977) |
| "Red cell aplasia developed in a case of Wilson's disease following an increase in D-penicillamine dosage after 14 years' treatment." | 2.35 | Red cell aplasia following prolonged D-penicillamine therapy. ( Gollan, JL; Hoffbrand, AV; Hussein, S; Sherlock, S, 1976) |
| "There is uncertainty regarding Wilson's disease (WD) management." | 1.91 | Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study. ( Almohalla, C; Berenguer, M; Bernal-Monterde, V; Blanco, S; Bonet, L; Casado, M; Castelló, I; Catalina, MV; Dominguez, N; García, M; Girona, E; Gisbert, C; Gomez, J; Gonzalez, M; Gonzalez, R; Gutierrez, ML; Hernáez-Alsina, T; Hernandez, A; Lazaro, M; Lorente, S; Masnou, H; Molina, E; Morillas, J; Muñoz, C; Otero, A; Pacheco, G; Pascual, S; Romero, M; Soto, S; Testillano, M; Valer, MP; Vergara, M, 2023) |
| "Copper deposition in Wilson disease can lead to oxidative stress injury, mitochondrial damage, and apoptosis in the testis, leading to the impairment of spermatogenesis." | 1.91 | Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease. ( Chen, K; Fang, X; Han, H; Liu, J; Liu, Q; Liu, X; Tan, F; Wang, L; Wu, L; Zhao, D, 2023) |
| "In patients with Wilson disease, defined as an excess accumulation of copper which can damage the liver, brain and other vital organs, neurological worsening can occur despite chelation therapy." | 1.91 | Neurological worsening in Wilson disease - clinical classification and outcome. ( Ala, A; Eker, E; Merle, U; Mohr, I; Pfeiffenberger, J; Poujois, A; Weiss, KH, 2023) |
| "BACKGROUND AND OBJECTIVE: There are limited data on the adverse events of D-penicillamine in Wilson's disease (WD) that can result in dose modification or treatment discontinuation." | 1.72 | Adverse Events with D-penicillamine Therapy in Hepatic Wilson's Disease: A Single-Center Retrospective Audit. ( Darak, H; Giri, S; Gopan, A; Irtaza, M; Kale, A; Kumar, S; Patra, BR; Rao, PK; Shukla, A, 2022) |
| "We evaluated a large cohort of Wilson disease patients from Northern Portugal during a 20-year follow-up period." | 1.72 | Wilson disease in Northern Portugal: a long-term follow-up study. ( Cardoso, H; Garrido, I; Liberal, R; Lopes, S; Macedo, G; Marques, M, 2022) |
| "Medical records of 77 Wilson disease patients were reviewed to collect data on hepatic and neurologic symptoms, copper (Cu) homeostasis and adverse events." | 1.72 | Multicentre, retrospective study to assess long-term outcomes of chelator based treatment with trientine in Wilson disease patients withdrawn from therapy with d -penicillamine. ( de Koning, CE; Dhawan, A; Ferenci, P; Kruse, C; Manolaki, N; van Scheppingen, D; Weiss, KH; Wijnberg, L; Zuin, M, 2022) |
| "Wilson's disease is an autosomal recessive disorder, that affects copper metabolism, leading to copper accumulation in the liver, nervous system, and cornea." | 1.72 | Epidemiology, clinical features, and mortality rate of Wilson disease in Moroccan children: A pediatric case series. ( Abbassi, N; Bedoya, EC; Belmalih, A; Bost, M; Bourrahouat, A; El Hanafi, FZ; Lachaux, A; Sedki, A, 2022) |
| "The patient was diagnosed with liver cirrhosis 6 years prior based on outside hospital ultrasound and liver biopsy." | 1.72 | Wilson's disease: neuropsychiatric presentation and delayed diagnosis. ( Alick-Lindstrom, S; Deme, P; Sheffield, A, 2022) |
| "Spontaneous abortion was observed in 8 (30." | 1.72 | Pregnancy Outcomes in Wilson's Disease Women: Single-Center Case Series. ( Abreu, ES; Cançado, GGL; Couto, CA; Faria, LC; Ferrari, TCA; Mussi, MCL; Nardelli, MJ; Osório, FMF; Santos, BC, 2022) |
| "Her jaundice was increasing along with prolonged prothrombin time and low albumin." | 1.62 | Prolonged Jaundice in a Patient with Coexisting Hepatitis A Virus Infection and Wilson's Disease. ( Chowdhury, M; Ghosh, CK; Hasan, MA; Miah, AR; Miah, SA, 2021) |
| "To describe a cohort of Wilson disease (WD) pediatric cases, and to point out the diagnostic particularities of this age group and the long-term outcome." | 1.62 | Pediatric Wilson's Disease: Phenotypic, Genetic Characterization and Outcome of 182 Children in France. ( Belmalih, A; Bost, M; Bridoux-Henno, L; Broué, P; Brunet, AS; Couchonnal, E; Debray, D; Dumortier, J; Fabre, A; Gottrand, F; Guillaud, O; Habes, D; Jacquemin, E; Lachaux, A; Lamireau, T; Lion-François, L; Poujois, A; Sobesky, R; Vanlemmens, C, 2021) |
| "A 37-year-old Wilson disease patient treated with D-penicillamine visited our hospital for the evaluation of his liver function." | 1.56 | Importance of a Liver Biopsy in the Management of Wilson Disease. ( Abe, S; Harada, M; Hayashi, T; Honma, Y; Kumamoto, K; Kusanaga, M; Minami, S; Morino, K; Oe, S; Ogino, N; Shibata, M; Yabuki, K, 2020) |
| "Oxidative stress has been reported in Wilson's disease with neurological manifestation (WDNM), but there is a paucity of studies on the role of adjunctive antioxidant therapy." | 1.56 | Adjunctive Antioxidant Therapy in Neurologic Wilson's Disease Improves the Outcomes. ( Kalita, J; Kumar, V; Misra, UK; Parashar, V; Ranjan, A, 2020) |
| "Wilson disease is a rare genetic disorder of copper metabolism with a wide range of clinical presentations." | 1.56 | Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers. ( Dalekos, GN; Deutsch, M; Gabeta, S; Gatselis, NK; Koskinas, J; Koullias, E; Manesis, E; Saitis, A; Savvanis, S; Tampaki, M, 2020) |
| "We describe a 14-year-old boy with Wilson disease (WD) who first developed pseudo-pseudoxanthoma elasticum (PPXE) after 4." | 1.56 | Pediatric Pseudo-pseudoxanthoma Elasticum Resulting From D-Penicillamine Treatment for Wilson Disease. ( Corey, K; Hawryluk, EB; Schmidt, B; Sheu Song, J; Yu, Z, 2020) |
| "Hypercalciuria was detected in 23% at baseline, 34% in those patients treated for up to 5 years and 37." | 1.51 | Urinary abnormalities in children and adolescents with Wilson disease before and during treatment with d-penicillamine. ( Abdel Aziz, H; Abdel Hameed, N; El-Karaksy, H; Fahmy, M; Ghobrial, C; Helmy, H, 2019) |
| "Subjects of Wilson disease were identified as those with International Classification of Diseases, Ninth Revision (ICD-9) code 275." | 1.48 | Modality of treatment and potential outcome of Wilson disease in Taiwan: A population-based longitudinal study. ( Chang, MH; Chen, HL; Hsu, HY; Ni, YH; Tai, CS; Wu, JF, 2018) |
| "Wilson disease is an autosomal recessive genetic disorder caused by loss-of-function mutations in the P-type copper ATPase, ATP7B, which leads to toxic accumulation of copper mainly in the liver and brain." | 1.48 | Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent. ( Bragina, O; Järving, I; Kabin, E; Palumaa, P; Plitz, T; Smirnova, J; Tõugu, V, 2018) |
| "After admission, she developed hepatic encephalopathy and was diagnosed with fulminant hepatitis based on the American Association for the Study of Liver Disease (AASLD) position paper." | 1.48 | Clinically diagnosed late-onset fulminant Wilson's disease without cirrhosis: A case report. ( Amano, T; Fukui, K; Hayashi, S; Inada, M; Matsubara, T; Mukai, K; Nakajima, S; Nishida, T; Shimakoshi, H; Shimoda, A; Sugimoto, A; Takahashi, K; Yamamoto, M, 2018) |
| "Both Wilson disease (WD) and Oculocutaneous Albinism (OCA) are rare autosomal recessive disorders that are caused by mutations on chromosome 13 and chromosome 11, respectively." | 1.48 | A case report: Co-occurrence of Wilson disease and oculocutaneous albinism in a Chinese patient. ( Chiu, YJ; Han, YS; Han, YZ; Rao, R; Shu, S, 2018) |
| "Four patients presented with acute liver failure, four with persistently elevated liver function tests, and two with decompensated cirrhosis; none had neurological manifestations." | 1.48 | Hepatic manifestations of Wilson's disease: 12-year experience in a Swiss tertiary referral centre. ( Ferenci, P; Fraga, M; Giostra, E; Hiroz, P; Moradpour, D; Saldarriaga, J; Sempoux, C; Vieira Barbosa, J, 2018) |
| "Sixty patients with liver fibrosis induced by hepatolenticular degeneration were randomly divided into two groups, a penicillamine group and a BMSCs plus penicillamine group, with 30 patients in each." | 1.46 | A clinical study of bone mesenchymal stem cells for the treatment of hepatic fibrosis induced by hepatolenticular degeneration. ( Zhang, D, 2017) |
| "We retrospectively analyzed 235 Wilson disease patients." | 1.43 | Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy. ( Ferenci, P; Gohdes, A; Gotthardt, DN; Pfeiffenberger, J; Schäfer, M; Seessle, J; Stremmel, W; Weiss, KH, 2016) |
| "We describe 2 patients with Wilson's disease treated with D-penicillamine who presented with ANCA (+) vasculitis and renal involvement." | 1.43 | D-penicillamine-induced ANA (+) ANCA (+) vasculitis in pediatric patients with Wilson's disease. ( Cho, H; Lee, ST; Lee, Y, 2016) |
| "The most common Wilson disease (WD) mutations p." | 1.43 | Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines. ( Aggarwal, A; Bhatt, M; Chandhok, G; Horvath, J; Schmidt, HH; Zibert, A, 2016) |
| "Wilson disease is an inherited disorder of excessive copper accumulation." | 1.42 | Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: a microdialysis study in vivo. ( Chen, DB; Feng, L; Hou, HM; Li, XH; Liu, JX; Wei, LT; Wu, C; Zhang, JW, 2015) |
| "Patients with neurologic Wilson disease (NWD) may worsen on treatment, but there is no study evaluating the role of oxidative stress." | 1.42 | Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy. ( Kalita, J; Kumar, V; Misra, UK; Ranjan, A, 2015) |
| "Penicillamine is a standard therapy for Wilson disease (WD) but some patients have paradoxical worsening." | 1.40 | Worsening of Wilson disease following penicillamine therapy. ( Chandra, S; Kalita, J; Kumar, B; Kumar, V; Misra, UK, 2014) |
| "We presented a rare atypical case of Wilson's disease with psy- chotic onset." | 1.40 | Atypical case of Wilson's disease with psychotic onset, low 24 hour urine copper and the absence of Kayser-Fleischer rings. ( Antonijević, J; Krstić, D; Špirić, Ž, 2014) |
| " Chelator-based treatment regimens were analyzed for their effect on neurologic and hepatic symptoms and for adverse events that led to discontinuation of therapy (Kaplan-Meier estimation; data were collected for a mean of 13." | 1.39 | Efficacy and safety of oral chelators in treatment of patients with Wilson disease. ( Ferenci, P; Ferenci-Foerster, D; Gotthardt, DN; Hefter, H; Houwen, RH; Maieron, A; Merle, U; Reuner, U; Schäfer, M; Schmidt, HH; Stauber, R; Stremmel, W; Teufel, U; Thurik, F; Trocello, JM; Weiss, KH; Wiegand, F; Zoller, H, 2013) |
| " Data about the dosage scheme of zinc sulphate, side effects and efficacy and toxicity of the treatment were collected and recorded in the patient's medical chart at each visit to the hospital." | 1.39 | Gastrointestinal side effects in children with Wilson's disease treated with zinc sulphate. ( Avsar, Y; Dądalski, M; Jańczyk, W; Schmidt, H; Socha, P; Wiernicka, A, 2013) |
| " During the treatment, clinical observations and 24-h urine copper excretion as well as adverse effects of medicines were recorded and analyzed." | 1.39 | Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease. ( Chen, L; Fang, F; Li, XF; Liu, Y; Xu, SQ; Zhu, HY, 2013) |
| "Wilson disease is an inherited autosomal recessive disorder causing copper accumulation and consequent toxicity." | 1.38 | Metal element excretion in 24-h urine in patients with Wilson disease under treatment of D-penicillamine. ( Huang, L; Jiao, X; Liu, X; Yu, X; Zhang, J; Zhang, Y, 2012) |
| "The case notes of 320 patients with Wilson disease, seen between 1960 and 1987, have been reviewed." | 1.38 | Serum 'free' copper in Wilson disease. ( Walshe, JM, 2012) |
| "Wilson disease is an autosomal recessive disease that produces a copper accumulation in many organs, initially in the liver, progressing to liver cirrhosis, and in the brain, with different neurologic symptoms." | 1.38 | [Diagnosis and care of Wilson disease with neurological revelation]. ( Bost, M; Broussolle, E; Brunet, AS; Des Portes, V; Lachaux, A; Lion-François, L; Wagner, S, 2012) |
| "A 38-year-old woman with Wilson's disease developed neurological deterioration after 25 years of low-dose penicillamine administration." | 1.38 | Resolution of cranial MRI and SPECT abnormalities in a patient with Wilson's disease following oral zinc monotherapy. ( Doi, Y; Fukui, H; Hanafusa, T; Ishida, S; Kimura, F; Sugino, M; Tamai, H; Yamane, K, 2012) |
| "To evaluate Wilson's disease (WD) features in Sardinian patients with Kayser-Fleischer (KF) ring and to evaluate correlations between modifications in KF and anti-copper therapy and systemic WD evolution." | 1.38 | Kayser-Fleischer ring in Wilson's disease: a cohort study. ( Civolani, A; Demelia, E; Demelia, L; Fenu, M; Liggi, M; Sorbello, O, 2012) |
| " Our patient is one of three siblings on Penicillamine, she was the only one who developed massive breast enlargement four months after commencing Penicillamine therapy, as well as dermatological adverse reactions and myasthenia gravis three more months later." | 1.38 | Concurrent massive breast enlargement, myasthenia gravis and dermopathy as manifestations of penicillamine toxicity in a Wilson's disease patient. ( Latif, SA; Poh, WY; Tan, SS, 2012) |
| "Thirty-six Wilson's disease patients, diagnosed from 1971 to 2010, were retrospectively evaluated according to their clinical presentation, epidemiological and social features, response to therapy and outcome." | 1.37 | Wilson's disease in southern Brazil: a 40-year follow-up study. ( Barbosa, ER; Bem, RS; Deguti, MM; Muzzillo, DA; Teive, HA; Werneck, LC, 2011) |
| "Those with neurological Wilson's disease gave an intermediate figure (305." | 1.37 | The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease. ( Walshe, JM, 2011) |
| "Most paediatric patients with Wilson's disease (WD) present with hepatic manifestations, but some may have neurologic or psychiatric features." | 1.37 | A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit. ( El-Hawary, M; El-Hennawy, A; El-Karaksy, H; El-Koofy, N; El-Mougy, F; El-Raziky, MS; El-Sayed, R; El-Shabrawi, M; Fahmy, M, 2011) |
| "The diagnosis of Wilson disease (WD) is challenging, especially in children." | 1.36 | Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. ( Iorio, R; Nicastro, E; Ranucci, G; Vajro, P; Vegnente, A, 2010) |
| " The authors measured spot urinary copper excretion, which gave an indication of the efficacy of treatment and of the sufficient dosage of zinc." | 1.36 | Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism. ( Aoki, T; Fujisawa, T; Fujiwara, J; Harada, M; Horiike, N; Ida, S; Inui, A; Ito, M; Itoh, S; Kodama, H; Kohsaka, T; Ohnishi, S; Sato, M; Shimizu, N; Tamai, H; Yoshino, M, 2010) |
| "We report a 47-year-old man with Wilson disease who developed bullous lesions on the trunk and extremities after 20 years of penicillamine treatment." | 1.35 | Bullous pemphigoid induced by penicillamine in a patient with Wilson disease. ( Medenica, L; Popadic, S; Skiljevic, D, 2009) |
| "Patients with late-onset Wilson disease accounted for 7." | 1.35 | [Clinical character and therapeutic effect of late-onset Wilson disease]. ( Lei, J; Luo, H; Tang, X; Yang, X; Zhang, Y, 2009) |
| "Wilson's disease is an autosomal-recessive disorder caused by mutation in the ATP7B gene, with resultant impairment of biliary excretion of copper." | 1.35 | [Wilson's disease in paediatric age: diagnosis and treatment. Recent advances]. ( Palumbo, E, 2008) |
| "Severe hemolytic anemia is an unusual complication of Wilson's disease." | 1.35 | [Acute recurrent hemolytic anemia as the first manifestation of Wilson's disease: Report of a case]. ( Amézyane, T; Badaoui, M; El Khattabi, A; Fatihi, J; Mahassine, F; Ohayon, V; Salaheddine, H; Seddik, H, 2009) |
| "Wilson disease is a disorder of copper metabolism characterized by copper overload." | 1.35 | Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease. ( Bahador, A; Dehghani, M; Dehghani, SM; Geramizadeh, B; Kakaei, F; Kazemi, K; Malek-Hosseini, SA; Nikeghbalian, S; Reza Nejatollahi, SM; Salahi, H, 2008) |
| "Severe hemolysis was reduced to low-grade hemolysis, with no further need for transfusions." | 1.35 | A 15-year-old girl with severe hemolytic Wilson's crisis recovered without transplantation after extracorporeal circulation with the Prometheus system. ( Aagaard, NK; Holland-Fischer, P; Jørgensen, SP; Ott, P; Thomsen, KL, 2009) |
| "Seventeen symptomatic patients with Wilson disease were treated with zinc only." | 1.35 | Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. ( Houwen, RH; Linn, FH; van der Kleij, S; van Erpecum, KJ; van Hattum, J, 2009) |
| " Zinc sulphate, aiming at the treatment of free-copper toxicosis, has emerged as effective, safe and cheap alternative." | 1.35 | Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap. ( Sinha, S; Taly, AB, 2008) |
| "The prevalence of osteopenia and osteoporosis in children with WD was found as 22." | 1.35 | Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy. ( Doneray, H; Ertekin, V; Selimoglu, MA; Yildirim, M, 2008) |
| "Diagnosis of Wilson's disease (WD) is reliant on liver biopsy (LB) and measurement of hepatic copper." | 1.35 | Usefulness of penicillamine-stimulated urinary copper excretion in the diagnosis of adult Wilson's disease. ( Boixeda, D; Camarero, C; de Argila, CM; Foruny, JR; López-Sanroman, A; Milicua, JM; Rodríguez-Gandía, M; Vázquez-Romero, M; Vázquez-Sequeiros, E; Villafruela, M, 2008) |
| "Patients with Wilson's disease having predominantly neuropsychiatric symptoms manifest symptoms later, have a longer time delay from onset of symptoms until definitive diagnosis and have a poorer outcome than patients with hepatic symptoms." | 1.34 | Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. ( Ferenci, P; Merle, U; Schaefer, M; Stremmel, W, 2007) |
| "Diagnosis of Wilson's disease with hepatic presentation in childhood using clinical and common laboratory parameters is still challenging and is often missed or delayed." | 1.34 | Wilson's disease with hepatic presentation in childhood. ( Islam, MS; Karim, MB; Rahman, MM, 2007) |
| "The clinical manifestations of Wilson disease (WD) are varied and challenging." | 1.34 | Wilson disease: description of 282 patients evaluated over 3 decades. ( Arunodaya, GR; Meenakshi-Sundaram, S; Sinha, S; Swamy, HS; Taly, AB, 2007) |
| "Wilson disease is an autosomal recessive disorder of copper metabolism in which copper is deposited in the brain and liver." | 1.34 | Wilson disease with visceral leishmaniasis: an extremely uncommon presentation. ( Bhattacharya, SK; Bimal, S; Das, P; Das, VN; Kumar, N; Lal, CS; Pandey, K; Singh, D; Sinha, PK; Topno, RK; Verma, N; Verma, RB, 2007) |
| "Because Wilson disease was never associated with ANCA-related nephritis, this case strongly supports that d-penicillamine can induce ANCA-vasculitis." | 1.34 | D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease. ( Bienaimé, F; Clerbaux, G; Mougenot, B; Plaisier, E; Ronco, P; Rougier, JP, 2007) |
| "The physiology of iron metabolism in Wilson's disease is largely unknown, and there is a paucity of data on the real presence and progression of iron accumulation." | 1.34 | Effect of penicillamine and zinc on iron metabolism in Wilson's disease. ( Bowlus, CL; Burra, P; D'Incà, R; Di Leo, V; Irato, P; Lamboglia, F; Martines, D; Medici, V; Sturniolo, GC; Tseng, SC, 2007) |
| "These patients had been treated for Wilson's disease since 14 and 16 years, respectively." | 1.33 | Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson's disease with penicillamine. ( Balme, B; Bécuwe, C; Dalle, S; Kanitakis, J; Ronger-Savlé, S; Skowron, F; Thomas, L, 2005) |
| "Wilson disease is an autosomal recessive inborn error of copper metabolism that leads to neurologic symptoms and variable degrees of hepatic damage." | 1.33 | Psychological presentations without hepatic involvement in Wilson disease. ( Lin, JJ; Lin, KL; Wang, HS; Wong, MC, 2006) |
| "A case of Wilson's disease, a rare autosomal recessive disorder of copper metabolism is reported here." | 1.32 | A case report on Wilson's disease. ( Paul, GK; Rahman, KM; Rahman, S; Sarker, CB; Siddiqui, NI, 2003) |
| "She was diagnosed as having fulminant Wilson's disease (FWD)." | 1.32 | Bridging use of plasma exchange and continuous hemodiafiltration before living donor liver transplantation in fulminant Wilson's disease. ( Eto, T; Hamakawa, T; Hasuike, S; Hayashi, K; Ido, A; Nagata, Y; Tanaka, K; Tsubouchi, H; Uto, H, 2003) |
| "The mother we present is a Wilson's disease patient who had been compliant with D-penicillamine for the preceding 13 years." | 1.32 | Transient fetal myelosuppressive effect of D-penicillamine when used in pregnancy. ( Akisu, M; Aydogdu, S; Kultursay, N; Ozgenc, F; Yagci, RV; Yalaz, M, 2003) |
| "Wilson's disease or hepatolenticular degeneration is an autosomal recessive disorder." | 1.32 | [Pathogenesis and treatment of Wilson's disease]. ( Csák, T; Folhoffer, A; Horváth, A; Nagy, J; Vincze, Z; Zelkó, R, 2003) |
| "The progression of Wilson disease (WD), a disorder of copper metabolism, can be arrested by chelation therapy." | 1.32 | Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease. ( Davie, CA; Lees, AJ; MacManus, D; Miller, DH; Miszkiel, KA; Page, RA; Schapira, AH; Walshe, JM, 2004) |
| "A case of a patient is reported in whom Wilson's disease presented in debut with a picture of decompensated liver cirrhosis and immune thrombocytopania complicated by recurrent hemorrhagic syndrome." | 1.32 | [Wilson's disease and secondary copper hemochromatoses in hematological practice]. ( Levina, AA; Lukina, EA; Solov'eva, TI; Sysoeva, EP; Vorob'ev, AI, 2004) |
| "One hundred and nine patients with Wilson's disease (median age at diagnosis, 7." | 1.32 | Serum transaminases in children with Wilson's disease. ( Barbera, C; Cirillo, F; D'Ambrosi, M; Francavilla, R; Frediani, T; Fusco, G; Giacchino, R; Iorio, R; Maggiore, G; Marazzi, MG; Marcellini, M; Mazzarella, G; Michielutti, F; Pastore, M; Resti, M; Vajro, P; Vegnente, A; Zancan, L, 2004) |
| " The resulting urinary copper excretion on each dosing schedule was compared." | 1.31 | [Appropriate administration schedule of D-penicillamine for pediatric Wilson's disease patients based on urinary copper excretion]. ( Fukuoka, N; Hamatani, S; Imai, T; Itoh, S; Kondoh, M; Morita, S; Ohnishi, S; Okada, H, 2002) |
| "In this case report we present hypersomnia as a symptom of WD." | 1.31 | Hypersomnia in Wilson's disease: an unusual symptom in an unusual case. ( Firneisz, G; Halasz, P; Komoly, S; Szalay, F, 2000) |
| "Ten newly diagnosed Wilson's disease patients underwent PRVEP and flash ERG soon after the diagnosis was established." | 1.31 | Visual pathway abnormalities Wilson's disease: an electrophysiological study using electroretinography and visual evoked potentials. ( Ravishankar Naik, K; Satishchandra, P, 2000) |
| "To report the features of Wilson's disease with severe hepatic insufficiency in a series of 17 patients and, during the second period of the study, to assess the efficacy of a policy consisting of early administration of D-penicillamine." | 1.31 | Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. ( Benhamou, JP; Bernuau, J; Degott, C; Durand, F; Giostra, E; Mentha, G; Shouval, D; Valla, D, 2001) |
| "Wilson's disease is an autosomal recessive disorder of copper metabolism characterized mainly by liver cirrhosis and neurological disorders." | 1.31 | Wilson's disease in pregnancy: five successful consecutive pregnancies of the same woman. ( Bashiri, A; Erez, O; Furman, B; Holcberg, G; Mazor, M; Wiznitzer, A, 2001) |
| "A 37-year-old man with Wilson's disease is described, in whom the introduction of penicillamine therapy was followed after 3." | 1.31 | Penicillamine-induced lethal status dystonicus in a patient with Wilson's disease. ( Kostić, VS; Pejović, S; Sternić, N; Svetel, M, 2001) |
| "Because most patients with Wilson's disease, a genetic copper toxicosis, have hypoceruloplasminemia, some could be affected by iron overload." | 1.31 | Iron accumulation in the liver of male patients with Wilson's disease. ( Hayashi, H; Kono, S; Mabuchi, H; Miyajima, H; Okada, T; Shiono, Y; Takikawa, T; Wakusawa, S; Yano, M, 2001) |
| "Wilson's disease is an inherited autosomal recessive (AR) disorder of copper metabolism transmitted by a mutant gene on chromosome 13q14-21 and results in abnormal accumulation of copper giving rise to protean manifestations." | 1.31 | Wilson's disease in Eastern India. ( Jha, DK; Sinha, KK; Sinha, S, 2001) |
| "Mutations in the Wilson disease gene ATP7B, a P-type ATPase, are responsible for copper accumulation in the liver and other organs leading to Wilson disease (WD, OMIM 277900)." | 1.31 | Disturbed copper transport in humans. Part 2: mutations of the ATP7B gene lead to Wilson disease (WD). ( Berr, F; Caca, K; Horn, N; Kauf, E; Mentzel, HJ; Schwab, SG; Seidel, J; Wildenauer, DB, 2001) |
| "We report 21 cases of Wilson's disease with neurological complications, emphasizing clinical semiology, diagnostic means and problems of the therapeutics in our country." | 1.31 | [Wilson's disease. Clinical presentation, treatment and evolution in 21 cases]. ( Aïdi, S; Benomar, A; Bono, W; Chkili, T; el Alaoui-Faris, M; Moutie, O; Yahyaoui, M, 2002) |
| "Wilson's disease is a rare inherited metabolic disorder usually characterized by liver and/or neurological degeneration." | 1.30 | [Wilson's disease]. ( Bascone, F; Bonfissuto, G; Carroccio, A; Costanza, G; Magliarisi, C; Montalto, G; Soresi, M, 1997) |
| "We conclude that Wilson's disease may be a good indication for LTX for both neurological manifestation with stable liver function and hepatic manifestation with cirrhosis or acute liver failure." | 1.30 | Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease. ( Bechstein, WO; Becker, M; Luck, W; Mueller, AR; Neuhaus, P; Neuhaus, R; Platz, KP; Schuelke, M; Schumacher, G; Steinmüller, T, 1997) |
| "Wilson's disease is an autosomal-recessive inherited disorder that results in predominantly hepatic and neurologic manifestations." | 1.30 | Pretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson's disease. ( Cordato, DJ; Fulham, MJ; Yiannikas, C, 1998) |
| "The generalized dystonia improved in the following 3 months and 3 years respectively in 2 patients." | 1.30 | Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease. ( Chu, NS; Huang, CC, 1998) |
| "The pseudosclerotic type of Wilson's disease, also known as the Westphal-Strümpell form, is distinguished by positional tremor, ataxia and dysarthria as the main symptoms." | 1.30 | [Schizophrenia-like symptoms in the Westphal-Strümpell variation of Wilson disease]. ( Landgraf, F; Müller, J; Trabert, W, 1998) |
| "Wilson disease is an inborn error of copper metabolism that has neurological and hepatic manifestations." | 1.30 | [Neuroradiological findings in 2 cases of Wilson disease with neurological involvement]. ( Badilla, L; Barrios, A; Bravo, E; Gajewski, C; Miranda, M; Troncoso, M; Villagra, R, 1998) |
| "In children with Wilson's disease, no clinical or laboratory data are specific for diagnosis as in adult age." | 1.30 | Syndromic variability of Wilson's disease in children. Clinical study of 44 cases. ( Barabino, A; Boni, L; Callea, F; Ciravegna, B; Famularo, L; Fasce, L; Giacchino, R; Marazzi, MG, 1997) |
| "Nephrotic syndrome is a late complication of D-penicillamine treatment." | 1.30 | Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease. ( Alexander, S; Furuta, GT; Herrin, J; Jonas, MM; Siafakas, CG, 1998) |
| "To study the clinical features of Wilson's disease in childhood." | 1.30 | A high index of suspicion: the key to an early diagnosis of Wilson's disease in childhood. ( Camarena, C; de la Vega, A; Díaz, MC; Frauca, E; Garde, T; Hierro, L; Jara, P; Larrauri, J; Sánchez-Albisua, I, 1999) |
| "Mucosal iron concentration increased in Wilson's disease patients whether they were treated with zinc or penicillamine." | 1.30 | Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients. ( Albergoni, V; D'Incà, R; Irato, P; Longo, G; Mestriner, C; Sturniolo, GC, 1999) |
| "Major depressive disorder was the first clinical manifestation at the age of 38 years." | 1.30 | Psychiatric symptoms as late onset of Wilson's disease: neuroradiological findings, clinical features and treatment. ( Bergamasco, B; Crasto, S; Keller, R; Lagget, M; Torta, R, 1999) |
| "Patients with Wilson's disease contemplating pregnancy should have their hepatic function and copper status assessed." | 1.29 | Wilson's disease in pregnancy. ( Goulding, P; Hawthorne, B; Maresh, M; Nunns, D, 1995) |
| "At the age of 10 years, Wilson disease was diagnosed in view of low concentration of serum ceruloplasmin, elevated urinary copper excretion and high copper content in a liver biopsy sample." | 1.29 | Effect of growth hormone on IGF-I levels in a patient with growth hormone deficiency and Wilson disease. ( Behrens, R; Böhles, HJ; Dörr, HG; Gerling, S; Koch, A, 1995) |
| "Now, the mass-screening for Wilson's disease is in progress." | 1.29 | [Wilson's disease--evolutive panorama of diagnosis and treatment in the last forty years]. ( Arima, M, 1995) |
| "Wilson's disease is a hereditary autosomal recessive disorder of copper metabolism." | 1.29 | Case report: concordant traumatic brainstem contusion delayed diagnosis in a young man with Wilson's disease. ( Ammermann, C; Klein, M; Marcus, A; Schmidt, MH, 1995) |
| "A case of a young patient with Wilson's disease who developed recurrent episodes of acute rhabdomyolysis is presented, and the accumulation of copper in muscle tissue as a possible complication is discussed." | 1.29 | Copper-induced acute rhabdomyolysis in Wilson's disease. ( Feichtinger, H; Judmaier, G; Propst, A; Propst, T; Vogel, W; Willeit, J, 1995) |
| "The clinical course of 18 patients with Wilson's disease is reported." | 1.29 | Wilson's disease--a review of cases at University Hospital, Kuala Lumpur. ( Mohamed, R; Tan, CT; Wong, NW, 1994) |
| "To report a case of presymptomatic Wilson's disease in a patient who became severely neurologically disabled after treatment with penicillamine and to discuss alternative initial therapy for such patients." | 1.29 | Development of neurologic symptoms in a patient with asymptomatic Wilson's disease treated with penicillamine. ( Brewer, GJ; Turkay, A; Yuzbaziyan-Gurkan, V, 1994) |
| "In 12 patients with Wilson's disease treated with D-penicillamine (DPA), the regional cerebral metabolic rate of glucose consumption of the lentiform and caudate nucleus was analysed using the 18Fluorodeoxyglucose method and correlated with the clinical symptoms of the patients, the ceruloplasmin level, the serum level of free copper and the 24-h copper excretion." | 1.29 | Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine. ( Arendt, G; Feinendegen, LE; Hefter, H; Herzog, H; Kuwert, T; Stremmel, W, 1993) |
| "Hypercalciuria and nephrocalcinosis are not uncommon in patients with Wilson's disease but have only once been reported as the presenting sign." | 1.29 | Hypercalciuria and nephrocalcinosis, a feature of Wilson's disease. ( Forster, I; Hoppe, B; Leumann, E; Neuhaus, T; Superti-Furga, A, 1993) |
| "Zinc treatment of Wilson's disease was introduced by Schouwink en 1961 and is still uncommon in France." | 1.29 | [Treatment of Wilson's disease with zinc. 5 cases]. ( Accominotti, M; Bona, I; Broussolle, E; Chazot, G; Confavreux, C; Fontanges, T; Neuschwander, P, 1993) |
| "A patient with untreated Wilson's disease showed the possibility of fetal liver damage and copper accumulation in the placenta by this disease." | 1.29 | Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease. ( Anai, T; Inoue, I; Matsui, N; Miyakawa, I; Oga, M; Yoshimatsu, J, 1993) |
| "In addition, Wilson's disease patients quite often take vitamin C in high doses in conjunction with Zn therapy, and there are indications of possible interactions among vitamin C, Zn and copper (Cu)." | 1.29 | Treatment of Wilson's disease with zinc: XI. Interaction with other anticopper agents. ( Brewer, GJ; Dick, RD; Johnson, V; Wang, Y; Yuzbasiyan-Gurkan, V, 1993) |
| "Twenty-three patients with Wilson's disease (WD) treated with D-penicillamine underwent clinical examination, as well as laboratory and motor testing." | 1.29 | Motor impairment in Wilson's disease, I: Slowness of voluntary limb movements. ( Arendt, G; Freund, HJ; Hefter, H; Stremmel, W, 1993) |
| "All patients had dystonia as their major clinical manifestation but also had dysarthria and at the presentation of the disease had choreoathetoid movements in at least one limb." | 1.29 | Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers. ( Andersson, Y; Aquilonius, SM; Hartvig, P; Hörnfeldt, K; Långström, B; Tedroff, J; Thuomas, KA; Westermark, K, 1995) |
| "In this paper we describe liver-related Wilson's disease in two sisters." | 1.29 | [Wilson disease with HCV infections]. ( Członkowska, A; Gajda, J; Nałecz, A; Socha, J, 1995) |
| "Wilson's Disease is an inherited disorder of copper metabolism." | 1.29 | [Wilson's disease: a review apropos of a clinical experience in 16 patients]. ( Alarcón, T; Brinck, P; González, M; Miranda, M; Roessler, JL; Troncoso Sch, M; Villagra, R, 1995) |
| "Renal function study revealed incomplete proximal renal tubular acidosis." | 1.29 | Recurrent hypokalemic muscle weakness as an initial manifestation of Wilson's disease. ( Chu, CC; Chu, NS; Huang, CC, 1996) |
| "Wilson's disease is an autosomal recessive disorder characterized by an accumulation of a toxic amount of copper in the body." | 1.28 | Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations. ( Hashimoto, T; Morita, J; Motohiro, T; Okano, Y; Watari, H; Yamashita, F; Yoshida, I; Yoshino, M, 1992) |
| "Seventeen had Wilson's disease, 22 had autoimmune chronic active hepatitis, 6 had primary sclerosing cholangitis, 12 had chronic liver disease of various etiologies, 4 had cryptogenic acute liver failure, 6 had acute hepatitic illnesses and 8 had a variety of disorders featuring normal liver histological appearance." | 1.28 | Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. ( Baldwin, D; Lolin, Y; Martins da Costa, C; Mieli-Vergani, G; Mowat, AP; Portmann, B, 1992) |
| "In this report, we describe a case of Wilson's disease with pancytopenia and liver cirrhosis for over 4 years, without any specific treatment." | 1.28 | Successful pregnancy after D-penicillamine therapy in a patient with Wilson's disease. ( Chu, NS; Huang, CC; Huang, HY; Soong, YK, 1991) |
| "The prevalence and clinical features of Wilson's disease in Scotland were investigated." | 1.28 | Wilson's disease in Scotland. ( Fell, GS; McCabe, P; Park, RH; Russell, RI, 1991) |
| "Fifty-one consecutive patients with Wilson disease were evaluated between 1957 and 1989." | 1.28 | Wilson disease: clinical presentation, treatment, and survival. ( Hefter, H; Kreuzpaintner, G; Meyerrose, KW; Niederau, C; Stremmel, W; Strohmeyer, G, 1991) |
| "A newly diagnosed patient with Wilson's disease is reported in whom the only clearly pathological neurophysiological findings before treatment were abnormal electromyographic (EMG) responses evoked by transcranial magnetic brain stimulation." | 1.28 | Wilson's disease: normalisation of cortically evoked motor responses with treatment. ( Benecke, R; Britton, TC; Meyer, BU, 1991) |
| "Treatment of 9 patients with Wilson's disease was prospectively studied with evoked potentials and magnetic resonance imaging (MRI)." | 1.28 | Evoked potentials in assessment and follow-up of patients with Wilson's disease. ( Ferenci, P; Grimm, G; Madl, C; Oder, W; Prayer, L, 1990) |
| "Twenty of 320 patients with Wilson's disease initially presented with chemical and laboratory features of chronic active hepatitis, confirmed histologically in 17." | 1.28 | Prognosis of Wilsonian chronic active hepatitis. ( Scheinberg, IH; Schilsky, ML; Sternlieb, I, 1991) |
| "She was diagnosed as having Wilson's disease at 12 years of age, at which time she started taking D-penicillamine." | 1.28 | Fulminant hepatic failure during perinatal period in a pregnant woman with Wilson's disease. ( Ikematsu, H; Inaba, S; Ishibashi, H; Kudo, J; Maeda, K; Niho, Y; Shimono, N; Shirahama, M; Yamasaki, K, 1991) |
| "A 30-year-old woman with Wilson's disease was treated with low-dose D-penicillamine." | 1.28 | Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine. ( de Leeuw, PW; van den Hamer, CJ; Veen, C, 1991) |
| "From 1974 to 1988, 418 cases of Wilson's disease were treated with TCM-WM in our hospital." | 1.28 | [Clinical analysis of 418 patients with Wilson's disease in traditional Chinese medicine and Western medicine therapy]. ( Yang, R, 1990) |
| " Only after drastic reduction of the penicillamine dosage to 600 mg three times daily was there any improvement and after 11 weeks the patient was again able to walk and was discharged." | 1.28 | [Wilson's disease--critical deterioration under high-dose parenteral penicillamine therapy]. ( Bauer, J; Druschky, KF; Hilz, MJ; Neundörfer, B; Schuierer, G, 1990) |
| "Trientine proved to be an effective alternative copper chelating agent in the treatment of Wilson's disease in patients with penicillamine-induced neutropenia, thrombocytopenia, SLE, and nephrosis." | 1.28 | Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine). ( Dubois, RS; Hambidge, KM; Rodgerson, DO, 1990) |
| "We describe a patient with Wilson's disease who developed extensive penicillamine dermatopathy." | 1.28 | Penicillamine dermatopathy with lymphangiectases. A clinical, immunohistologic, and ultrastructural study. ( Goldstein, JB; Hambrick, GW; Hsu, A; McNutt, NS, 1989) |
| "In two 19-year-old girls with Wilson's disease the condition took a fulminant course, including a poor general state, marked haemolysis and ascites." | 1.28 | [Indications for liver transplantation in Wilson's disease with a fulminant course]. ( Felgenhauer, N; Hibler, A; von Clarmann, M; Zilker, TR, 1989) |
| "Elastin fibers were altered in all patients." | 1.28 | Dermal alterations in patients with Wilson's disease treated with D-penicillamine. ( Baccarani Contri, M; Galassi, G; Hayek, J; Pasquali Ronchetti, I; Quaglino, D, 1989) |
| "5 patients with proven Wilson's disease had clinical examinations and follow-up scans up to 6 years while being under penicillamine treatment." | 1.27 | [Computer tomographic studies in Wilson disease]. ( Backmund, H; Ludwig, G; Nix, WA, 1984) |
| "The best treatment for fulminant Wilson's disease is prevention by diagnosis in a pre-symptomatic stage and institution of carefully supervised life-long therapy with penicillamine." | 1.27 | Fulminant hepatic and renal failure complicating Wilson's disease. ( Kanel, GC; Rector, WG; Redeker, AG; Reynolds, TB; Uchida, T, 1984) |
| "Wilson's disease is an inherited disorder of copper accumulation that is fatal if untreated." | 1.27 | Oral zinc therapy for Wilson's disease. ( Brewer, GJ; Cossack, ZT; Hill, GM; Prasad, AS; Rabbani, P, 1983) |
| "Although Wilson's Disease is a treatable disorder, 9 of 15 cases referred with undiagnosed liver disease in the present series died in 3 to 53 days of admission." | 1.27 | Wilson's disease in childhood. Variability of clinical presentation. ( Ede, RJ; Mowat, AP; Nazer, H; Williams, R, 1983) |
| "Penicillamine disulfides have been analysed by automatic amino acid analysis." | 1.27 | Methods for assaying D-penicillamine in a clinical setting. ( Crawhall, JC, 1984) |
| "A student was diagnosed as having Wilson's disease only after the severe, intermittent inability to open his eyes led him to seek neurologic evaluation." | 1.27 | Lid-opening apraxia in Wilson's disease. ( Keane, JR, 1988) |
| "121 serum samples from 54 patients with Wilson's disease were tested for antibodies against D-penicillamine by indirect immunofluorescence (DASS-system)." | 1.27 | [The detection of antibodies against D-penicillamine. 3. Detection of antibodies against D-penicillamine in the serum of patients with Wilson's disease treated with D-penicillamine--preliminary results]. ( Storch, W; Trautmann, B, 1986) |
| "We describe a patient with Wilson's disease who presented with neurologic disease, was treated with D-penicillamine, and suffered sudden neurologic deterioration coincident with therapy." | 1.27 | Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. ( Aisen, AM; Brewer, GJ; Hill, GM; Terry, CA, 1987) |
| "The prognosis of Wilson's disease was investigated in 96 patients, in whom the disease had presented before 15 years of age and had begun between 1965 and 1983 (when D-penicillamine was widely available in Japan)." | 1.27 | Factors modifying the prognosis of Wilson's disease in childhood. ( Arima, M; Kudo, H, 1987) |
| "Being a treatable condition, Wilson's Disease, although rare, should always be thought of in patients with haemolysis, liver diseases or extrapyramidal disorders." | 1.27 | Wilson's disease revisited in the tropics. ( Chan, HL; Cheah, JS; Guan, R; Gwee, HM; Ng, HS; Seah, CS; Tan, BY; Wong, PK; Yeo, PP, 1986) |
| " This is the first case reported in which long-term administration of penicillamine was followed by the development of systemic sclerosis-like lesions." | 1.27 | Systemic sclerosis-like lesions during long-term penicillamine therapy for Wilson's disease. ( Hatoko, M; Miyagawa, S; Okuchi, T; Sakamoto, K; Yoshioka, A, 1987) |
| "Women with Wilson's disease may have severe oligomenorrhea or amenorrhea whose cause is unknown." | 1.27 | Endocrine studies of the ovulatory disturbances in Wilson's disease (hepatolenticular degeneration). ( Frydman, M; Homburg, R; Kaufman, H; Kaushansky, A, 1987) |
| "Penicillamine is the drug of choice in Wilson's disease and a therapeutic alternative in rheumatoid arthritis." | 1.27 | Penicillamine associated pulmonary hemorrhage. ( Cross, CE; Gamble, CN; Louie, S, 1986) |
| "Thirty-one patients with Wilson's disease were evaluated with detailed neurologic and medical examinations." | 1.27 | Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. ( Aisen, AM; Brewer, GJ; Gabrielsen, T; Hill, G; Kluin, K; Starosta-Rubinstein, S; Young, AB, 1987) |
| "The first case reported in Dominica of Wilson's disease is described." | 1.27 | Wilson's disease in the Commonwealth of Dominica, a case report. ( Brathwaite, A; Cooles, P; Khosla, D, 1986) |
| "A patient with Wilson's disease underwent neuropsychological and electrophysiological examination 4 months following symptom onset." | 1.27 | Neuropsychological and electrophysiological examination of a patient with Wilson's disease. ( Bornstein, RA; Ho, K; McLean, DR, 1985) |
| " The dosage depends, however, on individual factors not yet well understood, and we recommend restriction of its use to patients who do not tolerate D-penicillamine well." | 1.27 | Oral zinc sulphate for Wilson's disease. ( Bouquet, J; Degenhart, HJ; Sinaasappel, M; Van Caillie-Bertrand, M; Visser, HK, 1985) |
| "Pregnancy in patients with Wilson's disease can be successfully managed." | 1.27 | Successful pregnancy in Wilson's disease: a case report and review of the literature. ( Biller, J; Brazis, PW; Swiontoniowski, M, 1985) |
| "Untreated Wilson's disease usually causes infertility or abortion, as a result of increased intrauterine copper level." | 1.27 | [Teratogenic risk during treatment of Wilson disease]. ( Mathieu, M; Piussan, C, 1985) |
| "Oral zinc therapy in Wilson's Disease may be regarded as an alternative to D-Penicillamine treatment when this drug has to be discontinued because of side effects." | 1.27 | [Oral zinc in Wilson disease--an alternative to D-penicillamine]. ( Dormeyer, HH; Hütteroth, T; Keidl, E; Manns, M; Meyer zum Büschenfelde, KH; Ramadori, G, 1985) |
| "Twenty patients with Wilson's disease in whom severe penicillamine intolerance developed have been managed with the orally active chelating agent trientine dihydrochloride (trien)." | 1.26 | Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. ( Walshe, JM, 1982) |
| "A sibling had died in childhood with Wilson's disease." | 1.26 | Porphyria cutanea tarda complicating Wilson's disease. ( Chesney, TM; Chow, JF; Kaplan, RJ; Wardlaw, LL, 1981) |
| "In treated Wilson's disease, measurement of urinary copper excretion should be valuable in estimating the degree of removal of copper from the body during therapy." | 1.26 | Urinary copper excretion and hepatic copper concentrations in liver disease. ( Frommer, DJ, 1981) |
| "Sixty patients with Wilson's disease have been studied by means of computerized cranial tomography (CT)." | 1.26 | Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents. ( Walshe, JM; Williams, FJ, 1981) |
| "A patient with Wilson Disease presenting neurologic signs was treated with d-Penicillamine." | 1.26 | Computerized cranial tomography in Wilson disease: report of a case before and after penicillamine therapy. ( Balottin, U; Cecchini, A; Lanzi, G; Ottolini, A, 1981) |
| "Wilson's disease is an autosomal recessive disorder characterized by progressive cirrhosis or neurological signs." | 1.26 | Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report. ( Berg, M; Haslam, RH; Sass-Kortsak, A; Stout, W, 1980) |
| "All patients with Wilson disease had hepatic copper levels greater than 400 microgram/gm dry weight, whereas patients with chronic active hepatitis had levels less than 300 microgram/gm dry weight." | 1.26 | Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children. ( Grand, RJ; Perman, JA; Watkins, JB; Werlin, SL, 1979) |
| "The Leipzig Center for Wilson's Disease in the GDR is charged with the registration and diagnosis of all homozygous Wilson gene carriers, the clarification of all suspected cases, including the heterozygote test, and the co-ordination of long-term treatment." | 1.26 | [Some problems of Wilson's disease]. ( Bachmann, H; Biesold, D; Günther, K; Lössner, J; Ruchholtz, U; Storch, W; Wagner, A, 1979) |
| "Hepatolenticular degeneration (Wilson disease) is suspected by the clinical picture and confirmed by characteristic laboratory demonstration of impaired copper metabolism." | 1.26 | Computerized cranial tomography in Wilson disease. ( Grahovac, Z; Guzman, DA; Howse, DC; Nelson, RF, 1979) |
| "Three patients with Wilson's disease and initial manifestations of intravascular hemolysis also had transient elevations of hemoglobin A2." | 1.26 | Hemolytic anemia in Wilson's disease. A report of three cases with transient increase in hemoglobin A2. ( Gelehrter, TD; Majeski, EJ; Piscatelli, RL; Robitaille, GA, 1977) |
| "During childhood, Wilson's disease becomes manifest mostly in the hepatic form." | 1.26 | [Morbus Wilson--pathogenesis, diagnosis, therapy, and course (author's transl)]. ( Helwig, H; Werner, JP, 1977) |
| "Patients with symptomatic Wilson's disease had by far the highest excretion of radiocopper in all three time periods which fell after treatment, pro rata with time, as had been found for stable copper." | 1.26 | The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management. ( Gibbs, K; Hanka, R; Walshe, JM, 1978) |
| "Fifty-eight patients with Wilson's disease are reviewed, of whom 25 symptomatic patients experienced liver disease first and 28, brain disease." | 1.26 | Clinical spectrum of Wilson's disease (hepatolenticular degeneration). ( Dobyns, WB; Goldstein, NP; Gordon, H, 1979) |
| "A patient with Wilson disease, under prolonged treatment with penicillamine, developed lesions of elastosis perforans serpiginosa (EPS)." | 1.26 | Elastosis perforans serpiginosa induced by penicillamine. ( Hukill, PB; Kirsch, N, 1977) |
| "Thus, since Wilson's disease may present with chronic active hepatitis or cirrhosis with a normal ESR and without ocular or neurologic signs, it may be a more common cause of liver disease in young people than has been appreciated." | 1.26 | Wilson's disease: a common liver disorder? ( Barr, R; Hyslop, PS; Sass-Kortsak, A; Thompson, WG, 1977) |
| "The effect of pregnancy has been studied in 10 mothers with Wilson's disease." | 1.26 | Pregnancy in Wilson's disease. ( Walshe, JM, 1977) |
| "Fifty-three patients with Wilson's disease were studied with regard to ophthalmologic abnormalities." | 1.26 | The ophthalmologic manifestations of Wilson's disease. ( Goldstein, NP; Hollenhorst, RW; Wiebers, DO, 1977) |
| "This was accompanied by acute renal failure." | 1.26 | Fulminant Wilson's disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens. ( Douglas, AP; Gollan, JL; Hamlyn, AN; Sherlock, S, 1977) |
| "Forty-nine children with Wilson's disease under the age of 15 were treated with D-penicillamine for 2 to 15 years." | 1.26 | Prognosis of Wilson's disease in childhood. ( Arima, M; Kitahara, T; Suzuki, Y; Takeshita, K; Yoshino, K, 1977) |
| "Seven cases of Wilson's disease have been presented in order to illustrate many of the features which have been discussed, with emphasis on the ocular findings." | 1.26 | Wilson's disease (hepatolenticular degeneration). ( Herron, BE, 1976) |
| "Moderate thrombocytopenia was observed in three of the five bleeders and in two of the others." | 1.26 | Platelet function and coagulation in patients with Wilson disease. ( Bowie, JW; Goldstein, NP; Owen, CA, 1976) |
| "A patient with Wilson's disease presented at the age of 41 with a neurological defect and gross osteomalacia secondary to a defect of renal tubular reabsorption." | 1.25 | Effect of treatment on renal function in severe osteomalacia due to Wilson's disease. ( Monro, P, 1970) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 507 (53.03) | 18.7374 |
| 1990's | 158 (16.53) | 18.2507 |
| 2000's | 120 (12.55) | 29.6817 |
| 2010's | 127 (13.28) | 24.3611 |
| 2020's | 44 (4.60) | 2.80 |
| Authors | Studies |
|---|---|
| Jacquelet, E | 1 |
| Poujois, A | 4 |
| Pheulpin, MC | 1 |
| Demain, A | 1 |
| Tinant, N | 1 |
| Gastellier, N | 1 |
| Woimant, F | 2 |
| Kumar, S | 1 |
| Patra, BR | 1 |
| Irtaza, M | 1 |
| Rao, PK | 1 |
| Giri, S | 1 |
| Darak, H | 1 |
| Gopan, A | 1 |
| Kale, A | 1 |
| Shukla, A | 1 |
| Garrido, I | 1 |
| Marques, M | 1 |
| Liberal, R | 1 |
| Cardoso, H | 1 |
| Lopes, S | 1 |
| Macedo, G | 1 |
| Weiss, KH | 11 |
| Kruse, C | 1 |
| Manolaki, N | 2 |
| Zuin, M | 2 |
| Ferenci, P | 9 |
| van Scheppingen, D | 1 |
| Wijnberg, L | 1 |
| de Koning, CE | 1 |
| Dhawan, A | 4 |
| Despotov, K | 1 |
| Klivényi, P | 1 |
| Nagy, I | 1 |
| Pálvölgyi, A | 1 |
| Vécsei, L | 1 |
| Rajda, C | 1 |
| Abbassi, N | 1 |
| Bourrahouat, A | 1 |
| Bedoya, EC | 1 |
| Belmalih, A | 3 |
| El Hanafi, FZ | 1 |
| Bost, M | 3 |
| Sedki, A | 1 |
| Lachaux, A | 5 |
| Deme, P | 1 |
| Sheffield, A | 1 |
| Alick-Lindstrom, S | 1 |
| Daniel-Robin, T | 1 |
| Bénichou, B | 1 |
| Leboucher, C | 1 |
| Blein, C | 1 |
| Combal, JP | 1 |
| Kerkar, N | 1 |
| Rana, A | 1 |
| Atzori, L | 2 |
| Ferreli, C | 1 |
| Agosta, D | 1 |
| Mou, M | 1 |
| Coni, P | 1 |
| Lachowicz, JI | 1 |
| Pilloni, L | 1 |
| Schilsky, ML | 8 |
| Czlonkowska, A | 8 |
| Cassiman, D | 2 |
| Twardowschy, C | 1 |
| Gondim, FAA | 1 |
| Denk, G | 1 |
| Cury, RG | 1 |
| Ott, P | 2 |
| Moore, J | 1 |
| Ala, A | 3 |
| D'Inca, R | 4 |
| Couchonnal-Bedoya, E | 1 |
| D'Hollander, K | 1 |
| Dubois, N | 1 |
| Kamlin, COF | 1 |
| Berenguer, M | 1 |
| Vergara, M | 1 |
| Almohalla, C | 1 |
| Hernandez, A | 1 |
| Blanco, S | 1 |
| Testillano, M | 1 |
| Girona, E | 1 |
| Casado, M | 1 |
| García, M | 1 |
| Catalina, MV | 1 |
| Muñoz, C | 1 |
| Gutierrez, ML | 1 |
| Molina, E | 1 |
| Romero, M | 1 |
| Otero, A | 1 |
| Hernáez-Alsina, T | 1 |
| Bernal-Monterde, V | 1 |
| Lorente, S | 1 |
| Masnou, H | 1 |
| Bonet, L | 1 |
| Soto, S | 1 |
| Gisbert, C | 1 |
| Valer, MP | 1 |
| Gomez, J | 1 |
| Pacheco, G | 1 |
| Morillas, J | 1 |
| Gonzalez, M | 2 |
| Dominguez, N | 1 |
| Lazaro, M | 1 |
| Pascual, S | 1 |
| Castelló, I | 1 |
| Gonzalez, R | 1 |
| Chen, K | 2 |
| Wu, L | 2 |
| Liu, Q | 2 |
| Tan, F | 2 |
| Wang, L | 2 |
| Zhao, D | 2 |
| Fang, X | 2 |
| Liu, X | 3 |
| Liu, J | 2 |
| Han, H | 2 |
| Chen, Y | 2 |
| Qiu, Y | 1 |
| Chen, M | 1 |
| Jiang, Y | 1 |
| Qiu, X | 1 |
| Gao, L | 1 |
| Lucena-Valera, A | 1 |
| Ruz-Zafra, P | 1 |
| Ampuero, J | 1 |
| Thapa, L | 1 |
| Thapa, M | 1 |
| Bhattarai, S | 1 |
| Shrestha, AM | 1 |
| Sharma, N | 1 |
| Rai, N | 1 |
| Pokharel, M | 1 |
| Paudel, R | 1 |
| Xiong, X | 1 |
| Wei, H | 1 |
| Zhu, Y | 1 |
| Zhou, X | 2 |
| Zhao, Z | 1 |
| Chen, Q | 1 |
| Diao, SP | 1 |
| Zhuang, YS | 1 |
| Huang, YQ | 1 |
| Zhou, ZH | 1 |
| Liu, AQ | 1 |
| Hong, MF | 1 |
| Pu, Y | 1 |
| Zhang, J | 3 |
| Peng, N | 1 |
| Li, R | 1 |
| Xie, DJ | 1 |
| Zhang, RX | 1 |
| Sun, LT | 1 |
| Wang, JL | 1 |
| Ye, H | 1 |
| Mohr, I | 2 |
| Pfeiffenberger, J | 4 |
| Eker, E | 1 |
| Merle, U | 4 |
| Antos, A | 1 |
| Członkowska, A | 9 |
| Smolinski, L | 1 |
| Bembenek, J | 1 |
| Przybyłkowski, A | 3 |
| Skowrońska, M | 1 |
| Kurkowska-Jastrzębska, I | 1 |
| Litwin, T | 10 |
| Mbala, J | 1 |
| Guillaud, O | 2 |
| Couchonnal Bedoya, E | 1 |
| Shimizu, N | 5 |
| Oe, S | 1 |
| Honma, Y | 1 |
| Yabuki, K | 1 |
| Morino, K | 1 |
| Kumamoto, K | 1 |
| Hayashi, T | 1 |
| Kusanaga, M | 1 |
| Ogino, N | 1 |
| Minami, S | 1 |
| Shibata, M | 1 |
| Abe, S | 1 |
| Harada, M | 2 |
| Khurana, S | 1 |
| Gupta, PC | 1 |
| Ram, J | 1 |
| Santos, BC | 2 |
| Guedes, LR | 1 |
| Faria, LC | 2 |
| Couto, CA | 2 |
| Rozina, T | 1 |
| Fastovets, S | 1 |
| Lee, O | 1 |
| Kuchieva, A | 1 |
| Bulanov, N | 1 |
| Moiseev, S | 1 |
| Masełbas, W | 1 |
| Niewada, M | 2 |
| Kalita, J | 4 |
| Kumar, V | 4 |
| Misra, UK | 4 |
| Parashar, V | 1 |
| Ranjan, A | 3 |
| Borrego García, E | 1 |
| Hernández García, E | 1 |
| Caba Molina, M | 1 |
| Navas-Parejo Casado, AM | 1 |
| Antczak-Kowalska, M | 1 |
| Nehring, P | 1 |
| Xiao, X | 2 |
| Li, XH | 4 |
| Qin, HL | 1 |
| Pu, XY | 2 |
| Chen, DB | 4 |
| Wu, C | 3 |
| Feng, L | 3 |
| Liang, XL | 3 |
| Tampaki, M | 1 |
| Gatselis, NK | 1 |
| Savvanis, S | 1 |
| Koullias, E | 1 |
| Saitis, A | 1 |
| Gabeta, S | 1 |
| Deutsch, M | 1 |
| Manesis, E | 1 |
| Dalekos, GN | 1 |
| Koskinas, J | 1 |
| Yuan, XZ | 1 |
| Yang, RM | 4 |
| Wang, XP | 3 |
| Xiao, L | 1 |
| Yang, W | 2 |
| Yu, Z | 1 |
| Sheu Song, J | 1 |
| Schmidt, B | 1 |
| Corey, K | 1 |
| Hawryluk, EB | 1 |
| Proost, R | 1 |
| Levtchenko, E | 1 |
| Morava-Kozicz, E | 1 |
| Neirynck, J | 1 |
| Witters, P | 2 |
| Zhu, XQ | 1 |
| Li, LY | 1 |
| Yang, WM | 1 |
| Wang, Y | 2 |
| Medici, V | 7 |
| Sarode, GV | 1 |
| Napoli, E | 1 |
| Song, GY | 1 |
| Shibata, NM | 4 |
| Guimarães, AO | 1 |
| Mordaunt, CE | 2 |
| Kieffer, DA | 3 |
| Mazi, TA | 1 |
| LaSalle, JM | 4 |
| Giulivi, C | 1 |
| Shi, W | 1 |
| Huang, X | 1 |
| Zhang, S | 1 |
| Jiao, Y | 1 |
| Janka, SS | 1 |
| Bätzing, J | 1 |
| Laux, G | 1 |
| Holstiege, J | 1 |
| Wahler, S | 1 |
| Mehrabi, A | 1 |
| Mieth, M | 1 |
| Zhou, XX | 1 |
| Chanpong, A | 1 |
| Roseira, J | 1 |
| Lopes, R | 1 |
| Silva, MJ | 1 |
| Vieira, AM | 1 |
| Sampaio, M | 1 |
| Calinas, F | 1 |
| Samanci, B | 1 |
| Sahin, E | 1 |
| Bilgic, B | 1 |
| Tufekcioglu, Z | 1 |
| Gurvit, H | 1 |
| Emre, M | 1 |
| Demir, K | 1 |
| Hanagasi, HA | 1 |
| Xiao, QQ | 1 |
| Fan, JG | 1 |
| Ghosh, CK | 1 |
| Miah, SA | 1 |
| Hasan, MA | 1 |
| Chowdhury, M | 1 |
| Miah, AR | 1 |
| Couchonnal, E | 1 |
| Lion-François, L | 2 |
| Habes, D | 1 |
| Debray, D | 2 |
| Lamireau, T | 2 |
| Broué, P | 1 |
| Fabre, A | 1 |
| Vanlemmens, C | 1 |
| Sobesky, R | 1 |
| Gottrand, F | 2 |
| Bridoux-Henno, L | 1 |
| Dumortier, J | 1 |
| Jacquemin, E | 1 |
| Brunet, AS | 2 |
| Mussi, MCL | 1 |
| Nardelli, MJ | 1 |
| Abreu, ES | 1 |
| Osório, FMF | 1 |
| Cançado, GGL | 1 |
| Ferrari, TCA | 1 |
| Dusek, P | 1 |
| Skoloudik, D | 1 |
| Maskova, J | 1 |
| Huelnhagen, T | 1 |
| Bruha, R | 3 |
| Zahorakova, D | 1 |
| Niendorf, T | 1 |
| Ruzicka, E | 1 |
| Schneider, SA | 1 |
| Wuerfel, J | 1 |
| Thwaites, PA | 1 |
| Khan, SA | 1 |
| Asadi, K | 1 |
| Angus, PW | 1 |
| Ashida, M | 1 |
| Okubo, Y | 1 |
| Iwanaga, A | 1 |
| Utani, A | 1 |
| Tai, CS | 1 |
| Wu, JF | 1 |
| Chen, HL | 1 |
| Hsu, HY | 1 |
| Chang, MH | 1 |
| Ni, YH | 1 |
| Rukunuzzaman, M | 2 |
| Karim, AB | 1 |
| Nurullah, M | 1 |
| Sultana, F | 1 |
| Mazumder, MW | 2 |
| Rahman, MA | 1 |
| Billah, SB | 1 |
| Begum, F | 1 |
| Oliullah, M | 1 |
| Avan, A | 1 |
| de Bie, RMA | 1 |
| Hoogenraad, TU | 9 |
| Wiernicka, A | 2 |
| Dądalski, M | 2 |
| Jańczyk, W | 2 |
| Kamińska, D | 1 |
| Naorniakowska, M | 1 |
| Hüsing-Kabar, A | 1 |
| Schmidt, H | 2 |
| Socha, P | 2 |
| Hachmöller, O | 1 |
| Zibert, A | 2 |
| Zischka, H | 1 |
| Sperling, M | 1 |
| Groba, SR | 1 |
| Grünewald, I | 1 |
| Wardelmann, E | 1 |
| Schmidt, HH | 4 |
| Karst, U | 1 |
| Pfister, ED | 1 |
| Smirnova, J | 1 |
| Kabin, E | 1 |
| Järving, I | 1 |
| Bragina, O | 1 |
| Tõugu, V | 1 |
| Plitz, T | 1 |
| Palumaa, P | 1 |
| Amano, T | 1 |
| Matsubara, T | 1 |
| Nishida, T | 1 |
| Shimakoshi, H | 1 |
| Shimoda, A | 1 |
| Sugimoto, A | 1 |
| Takahashi, K | 1 |
| Mukai, K | 1 |
| Yamamoto, M | 1 |
| Hayashi, S | 1 |
| Nakajima, S | 1 |
| Fukui, K | 1 |
| Inada, M | 1 |
| Gupta, P | 1 |
| Choksi, M | 1 |
| Goel, A | 1 |
| Zachariah, U | 1 |
| Sajith, KG | 1 |
| Ramachandran, J | 1 |
| Chandy, G | 1 |
| Kurian, G | 1 |
| Rebekah, G | 1 |
| Eapen, CE | 1 |
| Wan, Y | 1 |
| Jiang, X | 1 |
| Lin, X | 1 |
| Gotthardt, DN | 3 |
| Olson, K | 2 |
| Wei, D | 1 |
| Cooper, S | 1 |
| Wan, YY | 1 |
| Ali, MR | 1 |
| Wattacheril, J | 1 |
| Shea, PR | 1 |
| Mohammad, S | 1 |
| Behling, C | 1 |
| Aggarwal, V | 1 |
| Wilson, LA | 1 |
| Yates, KP | 1 |
| Ito, J | 1 |
| Fishbein, M | 1 |
| Stong, N | 1 |
| Lavine, JE | 1 |
| Goldstein, DB | 1 |
| Montesu, MA | 1 |
| Onnis, G | 1 |
| Gunnella, S | 1 |
| Lissia, A | 1 |
| Satta, R | 1 |
| Zhang, B | 1 |
| Cao, S | 1 |
| Huang, W | 1 |
| Liu, N | 1 |
| Damsgaard, J | 1 |
| Larsen, FS | 1 |
| Ytting, H | 1 |
| Capone, K | 1 |
| Azzam, RK | 1 |
| Rao, R | 1 |
| Shu, S | 1 |
| Han, YZ | 1 |
| Chiu, YJ | 1 |
| Han, YS | 1 |
| Asada, H | 1 |
| Kojima, M | 1 |
| Nagahara, T | 1 |
| Goto-Koshino, Y | 1 |
| Chambers, JK | 1 |
| Nakagawa, T | 1 |
| Yokoyama, N | 1 |
| Uchida, K | 1 |
| Tsujimoto, H | 1 |
| Ohno, K | 1 |
| Vieira Barbosa, J | 1 |
| Fraga, M | 1 |
| Saldarriaga, J | 1 |
| Hiroz, P | 1 |
| Giostra, E | 2 |
| Sempoux, C | 1 |
| Moradpour, D | 1 |
| Gerosa, C | 1 |
| Fanni, D | 2 |
| Congiu, T | 1 |
| Piras, M | 1 |
| Cau, F | 1 |
| Moi, M | 1 |
| Faa, G | 2 |
| Lohse, CM | 1 |
| Gotthardt, D | 2 |
| Rupp, C | 1 |
| Weiler, M | 1 |
| Teufel, U | 2 |
| Gauss, A | 1 |
| Goel, S | 1 |
| Sahay, P | 1 |
| Maharana, PK | 1 |
| Titiyal, JS | 1 |
| Helmy, H | 1 |
| Fahmy, M | 2 |
| Abdel Aziz, H | 1 |
| Ghobrial, C | 1 |
| Abdel Hameed, N | 1 |
| El-Karaksy, H | 2 |
| Kumar, N | 2 |
| Kumar, D | 1 |
| Appenzeller-Herzog, C | 1 |
| Mathes, T | 1 |
| Heeres, MLS | 1 |
| Houwen, RHJ | 1 |
| Ewald, H | 1 |
| Kang, S | 1 |
| Cho, MH | 1 |
| Hyun, H | 1 |
| Kim, JH | 1 |
| Ko, JS | 1 |
| Kang, HG | 1 |
| Cheong, HI | 1 |
| Kim, WS | 1 |
| Moon, KC | 2 |
| Ha, IS | 1 |
| Bersier, M | 1 |
| Pache, I | 1 |
| Idrissi, ML | 1 |
| Babakhoya, A | 1 |
| Khabbache, K | 1 |
| Souilmi, F | 1 |
| Benmiloud, S | 1 |
| Abourrazak, S | 1 |
| Chaouki, S | 1 |
| Atmani, S | 1 |
| Bouharrou, A | 1 |
| Hida, M | 1 |
| Thurik, F | 1 |
| Schäfer, M | 2 |
| Wiegand, F | 1 |
| Ferenci-Foerster, D | 1 |
| Maieron, A | 1 |
| Stauber, R | 1 |
| Zoller, H | 1 |
| Reuner, U | 2 |
| Hefter, H | 9 |
| Trocello, JM | 2 |
| Houwen, RH | 3 |
| Stremmel, W | 11 |
| Bruguera-Àvila, N | 1 |
| Sánchez-Martínez, E | 1 |
| Garcia-Olivé, I | 1 |
| Pérez-Ochoa, JF | 1 |
| Martínez-Barenys, C | 1 |
| Ruiz-Manzano, J | 1 |
| Kaler, SG | 1 |
| Hainmann, I | 1 |
| Woltering, T | 1 |
| Greiner, P | 1 |
| Nakamura, L | 1 |
| Podskarbi, T | 1 |
| Oldenburg, J | 1 |
| Zieger, B | 1 |
| Purchase, R | 1 |
| Avsar, Y | 1 |
| Mareček, Z | 5 |
| Jhunjhunwala, K | 1 |
| Prashanth, DK | 1 |
| Netravathi, M | 1 |
| Nagaraju, BC | 1 |
| Pal, PK | 1 |
| Choquette, M | 1 |
| Xu, SQ | 1 |
| Li, XF | 1 |
| Zhu, HY | 1 |
| Liu, Y | 1 |
| Fang, F | 1 |
| Chen, L | 1 |
| El Balkhi, S | 1 |
| Guichard, JP | 1 |
| Poupon, J | 1 |
| Chappuis, P | 1 |
| Feillet, F | 1 |
| Reynolds, HV | 1 |
| Talekar, CR | 1 |
| Bellapart, JB | 1 |
| Leggett, BA | 1 |
| Boots, RJ | 1 |
| Kanwar, P | 1 |
| Kowdley, KV | 1 |
| Dzieżyc, K | 3 |
| Karliński, M | 2 |
| Chandra, S | 1 |
| Kumar, B | 1 |
| Gromadzka, G | 1 |
| Grażyna, G | 1 |
| Karpińska, A | 1 |
| Agata, K | 1 |
| Adam, P | 1 |
| Tomasz, L | 1 |
| Wierzchowska-Ciok, A | 1 |
| Agata, WC | 1 |
| Karolina, D | 1 |
| Chabik, G | 2 |
| Grzegorz, C | 1 |
| Anna, C | 1 |
| Neri, I | 2 |
| Gurioli, C | 1 |
| Raggi, MA | 2 |
| Saracino, MA | 2 |
| Morganti, E | 2 |
| Bugamelli, F | 2 |
| de Ponti, F | 1 |
| Vaccari, S | 1 |
| Patrizi, A | 2 |
| Balestri, R | 2 |
| Czerska, M | 1 |
| Mitra, S | 1 |
| Ray, AK | 1 |
| Roy, S | 1 |
| El Raziky, MS | 1 |
| Ali, A | 1 |
| El Shahawy, A | 1 |
| Hamdy, MM | 1 |
| Hellriegel, S | 1 |
| Bertsch, HP | 1 |
| Emmert, S | 1 |
| Schön, MP | 1 |
| Haenssle, HA | 1 |
| Ingen-Housz-Oro, S | 1 |
| Grootenboer-Mignot, S | 1 |
| Ortonne, N | 1 |
| Nahon, S | 1 |
| Horvath, J | 2 |
| Bernardeschi, C | 1 |
| Laffitte, E | 1 |
| André, C | 1 |
| Chollet-Martin, S | 1 |
| Wolkenstein, P | 1 |
| Chosidow, O | 1 |
| Karim, MB | 2 |
| Yapali, S | 1 |
| Turan, I | 1 |
| Ozutemiz, O | 1 |
| Tekesin, O | 1 |
| Ranucci, G | 4 |
| Di Dato, F | 2 |
| Leone, F | 1 |
| Vajro, P | 4 |
| Spagnuolo, MI | 1 |
| Iorio, R | 6 |
| Berger, B | 1 |
| Mader, I | 1 |
| Damjanovic, K | 1 |
| Niesen, WD | 1 |
| Stich, O | 1 |
| Zhang, JW | 1 |
| Liu, JX | 1 |
| Hou, HM | 1 |
| Wei, LT | 1 |
| Krstić, D | 1 |
| Antonijević, J | 1 |
| Špirić, Ž | 1 |
| Ibáñez-Samaniego, L | 1 |
| Ochoa-Palominos, A | 1 |
| Catalina-Rodríguez, MV | 1 |
| Salcedo-Plaza, M | 1 |
| Clemente-Ricote, G | 1 |
| Xu, J | 1 |
| Jiang, H | 1 |
| Li, J | 1 |
| Cheng, KK | 1 |
| Dong, J | 1 |
| Chen, Z | 1 |
| Seessle, J | 2 |
| Gohdes, A | 1 |
| Schaefer, M | 2 |
| Weber, L | 1 |
| Santiago, R | 1 |
| Bridoux, L | 1 |
| Morali, A | 1 |
| Lapeyre, D | 1 |
| Li, WJ | 1 |
| Chen, C | 1 |
| You, ZF | 1 |
| Sintusek, P | 1 |
| Lee, Y | 1 |
| Lee, ST | 1 |
| Cho, H | 1 |
| Dubbioso, R | 1 |
| Esposito, M | 1 |
| Topa, A | 1 |
| Quarantelli, M | 1 |
| Matarazzo, M | 1 |
| Santoro, L | 1 |
| Manganelli, F | 1 |
| Chandhok, G | 1 |
| Aggarwal, A | 1 |
| Bhatt, M | 1 |
| Ignatova, TM | 3 |
| Arion, EA | 1 |
| Balashova, MS | 1 |
| Rozina, TP | 2 |
| Hafberg, ET | 1 |
| Dathe, K | 1 |
| Beck, E | 1 |
| Schaefer, C | 1 |
| Ramírez-Bellver, JL | 1 |
| Bernárdez, C | 1 |
| Macías, E | 1 |
| Moya, L | 1 |
| Molina-Ruiz, AM | 1 |
| Cannata Ortiz, P | 1 |
| Requena, L | 1 |
| Chima, H | 1 |
| Kim, K | 3 |
| Canovas, A | 1 |
| Medrano, JF | 1 |
| Islas-Trejo, AD | 1 |
| Kharbanda, KK | 2 |
| Su, RJ | 1 |
| Islam, MS | 2 |
| Syed, R | 1 |
| Keen, CL | 1 |
| Miller, AY | 1 |
| Rutledge, JC | 1 |
| Halsted, CH | 2 |
| Teive, HA | 2 |
| Barbosa, ER | 6 |
| Lees, AJ | 2 |
| Zhang, D | 1 |
| Tarnacka, B | 3 |
| Szeszkowski, W | 1 |
| Golebiowski, M | 1 |
| Kleinig, TJ | 1 |
| Harley, H | 1 |
| Thompson, PD | 2 |
| De Souza Hobaika, AB | 1 |
| Zhuang, XH | 1 |
| Mo, Y | 1 |
| Jiang, XY | 1 |
| Chen, SM | 1 |
| Brewer, GJ | 14 |
| Thapa, R | 1 |
| Ghosh, A | 1 |
| Kotalová, R | 1 |
| Jirsa, M | 1 |
| Vávrová, V | 1 |
| Vrábelová-Pouchlá, S | 1 |
| Macek, M | 1 |
| Hanukoglu, A | 1 |
| Curiel, B | 1 |
| Berkowitz, D | 1 |
| Levine, A | 1 |
| Sack, J | 1 |
| Lorberboym, M | 1 |
| Popadic, S | 1 |
| Skiljevic, D | 1 |
| Medenica, L | 1 |
| Nikolopoulou, G | 1 |
| Daikos, GL | 1 |
| Panagiotakaki, E | 1 |
| Tzetis, M | 1 |
| Roma, E | 1 |
| Kanavakis, E | 1 |
| Syriopoulou, VP | 1 |
| Zhang, Y | 2 |
| Yang, X | 1 |
| Tang, X | 1 |
| Luo, H | 1 |
| Lei, J | 1 |
| Palumbo, E | 1 |
| El Khattabi, A | 1 |
| Seddik, H | 1 |
| Fatihi, J | 1 |
| Salaheddine, H | 1 |
| Badaoui, M | 1 |
| Amézyane, T | 1 |
| Mahassine, F | 1 |
| Ohayon, V | 1 |
| Kazemi, K | 1 |
| Geramizadeh, B | 1 |
| Nikeghbalian, S | 1 |
| Salahi, H | 1 |
| Bahador, A | 1 |
| Reza Nejatollahi, SM | 1 |
| Dehghani, SM | 1 |
| Dehghani, M | 1 |
| Kakaei, F | 1 |
| Malek-Hosseini, SA | 1 |
| Seo, JY | 1 |
| Kim, SY | 1 |
| Choi, WC | 1 |
| Aagaard, NK | 1 |
| Thomsen, KL | 1 |
| Holland-Fischer, P | 1 |
| Jørgensen, SP | 1 |
| Svetel, M | 3 |
| Pekmezović, T | 1 |
| Petrović, I | 2 |
| Tomić, A | 1 |
| Kresojević, N | 1 |
| Jesić, R | 1 |
| Kazić, S | 1 |
| Raicević, R | 1 |
| Stefanović, D | 1 |
| Delibasić, N | 1 |
| Zivanović, D | 1 |
| Dordević, M | 1 |
| Kostić, VS | 3 |
| da Costa, Mdo D | 1 |
| Spitz, M | 1 |
| Bacheschi, LA | 1 |
| Leite, CC | 1 |
| Lucato, LT | 1 |
| Cocco, GA | 1 |
| Loudianos, G | 5 |
| Pes, GM | 1 |
| Tolu, F | 1 |
| Lepori, MB | 2 |
| Barrocu, M | 1 |
| Sechi, GP | 1 |
| Dastych, M | 1 |
| Procházková, D | 1 |
| Pokorný, A | 1 |
| Zdrazil, L | 1 |
| Seto, WK | 1 |
| Mak, CM | 1 |
| But, D | 1 |
| Hung, I | 1 |
| Lam, CW | 1 |
| Tam, S | 1 |
| Yuen, MF | 1 |
| Lai, CL | 1 |
| Linn, FH | 1 |
| van Hattum, J | 5 |
| van der Kleij, S | 1 |
| van Erpecum, KJ | 1 |
| Schilsky, M | 2 |
| Lowette, KF | 1 |
| Desmet, K | 1 |
| Laleman, W | 1 |
| Verslype, C | 1 |
| Nevens, F | 1 |
| Fevery, J | 2 |
| Cassiman, DM | 1 |
| Lu, Y | 1 |
| Liu, XQ | 1 |
| Wang, XH | 1 |
| Wang, JS | 1 |
| Cope-Yokoyama, S | 1 |
| Finegold, MJ | 1 |
| Sturniolo, GC | 8 |
| Mescoli, C | 1 |
| Rugge, M | 1 |
| Tovaru, S | 1 |
| Parlatescu, I | 1 |
| Dumitriu, AS | 1 |
| Bucur, A | 1 |
| Kaplan, I | 1 |
| Al Mohizea, S | 1 |
| Xie, XW | 1 |
| Li, T | 2 |
| Benbir, G | 1 |
| Gunduz, A | 1 |
| Ertan, S | 1 |
| Ozkara, C | 1 |
| Pospisilova, L | 1 |
| Nevsimalova, S | 2 |
| Vitek, L | 1 |
| Martasek, P | 1 |
| Nevoral, J | 1 |
| Petrtyl, J | 1 |
| Urbanek, P | 1 |
| Jiraskova, A | 1 |
| Nicastro, E | 1 |
| Vegnente, A | 3 |
| Fujiwara, J | 1 |
| Ohnishi, S | 2 |
| Sato, M | 1 |
| Kodama, H | 2 |
| Kohsaka, T | 1 |
| Inui, A | 1 |
| Fujisawa, T | 1 |
| Tamai, H | 2 |
| Ida, S | 1 |
| Itoh, S | 2 |
| Ito, M | 1 |
| Horiike, N | 1 |
| Yoshino, M | 2 |
| Aoki, T | 3 |
| Sotgia, S | 2 |
| Carru, C | 2 |
| Pinna, GA | 1 |
| Deiana, L | 2 |
| Zinellu, A | 2 |
| Oosthuizen, NM | 1 |
| Pinna, AL | 1 |
| Pau, M | 1 |
| Aste, N | 1 |
| Bem, RS | 1 |
| Muzzillo, DA | 1 |
| Deguti, MM | 3 |
| Werneck, LC | 1 |
| Walshe, JM | 46 |
| Peña-Quintana, L | 1 |
| García-Luzardo, MR | 1 |
| García-Villarreal, L | 1 |
| Arias-Santos, MD | 1 |
| Garay-Sánchez, P | 1 |
| Santana, A | 1 |
| González-Santana, D | 1 |
| Ramos-Varela, JC | 1 |
| Rial-González, R | 1 |
| Tugores, A | 1 |
| Sinha, R | 1 |
| Akhtar, S | 1 |
| Sawamura, R | 1 |
| Ottoboni-Brunaldi, M | 1 |
| Ramalho, LN | 1 |
| Zucoloto, S | 1 |
| Balancin, ML | 1 |
| Fernandes, MI | 1 |
| El-Raziky, MS | 1 |
| El-Hawary, M | 1 |
| El-Sayed, R | 1 |
| El-Koofy, N | 1 |
| El-Mougy, F | 1 |
| El-Hennawy, A | 1 |
| El-Shabrawi, M | 1 |
| Huang, L | 1 |
| Yu, X | 2 |
| Jiao, X | 1 |
| Vieira, J | 1 |
| Oliveira, PV | 1 |
| Juliano, Y | 1 |
| Warde, KR | 1 |
| Carrilho, FJ | 1 |
| Cancado, EL | 2 |
| Wagner, S | 1 |
| Broussolle, E | 2 |
| Des Portes, V | 1 |
| Gucev, ZS | 1 |
| Pop-Jordanova, N | 1 |
| Calovska, V | 1 |
| Tasic, V | 1 |
| Slavevska, N | 1 |
| Laban, N | 1 |
| Noli, MC | 1 |
| Delangle, P | 1 |
| Mintz, E | 1 |
| Dell'era, L | 1 |
| Boati, E | 1 |
| Nebbia, G | 1 |
| Corona, F | 1 |
| Noureen, N | 1 |
| Rana, MT | 1 |
| Lozano Herrero, J | 1 |
| Muñoz Bertrán, E | 1 |
| Ortega González, I | 1 |
| Gómez Espín, R | 1 |
| López Espín, MI | 1 |
| Lin, XP | 1 |
| Zhang, W | 1 |
| Li, FR | 1 |
| Moores, A | 1 |
| Fox, S | 1 |
| Lang, A | 1 |
| Hirschfield, GM | 1 |
| Ishida, S | 1 |
| Doi, Y | 1 |
| Yamane, K | 1 |
| Sugino, M | 1 |
| Kimura, F | 1 |
| Hanafusa, T | 1 |
| Fukui, H | 1 |
| Fenu, M | 1 |
| Liggi, M | 1 |
| Demelia, E | 1 |
| Sorbello, O | 2 |
| Civolani, A | 2 |
| Demelia, L | 2 |
| Coates, RA | 1 |
| Woods, R | 1 |
| Liu, S | 1 |
| Engelberg, JA | 1 |
| Devaraj, S | 1 |
| Török, NJ | 1 |
| Jiang, JX | 1 |
| Havel, PJ | 1 |
| Lönnerdal, B | 1 |
| Sini, M | 1 |
| Sanna, F | 1 |
| Battolu, F | 1 |
| Tan, SS | 1 |
| Latif, SA | 1 |
| Poh, WY | 1 |
| Verma, R | 1 |
| Lalla, R | 1 |
| Patil, TB | 1 |
| Cannistraci, C | 1 |
| Fukuoka, N | 1 |
| Morita, S | 1 |
| Hamatani, S | 1 |
| Okada, H | 1 |
| Kondoh, M | 1 |
| Imai, T | 1 |
| Mucenic, M | 1 |
| Tietge, UJ | 1 |
| Pandit, A | 2 |
| Bavdekar, A | 1 |
| Bhave, S | 2 |
| Santander Vaquero, C | 1 |
| Maier, KP | 1 |
| Pérez-Aguilar, F | 1 |
| Rodríguez Fariña, E | 1 |
| Tremosa Llurba, G | 1 |
| Xiol Quingles, X | 2 |
| Lores Obradors, A | 1 |
| Castellote Alonso, J | 2 |
| Gornals Soler, JB | 1 |
| López Núñez, C | 1 |
| Sproull, M | 1 |
| Brechbiel, M | 1 |
| Camphausen, K | 1 |
| Manz, T | 1 |
| Ochs, A | 1 |
| Bisse, E | 1 |
| Strey, C | 1 |
| Grotz, W | 1 |
| Farinati, F | 2 |
| Cardin, R | 2 |
| Naccarato, R | 3 |
| Rahman, S | 1 |
| Siddiqui, NI | 1 |
| Paul, GK | 1 |
| Sarker, CB | 1 |
| Rahman, KM | 1 |
| Rakhimova, OIu | 1 |
| El-Youssef, M | 1 |
| FISTER, WP | 1 |
| BOULDING, JE | 1 |
| BAKER, RA | 1 |
| OSBORN, SB | 4 |
| SEVEN, MJ | 1 |
| KLIMAN, B | 1 |
| PETERSON, RE | 1 |
| MONNET, P | 1 |
| GAUTHIER, J | 1 |
| COTTE, J | 1 |
| VALLON, JJ | 1 |
| NICOLAS, A | 1 |
| LANGE, J | 3 |
| HAGER, H | 1 |
| BLEHOVA, B | 3 |
| HEYROVSKY, L | 1 |
| GOLDSTEIN, NP | 23 |
| RANDALL, RV | 13 |
| GROSS, JB | 13 |
| ROSEVEAR, JW | 3 |
| McGUCKIN, WF | 5 |
| MICHIELS, J | 1 |
| LATERRE, C | 1 |
| DUMOULIN, D | 1 |
| NISHI, N | 1 |
| IIZUKA, R | 1 |
| FUJII, H | 1 |
| KAWAMURA, K | 1 |
| TAKAHATA, N | 1 |
| PIERI, J | 1 |
| HEYROVSKY, A | 6 |
| NEBUDOVA, J | 2 |
| VOTAVA, Z | 1 |
| HARTLEY, BS | 1 |
| WILLIAMSON, CI | 1 |
| BLAKEY, CL | 1 |
| LITTLE, SC | 1 |
| DEMPSEY, H | 1 |
| BRANSCOMB, BV | 1 |
| BUTTERWORTH, CE | 1 |
| PITTMAN, JA | 1 |
| TU, JB | 5 |
| HUNG, TP | 2 |
| LIN, TY | 1 |
| BLACKWELL, RQ | 6 |
| WATTEN, RH | 3 |
| COOPER, WC | 3 |
| HERRING, VG | 1 |
| KLATSKIN, G | 1 |
| BRANDT, IK | 2 |
| BISIACH, E | 1 |
| BOUDIN, G | 5 |
| PEPIN, B | 8 |
| LAURAS, A | 1 |
| BARRAINE, R | 3 |
| ADAMS, DA | 1 |
| GOLDMAN, R | 1 |
| MAXWELL, MH | 1 |
| LATTA, H | 1 |
| DENNY-BROWN, D | 1 |
| WEINER, C | 1 |
| AKSOY, M | 2 |
| BIYAL, F | 1 |
| SECER, F | 1 |
| CAKIRGOEZ, C | 1 |
| CETINGIL, AI | 1 |
| SCHEINBERG, IH | 18 |
| BUMBALO, TS | 1 |
| STAUB, RU | 1 |
| VILLANUEVA, OQ | 1 |
| RAVIN, HA | 1 |
| FISHER, MM | 1 |
| SHERLOCK, S | 6 |
| WARREN, CB | 1 |
| BROUGHTON, PM | 1 |
| STERNLIEB, I | 23 |
| PETIT, H | 2 |
| LISA, L | 1 |
| ROESSLER, M | 1 |
| OZKAN, E | 1 |
| PRIFTI, J | 1 |
| TAG, T | 1 |
| EKMEKCI, A | 1 |
| JANSEN, EG | 1 |
| BEN-GERSHOM, E | 1 |
| RICHMOND, J | 1 |
| ROSENOER, VM | 2 |
| TOMPSETT, SL | 1 |
| DRAPER, I | 1 |
| SIMPSON, JA | 1 |
| CHEN, YH | 1 |
| HEINRICH, F | 1 |
| KALTENBACH, M | 1 |
| HOU, TY | 1 |
| HIRSCHMAN, SZ | 1 |
| ISSELBACHER, KJ | 1 |
| RIX, J | 1 |
| LAURANCE, BM | 1 |
| LITIN, RB | 1 |
| POWER, MH | 1 |
| DIESSNER, GR | 1 |
| SEIGNETTE, WT | 1 |
| HAANEN, CA | 1 |
| JANSEN, AP | 1 |
| MAJOOR, CL | 1 |
| Campos Franco, J | 1 |
| Domínguez Santalla, MJ | 1 |
| Tomé Martínez de Rituerto, S | 1 |
| Otero Antón, E | 1 |
| González Quintela, A | 1 |
| Türk-Börü, U | 1 |
| Kocer, A | 1 |
| Alp, R | 1 |
| Gümüş, M | 2 |
| Nagata, Y | 1 |
| Uto, H | 1 |
| Hasuike, S | 1 |
| Ido, A | 1 |
| Hayashi, K | 1 |
| Eto, T | 1 |
| Hamakawa, T | 1 |
| Tanaka, K | 2 |
| Tsubouchi, H | 1 |
| Tang, MB | 1 |
| Chin, TM | 1 |
| Yap, CK | 1 |
| Ng, SK | 1 |
| Yalaz, M | 1 |
| Aydogdu, S | 1 |
| Ozgenc, F | 1 |
| Akisu, M | 1 |
| Kultursay, N | 1 |
| Yagci, RV | 1 |
| Li, M | 1 |
| Zhang, YH | 1 |
| Qin, J | 1 |
| Szalay, F | 2 |
| Jabłońska-Kaszewska, I | 1 |
| Drobińska-Jurowiecka, A | 1 |
| Dabrowska, E | 1 |
| Trocha, H | 1 |
| Pinter, R | 1 |
| Hogge, WA | 1 |
| McPherson, E | 1 |
| Nagy, J | 1 |
| Vincze, Z | 1 |
| Folhoffer, A | 1 |
| Horváth, A | 1 |
| Csák, T | 1 |
| Zelkó, R | 1 |
| Page, RA | 1 |
| Davie, CA | 1 |
| MacManus, D | 1 |
| Miszkiel, KA | 1 |
| Miller, DH | 1 |
| Schapira, AH | 1 |
| Komal Kumar, RN | 1 |
| Patil, SA | 1 |
| Taly, AB | 8 |
| Nirmala, M | 1 |
| Sinha, S | 8 |
| Arunodaya, GR | 6 |
| Vorob'ev, AI | 2 |
| Lukina, EA | 1 |
| Sysoeva, EP | 1 |
| Levina, AA | 1 |
| Solov'eva, TI | 1 |
| D'Ambrosi, M | 1 |
| Marcellini, M | 1 |
| Barbera, C | 1 |
| Maggiore, G | 2 |
| Zancan, L | 2 |
| Giacchino, R | 3 |
| Marazzi, MG | 2 |
| Francavilla, R | 1 |
| Michielutti, F | 1 |
| Resti, M | 1 |
| Frediani, T | 1 |
| Pastore, M | 1 |
| Mazzarella, G | 1 |
| Fusco, G | 1 |
| Cirillo, F | 1 |
| Hayashi, H | 4 |
| Suzuki, R | 1 |
| Wakusawa, S | 2 |
| Bécuwe, C | 1 |
| Dalle, S | 1 |
| Ronger-Savlé, S | 1 |
| Skowron, F | 1 |
| Balme, B | 1 |
| Kanitakis, J | 1 |
| Thomas, L | 1 |
| Macintyre, G | 1 |
| Gutfreund, KS | 1 |
| Martin, WR | 1 |
| Camicioli, R | 1 |
| Cox, DW | 1 |
| Gajda, J | 3 |
| Rodo, M | 3 |
| Chan, KH | 1 |
| Cheung, RT | 1 |
| Au-Yeung, KM | 1 |
| Mak, W | 1 |
| Cheng, TS | 1 |
| Ho, SL | 1 |
| Choi, HJ | 1 |
| Lee, DK | 1 |
| Chang, SE | 1 |
| Lee, MW | 1 |
| Choi, JH | 1 |
| Koh, JK | 1 |
| Prashanth, LK | 4 |
| Ravishankar, S | 3 |
| Vasudev, MK | 3 |
| Swamy, HS | 3 |
| Sakaida, I | 1 |
| Kawaguchi, K | 1 |
| Kimura, T | 1 |
| Tamura, F | 1 |
| Okita, K | 1 |
| Kobayashi, S | 1 |
| Inuzuka, R | 1 |
| Mori, Y | 1 |
| Yanagawa, Y | 1 |
| Noble, JA | 1 |
| Davis, DM | 1 |
| Otley, CC | 1 |
| Witman, PM | 1 |
| Shafagh, H | 1 |
| Soltani, MA | 1 |
| Douvoyiannis, M | 1 |
| Widness, J | 1 |
| Di Paola, J | 1 |
| Yadav, N | 1 |
| Jatzlau, A | 1 |
| Pohl, J | 1 |
| Weir, M | 1 |
| Caprai, S | 1 |
| Massei, F | 1 |
| Gori, L | 1 |
| Lovicu, M | 1 |
| Lo Curto, AG | 1 |
| Marchi, A | 1 |
| Grasso, M | 1 |
| Arbustini, E | 1 |
| Brega, A | 1 |
| Kozic, D | 1 |
| Sener, RN | 2 |
| Aikath, D | 1 |
| Gupta, A | 1 |
| Chattopadhyay, I | 1 |
| Hashmi, MA | 1 |
| Gangopadhyay, PK | 1 |
| Das, SK | 1 |
| Ray, K | 1 |
| Lin, JJ | 1 |
| Lin, KL | 1 |
| Wang, HS | 1 |
| Wong, MC | 1 |
| Seo, JK | 1 |
| Sohtaoglu, M | 1 |
| Ergin, H | 1 |
| Ozekmekçi, S | 1 |
| Gökdemir, S | 1 |
| Sonsuz, A | 1 |
| Arici, C | 1 |
| Jara Vega, P | 1 |
| Hierro Llanillo, L | 1 |
| Walker, AP | 1 |
| Ashkan, K | 1 |
| Dooley, JS | 1 |
| Ping, CC | 1 |
| Hassan, Y | 1 |
| Aziz, NA | 1 |
| Ghazali, R | 1 |
| Awaisu, A | 1 |
| Rahman, MM | 1 |
| Rossaro, L | 2 |
| Meenakshi-Sundaram, S | 2 |
| Müller, T | 1 |
| Koppikar, S | 1 |
| Taylor, RM | 1 |
| Carragher, F | 1 |
| Schlenck, B | 1 |
| Heinz-Erian, P | 1 |
| Kronenberg, F | 1 |
| Tanner, S | 1 |
| Siebert, U | 1 |
| Staudinger, R | 1 |
| Mieli-Vergani, G | 3 |
| Pandey, K | 1 |
| Sinha, PK | 1 |
| Das, VN | 1 |
| Verma, N | 1 |
| Bimal, S | 1 |
| Lal, CS | 1 |
| Topno, RK | 1 |
| Singh, D | 1 |
| Verma, RB | 1 |
| Bhattacharya, SK | 1 |
| Das, P | 1 |
| Srinivas, K | 1 |
| Janardhana Reddy, YC | 1 |
| Khanna, S | 1 |
| Bienaimé, F | 1 |
| Clerbaux, G | 1 |
| Plaisier, E | 1 |
| Mougenot, B | 1 |
| Ronco, P | 1 |
| Rougier, JP | 1 |
| Leinweber, B | 1 |
| Möller, JC | 1 |
| Scherag, A | 1 |
| Günther, P | 1 |
| Lang, CJ | 2 |
| Schrader, C | 1 |
| Bandmann, O | 1 |
| Oertel, WH | 2 |
| Di Leo, V | 1 |
| Lamboglia, F | 1 |
| Bowlus, CL | 1 |
| Tseng, SC | 1 |
| Irato, P | 2 |
| Burra, P | 1 |
| Martines, D | 1 |
| Selimoglu, MA | 1 |
| Ertekin, V | 1 |
| Doneray, H | 1 |
| Yildirim, M | 1 |
| Mahadevan, A | 1 |
| Shankar, SK | 1 |
| Foruny, JR | 1 |
| Boixeda, D | 1 |
| López-Sanroman, A | 1 |
| Vázquez-Sequeiros, E | 1 |
| Villafruela, M | 1 |
| Vázquez-Romero, M | 1 |
| Rodríguez-Gandía, M | 1 |
| de Argila, CM | 1 |
| Camarero, C | 1 |
| Milicua, JM | 1 |
| Korshunova, TS | 1 |
| Gellis, SS | 1 |
| Feingold, M | 1 |
| Holtzman, NA | 2 |
| Naughton, MA | 1 |
| Iber, FL | 1 |
| Gaumnitz, BM | 1 |
| Wallauer, P | 1 |
| Harbauer, H | 1 |
| McCall, JT | 5 |
| Bennett, RA | 1 |
| Harbilas, E | 1 |
| Thiele, KG | 1 |
| Muehrcke, RC | 1 |
| Berning, H | 1 |
| Canelas, HM | 4 |
| de Jorge, FB | 1 |
| Tognola, WA | 1 |
| Růzicková, R | 2 |
| Hauftová, D | 7 |
| Hartl, J | 4 |
| Slavícek, J | 3 |
| Valach, V | 1 |
| Fialová, J | 1 |
| Pojerová, M | 1 |
| May, PM | 2 |
| Jones, DC | 2 |
| Williams, DR | 2 |
| Danks, DM | 3 |
| Gattoni, A | 1 |
| De Donato, MT | 1 |
| Catalano, G | 1 |
| Astarita, C | 1 |
| Bernabò, R | 1 |
| Altucci, P | 1 |
| Gilsanz García, V | 1 |
| Dalmau Obrador, J | 1 |
| Martí-Vilalta, JL | 1 |
| Aguilar Barberá, M | 1 |
| Parkes, D | 1 |
| Lössner, J | 12 |
| Storch, W | 6 |
| Bachmann, H | 10 |
| Biesold, D | 9 |
| Kühn, HJ | 4 |
| Shaw, M | 1 |
| Jarrett, A | 1 |
| Nix, WA | 1 |
| Ludwig, G | 1 |
| Backmund, H | 1 |
| van Wouwe, JP | 1 |
| van Weel-Sipman, MH | 1 |
| Giesberts, MA | 1 |
| Ruiter, DJ | 1 |
| van Gelderen, HH | 1 |
| Ede, RJ | 2 |
| Mowat, AP | 5 |
| Rector, WG | 1 |
| Uchida, T | 1 |
| Kanel, GC | 1 |
| Redeker, AG | 2 |
| Reynolds, TB | 1 |
| Hill, GM | 2 |
| Prasad, AS | 1 |
| Cossack, ZT | 3 |
| Rabbani, P | 1 |
| Deiss, A | 3 |
| Nazer, H | 2 |
| Williams, R | 2 |
| Loffredo, A | 1 |
| Sammartino, A | 1 |
| Cecio, A | 1 |
| Campanella, G | 2 |
| Mzhel'skaia, TI | 1 |
| Gomovtseva, EV | 1 |
| Crawhall, JC | 2 |
| Kean, WF | 1 |
| Bellamy, N | 1 |
| Lock, CJ | 1 |
| Adachi, J | 1 |
| Lindahl, JA | 1 |
| Sharp, HL | 1 |
| Sánchez Rodríguez, A | 1 |
| González Macías, J | 1 |
| Díez Jarilla, JL | 1 |
| Suquia Múgica, B | 1 |
| de Portugal Alvarez, J | 1 |
| Rao, SV | 1 |
| Greene, CA | 1 |
| Ellinoff, V | 1 |
| Asatoor, AM | 1 |
| Milne, MD | 1 |
| Mizutani, N | 1 |
| Maehara, M | 1 |
| Negoro, T | 1 |
| Watanabe, K | 2 |
| Shoulson, I | 1 |
| Goldblatt, D | 1 |
| Plassche, W | 1 |
| Wilson, G | 1 |
| Eisenberg, E | 1 |
| Ballow, M | 1 |
| Wolfe, SH | 1 |
| Krutchkoff, DJ | 1 |
| Tanzer, JM | 1 |
| Gilman, PA | 1 |
| Jaffe, IA | 1 |
| Holmgren, G | 1 |
| Samuelson, G | 3 |
| Sjögren, S | 1 |
| Sfar, Z | 1 |
| Lakhoua, M | 1 |
| Kamoun, MR | 1 |
| Kamoun, F | 1 |
| Hafsia, M | 1 |
| Vielhauer, W | 1 |
| Eckardt, V | 1 |
| Holtermüller, KH | 1 |
| Lüth, JB | 1 |
| Schulte, B | 1 |
| Prellwitz, W | 1 |
| Sonntag, W | 1 |
| Vasen, HF | 1 |
| Sindram, JW | 1 |
| Struyvenberg, A | 1 |
| Bowman, MB | 1 |
| Lewis, MS | 1 |
| Harik, SI | 1 |
| Post, MJ | 1 |
| Chesney, TM | 1 |
| Wardlaw, LL | 1 |
| Kaplan, RJ | 1 |
| Chow, JF | 1 |
| Brandt, G | 1 |
| Frommer, DJ | 1 |
| Mörl, M | 3 |
| Gebhart, W | 3 |
| Bardach, H | 3 |
| Klepach, GL | 1 |
| Wray, SH | 1 |
| Botvinnik, VS | 2 |
| Lekar', PG | 2 |
| Makarova, VA | 2 |
| Endres, W | 1 |
| Niebauer, G | 1 |
| Bardach, G | 1 |
| Thierman-Duffaud, D | 1 |
| Lévy, VG | 1 |
| Williams, FJ | 1 |
| Pigrau Serrallach, C | 1 |
| Pahissa Berga, A | 1 |
| Clotet Sala, B | 1 |
| Guardia Massó, J | 1 |
| Lanzi, G | 1 |
| Balottin, U | 1 |
| Cecchini, A | 1 |
| Ottolini, A | 1 |
| Borthwick, TR | 2 |
| Benson, GD | 2 |
| Schugar, HJ | 2 |
| Vakharlovskiĭ, VG | 4 |
| Nikitina, LI | 1 |
| Bondarchuk, AN | 1 |
| Haggstrom, GD | 1 |
| Hirschowitz, BI | 1 |
| Flint, A | 1 |
| Hiti, H | 1 |
| Harpf, H | 1 |
| Wutz, W | 1 |
| Schmut, O | 1 |
| Ditscherlein, G | 1 |
| Lange, E | 1 |
| Haslam, RH | 1 |
| Sass-Kortsak, A | 3 |
| Stout, W | 1 |
| Berg, M | 1 |
| Gadoth, N | 1 |
| Liel, Y | 1 |
| Berger, H | 1 |
| Nunns, D | 1 |
| Hawthorne, B | 1 |
| Goulding, P | 1 |
| Maresh, M | 1 |
| Dahlman, T | 1 |
| Hartvig, P | 2 |
| Löfholm, M | 1 |
| Nordlinder, H | 1 |
| Lööf, L | 1 |
| Westermark, K | 2 |
| Koch, A | 1 |
| Dörr, HG | 1 |
| Gerling, S | 1 |
| Behrens, R | 1 |
| Böhles, HJ | 1 |
| Barthel, HR | 1 |
| Hiepe, F | 1 |
| Arima, M | 5 |
| Ogihara, H | 1 |
| Ogihara, T | 1 |
| Miki, M | 2 |
| Yasuda, H | 1 |
| Mino, M | 1 |
| Yarze, JC | 2 |
| Marcus, A | 1 |
| Ammermann, C | 1 |
| Klein, M | 1 |
| Schmidt, MH | 1 |
| Munro, NA | 1 |
| Schlaug, G | 1 |
| Nebeling, B | 1 |
| Engelbrecht, V | 1 |
| Weiss, P | 3 |
| Stöcklin, G | 1 |
| Seitz, RJ | 1 |
| Gallo, V | 1 |
| Riva, P | 1 |
| Sidoli, L | 1 |
| Bisbocci, D | 1 |
| Hartard, C | 3 |
| Kunze, K | 2 |
| Garg, RK | 2 |
| Kar, AM | 1 |
| Agrawal, A | 1 |
| Agrawal, S | 1 |
| Agrawal, V | 1 |
| Propst, A | 2 |
| Propst, T | 2 |
| Feichtinger, H | 1 |
| Judmaier, G | 3 |
| Willeit, J | 3 |
| Vogel, W | 2 |
| Amato, C | 1 |
| Bisceglie, P | 1 |
| Moschini, M | 1 |
| el Alaoui-Faris, M | 2 |
| Benabdeljalil, M | 1 |
| Slassi, I | 1 |
| Boutchiche, M | 1 |
| Birouk, N | 1 |
| Belaidi, H | 1 |
| Saidi, A | 1 |
| Chkili, T | 2 |
| Roick, H | 1 |
| von Giesen, HJ | 1 |
| Arendt, G | 5 |
| Benecke, R | 3 |
| Ratnavel, RC | 1 |
| Norris, PG | 1 |
| Amichai, B | 1 |
| Rotem, A | 1 |
| Metzker, A | 1 |
| Mohamed, R | 1 |
| Tan, CT | 1 |
| Wong, NW | 1 |
| Balistreri, WF | 1 |
| Chan, CY | 1 |
| Baker, AL | 1 |
| Turkay, A | 1 |
| Yuzbaziyan-Gurkan, V | 1 |
| Kuwert, T | 2 |
| Herzog, H | 2 |
| Feinendegen, LE | 2 |
| Weisner, B | 2 |
| Dieu, C | 2 |
| Wilhelm, KP | 1 |
| Wolff, HH | 1 |
| Gregorio, GV | 1 |
| Jackson, GH | 1 |
| Meyer, A | 1 |
| Lippmann, S | 1 |
| Schwarz, J | 1 |
| Antonini, A | 1 |
| Kraft, E | 1 |
| Tatsch, K | 1 |
| Vogl, T | 1 |
| Kirsch, CM | 1 |
| Leenders, KL | 1 |
| Shimon, I | 1 |
| Moses, B | 1 |
| Sela, BA | 1 |
| Dolev, E | 1 |
| Castellví Suaña, JM | 1 |
| Guardiola Capón, J | 1 |
| Hoppe, B | 1 |
| Neuhaus, T | 1 |
| Superti-Furga, A | 1 |
| Forster, I | 1 |
| Leumann, E | 1 |
| Bona, I | 1 |
| Neuschwander, P | 1 |
| Confavreux, C | 1 |
| Fontanges, T | 1 |
| Accominotti, M | 1 |
| Chazot, G | 1 |
| McIntyre, N | 1 |
| Oga, M | 1 |
| Matsui, N | 1 |
| Anai, T | 1 |
| Yoshimatsu, J | 1 |
| Inoue, I | 1 |
| Miyakawa, I | 1 |
| Mason, AL | 1 |
| Marsh, W | 1 |
| Alpers, DH | 1 |
| Yealland, M | 1 |
| Suda, M | 1 |
| Kubota, J | 1 |
| Yamaguchi, Y | 2 |
| Fujioka, Y | 1 |
| Saito, Y | 1 |
| Chu, NS | 5 |
| Yuzbasiyan-Gurkan, V | 3 |
| Johnson, V | 1 |
| Dick, RD | 1 |
| Freund, HJ | 2 |
| Manohar, MB | 1 |
| Boldy, DA | 1 |
| Bryan, RL | 1 |
| Pearman, K | 1 |
| Keller, DH | 1 |
| Mestriner, C | 2 |
| Tedroff, J | 1 |
| Thuomas, KA | 1 |
| Långström, B | 1 |
| Andersson, Y | 1 |
| Hörnfeldt, K | 1 |
| Aquilonius, SM | 1 |
| Obara, H | 1 |
| Ikoma, N | 1 |
| Sasaki, K | 1 |
| Tachi, K | 1 |
| Anlar, B | 1 |
| Kuruoğlu, R | 1 |
| Varli, K | 1 |
| Topçu, M | 1 |
| Santos Silva, EE | 1 |
| Sarles, J | 1 |
| Buts, JP | 1 |
| Sokal, EM | 1 |
| Dukas, L | 1 |
| Vogt, M | 1 |
| Il'ina, NA | 1 |
| Potapova, AV | 1 |
| Iusov, SP | 1 |
| Popova, IV | 1 |
| Nałecz, A | 1 |
| Socha, J | 1 |
| Vitorovic, S | 1 |
| Lieina, M | 1 |
| Miranda, M | 2 |
| Brinck, P | 1 |
| Roessler, JL | 1 |
| Troncoso Sch, M | 1 |
| Alarcón, T | 1 |
| Villagra, R | 2 |
| Cai, YL | 2 |
| Xu, SH | 2 |
| Karkos, C | 1 |
| Moore, A | 1 |
| Manche, A | 1 |
| Thorpe, JA | 1 |
| Chu, CC | 1 |
| Huang, CC | 4 |
| Nag, D | 1 |
| Pless, M | 1 |
| Sandson, T | 1 |
| Bonfissuto, G | 1 |
| Magliarisi, C | 1 |
| Soresi, M | 1 |
| Bascone, F | 1 |
| Costanza, G | 1 |
| Carroccio, A | 1 |
| Montalto, G | 1 |
| Kong, HL | 1 |
| Yap, IL | 1 |
| Kueh, YK | 1 |
| Rath, HC | 1 |
| Enger, IM | 1 |
| Rüschoff, J | 1 |
| Schölmerich, J | 1 |
| Holstege, A | 1 |
| Schumacher, G | 1 |
| Platz, KP | 1 |
| Mueller, AR | 1 |
| Neuhaus, R | 1 |
| Steinmüller, T | 1 |
| Bechstein, WO | 1 |
| Becker, M | 1 |
| Luck, W | 1 |
| Schuelke, M | 1 |
| Neuhaus, P | 1 |
| Sözeri, E | 1 |
| Feist, D | 2 |
| Ruder, H | 1 |
| Schärer, K | 2 |
| Yorio, AA | 1 |
| Mesri, JC | 1 |
| Pagano, MA | 1 |
| Lera, G | 1 |
| Iozumi, K | 1 |
| Nakagawa, H | 1 |
| Tamaki, K | 1 |
| Porzio, S | 1 |
| Pensati, P | 1 |
| Cordato, DJ | 1 |
| Fulham, MJ | 1 |
| Yiannikas, C | 1 |
| Martínez-Frías, ML | 1 |
| Rodríguez-Pinilla, E | 1 |
| Bermejo, E | 1 |
| Blanco, M | 1 |
| Müller, J | 1 |
| Landgraf, F | 1 |
| Trabert, W | 1 |
| Coatesworth, AP | 1 |
| Darnton, SJ | 1 |
| Green, RM | 1 |
| Cayton, RM | 1 |
| Antonakopoulos, GN | 1 |
| Troncoso, M | 1 |
| Badilla, L | 1 |
| Bravo, E | 1 |
| Gajewski, C | 1 |
| Barrios, A | 1 |
| Barabino, A | 1 |
| Fasce, L | 1 |
| Ciravegna, B | 2 |
| Famularo, L | 1 |
| Boni, L | 1 |
| Callea, F | 1 |
| Mustafa, MS | 1 |
| Shamina, AH | 1 |
| Zachoval, R | 1 |
| Glaser, C | 1 |
| Kauschansky, A | 1 |
| Frydman, M | 2 |
| Assa, S | 1 |
| Kwon, OJ | 1 |
| Israel, S | 1 |
| Lazard, D | 1 |
| Sprecher, E | 1 |
| Bloch, K | 1 |
| Brautbar, C | 1 |
| Vardi, P | 1 |
| Siafakas, CG | 1 |
| Jonas, MM | 1 |
| Alexander, S | 1 |
| Herrin, J | 1 |
| Furuta, GT | 1 |
| Sánchez-Albisua, I | 1 |
| Garde, T | 1 |
| Hierro, L | 1 |
| Camarena, C | 1 |
| Frauca, E | 1 |
| de la Vega, A | 1 |
| Díaz, MC | 1 |
| Larrauri, J | 1 |
| Jara, P | 1 |
| Lin, R | 1 |
| Du, S | 1 |
| Qu, Z | 1 |
| Albergoni, V | 1 |
| Longo, G | 1 |
| Bonet Serra, B | 1 |
| Henry Knopp, R | 1 |
| Ramírez Sánchez, MJ | 1 |
| Calvo Villas, JM | 1 |
| Sicilia Guillén, FJ | 1 |
| Salah, S | 1 |
| Smolarek, C | 1 |
| LeWitt, PA | 1 |
| Imai, N | 1 |
| Nozaki, H | 1 |
| Miyata, K | 1 |
| Terayama, Y | 1 |
| Ishihara, N | 1 |
| Deutscher, J | 1 |
| Kiess, W | 1 |
| Scheerschmidt, G | 1 |
| Willgerodt, H | 3 |
| Hlinst'ák, K | 1 |
| Borovský, M | 1 |
| Hlinst'áková, S | 1 |
| Alanen, A | 1 |
| Komu, M | 1 |
| Penttinen, M | 1 |
| Leino, R | 1 |
| Firneisz, G | 1 |
| Halasz, P | 1 |
| Komoly, S | 1 |
| Hill, VA | 1 |
| Seymour, CA | 1 |
| Mortimer, PS | 1 |
| Heckmann, JG | 1 |
| Neundörfer, B | 2 |
| Küchle, M | 1 |
| Averkina, NA | 1 |
| Orlova, OR | 1 |
| Shariapova, RB | 1 |
| Stuerenburg, HJ | 1 |
| Milkiewicz, P | 1 |
| Saksena, S | 1 |
| Hubscher, SG | 1 |
| Elias, E | 1 |
| Satishchandra, P | 1 |
| Ravishankar Naik, K | 1 |
| Takahashi, A | 1 |
| Suzuki, T | 1 |
| Shishido, S | 1 |
| Tojo, J | 1 |
| Ito, O | 1 |
| Kazuta, Y | 1 |
| Watanabe, H | 1 |
| Ishikawa, H | 1 |
| Ohira, H | 1 |
| Obara, K | 1 |
| Kasukawa, R | 1 |
| Keller, R | 1 |
| Torta, R | 1 |
| Lagget, M | 1 |
| Crasto, S | 1 |
| Bergamasco, B | 1 |
| Narayanan, CS | 1 |
| Behari, M | 2 |
| Castilla-Higuero, L | 1 |
| Romero-Gomez, M | 1 |
| Suarez, E | 1 |
| Castro, M | 1 |
| Czonkowska, A | 1 |
| Pulawska, M | 1 |
| Swiderska, M | 1 |
| Wehr, H | 1 |
| Gitlin, JD | 1 |
| Durand, F | 1 |
| Bernuau, J | 1 |
| Mentha, G | 1 |
| Shouval, D | 1 |
| Degott, C | 1 |
| Benhamou, JP | 2 |
| Valla, D | 1 |
| Furman, B | 1 |
| Bashiri, A | 1 |
| Wiznitzer, A | 1 |
| Erez, O | 1 |
| Holcberg, G | 1 |
| Mazor, M | 1 |
| Sternić, N | 1 |
| Pejović, S | 1 |
| Hawkes, ND | 1 |
| Mutimer, D | 1 |
| Thomas, GA | 1 |
| Shiono, Y | 1 |
| Takikawa, T | 1 |
| Yano, M | 1 |
| Okada, T | 1 |
| Mabuchi, H | 1 |
| Kono, S | 1 |
| Miyajima, H | 1 |
| Jha, DK | 1 |
| Sinha, KK | 1 |
| Seidel, J | 1 |
| Caca, K | 1 |
| Schwab, SG | 1 |
| Berr, F | 1 |
| Wildenauer, DB | 1 |
| Mentzel, HJ | 1 |
| Horn, N | 1 |
| Kauf, E | 1 |
| Jayasundar, R | 1 |
| Sahani, AK | 1 |
| Gaikwad, S | 1 |
| Singh, S | 2 |
| Subramanian, I | 1 |
| Vanek, ZF | 1 |
| Bronstein, JM | 1 |
| Bono, W | 1 |
| Moutie, O | 1 |
| Benomar, A | 1 |
| Aïdi, S | 1 |
| Yahyaoui, M | 1 |
| Arbisser, AI | 1 |
| Scott, CI | 1 |
| Howell, BR | 1 |
| Lyle, WH | 4 |
| Proesmans, W | 2 |
| Jaeken, J | 1 |
| Eeckels, R | 1 |
| Linares, A | 1 |
| Zarranz, JJ | 1 |
| Rodriguez-Alarcon, J | 1 |
| Diaz-Perez, JL | 1 |
| Kuntz, HD | 1 |
| May, B | 1 |
| Ulmer, WT | 1 |
| Harders, H | 1 |
| Cohnen, E | 1 |
| Golding, DN | 1 |
| Ruchholtz, U | 2 |
| Hopkins, SJ | 1 |
| Kashani, AA | 1 |
| Bassetti, D | 1 |
| Ferrea, G | 1 |
| Toaff, R | 1 |
| Toaff, ME | 1 |
| Peyser, MR | 1 |
| Streifler, M | 1 |
| Grand, RJ | 4 |
| Hach, B | 1 |
| Hartung, ML | 1 |
| Perman, JA | 2 |
| Werlin, SL | 2 |
| Watkins, JB | 2 |
| Sarosiek, J | 1 |
| Rudy, J | 1 |
| Koevoet, R | 1 |
| de Ruyter Korver, EG | 1 |
| Højer-Pedersen, E | 1 |
| Lodemann, E | 1 |
| Laurie, SH | 1 |
| Prime, DM | 1 |
| Günther, K | 6 |
| Wagner, A | 1 |
| Talke, H | 1 |
| Indaco, A | 1 |
| Pellegrino, L | 1 |
| Ferrari, E | 1 |
| Puca, FM | 1 |
| Specchio, LM | 1 |
| Perniola, T | 1 |
| Leomanni, R | 1 |
| Gabriel, L | 2 |
| Nelson, RF | 1 |
| Guzman, DA | 1 |
| Grahovac, Z | 1 |
| Howse, DC | 1 |
| Robitaille, GA | 1 |
| Piscatelli, RL | 1 |
| Majeski, EJ | 1 |
| Gelehrter, TD | 1 |
| Fouquet, H | 1 |
| Broser, F | 1 |
| Werner, JP | 2 |
| Helwig, H | 2 |
| Michel, FB | 1 |
| Bousquet, J | 1 |
| Robinet-Levy, M | 1 |
| Mary, P | 3 |
| Fukuda, K | 1 |
| Ishii, A | 1 |
| Matsue, Y | 1 |
| Funaki, K | 1 |
| Hoshiai, H | 1 |
| Maeda, S | 1 |
| Nijeholt, JL | 1 |
| Korf, J | 1 |
| Rabenalt, P | 1 |
| Gibbs, K | 6 |
| Hanka, R | 1 |
| Dingle, J | 1 |
| Havener, WH | 1 |
| Bollen, J | 1 |
| Seurynck, D | 1 |
| De Groote, J | 1 |
| Dobyns, WB | 1 |
| Gordon, H | 1 |
| Gollan, JL | 3 |
| Hussein, S | 1 |
| Hoffbrand, AV | 1 |
| Eichner, B | 4 |
| Hjalmarson, O | 1 |
| Hanson, LA | 1 |
| Nilsson, LA | 1 |
| Petushkov, EP | 1 |
| Kirsch, N | 1 |
| Hukill, PB | 1 |
| Thompson, WG | 1 |
| Hyslop, PS | 1 |
| Barr, R | 1 |
| Wiebers, DO | 1 |
| Hollenhorst, RW | 1 |
| Hamlyn, AN | 1 |
| Douglas, AP | 1 |
| Birker, PJ | 1 |
| Freeman, HC | 1 |
| Takeshita, K | 1 |
| Yoshino, K | 1 |
| Kitahara, T | 1 |
| Suzuki, Y | 1 |
| Runge, E | 1 |
| Tellkamp, F | 1 |
| Webster, DD | 1 |
| Mortimer, JA | 1 |
| Feldmann, G | 1 |
| Graf, M | 1 |
| Hampel, R | 1 |
| Meng, W | 1 |
| Kallwellis, G | 1 |
| Osswald, P | 1 |
| Niessen, KH | 1 |
| Rupp, H | 1 |
| Weser, U | 1 |
| Fujita, T | 1 |
| Fujita, H | 1 |
| Okawa, M | 1 |
| Yokoi, S | 1 |
| Aksamija-Rizvić, B | 1 |
| Balcells, A | 1 |
| Cabrer, B | 1 |
| Cano, JF | 1 |
| Coll, J | 1 |
| Ingelmo, M | 1 |
| Vivancos, J | 1 |
| Herron, BE | 1 |
| Francone, CA | 1 |
| Basner, NH | 1 |
| Bennett, B | 1 |
| Perings, E | 1 |
| Junge, U | 1 |
| Strickland, GT | 8 |
| Leu, ML | 5 |
| Gasbarrini, G | 1 |
| Miglio, F | 1 |
| Corazza, GR | 2 |
| Stefanini, GF | 1 |
| Fitzgerald, MA | 1 |
| Wahner, HW | 1 |
| Tiwary, CM | 1 |
| Rennert, OM | 1 |
| Garnica, A | 1 |
| Vawter, GF | 1 |
| Koziolowa, H | 1 |
| Dziezbicka, E | 1 |
| Volek, V | 1 |
| Malyshev, IuI | 1 |
| Rigardetto, R | 1 |
| Trevisio, A | 1 |
| Seidlová, V | 3 |
| Kuba, J | 1 |
| Sack, G | 1 |
| Albukerk, JN | 2 |
| Owen, CA | 2 |
| Bowie, JW | 1 |
| Perrett, D | 1 |
| Sneddon, W | 1 |
| Stephens, AD | 1 |
| Findlay, D | 1 |
| Morita, J | 1 |
| Watari, H | 1 |
| Yoshida, I | 1 |
| Motohiro, T | 1 |
| Yamashita, F | 1 |
| Okano, Y | 1 |
| Hashimoto, T | 2 |
| Burdmann, Ede A | 1 |
| Cançado, ER | 1 |
| Haddad, MS | 1 |
| Scaff, M | 2 |
| Cheng, WS | 1 |
| Govindarajan, S | 1 |
| Kher, A | 1 |
| Bharucha, BA | 1 |
| Kumta, NB | 1 |
| Cramarossa, L | 1 |
| D'Angelo, D | 1 |
| D'Ascanio, I | 1 |
| Ferri, GB | 1 |
| Piane, E | 1 |
| Prokhorova, MV | 1 |
| Krel', PE | 1 |
| Martins da Costa, C | 1 |
| Baldwin, D | 1 |
| Portmann, B | 1 |
| Lolin, Y | 1 |
| Scholz, D | 1 |
| Milz, M | 1 |
| Loken, M | 1 |
| Hennerici, M | 1 |
| Kiechl, SG | 2 |
| Aichner, F | 2 |
| Felber, S | 2 |
| Castellano, G | 1 |
| Blasco, A | 1 |
| Ballesta, F | 1 |
| Colina, F | 1 |
| Moreno, D | 1 |
| Franch, O | 1 |
| Urruzuno, P | 1 |
| Solís, JA | 1 |
| McQuaid, A | 2 |
| Lamand, M | 1 |
| Mason, J | 2 |
| Sowa, JM | 1 |
| Martin, P | 1 |
| Muñoz, SJ | 1 |
| Friedman, LS | 1 |
| Laufer, J | 1 |
| Passwell, J | 1 |
| Lotan, D | 1 |
| Boichis, H | 1 |
| Menara, M | 1 |
| Birbamer, G | 1 |
| Schmidauer, C | 1 |
| Saltvari, L | 1 |
| Metzler, R | 1 |
| Meyer, BU | 2 |
| Britton, TC | 2 |
| Bischoff, C | 1 |
| Machetanz, J | 1 |
| Conrad, B | 1 |
| Soong, YK | 1 |
| Huang, HY | 1 |
| Skeen, MB | 1 |
| Park, RH | 1 |
| McCabe, P | 1 |
| Fell, GS | 2 |
| Russell, RI | 1 |
| Buckley, C | 1 |
| Sankey, EA | 1 |
| Harris, D | 1 |
| Wright, S | 1 |
| Kohli, V | 1 |
| Chin, RK | 1 |
| Siegemund, R | 4 |
| Saito, H | 1 |
| Sahara, M | 1 |
| Mochizuki, R | 1 |
| Edo, K | 1 |
| Ohyama, Y | 1 |
| Meyerrose, KW | 1 |
| Niederau, C | 1 |
| Kreuzpaintner, G | 1 |
| Strohmeyer, G | 1 |
| Lee, AH | 1 |
| Lawton, NF | 1 |
| Li, Y | 1 |
| Johnson, PJ | 1 |
| Grimm, G | 1 |
| Oder, W | 1 |
| Prayer, L | 1 |
| Madl, C | 1 |
| Olsson, R | 1 |
| Lindgren, A | 1 |
| Frizell, M | 1 |
| Shimono, N | 1 |
| Ishibashi, H | 1 |
| Ikematsu, H | 1 |
| Kudo, J | 1 |
| Shirahama, M | 1 |
| Inaba, S | 1 |
| Maeda, K | 1 |
| Yamasaki, K | 1 |
| Niho, Y | 1 |
| Veen, C | 1 |
| van den Hamer, CJ | 2 |
| de Leeuw, PW | 1 |
| Gorelov, VG | 1 |
| Razevig, ND | 1 |
| Yang, R | 1 |
| Dupont, P | 1 |
| Irion, O | 1 |
| Béguin, F | 1 |
| Berardelli, A | 1 |
| Inghilleri, M | 1 |
| Priori, A | 1 |
| Fabri, S | 1 |
| Fieschi, C | 1 |
| Manfredi, M | 1 |
| Mayet, IY | 1 |
| Hilz, MJ | 1 |
| Druschky, KF | 1 |
| Bauer, J | 1 |
| Schuierer, G | 1 |
| Rose, BI | 1 |
| LeMaire, WJ | 1 |
| Jeffers, LJ | 1 |
| Dubois, RS | 2 |
| Rodgerson, DO | 2 |
| Hambidge, KM | 1 |
| Glass, JD | 1 |
| Reich, SG | 1 |
| DeLong, MR | 1 |
| Meiner, Z | 1 |
| Giacon, G | 1 |
| Montino, MC | 1 |
| Lecis, PE | 1 |
| Schade, RR | 1 |
| Trevisan, C | 1 |
| Longhi, R | 1 |
| Riva, E | 1 |
| Rottoli, A | 1 |
| Valsasina, R | 1 |
| Pinelli, P | 1 |
| Giovannini, M | 1 |
| Kunath, B | 3 |
| Teichmann, B | 1 |
| Wieczorek, V | 1 |
| Mühlau, G | 1 |
| Goldstein, JB | 1 |
| McNutt, NS | 1 |
| Hambrick, GW | 1 |
| Hsu, A | 1 |
| Zilker, TR | 1 |
| Felgenhauer, N | 1 |
| Hibler, A | 1 |
| von Clarmann, M | 1 |
| Woods, SE | 1 |
| Colón, VF | 1 |
| Pasquali Ronchetti, I | 1 |
| Quaglino, D | 1 |
| Baccarani Contri, M | 1 |
| Hayek, J | 1 |
| Galassi, G | 1 |
| Pall, HS | 1 |
| Williams, AC | 1 |
| Blake, DR | 1 |
| Yoshida, K | 2 |
| Maruyama, K | 1 |
| Shindo, M | 1 |
| Shoji, S | 1 |
| Yanagisawa, N | 1 |
| Ishitsu, T | 1 |
| Chikazawa, S | 1 |
| Lang, C | 1 |
| Verovaia, AV | 1 |
| Dixon, AK | 1 |
| Emery, P | 1 |
| Mackay, IR | 1 |
| Rothuizen, J | 1 |
| Stockert, RJ | 1 |
| van Joost, T | 1 |
| de Leeuw, J | 1 |
| Keane, JR | 1 |
| Zaïmi, I | 1 |
| Khiari, A | 1 |
| Ben Dridi, MF | 1 |
| Maherzi, H | 1 |
| Ben Osman, R | 1 |
| Greene, MW | 1 |
| King, RC | 1 |
| Alley, RS | 1 |
| Miehle, W | 1 |
| Jeffers, L | 1 |
| Maurer, K | 1 |
| Ihl, R | 1 |
| Dierks, T | 1 |
| Shekhtman, MM | 1 |
| Koridze, RS | 1 |
| Babić, T | 1 |
| Relja, M | 1 |
| De Volder, A | 1 |
| Sindic, CJ | 1 |
| Goffinet, AM | 1 |
| Young, AB | 2 |
| Pfeiffer, CC | 1 |
| Camo, B | 1 |
| Berkow, R | 1 |
| Kaur, U | 1 |
| Bambery, P | 1 |
| Bhushnurmath, SR | 1 |
| Deodhar, SD | 1 |
| Dilawari, JB | 1 |
| Kolarski, V | 2 |
| Breen, E | 1 |
| Tolan, M | 1 |
| Meaney, J | 1 |
| Lucey, C | 1 |
| McCarthy, C | 1 |
| O'Gorman, T | 1 |
| Trautmann, B | 1 |
| Camus, JP | 1 |
| Koeger, AC | 1 |
| Lingam, S | 1 |
| Wilson, J | 1 |
| Hill, G | 2 |
| Prasad, A | 1 |
| Dick, R | 1 |
| Sasa, A | 1 |
| Yagi, A | 1 |
| Ohguchi, S | 1 |
| Kidokoro, R | 1 |
| Sato, Y | 1 |
| Sakamoto, N | 1 |
| Terry, CA | 1 |
| Aisen, AM | 2 |
| López-Guerra, N | 1 |
| Alvarez Lario, B | 1 |
| García-Moncó, C | 1 |
| Peña Sagredo, JL | 1 |
| Rosselli, M | 1 |
| Lorenzana, P | 1 |
| Rosselli, A | 1 |
| Vergara, I | 1 |
| Jaffe, ME | 1 |
| Kudo, H | 1 |
| Dootson, G | 1 |
| Sarkany, I | 1 |
| Ritland, S | 1 |
| Nuccetelli, F | 1 |
| Assetta, M | 1 |
| Colangelo, U | 1 |
| Gambi, D | 1 |
| Morimoto, I | 1 |
| Ninomiya, H | 1 |
| Komatsu, K | 1 |
| Satho, M | 1 |
| Rave, D | 1 |
| Vengrover, D | 1 |
| Kleinman, J | 1 |
| Leitersdorf, E | 1 |
| Rosa, FW | 1 |
| Guan, R | 1 |
| Yeo, PP | 1 |
| Ng, HS | 1 |
| Chan, HL | 1 |
| Gwee, HM | 1 |
| Tan, BY | 1 |
| Seah, CS | 1 |
| Wong, PK | 1 |
| Cheah, JS | 1 |
| Dorney, SF | 1 |
| Kamath, KR | 1 |
| Procopis, PG | 1 |
| Kan, AE | 1 |
| Aagenaes, O | 1 |
| Berg, K | 1 |
| Sagen, E | 1 |
| Lange, O | 1 |
| Westgaard, G | 1 |
| Bland, J | 1 |
| Romslo, I | 1 |
| Bouquet, J | 3 |
| Umeki, S | 2 |
| Ohga, R | 1 |
| Konishi, Y | 2 |
| Yasuda, T | 2 |
| Morimoto, K | 2 |
| Terao, A | 2 |
| Weinrauder, H | 1 |
| Mossakowski, MJ | 1 |
| Ganuszkina, IV | 1 |
| Miyagawa, S | 1 |
| Yoshioka, A | 1 |
| Hatoko, M | 1 |
| Okuchi, T | 1 |
| Sakamoto, K | 1 |
| Kaushansky, A | 1 |
| Kaufman, H | 1 |
| Homburg, R | 1 |
| Louie, S | 1 |
| Gamble, CN | 1 |
| Cross, CE | 1 |
| Starosta-Rubinstein, S | 1 |
| Kluin, K | 1 |
| Gabrielsen, T | 1 |
| Itoyama, Y | 1 |
| Tobimatsu, S | 1 |
| Goto, I | 1 |
| Kuroiwa, Y | 1 |
| Manghani, DK | 1 |
| Dastur, DK | 1 |
| Smithgall, JM | 1 |
| Liu, DK | 1 |
| Li, NZ | 1 |
| Chen, XZ | 1 |
| Yang, YF | 1 |
| Kamoun, P | 1 |
| Cadoudal, M | 1 |
| Rabier, D | 1 |
| Jérôme, H | 2 |
| Cooles, P | 1 |
| Khosla, D | 1 |
| Brathwaite, A | 1 |
| Wassef, M | 1 |
| Galian, A | 1 |
| Haguenau, M | 1 |
| Vassel, P | 1 |
| Hautefeuille, P | 1 |
| Brazy, J | 1 |
| Hamann, KU | 1 |
| Hellner, KA | 1 |
| Müller-Jensen, A | 1 |
| Zschocke, S | 1 |
| Bornstein, RA | 1 |
| McLean, DR | 1 |
| Ho, K | 1 |
| Van Caillie-Bertrand, M | 2 |
| Degenhart, HJ | 2 |
| Visser, HK | 1 |
| Sinaasappel, M | 2 |
| Luijendijk, I | 1 |
| Kalina, P | 1 |
| Procházková, L | 1 |
| De Bont, B | 1 |
| Moulin, D | 1 |
| Stein, F | 1 |
| Van Hoof, F | 1 |
| Lauwerys, R | 1 |
| Bentley-Phillips, B | 1 |
| Biller, J | 1 |
| Swiontoniowski, M | 1 |
| Brazis, PW | 1 |
| Piussan, C | 1 |
| Mathieu, M | 1 |
| Modai, I | 1 |
| Karp, L | 1 |
| Liberman, UA | 1 |
| Munitz, H | 1 |
| Ramadori, G | 1 |
| Keidl, E | 1 |
| Hütteroth, T | 1 |
| Dormeyer, HH | 1 |
| Manns, M | 1 |
| Meyer zum Büschenfelde, KH | 1 |
| Segal, A | 2 |
| Ducasse, A | 1 |
| Chen, ZR | 1 |
| Harpey, JP | 3 |
| Caille, B | 2 |
| Moulias, R | 2 |
| Goust, JM | 2 |
| Cumings, JN | 3 |
| Schraeder, PL | 1 |
| Peters, HA | 1 |
| Dahl, DS | 1 |
| Guilaine, J | 1 |
| Molas, G | 1 |
| Schmid-Rüter, E | 1 |
| Wesch, H | 1 |
| Rossner, JA | 1 |
| Harris, ED | 1 |
| Sjoerdsma, A | 1 |
| Levi, AJ | 1 |
| Scheuer, PJ | 1 |
| Henkin, RI | 1 |
| Keiser, HR | 1 |
| Jafee, IA | 1 |
| Felts, JH | 1 |
| King, JS | 1 |
| Boyce, WH | 1 |
| Troelstra, JA | 2 |
| Holl, H | 2 |
| Smallwood, RA | 2 |
| Williams, HA | 1 |
| Stevens, BJ | 2 |
| Mera, A | 1 |
| Barbeau, A | 2 |
| Friesen, H | 1 |
| Morgan, JP | 1 |
| Preziosi, TJ | 1 |
| Bianchine, JR | 1 |
| Frommer, D | 2 |
| Pollard, R | 1 |
| Löbbner, J | 1 |
| Escartín Marín, P | 1 |
| García Plaza, A | 1 |
| Chantar Barrios, C | 1 |
| Katz, R | 1 |
| Werner, T | 2 |
| Weinmann, HM | 1 |
| Christeler, A | 1 |
| Delacrétaz, J | 1 |
| Mirouze, J | 2 |
| Jaffiol, C | 1 |
| Berthaux, P | 1 |
| Rimbaud, P | 1 |
| Meynadier, J | 1 |
| Peisach, J | 1 |
| Blumberg, WE | 1 |
| Gharib, M | 1 |
| Hayek, HW | 2 |
| Knoll, E | 1 |
| Widhalm, S | 2 |
| Ewert, JC | 1 |
| Aposhian, HV | 1 |
| Diessner, H | 1 |
| Furrer, HU | 1 |
| Tönz, O | 1 |
| Chajek, T | 1 |
| Kuffer, R | 1 |
| Noble, JP | 1 |
| Amos, HE | 1 |
| Bogdanikowa, B | 1 |
| Markoff, N | 1 |
| Damaske, E | 1 |
| Althoff, W | 2 |
| Faur, A | 1 |
| Păsculescu, G | 1 |
| Dörl, F | 1 |
| Schnack, H | 3 |
| Charlebois, G | 1 |
| Cadotte, M | 1 |
| Stähler, E | 1 |
| Stähler, F | 1 |
| Sturm, G | 1 |
| Lynch, RE | 2 |
| Lee, GR | 3 |
| Cartwright, GE | 3 |
| Tschumi, A | 1 |
| Colombo, JP | 2 |
| Moser, H | 1 |
| Tkachev, RA | 1 |
| Markova, ED | 1 |
| Gotovtseva, EV | 1 |
| Barkhatova, VP | 1 |
| Ivanova-Smolenskaia, IA | 1 |
| Berio, A | 1 |
| Vento, R | 1 |
| Di Stefano, A | 1 |
| Rosenberger, K | 1 |
| Pass, F | 1 |
| Goldfischer, S | 1 |
| Sutor, AH | 1 |
| Ketelsen, UP | 1 |
| Wilson, DM | 2 |
| Karma, A | 1 |
| Gelmers, HJ | 1 |
| Troost, J | 1 |
| Willemse, J | 1 |
| Goldstein, P | 1 |
| Davis, LJ | 1 |
| Berry, WR | 2 |
| Aronson, AE | 2 |
| Darley, FL | 2 |
| Iser, JH | 1 |
| Stening, GF | 1 |
| Hurley, TH | 1 |
| Caron, GA | 1 |
| Linke, A | 1 |
| Hansen, HJ | 1 |
| Andersen, OS | 2 |
| Blattner, RJ | 1 |
| Bickel, H | 1 |
| Spellberg, MA | 1 |
| Carmichael, BM | 1 |
| Henke, G | 1 |
| Möllmann, H | 1 |
| Mancosu, M | 1 |
| Bottino, D | 1 |
| Previati, G | 1 |
| Pighini, A | 1 |
| Valli, F | 1 |
| Colombo, B | 1 |
| Johansen, K | 1 |
| Gregersen, G | 3 |
| Lang, HD | 1 |
| Reichenmiller, HE | 1 |
| Tigges, FJ | 1 |
| Braun, HJ | 1 |
| Golisch, G | 1 |
| Sugiura, Y | 1 |
| Tanaka, H | 1 |
| Herishanu, Y | 1 |
| Loewinger, E | 1 |
| Schonheyder, F | 1 |
| Hansen, HE | 1 |
| Skov, PE | 1 |
| Monro, P | 1 |
| Elsas, LJ | 1 |
| Hayslett, JP | 1 |
| Spargo, BH | 1 |
| Durant, JL | 1 |
| Rosenberg, LE | 1 |
| Hsia, YE | 1 |
| Combs, JT | 1 |
| Hook, L | 1 |
| Sussman, W | 1 |
| Szaz, KF | 1 |
| Julesz, J | 1 |
| Bodor, F | 1 |
| Szarvas, F | 1 |
| Tauxe, WN | 5 |
| Jochmus, I | 1 |
| Krienitz, B | 1 |
| Rey, U | 1 |
| Degos, R | 1 |
| Touraine, R | 1 |
| Belaïch, S | 1 |
| Revuz, J | 1 |
| Dupuy, R | 1 |
| Vallin, J | 1 |
| Fabiani, F | 1 |
| Falkmer, S | 2 |
| Sjölin, S | 2 |
| Kubĕna, K | 1 |
| Komenda, S | 1 |
| Metz, G | 1 |
| Pevny, I | 1 |
| Metz, J | 1 |
| Hicks, EP | 1 |
| Gordo, JV | 1 |
| Brailski, C | 1 |
| Krastev, I | 1 |
| Gutman, RA | 1 |
| Komiya, K | 2 |
| Slovis, TL | 1 |
| Silverman, A | 1 |
| Kuncová, Z | 1 |
| Dittrich, J | 1 |
| Yeh, SJ | 1 |
| O'Reilly, S | 2 |
| Weber, PM | 2 |
| Beckner, WM | 1 |
| Shipley, L | 2 |
| Frederiksen, G | 1 |
| Lejeune, C | 1 |
| Sudre, Y | 1 |
| Turpin, R | 1 |
| Godeau, P | 1 |
| Vernant, JC | 1 |
| Gouerou, H | 1 |
| Wewalka, F | 1 |
| Schindler, H | 1 |
| Vodicková, L | 1 |
| Neruda, O | 1 |
| Bell, GE | 1 |
| Slivka, DC | 1 |
| Huston, JR | 1 |
| Chalmers, TC | 1 |
| Cavallino, R | 1 |
| Grossman, H | 1 |
| Fulop, M | 1 |
| Richardson, JC | 1 |
| Fagan, TJ | 1 |
| Thivolet, J | 1 |
| Perrot, H | 1 |
| François, R | 1 |
| Mitchell, AM | 1 |
| Heller, GL | 1 |
| Atsuba, Y | 1 |
| Nakahachi, T | 1 |
| Terai, T | 1 |
| Kozakai, T | 1 |
| Smith, H | 1 |
| Howie, RA | 1 |
| Hamamoto, K | 1 |
| Novak, LP | 1 |
| Milhaud, M | 1 |
| Pacilly, A | 1 |
| Lachmann, PJ | 1 |
| Fujisawa, A | 1 |
| Matsuoka, K | 1 |
| Ferrer, S | 1 |
| Grismali, J | 1 |
| Vergara, F | 1 |
| Madrid, R | 1 |
| Colombo, M | 1 |
| Kittoe, K | 1 |
| Baumgartner, G | 1 |
| Stern, P | 1 |
| Kuljak, S | 1 |
| Cairns, JE | 1 |
| Williams, HP | 1 |
| Pollycove, M | 1 |
| Kamm, G | 1 |
| Petera, V | 1 |
| Lahn, V | 1 |
| Virt, S | 1 |
| Voleníková, L | 1 |
| Kohout, J | 1 |
| Fischer, M | 1 |
| Hayek, H | 1 |
| Schenck, W | 1 |
| Bauer, B | 1 |
| Künzer, W | 1 |
| Hansen, J | 1 |
| Patston, V | 1 |
| Julien, C | 1 |
| Caroli, J | 1 |
| Valla, A | 1 |
| Pousset, JL | 1 |
| Procházka, J | 1 |
| Gebert, P | 1 |
| Weinmann, H | 1 |
| Takagi, H | 1 |
| Okamura, S | 1 |
| Maehashi, M | 1 |
| Kekki, M | 1 |
| Koskelo, P | 1 |
| Nikkilä, EA | 1 |
| Rice, EW | 1 |
| Karp, M | 1 |
| Lurie, M | 1 |
| Yonis, Z | 1 |
| Chromy, K | 1 |
| Sorensen, LB | 1 |
| Kappas, A | 1 |
| Barraquer-Bordas, L | 1 |
| Tolosa, E | 1 |
| Grau-Veciana, JM | 1 |
| Salisachs-Rowe, P | 1 |
| Tavolato, B | 1 |
| De Zanche, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicentre, Retrospective and Prospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment With Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine[NCT02426905] | Phase 4 | 90 participants (Anticipated) | Interventional | 2016-01-31 | Active, not recruiting | ||
| CHELATE STUDY: Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease[NCT03539952] | Phase 3 | 77 participants (Actual) | Interventional | 2018-09-03 | Completed | ||
| Phase3, Open-Label, Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.[NCT00212355] | Phase 3 | 37 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
| Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease[NCT01472874] | 8 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
| [NCT00004338] | Phase 4 | 300 participants | Interventional | 1993-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
24-hour urinary copper excretion (μg/ 24 hr) from urine collected by the patient over a 24-hour period. (NCT03539952)
Timeframe: Week 36
| Intervention | μg/24 hours (Mean) |
|---|---|
| TETA 4HCL | 274.5 |
| Penicillamine | 510.8 |
"The clinician will rate the change in the patient's Wilson's disease relative to the prior study clinic visit using a 7-point scale to a specific statement: 'Please rate the change in the overall severity of the patients Wilson's disease compared to the previous study clinic visit.~Available options were (1) very much improved; (2) much improved; (3) minimally improved; (4) no change; (5) minimally worse; (6), much worse; or (7) very much worse." (NCT03539952)
Timeframe: Week 36
| Intervention | score on a scale (Mean) |
|---|---|
| Penicillamine | 4.1 |
| TETA 4HCL | 3.9 |
The primary outcome of efficacy was serum NCC by speciation assay (μg/L), with comparative analysis of mean difference between the two groups 24 weeks after randomization. The non-inferiority margin was set at -50 μg/L. (NCT03539952)
Timeframe: Week 36
| Intervention | µg/L (Mean) |
|---|---|
| Penicillamine Arm | 46.5 |
| TETA 4HCL Arm | 58.7 |
Number of patients who have at least one adverse events. ALT Change (NCT00212355)
Timeframe: During study period (up to 96W )
| Intervention | participants (Number) |
|---|---|
| NPC-02 | 37 |
(NCT01472874)
Timeframe: Months 1,2,3,6,9,12 (mean)
| Intervention | g/dL (Mean) |
|---|---|
| Once a Day Trientine | 0.52 |
(NCT01472874)
Timeframe: Pre Treatment (mean)
| Intervention | g/dL (Mean) |
|---|---|
| Once a Day Trientine | 0.54 |
Alanine transaminase (NCT01472874)
Timeframe: Months 1,2,3,6,9,12 (mean)
| Intervention | U/L (Mean) |
|---|---|
| Once a Day Trientine | 50.89 |
Alanine transaminase (NCT01472874)
Timeframe: Pre Treatment (mean)
| Intervention | U/L (Mean) |
|---|---|
| Once a Day Trientine | 41.38 |
(NCT01472874)
Timeframe: Months 1,2,3,6,9,12 (mean)
| Intervention | mcg/24h (Mean) |
|---|---|
| Once a Day Trientine | 0.52 |
(NCT01472874)
Timeframe: Pre Treatment (mean)
| Intervention | mcg/24h (Mean) |
|---|---|
| Once a Day Trientine | 0.54 |
(NCT01472874)
Timeframe: Months 1,2,3,6,9,12 (mean)
| Intervention | mcg/24hr (Mean) |
|---|---|
| Once a Day Trientine | 313.4 |
(NCT01472874)
Timeframe: Pre Treatment (mean)
| Intervention | mcg/24hr (Mean) |
|---|---|
| Once a Day Trientine | 287.9 |
The International Normalized Ratio (INR) is a standard way to describe the time it takes for blood to clot; an INR range of 0.8 to 1.2 is considered normal for a healthy person who is not using oral anticoagulant therapy (NCT01472874)
Timeframe: Months 1,2,3,6,9,12 (mean)
| Intervention | international normalized ratio (Mean) |
|---|---|
| Once a Day Trientine | 1.05 |
The International Normalized Ratio (INR) is a standard way to describe the time it takes for blood to clot; an INR range of 0.8 to 1.2 is considered normal for a healthy person who is not using oral anticoagulant therapy (NCT01472874)
Timeframe: Pre Treatment (mean)
| Intervention | international normalized ratio (Mean) |
|---|---|
| Once a Day Trientine | 0.99 |
(NCT01472874)
Timeframe: Months 1,2,3,6,9,12 (mean)
| Intervention | mcg/24hr (Mean) |
|---|---|
| Once a Day Trientine | 2214 |
(NCT01472874)
Timeframe: Pre Treatment (mean)
| Intervention | mcg/24hr (Mean) |
|---|---|
| Once a Day Trientine | 1959 |
106 reviews available for penicillamine and Hepatolenticular Degeneration
| Article | Year |
|---|---|
Rare co-occurrence of multiple sclerosis and Wilson's disease - case report.
Topics: Copper; Hepatolenticular Degeneration; Humans; Multiple Sclerosis; Penicillamine; Quality of Life | 2022 |
Rare co-occurrence of multiple sclerosis and Wilson's disease - case report.
Topics: Copper; Hepatolenticular Degeneration; Humans; Multiple Sclerosis; Penicillamine; Quality of Life | 2022 |
Wilson Disease in Children.
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine | 2022 |
Wilson Disease in Children.
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine | 2022 |
[Wilson's disease: overview].
Topics: Ceruloplasmin; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 2023 |
[Wilson's disease: overview].
Topics: Ceruloplasmin; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 2023 |
Early neurological deterioration in Wilson's disease: a systematic literature review and meta-analysis.
Topics: Copper; Hepatolenticular Degeneration; Humans; Nervous System Diseases; Penicillamine; Trientine | 2023 |
Early neurological deterioration in Wilson's disease: a systematic literature review and meta-analysis.
Topics: Copper; Hepatolenticular Degeneration; Humans; Nervous System Diseases; Penicillamine; Trientine | 2023 |
[Diagnosis and treatment of Wilson disease in Japan].
Topics: Adolescent; Adult; Biomarkers; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Copper; Cop | 2019 |
[Diagnosis and treatment of Wilson disease in Japan].
Topics: Adolescent; Adult; Biomarkers; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Copper; Cop | 2019 |
Fulminant Wilson Disease in Children: Recovery After Plasma Exchange Without Transplantation.
Topics: Adolescent; Child; Female; Hepatolenticular Degeneration; Humans; Liver Failure, Acute; Liver Transp | 2020 |
Fulminant Wilson Disease in Children: Recovery After Plasma Exchange Without Transplantation.
Topics: Adolescent; Child; Female; Hepatolenticular Degeneration; Humans; Liver Failure, Acute; Liver Transp | 2020 |
Co-occurring Wilson's disease and non-penicillamine-induced systematic lupus erythematosus: a case report and literature review.
Topics: Adolescent; Copper; Female; Hepatolenticular Degeneration; Humans; Lupus Erythematosus, Systemic; Ma | 2021 |
Co-occurring Wilson's disease and non-penicillamine-induced systematic lupus erythematosus: a case report and literature review.
Topics: Adolescent; Copper; Female; Hepatolenticular Degeneration; Humans; Lupus Erythematosus, Systemic; Ma | 2021 |
[Advances in the treatment of Wilson Disease].
Topics: Genetic Therapy; Hepatolenticular Degeneration; Humans; Liver Transplantation; Penicillamine; Zinc | 2021 |
[Advances in the treatment of Wilson Disease].
Topics: Genetic Therapy; Hepatolenticular Degeneration; Humans; Liver Transplantation; Penicillamine; Zinc | 2021 |
Wilson disease - currently used anticopper therapy.
Topics: Chelating Agents; Copper; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Molybdenum; Peni | 2017 |
Wilson disease - currently used anticopper therapy.
Topics: Chelating Agents; Copper; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Molybdenum; Peni | 2017 |
Wilson Disease: Diagnosis, Treatment, and Follow-up.
Topics: Aftercare; Biopsy; Ceruloplasmin; Chelating Agents; Copper; Copper-Transporting ATPases; Disease Man | 2017 |
Wilson Disease: Diagnosis, Treatment, and Follow-up.
Topics: Aftercare; Biopsy; Ceruloplasmin; Chelating Agents; Copper; Copper-Transporting ATPases; Disease Man | 2017 |
[Wilson's disease : What has been confirmed in diagnostic and therapy?]
Topics: Chelating Agents; Chromosome Aberrations; Copper; Diet Therapy; Genes, Recessive; Hepatolenticular D | 2017 |
[Wilson's disease : What has been confirmed in diagnostic and therapy?]
Topics: Chelating Agents; Chromosome Aberrations; Copper; Diet Therapy; Genes, Recessive; Hepatolenticular D | 2017 |
Elastosis perforans serpiginosa: causes and associated disorders.
Topics: Adult; Animals; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Skin | 2018 |
Elastosis perforans serpiginosa: causes and associated disorders.
Topics: Adult; Animals; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Skin | 2018 |
Wilson's Disease: A Review for the General Pediatrician.
Topics: Chelating Agents; Child; Child, Preschool; Copper; Hepatolenticular Degeneration; Humans; Pediatrici | 2018 |
Wilson's Disease: A Review for the General Pediatrician.
Topics: Chelating Agents; Child; Child, Preschool; Copper; Hepatolenticular Degeneration; Humans; Pediatrici | 2018 |
Liver pathology in Wilson's disease: From copper overload to cirrhosis.
Topics: Copper; Copper-Transporting ATPases; Epigenesis, Genetic; Hepatolenticular Degeneration; Humans; Liv | 2019 |
Liver pathology in Wilson's disease: From copper overload to cirrhosis.
Topics: Copper; Copper-Transporting ATPases; Epigenesis, Genetic; Hepatolenticular Degeneration; Humans; Liv | 2019 |
Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver; Molybdenum; Penicillamine; R | 2019 |
Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver; Molybdenum; Penicillamine; R | 2019 |
[Wilson's disease in the child: apropos of 20 cases].
Topics: Adolescent; Anemia, Hemolytic; Ceruloplasmin; Chelation Therapy; Child; Child, Preschool; Consanguin | 2013 |
[Wilson's disease in the child: apropos of 20 cases].
Topics: Adolescent; Anemia, Hemolytic; Ceruloplasmin; Chelation Therapy; Child; Child, Preschool; Consanguin | 2013 |
Inborn errors of copper metabolism.
Topics: Chelating Agents; Child; Copper; Cutis Laxa; Ehlers-Danlos Syndrome; Hepatolenticular Degeneration; | 2013 |
Inborn errors of copper metabolism.
Topics: Chelating Agents; Child; Copper; Cutis Laxa; Ehlers-Danlos Syndrome; Hepatolenticular Degeneration; | 2013 |
The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
Topics: Brain; Chelating Agents; Copper; Cornea; Dimercaprol; Drug Discovery; Hepatolenticular Degeneration; | 2013 |
The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
Topics: Brain; Chelating Agents; Copper; Cornea; Dimercaprol; Drug Discovery; Hepatolenticular Degeneration; | 2013 |
[Wilsons disease].
Topics: Adenosine Triphosphatases; Adult; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transp | 2013 |
[Wilsons disease].
Topics: Adenosine Triphosphatases; Adult; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transp | 2013 |
Metal storage disorders: Wilson disease and hemochromatosis.
Topics: Biopsy; Chelating Agents; Disease Progression; Genetic Predisposition to Disease; Genetic Testing; H | 2014 |
Metal storage disorders: Wilson disease and hemochromatosis.
Topics: Biopsy; Chelating Agents; Disease Progression; Genetic Predisposition to Disease; Genetic Testing; H | 2014 |
Clinical considerations for an effective medical therapy in Wilson's disease.
Topics: Ceruloplasmin; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Molybdenum; Penicill | 2014 |
Clinical considerations for an effective medical therapy in Wilson's disease.
Topics: Ceruloplasmin; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Molybdenum; Penicill | 2014 |
Current Drug Managements of Wilson's Disease: From West to East.
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Medicine, Chinese Traditional; Moly | 2016 |
Current Drug Managements of Wilson's Disease: From West to East.
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Medicine, Chinese Traditional; Moly | 2016 |
The risks of free copper in the body and the development of useful anticopper drugs.
Topics: Alzheimer Disease; Angiogenesis Inhibitors; Autoimmunity; Copper; Fibrosis; Hepatolenticular Degener | 2008 |
The risks of free copper in the body and the development of useful anticopper drugs.
Topics: Alzheimer Disease; Angiogenesis Inhibitors; Autoimmunity; Copper; Fibrosis; Hepatolenticular Degener | 2008 |
D-penicillamine elastosis perforans serpiginosa: description of two cases and review of the literature.
Topics: Adult; Chelating Agents; Cryotherapy; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Sk | 2011 |
D-penicillamine elastosis perforans serpiginosa: description of two cases and review of the literature.
Topics: Adult; Chelating Agents; Cryotherapy; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Sk | 2011 |
Chelation therapy in Wilson's disease: from D-penicillamine to the design of selective bioinspired intracellular Cu(I) chelators.
Topics: Animals; Biomimetics; Chelating Agents; Copper; Drug Design; Hepatolenticular Degeneration; Humans; | 2012 |
Chelation therapy in Wilson's disease: from D-penicillamine to the design of selective bioinspired intracellular Cu(I) chelators.
Topics: Animals; Biomimetics; Chelating Agents; Copper; Drug Design; Hepatolenticular Degeneration; Humans; | 2012 |
Wilson's disease.
Topics: Adolescent; Biopsy, Needle; Blood Chemical Analysis; Child; Child, Preschool; Combined Modality Ther | 2002 |
Wilson's disease.
Topics: Adolescent; Biopsy, Needle; Blood Chemical Analysis; Child; Child, Preschool; Combined Modality Ther | 2002 |
[Rare, but important chronic liver diseases].
Topics: Adolescent; Adult; Biopsy; Ceruloplasmin; Chelating Agents; Child; Chronic Disease; Copper; Diabetes | 2002 |
[Rare, but important chronic liver diseases].
Topics: Adolescent; Adult; Biopsy; Ceruloplasmin; Chelating Agents; Child; Chronic Disease; Copper; Diabetes | 2002 |
[Wilson's disease: physiopathological, clinical and therapeutic considerations].
Topics: Adenosine Triphosphatases; Adolescent; Adult; Basal Ganglia Diseases; Brain; Cation Transport Protei | 2003 |
[Wilson's disease: physiopathological, clinical and therapeutic considerations].
Topics: Adenosine Triphosphatases; Adolescent; Adult; Basal Ganglia Diseases; Brain; Cation Transport Protei | 2003 |
Antiangiogenic therapy through copper chelation.
Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Chelation Therapy; Copper; Corneal Neovasculariz | 2003 |
Antiangiogenic therapy through copper chelation.
Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Chelation Therapy; Copper; Corneal Neovasculariz | 2003 |
Wilson disease.
Topics: Adenosine Triphosphatases; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver Tr | 2003 |
Wilson disease.
Topics: Adenosine Triphosphatases; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver Tr | 2003 |
[Wilson disease].
Topics: Adenosine Triphosphatases; Age of Onset; Biomarkers; Cation Transport Proteins; Ceruloplasmin; Chela | 2004 |
[Wilson disease].
Topics: Adenosine Triphosphatases; Age of Onset; Biomarkers; Cation Transport Proteins; Ceruloplasmin; Chela | 2004 |
[Wilson disease in 2003].
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transporting | 2003 |
[Wilson disease in 2003].
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transporting | 2003 |
[Wilson's disease and its pharmacological treatment].
Topics: Adenosine Triphosphatases; Biomarkers; Cation Transport Proteins; Ceruloplasmin; Chelating Agents; C | 2004 |
[Wilson's disease and its pharmacological treatment].
Topics: Adenosine Triphosphatases; Biomarkers; Cation Transport Proteins; Ceruloplasmin; Chelating Agents; C | 2004 |
Wilson's disease.
Topics: Copper; Hepatolenticular Degeneration; Humans; Liver; Liver Transplantation; Mutation; Penicillamine | 1998 |
Wilson's disease.
Topics: Copper; Hepatolenticular Degeneration; Humans; Liver; Liver Transplantation; Mutation; Penicillamine | 1998 |
Wilson disease: new insights into pathogenesis, diagnosis, and future therapy.
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Cell Transplantation; Copper-Transporting ATPa | 2005 |
Wilson disease: new insights into pathogenesis, diagnosis, and future therapy.
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Cell Transplantation; Copper-Transporting ATPa | 2005 |
Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
Topics: Behavior; Chelating Agents; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Molybdenum; Ne | 2005 |
Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
Topics: Behavior; Chelating Agents; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Molybdenum; Ne | 2005 |
A case study: identifying a new case of Wilson's disease.
Topics: Abdominal Pain; Adult; Chelating Agents; Diagnosis, Differential; Drug Monitoring; Drug Therapy, Com | 2005 |
A case study: identifying a new case of Wilson's disease.
Topics: Abdominal Pain; Adult; Chelating Agents; Diagnosis, Differential; Drug Monitoring; Drug Therapy, Com | 2005 |
Novel therapeutic approaches to the treatment of Wilson's disease.
Topics: Chelating Agents; Child; Child, Preschool; Clinical Trials as Topic; Copper; Female; Hepatolenticula | 2006 |
Novel therapeutic approaches to the treatment of Wilson's disease.
Topics: Chelating Agents; Child; Child, Preschool; Clinical Trials as Topic; Copper; Female; Hepatolenticula | 2006 |
[Wilson disease: an update].
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Copper; Copper-Transporting ATPases; Diagnosis | 2006 |
[Wilson disease: an update].
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Copper; Copper-Transporting ATPases; Diagnosis | 2006 |
Wilson's disease.
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver Transplantation; Penicillamin | 2007 |
Wilson's disease.
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver Transplantation; Penicillamin | 2007 |
Wilson disease--a practical approach to diagnosis, treatment and follow-up.
Topics: Ceruloplasmin; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver Transplantatio | 2007 |
Wilson disease--a practical approach to diagnosis, treatment and follow-up.
Topics: Ceruloplasmin; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver Transplantatio | 2007 |
[D(-)penicillamine: pharmacology and clinical uses].
Topics: Arthritis, Rheumatoid; Hepatolenticular Degeneration; Humans; Huntington Disease; Lead Poisoning; Li | 1982 |
[D(-)penicillamine: pharmacology and clinical uses].
Topics: Arthritis, Rheumatoid; Hepatolenticular Degeneration; Humans; Huntington Disease; Lead Poisoning; Li | 1982 |
Copper and the liver.
Topics: Acute Disease; Adult; Age Factors; Animals; Bufo marinus; Carcinoma, Hepatocellular; Chemical and Dr | 1980 |
Copper and the liver.
Topics: Acute Disease; Adult; Age Factors; Animals; Bufo marinus; Carcinoma, Hepatocellular; Chemical and Dr | 1980 |
Oral zinc therapy for Wilson's disease.
Topics: Administration, Oral; Adult; Animals; Copper; Female; Hepatolenticular Degeneration; Humans; Male; P | 1984 |
Oral zinc therapy for Wilson's disease.
Topics: Administration, Oral; Adult; Animals; Copper; Female; Hepatolenticular Degeneration; Humans; Male; P | 1984 |
[Current problems in Wilson's disease].
Topics: Basal Ganglia; Ceruloplasmin; Copper; Cornea; Hepatolenticular Degeneration; Humans; Kidney; Liver; | 1984 |
[Current problems in Wilson's disease].
Topics: Basal Ganglia; Ceruloplasmin; Copper; Cornea; Hepatolenticular Degeneration; Humans; Kidney; Liver; | 1984 |
[Wilson's disease (hepatolenticular degeneration)].
Topics: Adolescent; Adult; Anemia, Hemolytic; Central Nervous System Diseases; Child; Combined Modality Ther | 1984 |
[Wilson's disease (hepatolenticular degeneration)].
Topics: Adolescent; Adult; Anemia, Hemolytic; Central Nervous System Diseases; Child; Combined Modality Ther | 1984 |
Screening asymptomatic family members for Wilson's disease.
Topics: Adolescent; Ceruloplasmin; Copper; Female; Genetic Carrier Screening; Genetic Testing; Hepatolenticu | 1982 |
Screening asymptomatic family members for Wilson's disease.
Topics: Adolescent; Ceruloplasmin; Copper; Female; Genetic Carrier Screening; Genetic Testing; Hepatolenticu | 1982 |
[Wilson's disease. II].
Topics: Adolescent; Bone Diseases; Ceruloplasmin; Child; Copper; Eye Diseases; Female; Hematologic Diseases; | 1982 |
[Wilson's disease. II].
Topics: Adolescent; Bone Diseases; Ceruloplasmin; Child; Copper; Eye Diseases; Female; Hematologic Diseases; | 1982 |
Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Captopril; Cystinuria; Hepatolenticular Degeneration; Hu | 1981 |
Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Captopril; Cystinuria; Hepatolenticular Degeneration; Hu | 1981 |
[Lupus erythematosus and liver diseases].
Topics: Autoimmune Diseases; Budd-Chiari Syndrome; Chelating Agents; Hepatitis; Hepatitis, Chronic; Hepatole | 1995 |
[Lupus erythematosus and liver diseases].
Topics: Autoimmune Diseases; Budd-Chiari Syndrome; Chelating Agents; Hepatitis; Hepatitis, Chronic; Hepatole | 1995 |
Wilson's disease. Psychiatric manifestations may be the clinical presentation.
Topics: Clonazepam; Copper; Cornea; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; Liver Fu | 1994 |
Wilson's disease. Psychiatric manifestations may be the clinical presentation.
Topics: Clonazepam; Copper; Cornea; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; Liver Fu | 1994 |
Wilson disease.
Topics: Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Liver; Penicillamine; Sulfates; Zinc C | 1993 |
Wilson disease.
Topics: Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Liver; Penicillamine; Sulfates; Zinc C | 1993 |
Geographic variations in Wilson's disease.
Topics: Adolescent; Adult; Brain Diseases, Metabolic; Carcinoma, Hepatocellular; China; Comorbidity; Consang | 1993 |
Geographic variations in Wilson's disease.
Topics: Adolescent; Adult; Brain Diseases, Metabolic; Carcinoma, Hepatocellular; China; Comorbidity; Consang | 1993 |
Practical recommendations and new therapies for Wilson's disease.
Topics: Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Metallothionein; Mol | 1995 |
Practical recommendations and new therapies for Wilson's disease.
Topics: Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Metallothionein; Mol | 1995 |
[Wilson's disease].
Topics: Adolescent; Adult; Chelating Agents; Child; Chromosomes, Human, Pair 13; Diagnosis, Differential; He | 1996 |
[Wilson's disease].
Topics: Adolescent; Adult; Chelating Agents; Child; Chromosomes, Human, Pair 13; Diagnosis, Differential; He | 1996 |
Wilson disease: genetic basis of copper toxicity and natural history.
Topics: Adenosine Triphosphatases; Carrier Proteins; Cation Transport Proteins; Chelating Agents; Chelation | 1996 |
Wilson disease: genetic basis of copper toxicity and natural history.
Topics: Adenosine Triphosphatases; Carrier Proteins; Cation Transport Proteins; Chelating Agents; Chelation | 1996 |
Wilson's disease: an update.
Topics: Copper; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; Liver Function Tests; Neurol | 1995 |
Wilson's disease: an update.
Topics: Copper; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; Liver Function Tests; Neurol | 1995 |
Penicillamine-induced degenerative dermatoses: report of a case and brief review of such dermatoses.
Topics: Adult; Chelating Agents; Collagen; Drug Eruptions; Elastic Tissue; Hepatolenticular Degeneration; Hu | 1997 |
Penicillamine-induced degenerative dermatoses: report of a case and brief review of such dermatoses.
Topics: Adult; Chelating Agents; Collagen; Drug Eruptions; Elastic Tissue; Hepatolenticular Degeneration; Hu | 1997 |
[Wilson disease].
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Biomarkers; Ceruloplasmin; Chelating Agents; Copp | 1998 |
[Wilson disease].
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Biomarkers; Ceruloplasmin; Chelating Agents; Copp | 1998 |
[Type-III hyperlipoproteinemia in a girl with Wilson's disease].
Topics: Biopsy; Child; Female; Hepatolenticular Degeneration; Humans; Hyperlipoproteinemia Type III; Lipopro | 1999 |
[Type-III hyperlipoproteinemia in a girl with Wilson's disease].
Topics: Biopsy; Child; Female; Hepatolenticular Degeneration; Humans; Hyperlipoproteinemia Type III; Lipopro | 1999 |
[Therapy of Wilson disease].
Topics: Adolescent; Adult; Ceruloplasmin; Chelating Agents; Child; Copper; Female; Hepatolenticular Degenera | 1999 |
[Therapy of Wilson disease].
Topics: Adolescent; Adult; Ceruloplasmin; Chelating Agents; Child; Copper; Female; Hepatolenticular Degenera | 1999 |
Treatment and management of Wilson's disease.
Topics: Chelating Agents; Chelation Therapy; Copper; Hepatolenticular Degeneration; Humans; Liver; Liver Tra | 1999 |
Treatment and management of Wilson's disease.
Topics: Chelating Agents; Chelation Therapy; Copper; Hepatolenticular Degeneration; Humans; Liver; Liver Tra | 1999 |
Recognition, diagnosis, and management of Wilson's disease.
Topics: Adolescent; Adult; Chelating Agents; Child; Copper; Hepatolenticular Degeneration; Humans; Penicilla | 2000 |
Recognition, diagnosis, and management of Wilson's disease.
Topics: Adolescent; Adult; Chelating Agents; Child; Copper; Hepatolenticular Degeneration; Humans; Penicilla | 2000 |
Wilson's disease and pregnancy.
Topics: Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Pregnancy | 2000 |
Wilson's disease and pregnancy.
Topics: Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Pregnancy | 2000 |
Wilson's disease with superimposed autoimmune features: report of two cases and review.
Topics: Adolescent; Adult; Azathioprine; Copper; Diagnostic Errors; Female; Glucocorticoids; Hepatitis, Auto | 2000 |
Wilson's disease with superimposed autoimmune features: report of two cases and review.
Topics: Adolescent; Adult; Azathioprine; Copper; Diagnostic Errors; Female; Glucocorticoids; Hepatitis, Auto | 2000 |
Wilson's disease.
Topics: Adenosine Triphosphatases; Adult; Carrier Proteins; Cation Transport Proteins; Chelating Agents; Chi | 2000 |
Wilson's disease.
Topics: Adenosine Triphosphatases; Adult; Carrier Proteins; Cation Transport Proteins; Chelating Agents; Chi | 2000 |
Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
Topics: Adenosine Triphosphatases; Chelating Agents; Drug Therapy, Combination; Female; Hepatolenticular Deg | 2001 |
Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
Topics: Adenosine Triphosphatases; Chelating Agents; Drug Therapy, Combination; Female; Hepatolenticular Deg | 2001 |
Diagnosis and treatment of Wilson's disease.
Topics: Chelating Agents; Copper; Dimercaprol; Enzyme Inhibitors; Female; Hepatolenticular Degeneration; Hum | 2002 |
Diagnosis and treatment of Wilson's disease.
Topics: Chelating Agents; Copper; Dimercaprol; Enzyme Inhibitors; Female; Hepatolenticular Degeneration; Hum | 2002 |
Brief observations on the management of Wilson's disease.
Topics: Chelating Agents; Hepatolenticular Degeneration; Humans; Penicillamine; Pyridoxine | 1977 |
Brief observations on the management of Wilson's disease.
Topics: Chelating Agents; Hepatolenticular Degeneration; Humans; Penicillamine; Pyridoxine | 1977 |
Penicillamine-induced arthropathy in Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Joint Diseases; Penicillamine | 1977 |
Penicillamine-induced arthropathy in Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Joint Diseases; Penicillamine | 1977 |
Hepatolenticular degeneration (Wilson's disease) and pregnancy. A review and report of a case.
Topics: Adolescent; Adult; Animals; Ceruloplasmin; Copper; Estrogens; Female; Fertility; Hepatolenticular De | 1977 |
Hepatolenticular degeneration (Wilson's disease) and pregnancy. A review and report of a case.
Topics: Adolescent; Adult; Animals; Ceruloplasmin; Copper; Estrogens; Female; Fertility; Hepatolenticular De | 1977 |
Red cell aplasia following prolonged D-penicillamine therapy.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow; Bone Marrow Cells; Chelating Agents; Child; Child, | 1976 |
Red cell aplasia following prolonged D-penicillamine therapy.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow; Bone Marrow Cells; Chelating Agents; Child; Child, | 1976 |
[Hepatolenticular degeneration: biochemical and therapeutic considerations].
Topics: Adrenal Cortex Hormones; Brain; Ceruloplasmin; Chelating Agents; Copper; Dimercaprol; Edetic Acid; H | 1976 |
[Hepatolenticular degeneration: biochemical and therapeutic considerations].
Topics: Adrenal Cortex Hormones; Brain; Ceruloplasmin; Chelating Agents; Copper; Dimercaprol; Edetic Acid; H | 1976 |
The development of cirrhosis in Wilson's disease.
Topics: Ceruloplasmin; Copper; Cornea; Cytosol; Hepatolenticular Degeneration; Humans; Liver; Liver Cirrhosi | 1975 |
The development of cirrhosis in Wilson's disease.
Topics: Ceruloplasmin; Copper; Cornea; Cytosol; Hepatolenticular Degeneration; Humans; Liver; Liver Cirrhosi | 1975 |
Wilson's disease. A treatable liver disease in children.
Topics: Adolescent; Adult; Age Factors; Ceruloplasmin; Child; Child, Preschool; Copper; Diagnosis, Different | 1975 |
Wilson's disease. A treatable liver disease in children.
Topics: Adolescent; Adult; Age Factors; Ceruloplasmin; Child; Child, Preschool; Copper; Diagnosis, Different | 1975 |
[Effects and adverse effects of D-penicillamine].
Topics: Bone Marrow Diseases; Chronic Disease; Cystinuria; Erythropoiesis; Hepatitis; Hepatolenticular Degen | 1975 |
[Effects and adverse effects of D-penicillamine].
Topics: Bone Marrow Diseases; Chronic Disease; Cystinuria; Erythropoiesis; Hepatitis; Hepatolenticular Degen | 1975 |
Hepatocellular carcinoma in a case of Wilson's disease.
Topics: Adult; Carcinoma, Hepatocellular; Female; Hepatolenticular Degeneration; Humans; Liver; Liver Neopla | 1992 |
Hepatocellular carcinoma in a case of Wilson's disease.
Topics: Adult; Carcinoma, Hepatocellular; Female; Hepatolenticular Degeneration; Humans; Liver; Liver Neopla | 1992 |
[Wilson's disease].
Topics: Acetates; Acetic Acid; Adult; Diagnosis, Differential; Diet; Female; Hepatolenticular Degeneration; | 1992 |
[Wilson's disease].
Topics: Acetates; Acetic Acid; Adult; Diagnosis, Differential; Diet; Female; Hepatolenticular Degeneration; | 1992 |
Wilson's disease: current status.
Topics: Administration, Oral; Ceruloplasmin; Copper; Copper Radioisotopes; Drug Monitoring; Genetic Testing; | 1992 |
Wilson's disease: current status.
Topics: Administration, Oral; Ceruloplasmin; Copper; Copper Radioisotopes; Drug Monitoring; Genetic Testing; | 1992 |
[Wilson's disease with primary CNS manifestation--current status in diagnosis and therapy].
Topics: Adolescent; Adult; Basal Ganglia Diseases; Brain; Female; Hepatolenticular Degeneration; Humans; Mag | 1992 |
[Wilson's disease with primary CNS manifestation--current status in diagnosis and therapy].
Topics: Adolescent; Adult; Basal Ganglia Diseases; Brain; Female; Hepatolenticular Degeneration; Humans; Mag | 1992 |
D-penicillamine.
Topics: Child; Hepatolenticular Degeneration; Humans; India; Liver Cirrhosis; Penicillamine | 1991 |
D-penicillamine.
Topics: Child; Hepatolenticular Degeneration; Humans; India; Liver Cirrhosis; Penicillamine | 1991 |
Copper and liver disease.
Topics: Adult; Chelating Agents; Child; Cholestasis; Copper; Hepatolenticular Degeneration; Humans; Infant; | 1991 |
Copper and liver disease.
Topics: Adult; Chelating Agents; Child; Cholestasis; Copper; Hepatolenticular Degeneration; Humans; Infant; | 1991 |
Wilson's disease.
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Pregnancy | 1989 |
Wilson's disease.
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Pregnancy | 1989 |
Wilson's disease: an update, with emphasis on new approaches to treatment.
Topics: Copper; Female; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Pregnancy; Trienti | 1989 |
Wilson's disease: an update, with emphasis on new approaches to treatment.
Topics: Copper; Female; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Pregnancy; Trienti | 1989 |
Wilson's disease: yesterday, today, and tomorrow.
Topics: Brain; Female; Hepatolenticular Degeneration; History, 20th Century; Humans; Male; Penicillamine; To | 1988 |
Wilson's disease: yesterday, today, and tomorrow.
Topics: Brain; Female; Hepatolenticular Degeneration; History, 20th Century; Humans; Male; Penicillamine; To | 1988 |
Management of an oroantral fistula in a patient with Wilson's disease: case report and review of the literature.
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Molar, Third; Oroantral Fistula; Penicillamine; | 1988 |
Management of an oroantral fistula in a patient with Wilson's disease: case report and review of the literature.
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Molar, Third; Oroantral Fistula; Penicillamine; | 1988 |
[Current aspects of D-penicillamine and pregnancy].
Topics: Abnormalities, Drug-Induced; Arthritis, Rheumatoid; Cystinuria; Female; Hepatolenticular Degeneratio | 1988 |
[Current aspects of D-penicillamine and pregnancy].
Topics: Abnormalities, Drug-Induced; Arthritis, Rheumatoid; Cystinuria; Female; Hepatolenticular Degeneratio | 1988 |
[Hepatolenticular degeneration. Apropos of 102 cases].
Topics: Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1987 |
[Hepatolenticular degeneration. Apropos of 102 cases].
Topics: Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1987 |
Treatment of Wilson's disease.
Topics: Copper; Ethylenediamines; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; T | 1987 |
Treatment of Wilson's disease.
Topics: Copper; Ethylenediamines; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; T | 1987 |
[D-penicillamine and collagen].
Topics: Aminopropionitrile; Arthritis, Rheumatoid; Autoantibodies; Bronchi; Cicatrix; Collagen; Collagen Dis | 1986 |
[D-penicillamine and collagen].
Topics: Aminopropionitrile; Arthritis, Rheumatoid; Autoantibodies; Bronchi; Cicatrix; Collagen; Collagen Dis | 1986 |
Wilson's disease and copper metabolism--a review.
Topics: Brain; Ceruloplasmin; Child; Copper; Cornea; Hepatolenticular Degeneration; Humans; India; Kidney; L | 1985 |
Wilson's disease and copper metabolism--a review.
Topics: Brain; Ceruloplasmin; Child; Copper; Cornea; Hepatolenticular Degeneration; Humans; India; Kidney; L | 1985 |
The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders.
Topics: Chelating Agents; Copper; Diet; Hepatolenticular Degeneration; Humans; Liver Cirrhosis, Biliary; Pen | 1985 |
The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders.
Topics: Chelating Agents; Copper; Diet; Hepatolenticular Degeneration; Humans; Liver Cirrhosis, Biliary; Pen | 1985 |
[Advances in the study of hepatolenticular degeneration].
Topics: Ceruloplasmin; Copper; Dimercaprol; Hepatolenticular Degeneration; Humans; Liver Transplantation; Pe | 1985 |
[Advances in the study of hepatolenticular degeneration].
Topics: Ceruloplasmin; Copper; Dimercaprol; Hepatolenticular Degeneration; Humans; Liver Transplantation; Pe | 1985 |
[10 years of penicillamine].
Topics: Cystinuria; Drug Eruptions; Gold; Hepatolenticular Degeneration; Humans; Lead Poisoning; Leukopenia; | 1966 |
[10 years of penicillamine].
Topics: Cystinuria; Drug Eruptions; Gold; Hepatolenticular Degeneration; Humans; Lead Poisoning; Leukopenia; | 1966 |
Penicillamine and analogous chelating agents.
Topics: Acetates; Amino Acid Oxidoreductases; Animals; Chelating Agents; Copper; Cysteine; D-Amino-Acid Oxid | 1971 |
Penicillamine and analogous chelating agents.
Topics: Acetates; Amino Acid Oxidoreductases; Animals; Chelating Agents; Copper; Cysteine; D-Amino-Acid Oxid | 1971 |
[Therapeutic use of d-penicillamine].
Topics: Arthritis, Rheumatoid; Basement Membrane; Collagen; Copper; Cystinuria; Hematopoiesis; Hepatolenticu | 1972 |
[Therapeutic use of d-penicillamine].
Topics: Arthritis, Rheumatoid; Basement Membrane; Collagen; Copper; Cystinuria; Hematopoiesis; Hepatolenticu | 1972 |
Introduction. Symposium on copper metabolism and Wilson's disease.
Topics: Ceruloplasmin; Consanguinity; Copper; Diet Therapy; Dimercaprol; Hepatolenticular Degeneration; Huma | 1974 |
Introduction. Symposium on copper metabolism and Wilson's disease.
Topics: Ceruloplasmin; Consanguinity; Copper; Diet Therapy; Dimercaprol; Hepatolenticular Degeneration; Huma | 1974 |
[Long-term therapy of liver diseases].
Topics: Aged; Anabolic Agents; Chronic Disease; Cortisone; Diet Therapy; Fatty Liver; Female; Fluorouracil; | 1972 |
[Long-term therapy of liver diseases].
Topics: Aged; Anabolic Agents; Chronic Disease; Cortisone; Diet Therapy; Fatty Liver; Female; Fluorouracil; | 1972 |
Penicillamine.
Topics: Animals; Collagen Diseases; Darier Disease; Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
Penicillamine.
Topics: Animals; Collagen Diseases; Darier Disease; Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
[New views on the etiology, diagnosis and therapy of Wilson's disease].
Topics: Ceruloplasmin; Copper; Diagnosis, Differential; Diet Therapy; Hepatolenticular Degeneration; Humans; | 1967 |
[New views on the etiology, diagnosis and therapy of Wilson's disease].
Topics: Ceruloplasmin; Copper; Diagnosis, Differential; Diet Therapy; Hepatolenticular Degeneration; Humans; | 1967 |
Copper and taste sensitivity.
Topics: Arthritis, Rheumatoid; Ceruloplasmin; Copper; Cystinuria; Depression, Chemical; Hepatolenticular Deg | 1968 |
Copper and taste sensitivity.
Topics: Arthritis, Rheumatoid; Ceruloplasmin; Copper; Cystinuria; Depression, Chemical; Hepatolenticular Deg | 1968 |
[Hepatolenticular degeneration. Wilson's disease].
Topics: Age Factors; Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Penicill | 1969 |
[Hepatolenticular degeneration. Wilson's disease].
Topics: Age Factors; Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Penicill | 1969 |
Continuing the copper saga.
Topics: Adult; Animals; Brain Diseases; Copper; Diet; Female; Gastrointestinal Diseases; Hepatolenticular De | 1970 |
Continuing the copper saga.
Topics: Adult; Animals; Brain Diseases; Copper; Diet; Female; Gastrointestinal Diseases; Hepatolenticular De | 1970 |
[Wilson's disease (hepatolenticular degeneration)].
Topics: Adolescent; Adult; Biopsy; Brain; Ceruloplasmin; Child; Copper; Dimercaprol; Edetic Acid; Hepatolent | 1966 |
[Wilson's disease (hepatolenticular degeneration)].
Topics: Adolescent; Adult; Biopsy; Brain; Ceruloplasmin; Child; Copper; Dimercaprol; Edetic Acid; Hepatolent | 1966 |
Treatment of hepatolenticular degeneration. (Wilson's disease).
Topics: Acute Disease; Ceruloplasmin; Copper; Diet Therapy; Dimercaprol; Edetic Acid; Ethinyl Estradiol; Hep | 1969 |
Treatment of hepatolenticular degeneration. (Wilson's disease).
Topics: Acute Disease; Ceruloplasmin; Copper; Diet Therapy; Dimercaprol; Edetic Acid; Ethinyl Estradiol; Hep | 1969 |
The physiology of copper in man and its relation to Wilson's disease.
Topics: Adolescent; Adult; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1967 |
The physiology of copper in man and its relation to Wilson's disease.
Topics: Adolescent; Adult; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1967 |
9 trials available for penicillamine and Hepatolenticular Degeneration
| Article | Year |
|---|---|
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
Topics: Adult; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine | 2022 |
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
Topics: Adult; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine | 2022 |
A study of susceptibility-weighted imaging in patients with Wilson disease during the treatment of metal chelator.
Topics: Adolescent; Adult; Chelating Agents; Copper; Female; Globus Pallidus; Hepatolenticular Degeneration; | 2020 |
A study of susceptibility-weighted imaging in patients with Wilson disease during the treatment of metal chelator.
Topics: Adolescent; Adult; Chelating Agents; Copper; Female; Globus Pallidus; Hepatolenticular Degeneration; | 2020 |
MR spectroscopy in monitoring the treatment of Wilson's disease patients.
Topics: Adolescent; Adult; Antidotes; Aspartic Acid; Brain; Case-Control Studies; Choline; Creatine; Female; | 2008 |
MR spectroscopy in monitoring the treatment of Wilson's disease patients.
Topics: Adolescent; Adult; Antidotes; Aspartic Acid; Brain; Case-Control Studies; Choline; Creatine; Female; | 2008 |
Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
Topics: Adolescent; Adult; Aged; Chelating Agents; Copper; Female; Glutathione; Hepatitis C; Hepatolenticula | 2003 |
Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
Topics: Adolescent; Adult; Aged; Chelating Agents; Copper; Female; Glutathione; Hepatitis C; Hepatolenticula | 2003 |
[Treatment of Wilson's disease with penicillamine and zinc salts: a follow-up study].
Topics: Adolescent; Antidotes; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatolenticular | 2003 |
[Treatment of Wilson's disease with penicillamine and zinc salts: a follow-up study].
Topics: Adolescent; Antidotes; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatolenticular | 2003 |
Wilson's disease: a clinico-neuropathological autopsy study.
Topics: Adolescent; Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antirheumatic Agents; Au | 2008 |
Wilson's disease: a clinico-neuropathological autopsy study.
Topics: Adolescent; Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antirheumatic Agents; Au | 2008 |
Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate.
Topics: Adult; Hepatolenticular Degeneration; Humans; Patient Compliance; Penicillamine; Time Factors; Treat | 1996 |
Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate.
Topics: Adult; Hepatolenticular Degeneration; Humans; Patient Compliance; Penicillamine; Time Factors; Treat | 1996 |
Proteinuria and other renal functions in Wilson's disease.
Topics: Acetylglucosamine; Adolescent; Chelating Agents; Child; Child, Preschool; Female; Glomerular Filtrat | 1997 |
Proteinuria and other renal functions in Wilson's disease.
Topics: Acetylglucosamine; Adolescent; Chelating Agents; Child; Child, Preschool; Female; Glomerular Filtrat | 1997 |
Hepatolenticular degeneration: the comparative effectiveness of d-penicillamine, potassium sulfide, and diethylditbiocarbamate as decoppering agents.
Topics: Adolescent; Child; Clinical Trials as Topic; Copper; Female; Hepatolenticular Degeneration; Humans; | 1966 |
Hepatolenticular degeneration: the comparative effectiveness of d-penicillamine, potassium sulfide, and diethylditbiocarbamate as decoppering agents.
Topics: Adolescent; Child; Clinical Trials as Topic; Copper; Female; Hepatolenticular Degeneration; Humans; | 1966 |
841 other studies available for penicillamine and Hepatolenticular Degeneration
| Article | Year |
|---|---|
Adherence to treatment, a challenge even in treatable metabolic rare diseases: A cross sectional study of Wilson's disease.
Topics: Adolescent; Adult; Anxiety; Chelating Agents; Child; Copper; Cross-Sectional Studies; Depression; Fe | 2021 |
Adherence to treatment, a challenge even in treatable metabolic rare diseases: A cross sectional study of Wilson's disease.
Topics: Adolescent; Adult; Anxiety; Chelating Agents; Child; Copper; Cross-Sectional Studies; Depression; Fe | 2021 |
Adverse Events with D-penicillamine Therapy in Hepatic Wilson's Disease: A Single-Center Retrospective Audit.
Topics: Chelating Agents; Hepatolenticular Degeneration; Humans; Penicillamine; Retrospective Studies; Trien | 2022 |
Adverse Events with D-penicillamine Therapy in Hepatic Wilson's Disease: A Single-Center Retrospective Audit.
Topics: Chelating Agents; Hepatolenticular Degeneration; Humans; Penicillamine; Retrospective Studies; Trien | 2022 |
Wilson disease in Northern Portugal: a long-term follow-up study.
Topics: Adult; Copper; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Portug | 2022 |
Wilson disease in Northern Portugal: a long-term follow-up study.
Topics: Adult; Copper; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Portug | 2022 |
Multicentre, retrospective study to assess long-term outcomes of chelator based treatment with trientine in Wilson disease patients withdrawn from therapy with d -penicillamine.
Topics: Chelating Agents; Hepatolenticular Degeneration; Humans; Penicillamine; Retrospective Studies; Trien | 2022 |
Multicentre, retrospective study to assess long-term outcomes of chelator based treatment with trientine in Wilson disease patients withdrawn from therapy with d -penicillamine.
Topics: Chelating Agents; Hepatolenticular Degeneration; Humans; Penicillamine; Retrospective Studies; Trien | 2022 |
Epidemiology, clinical features, and mortality rate of Wilson disease in Moroccan children: A pediatric case series.
Topics: Ceruloplasmin; Child; Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 2022 |
Epidemiology, clinical features, and mortality rate of Wilson disease in Moroccan children: A pediatric case series.
Topics: Ceruloplasmin; Child; Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 2022 |
Wilson's disease: neuropsychiatric presentation and delayed diagnosis.
Topics: Ataxia; Delayed Diagnosis; Female; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Penicilla | 2022 |
Wilson's disease: neuropsychiatric presentation and delayed diagnosis.
Topics: Ataxia; Delayed Diagnosis; Female; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Penicilla | 2022 |
Epidemiology, treatment and burden of Wilson disease in France: A 10-year analysis of the national health insurance database.
Topics: Adult; Aged; Aged, 80 and over; Copper; Hepatolenticular Degeneration; Humans; Middle Aged; National | 2022 |
Epidemiology, treatment and burden of Wilson disease in France: A 10-year analysis of the national health insurance database.
Topics: Adult; Aged; Aged, 80 and over; Copper; Hepatolenticular Degeneration; Humans; Middle Aged; National | 2022 |
Generalized scleroderma-like induration associated with D-penicillamine elastosis perforans serpiginosa in Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Scleroderma, Localized; Scleroderma, Systemic; | 2023 |
Generalized scleroderma-like induration associated with D-penicillamine elastosis perforans serpiginosa in Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Scleroderma, Localized; Scleroderma, Systemic; | 2023 |
Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study.
Topics: Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Retros | 2023 |
Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study.
Topics: Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Retros | 2023 |
Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Copper; Gl | 2023 |
Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Copper; Gl | 2023 |
Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Copper; Gl | 2023 |
Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Copper; Gl | 2023 |
Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Copper; Gl | 2023 |
Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Copper; Gl | 2023 |
Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Copper; Gl | 2023 |
Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Copper; Gl | 2023 |
Penicillamine-induced degenerative dermopathy in a patient with Wilson's disease.
Topics: Adult; Arthritis, Rheumatoid; Chelating Agents; Cystinuria; Hepatolenticular Degeneration; Humans; M | 2023 |
Penicillamine-induced degenerative dermopathy in a patient with Wilson's disease.
Topics: Adult; Arthritis, Rheumatoid; Chelating Agents; Cystinuria; Hepatolenticular Degeneration; Humans; M | 2023 |
D-penicillamine Induced Myasthenia Gravis in Wilson's Disease: A Case Report.
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Myasthenia Gravis; Penicillamine | 2022 |
D-penicillamine Induced Myasthenia Gravis in Wilson's Disease: A Case Report.
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Myasthenia Gravis; Penicillamine | 2022 |
Wilson disease in pregnancy: A case series.
Topics: Abortion, Spontaneous; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine; | 2023 |
Wilson disease in pregnancy: A case series.
Topics: Abortion, Spontaneous; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine; | 2023 |
Analysis of risk factors for neurological symptoms in patients with purely hepatic Wilson's disease at diagnosis.
Topics: Brain; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Retrospective Studies; Risk Fac | 2023 |
Analysis of risk factors for neurological symptoms in patients with purely hepatic Wilson's disease at diagnosis.
Topics: Brain; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Retrospective Studies; Risk Fac | 2023 |
Topics: Animals; Aspartic Acid; Copper; Hepatolenticular Degeneration; Metabolomics; Penicillamine; Proton M | 2023 |
Topics: Animals; Aspartic Acid; Copper; Hepatolenticular Degeneration; Metabolomics; Penicillamine; Proton M | 2023 |
Neurological worsening in Wilson disease - clinical classification and outcome.
Topics: Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine; Zinc | 2023 |
Neurological worsening in Wilson disease - clinical classification and outcome.
Topics: Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine; Zinc | 2023 |
Evaluation of vitamin B
Topics: Adolescent; Adult; Child; Copper; Dietary Supplements; Hepatolenticular Degeneration; Humans; Penici | 2023 |
Evaluation of vitamin B
Topics: Adolescent; Adult; Child; Copper; Dietary Supplements; Hepatolenticular Degeneration; Humans; Penici | 2023 |
Importance of a Liver Biopsy in the Management of Wilson Disease.
Topics: Adult; Biopsy; Ceruloplasmin; Chelating Agents; Copper; Disease Management; Hepatolenticular Degener | 2020 |
Importance of a Liver Biopsy in the Management of Wilson Disease.
Topics: Adult; Biopsy; Ceruloplasmin; Chelating Agents; Copper; Disease Management; Hepatolenticular Degener | 2020 |
Resolution of Kayser-Fleischer ring in Wilson disease.
Topics: Chelating Agents; Child; Copper; Corneal Diseases; Descemet Membrane; Drug Therapy, Combination; Glu | 2019 |
Resolution of Kayser-Fleischer ring in Wilson disease.
Topics: Chelating Agents; Child; Copper; Corneal Diseases; Descemet Membrane; Drug Therapy, Combination; Glu | 2019 |
Wilson's disease presentation resembling autoimmune hepatitis.
Topics: Adult; Chelating Agents; Diagnosis, Differential; Female; Hepatitis, Autoimmune; Hepatolenticular De | 2019 |
Wilson's disease presentation resembling autoimmune hepatitis.
Topics: Adult; Chelating Agents; Diagnosis, Differential; Female; Hepatitis, Autoimmune; Hepatolenticular De | 2019 |
D-penicillamine-induced autoimmune disorders.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Autoimmune Diseases; Autoimmunity | 2019 |
D-penicillamine-induced autoimmune disorders.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Autoimmune Diseases; Autoimmunity | 2019 |
Persistence with treatment for Wilson disease: a retrospective study.
Topics: Adult; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Male; Medication Adherence; | 2019 |
Persistence with treatment for Wilson disease: a retrospective study.
Topics: Adult; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Male; Medication Adherence; | 2019 |
Adjunctive Antioxidant Therapy in Neurologic Wilson's Disease Improves the Outcomes.
Topics: Adolescent; Adult; Antioxidants; Ascorbic Acid; Chelating Agents; Child; Drug Combinations; Female; | 2020 |
Adjunctive Antioxidant Therapy in Neurologic Wilson's Disease Improves the Outcomes.
Topics: Adolescent; Adult; Antioxidants; Ascorbic Acid; Chelating Agents; Child; Drug Combinations; Female; | 2020 |
Massive proteinuria for minimal change nephropathy secondary to treatment with D-penicilamine in a patient with Wilson's disease. Case report.
Topics: Hepatolenticular Degeneration; Humans; Male; Middle Aged; Nephrosis, Lipoid; Penicillamine; Proteinu | 2020 |
Massive proteinuria for minimal change nephropathy secondary to treatment with D-penicilamine in a patient with Wilson's disease. Case report.
Topics: Hepatolenticular Degeneration; Humans; Male; Middle Aged; Nephrosis, Lipoid; Penicillamine; Proteinu | 2020 |
Gastropathy in patients with Wilson disease.
Topics: Adult; Cross-Sectional Studies; Esophageal and Gastric Varices; Female; Helicobacter Infections; Hep | 2020 |
Gastropathy in patients with Wilson disease.
Topics: Adult; Cross-Sectional Studies; Esophageal and Gastric Varices; Female; Helicobacter Infections; Hep | 2020 |
Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Greece; Hepatolenticular Degeneration; Humans; Liver Neoplas | 2020 |
Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Greece; Hepatolenticular Degeneration; Humans; Liver Neoplas | 2020 |
Management Perspective of Wilson's Disease: Early Diagnosis and Individualized Therapy.
Topics: Copper; Early Diagnosis; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine | 2021 |
Management Perspective of Wilson's Disease: Early Diagnosis and Individualized Therapy.
Topics: Copper; Early Diagnosis; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine | 2021 |
Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson's disease.
Topics: Adult; Chelating Agents; Drug Therapy, Combination; Female; Hepatolenticular Degeneration; Humans; M | 2020 |
Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson's disease.
Topics: Adult; Chelating Agents; Drug Therapy, Combination; Female; Hepatolenticular Degeneration; Humans; M | 2020 |
Pediatric Pseudo-pseudoxanthoma Elasticum Resulting From D-Penicillamine Treatment for Wilson Disease.
Topics: Adolescent; Adult; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Pseudoxanthoma Elasti | 2020 |
Pediatric Pseudo-pseudoxanthoma Elasticum Resulting From D-Penicillamine Treatment for Wilson Disease.
Topics: Adolescent; Adult; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Pseudoxanthoma Elasti | 2020 |
Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson's disease patients with penicillamine-induced allergy or early neurological deterioration.
Topics: Adolescent; Adult; Brain; Chelating Agents; Child; Disease Progression; Drug Hypersensitivity; Drug | 2020 |
Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson's disease patients with penicillamine-induced allergy or early neurological deterioration.
Topics: Adolescent; Adult; Brain; Chelating Agents; Child; Disease Progression; Drug Hypersensitivity; Drug | 2020 |
mtDNA depletion-like syndrome in Wilson disease.
Topics: Animals; Copper; Copper-Transporting ATPases; DNA, Mitochondrial; Hepatolenticular Degeneration; Hum | 2020 |
mtDNA depletion-like syndrome in Wilson disease.
Topics: Animals; Copper; Copper-Transporting ATPases; DNA, Mitochondrial; Hepatolenticular Degeneration; Hum | 2020 |
[Retrospective cross-sectional study based on nationwide data of drug prescriptions and contractional data of outpatient offices regarding Morbus Wilson's disease].
Topics: Cross-Sectional Studies; Drug Prescriptions; Germany; Hepatolenticular Degeneration; Humans; Penicil | 2020 |
[Retrospective cross-sectional study based on nationwide data of drug prescriptions and contractional data of outpatient offices regarding Morbus Wilson's disease].
Topics: Cross-Sectional Studies; Drug Prescriptions; Germany; Hepatolenticular Degeneration; Humans; Penicil | 2020 |
Observation on the changes of clinical symptoms, blood and brain copper deposition in Wilson disease patients treated with dimercaptosuccinic acid for 2 years.
Topics: Adult; Brain; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicil | 2020 |
Observation on the changes of clinical symptoms, blood and brain copper deposition in Wilson disease patients treated with dimercaptosuccinic acid for 2 years.
Topics: Adult; Brain; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicil | 2020 |
Long-Term Urinary Copper Excretion on Chelation Therapy in Children with Wilson Disease.
Topics: Adolescent; Ceruloplasmin; Chelation Therapy; Child; Child, Preschool; Copper; Hepatolenticular Dege | 2021 |
Long-Term Urinary Copper Excretion on Chelation Therapy in Children with Wilson Disease.
Topics: Adolescent; Ceruloplasmin; Chelation Therapy; Child; Child, Preschool; Copper; Hepatolenticular Dege | 2021 |
Gynecological history to diagnosis and pregnancy outcomes in diagnosed Wilson's disease patients under therapy - A bicentric matched-control cohort study.
Topics: Cohort Studies; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Pregnancy; Pregn | 2022 |
Gynecological history to diagnosis and pregnancy outcomes in diagnosed Wilson's disease patients under therapy - A bicentric matched-control cohort study.
Topics: Cohort Studies; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Pregnancy; Pregn | 2022 |
Neurological features and outcomes of Wilson's disease: a single-center experience.
Topics: Copper; Dystonia; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Tremor | 2021 |
Neurological features and outcomes of Wilson's disease: a single-center experience.
Topics: Copper; Dystonia; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Tremor | 2021 |
Prolonged Jaundice in a Patient with Coexisting Hepatitis A Virus Infection and Wilson's Disease.
Topics: Adolescent; Bangladesh; Copper; Female; Hepatitis A; Hepatitis A virus; Hepatolenticular Degeneratio | 2021 |
Prolonged Jaundice in a Patient with Coexisting Hepatitis A Virus Infection and Wilson's Disease.
Topics: Adolescent; Bangladesh; Copper; Female; Hepatitis A; Hepatitis A virus; Hepatolenticular Degeneratio | 2021 |
Pediatric Wilson's Disease: Phenotypic, Genetic Characterization and Outcome of 182 Children in France.
Topics: Adolescent; Child; Child, Preschool; Copper; France; Hepatolenticular Degeneration; Humans; Infant; | 2021 |
Pediatric Wilson's Disease: Phenotypic, Genetic Characterization and Outcome of 182 Children in France.
Topics: Adolescent; Child; Child, Preschool; Copper; France; Hepatolenticular Degeneration; Humans; Infant; | 2021 |
Pregnancy Outcomes in Wilson's Disease Women: Single-Center Case Series.
Topics: Abortion, Spontaneous; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Preg | 2022 |
Pregnancy Outcomes in Wilson's Disease Women: Single-Center Case Series.
Topics: Abortion, Spontaneous; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Preg | 2022 |
Brain iron accumulation in Wilson's disease: A longitudinal imaging case study during anticopper treatment using 7.0T MRI and transcranial sonography.
Topics: Adolescent; Adult; Case-Control Studies; Chelating Agents; Copper; Female; Gray Matter; Hepatolentic | 2018 |
Brain iron accumulation in Wilson's disease: A longitudinal imaging case study during anticopper treatment using 7.0T MRI and transcranial sonography.
Topics: Adolescent; Adult; Case-Control Studies; Chelating Agents; Copper; Female; Gray Matter; Hepatolentic | 2018 |
Elastosis perforans serpiginosa in a patient with Wilson's disease.
Topics: Adult; Chelating Agents; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Skin Diseases | 2017 |
Elastosis perforans serpiginosa in a patient with Wilson's disease.
Topics: Adult; Chelating Agents; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Skin Diseases | 2017 |
No rubbing, no elastosis perforans serpiginosa.
Topics: Chelating Agents; Diagnosis, Differential; Female; Hepatolenticular Degeneration; Humans; Middle Age | 2017 |
No rubbing, no elastosis perforans serpiginosa.
Topics: Chelating Agents; Diagnosis, Differential; Female; Hepatolenticular Degeneration; Humans; Middle Age | 2017 |
Modality of treatment and potential outcome of Wilson disease in Taiwan: A population-based longitudinal study.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Hepatolenticular Degeneration; Humans; Liver Tra | 2018 |
Modality of treatment and potential outcome of Wilson disease in Taiwan: A population-based longitudinal study.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Hepatolenticular Degeneration; Humans; Liver Tra | 2018 |
Childhood Wilson Disease: Bangladesh Perspective.
Topics: Adolescent; Bangladesh; Ceruloplasmin; Child; Child, Preschool; Copper; Cross-Sectional Studies; Fem | 2017 |
Childhood Wilson Disease: Bangladesh Perspective.
Topics: Adolescent; Bangladesh; Ceruloplasmin; Child; Child, Preschool; Copper; Cross-Sectional Studies; Fem | 2017 |
Wilson's Disease Should Be Treated with Zinc rather than Trientine or Penicillamine.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Trientine; Zinc | 2017 |
Wilson's Disease Should Be Treated with Zinc rather than Trientine or Penicillamine.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Trientine; Zinc | 2017 |
Early Onset of Wilson Disease: Diagnostic Challenges.
Topics: Biomarkers; Chelating Agents; Child, Preschool; Early Diagnosis; Female; Hepatolenticular Degenerati | 2017 |
Early Onset of Wilson Disease: Diagnostic Challenges.
Topics: Biomarkers; Chelating Agents; Child, Preschool; Early Diagnosis; Female; Hepatolenticular Degenerati | 2017 |
Spatial investigation of the elemental distribution in Wilson's disease liver after d-penicillamine treatment by LA-ICP-MS.
Topics: Animals; Biomarkers; Calibration; Copper; Disease Models, Animal; Fluorescence; Gelatin; Hepatolenti | 2017 |
Spatial investigation of the elemental distribution in Wilson's disease liver after d-penicillamine treatment by LA-ICP-MS.
Topics: Animals; Biomarkers; Calibration; Copper; Disease Models, Animal; Fluorescence; Gelatin; Hepatolenti | 2017 |
Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent.
Topics: Apoptosis; Carrier Proteins; Cell Line; Cell Proliferation; Chelating Agents; Copper; Copper Transpo | 2018 |
Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent.
Topics: Apoptosis; Carrier Proteins; Cell Line; Cell Proliferation; Chelating Agents; Copper; Copper Transpo | 2018 |
Clinically diagnosed late-onset fulminant Wilson's disease without cirrhosis: A case report.
Topics: Age of Onset; Biopsy; Bone Marrow Examination; Disease Progression; Fatal Outcome; Female; Hepatic E | 2018 |
Clinically diagnosed late-onset fulminant Wilson's disease without cirrhosis: A case report.
Topics: Age of Onset; Biopsy; Bone Marrow Examination; Disease Progression; Fatal Outcome; Female; Hepatic E | 2018 |
Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
Topics: Adolescent; Adult; Chelating Agents; Child; Child, Preschool; Copper; Cost Savings; Drug Substitutio | 2018 |
Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
Topics: Adolescent; Adult; Chelating Agents; Child; Child, Preschool; Copper; Cost Savings; Drug Substitutio | 2018 |
Anesthetic management of cesarean delivery for a parturient with Wilson's disease: A case report.
Topics: Adult; Anesthetics, General; Cesarean Section; Chelating Agents; Female; Hepatolenticular Degenerati | 2018 |
Anesthetic management of cesarean delivery for a parturient with Wilson's disease: A case report.
Topics: Adult; Anesthetics, General; Cesarean Section; Chelating Agents; Female; Hepatolenticular Degenerati | 2018 |
Epigenetic changes of the thioredoxin system in the tx-j mouse model and in patients with Wilson disease.
Topics: Animals; Chelating Agents; Choline; Copper; Copper-Transporting ATPases; Disease Models, Animal; DNA | 2018 |
Epigenetic changes of the thioredoxin system in the tx-j mouse model and in patients with Wilson disease.
Topics: Animals; Chelating Agents; Choline; Copper; Copper-Transporting ATPases; Disease Models, Animal; DNA | 2018 |
Exome sequencing of an adolescent with nonalcoholic fatty liver disease identifies a clinically actionable case of Wilson disease.
Topics: Adolescent; Chelating Agents; Copper; Copper-Transporting ATPases; Diagnostic Errors; Exome; Exome S | 2018 |
Exome sequencing of an adolescent with nonalcoholic fatty liver disease identifies a clinically actionable case of Wilson disease.
Topics: Adolescent; Chelating Agents; Copper; Copper-Transporting ATPases; Diagnostic Errors; Exome; Exome S | 2018 |
GanDouLing combined with Penicillamine improves cerebrovascular injury via PERK/eIF2α/CHOP endoplasmic reticulum stress pathway in the mouse model of Wilson's disease.
Topics: Animals; Apoptosis; Brain Injuries, Diffuse; Caspase 12; Caspase 3; Cerebrovascular Disorders; Disea | 2018 |
GanDouLing combined with Penicillamine improves cerebrovascular injury via PERK/eIF2α/CHOP endoplasmic reticulum stress pathway in the mouse model of Wilson's disease.
Topics: Animals; Apoptosis; Brain Injuries, Diffuse; Caspase 12; Caspase 3; Cerebrovascular Disorders; Disea | 2018 |
Reversal of Acute Liver Failure Due to Wilson Disease by a Regimen of High-Volume Plasma Exchange and Penicillamine.
Topics: Adult; Chelating Agents; Hepatolenticular Degeneration; Humans; Liver Failure, Acute; Male; Penicill | 2019 |
Reversal of Acute Liver Failure Due to Wilson Disease by a Regimen of High-Volume Plasma Exchange and Penicillamine.
Topics: Adult; Chelating Agents; Hepatolenticular Degeneration; Humans; Liver Failure, Acute; Male; Penicill | 2019 |
A case report: Co-occurrence of Wilson disease and oculocutaneous albinism in a Chinese patient.
Topics: Albinism, Oculocutaneous; Asian People; Astringents; Chelating Agents; Female; Hepatolenticular Dege | 2018 |
A case report: Co-occurrence of Wilson disease and oculocutaneous albinism in a Chinese patient.
Topics: Albinism, Oculocutaneous; Asian People; Astringents; Chelating Agents; Female; Hepatolenticular Dege | 2018 |
Hepatic copper accumulation in a young cat with familial variations in the ATP7B gene.
Topics: Animals; Cat Diseases; Cats; Chelating Agents; Copper; Copper-Transporting ATPases; Female; Hepatole | 2019 |
Hepatic copper accumulation in a young cat with familial variations in the ATP7B gene.
Topics: Animals; Cat Diseases; Cats; Chelating Agents; Copper; Copper-Transporting ATPases; Female; Hepatole | 2019 |
Hepatic manifestations of Wilson's disease: 12-year experience in a Swiss tertiary referral centre.
Topics: Adult; Chelating Agents; Copper; Copper-Transporting ATPases; Female; Hepatolenticular Degeneration; | 2018 |
Hepatic manifestations of Wilson's disease: 12-year experience in a Swiss tertiary referral centre.
Topics: Adult; Chelating Agents; Copper; Copper-Transporting ATPases; Female; Hepatolenticular Degeneration; | 2018 |
Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
Topics: Adolescent; Adult; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Copper; Female; Germany | 2019 |
Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
Topics: Adolescent; Adult; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Copper; Female; Germany | 2019 |
Ocular manifestations of Wilson's disease.
Topics: Adolescent; Anterior Eye Segment; Cataract; Chelating Agents; Descemet Membrane; Diet Therapy; Hepat | 2019 |
Ocular manifestations of Wilson's disease.
Topics: Adolescent; Anterior Eye Segment; Cataract; Chelating Agents; Descemet Membrane; Diet Therapy; Hepat | 2019 |
Urinary abnormalities in children and adolescents with Wilson disease before and during treatment with d-penicillamine.
Topics: Adolescent; Age Factors; Albuminuria; Asymptomatic Diseases; Child; Child, Preschool; Egypt; Female; | 2019 |
Urinary abnormalities in children and adolescents with Wilson disease before and during treatment with d-penicillamine.
Topics: Adolescent; Age Factors; Albuminuria; Asymptomatic Diseases; Child; Child, Preschool; Egypt; Female; | 2019 |
Teaching Video NeuroImages: Myoclonus as the presenting feature of Wilson disease.
Topics: Brain; Chelating Agents; Child; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; M | 2019 |
Teaching Video NeuroImages: Myoclonus as the presenting feature of Wilson disease.
Topics: Brain; Chelating Agents; Child; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; M | 2019 |
A Pediatric Case of a D-Penicillamine Induced ANCA-associated Vasculitis Manifesting a Pulmonary-Renal Syndrome.
Topics: Adolescent; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Female; Glomerulonephritis; | 2019 |
A Pediatric Case of a D-Penicillamine Induced ANCA-associated Vasculitis Manifesting a Pulmonary-Renal Syndrome.
Topics: Adolescent; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Female; Glomerulonephritis; | 2019 |
[Wilson's disease: programed wandering?].
Topics: Adenosine Triphosphatases; Administration, Oral; Adult; Biomarkers; Carcinoma, Hepatocellular; Catio | 2013 |
[Wilson's disease: programed wandering?].
Topics: Adenosine Triphosphatases; Administration, Oral; Adult; Biomarkers; Carcinoma, Hepatocellular; Catio | 2013 |
Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Topics: Adolescent; Adult; Austria; Chelating Agents; Child; Child, Preschool; Cohort Studies; Drug-Related | 2013 |
Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Topics: Adolescent; Adult; Austria; Chelating Agents; Child; Child, Preschool; Cohort Studies; Drug-Related | 2013 |
Obliterating bronchiolitis in a patient treated with (D)-penicillamine.
Topics: Bronchiolitis Obliterans; Bronchodilator Agents; Chelating Agents; Chelation Therapy; Combined Modal | 2013 |
Obliterating bronchiolitis in a patient treated with (D)-penicillamine.
Topics: Bronchiolitis Obliterans; Bronchodilator Agents; Chelating Agents; Chelation Therapy; Combined Modal | 2013 |
Coincidence of 2 severe chronic diseases: presymptomatic diagnosis of Wilson disease in a boy with severe haemophilia A.
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Chromosome Deletion; Chromosome Inversion; Cop | 2013 |
Coincidence of 2 severe chronic diseases: presymptomatic diagnosis of Wilson disease in a boy with severe haemophilia A.
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Chromosome Deletion; Chromosome Inversion; Cop | 2013 |
Gastrointestinal side effects in children with Wilson's disease treated with zinc sulphate.
Topics: Adenosine Triphosphatases; Adolescent; Cation Transport Proteins; Child; Child, Preschool; Copper-Tr | 2013 |
Gastrointestinal side effects in children with Wilson's disease treated with zinc sulphate.
Topics: Adenosine Triphosphatases; Adolescent; Cation Transport Proteins; Child; Child, Preschool; Copper-Tr | 2013 |
Alterations of cortical excitability and central motor conduction time in Wilson's disease.
Topics: Adolescent; Adult; Cerebral Cortex; Child; Evoked Potentials, Motor; Female; Hepatolenticular Degene | 2013 |
Alterations of cortical excitability and central motor conduction time in Wilson's disease.
Topics: Adolescent; Adult; Cerebral Cortex; Child; Evoked Potentials, Motor; Female; Hepatolenticular Degene | 2013 |
50 Years Ago in The Journal of Pediatrics: hepatolenticular degeneration: observations on a case treated with D-penicillamine.
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transporting | 2013 |
50 Years Ago in The Journal of Pediatrics: hepatolenticular degeneration: observations on a case treated with D-penicillamine.
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transporting | 2013 |
Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease.
Topics: Administration, Oral; Adolescent; Chelating Agents; Chelation Therapy; Child; Copper; Drug Administr | 2013 |
Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease.
Topics: Administration, Oral; Adolescent; Chelating Agents; Chelation Therapy; Child; Copper; Drug Administr | 2013 |
Extensive striatal, cortical, and white matter brain MRI abnormalities in Wilson disease.
Topics: Adolescent; Cerebral Cortex; Cerebrum; Chelating Agents; Chelation Therapy; Corpus Striatum; Hepatol | 2013 |
Extensive striatal, cortical, and white matter brain MRI abnormalities in Wilson disease.
Topics: Adolescent; Cerebral Cortex; Cerebrum; Chelating Agents; Chelation Therapy; Corpus Striatum; Hepatol | 2013 |
Therapeutic plasma exchange as de-coppering technique in intensive care for an adult in a Wilson's crisis.
Topics: Chelating Agents; Copper; Critical Care; Critical Illness; Fatal Outcome; Female; Hemodiafiltration; | 2013 |
Therapeutic plasma exchange as de-coppering technique in intensive care for an adult in a Wilson's crisis.
Topics: Chelating Agents; Copper; Critical Care; Critical Illness; Fatal Outcome; Female; Hemodiafiltration; | 2013 |
Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
Topics: Adolescent; Adult; Chelating Agents; Child; Female; Follow-Up Studies; Hepatolenticular Degeneration | 2014 |
Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
Topics: Adolescent; Adult; Chelating Agents; Child; Female; Follow-Up Studies; Hepatolenticular Degeneration | 2014 |
Worsening of Wilson disease following penicillamine therapy.
Topics: Adolescent; Chelating Agents; Child; Female; Hepatolenticular Degeneration; Humans; Male; Penicillam | 2014 |
Worsening of Wilson disease following penicillamine therapy.
Topics: Adolescent; Chelating Agents; Child; Female; Hepatolenticular Degeneration; Humans; Male; Penicillam | 2014 |
Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease.
Topics: Adult; Antioxidants; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Zin | 2014 |
Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease.
Topics: Adult; Antioxidants; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Zin | 2014 |
Detection of D-penicillamine in skin lesions in a case of dermal elastosis after a previous long-term treatment for Wilson's disease.
Topics: Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Middle Aged; Penicillamine; Skin Di | 2015 |
Detection of D-penicillamine in skin lesions in a case of dermal elastosis after a previous long-term treatment for Wilson's disease.
Topics: Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Middle Aged; Penicillamine; Skin Di | 2015 |
D-penicillamine versus zinc sulfate as first-line therapy for Wilson's disease.
Topics: Adult; Antirheumatic Agents; Female; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Kapla | 2014 |
D-penicillamine versus zinc sulfate as first-line therapy for Wilson's disease.
Topics: Adult; Antirheumatic Agents; Female; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Kapla | 2014 |
Control of mania with chelation-only in a case of Wilson's disease.
Topics: Bipolar Disorder; Chelation Therapy; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Tra | 2014 |
Control of mania with chelation-only in a case of Wilson's disease.
Topics: Bipolar Disorder; Chelation Therapy; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Tra | 2014 |
Acute hemolytic anemia as an initial presentation of Wilson disease in children.
Topics: Acute Disease; Adolescent; Anemia, Hemolytic; Ceruloplasmin; Chelating Agents; Child; Child, Prescho | 2014 |
Acute hemolytic anemia as an initial presentation of Wilson disease in children.
Topics: Acute Disease; Adolescent; Anemia, Hemolytic; Ceruloplasmin; Chelating Agents; Child; Child, Prescho | 2014 |
Elastosis perforans serpiginosa: a case of a penicillamine-induced degenerative dermatosis.
Topics: Aged; Chelating Agents; Cutis Laxa; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penici | 2014 |
Elastosis perforans serpiginosa: a case of a penicillamine-induced degenerative dermatosis.
Topics: Aged; Chelating Agents; Cutis Laxa; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penici | 2014 |
[Wilson Disease].
Topics: Brain; Chelating Agents; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Penicill | 2014 |
[Wilson Disease].
Topics: Brain; Chelating Agents; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Penicill | 2014 |
Epidermolysis bullosa acquisita-like eruption with anticollagen VII autoantibodies induced by D-penicillamine in Wilson disease.
Topics: Adult; Autoantibodies; Chelating Agents; Collagen Type VII; Drug Eruptions; Epidermolysis Bullosa Ac | 2014 |
Epidermolysis bullosa acquisita-like eruption with anticollagen VII autoantibodies induced by D-penicillamine in Wilson disease.
Topics: Adult; Autoantibodies; Chelating Agents; Collagen Type VII; Drug Eruptions; Epidermolysis Bullosa Ac | 2014 |
Penicillamine challenge test in the diagnosis of Wilson's disease.
Topics: Adolescent; Ceruloplasmin; Child; Child, Preschool; Copper; Cross-Sectional Studies; Female; Hepatol | 2014 |
Penicillamine challenge test in the diagnosis of Wilson's disease.
Topics: Adolescent; Ceruloplasmin; Child; Child, Preschool; Copper; Cross-Sectional Studies; Female; Hepatol | 2014 |
A severe case of esophageal ulcer causing a tight stricture despite long-term D-penicillamine treatment.
Topics: Adult; Chelating Agents; Esophageal Diseases; Esophageal Stenosis; Hepatolenticular Degeneration; Hu | 2014 |
A severe case of esophageal ulcer causing a tight stricture despite long-term D-penicillamine treatment.
Topics: Adult; Chelating Agents; Esophageal Diseases; Esophageal Stenosis; Hepatolenticular Degeneration; Hu | 2014 |
Penicillamine-induced Elastosis Perforans Serpiginosa in Wilson Disease: Is Useful Switching to Zinc?
Topics: Adolescent; Chelating Agents; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Skin; Skin | 2017 |
Penicillamine-induced Elastosis Perforans Serpiginosa in Wilson Disease: Is Useful Switching to Zinc?
Topics: Adolescent; Chelating Agents; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Skin; Skin | 2017 |
Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
Topics: Adult; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance I | 2014 |
Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
Topics: Adult; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance I | 2014 |
Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: a microdialysis study in vivo.
Topics: Animals; Brain; Chelating Agents; Copper; Corpus Striatum; Disease Models, Animal; Hepatolenticular | 2015 |
Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: a microdialysis study in vivo.
Topics: Animals; Brain; Chelating Agents; Copper; Corpus Striatum; Disease Models, Animal; Hepatolenticular | 2015 |
Atypical case of Wilson's disease with psychotic onset, low 24 hour urine copper and the absence of Kayser-Fleischer rings.
Topics: Biomarkers; Chelating Agents; Copper; Diagnosis, Differential; Diagnostic Imaging; Hepatolenticular | 2014 |
Atypical case of Wilson's disease with psychotic onset, low 24 hour urine copper and the absence of Kayser-Fleischer rings.
Topics: Biomarkers; Chelating Agents; Copper; Diagnosis, Differential; Diagnostic Imaging; Hepatolenticular | 2014 |
Penicillamine induced pseudo-pseudoxanthoma elasticum in a patient with Wilson's disease, which role plays the hepatologist?
Topics: Adult; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pseudoxanthom | 2015 |
Penicillamine induced pseudo-pseudoxanthoma elasticum in a patient with Wilson's disease, which role plays the hepatologist?
Topics: Adult; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pseudoxanthom | 2015 |
1H NMR-based metabolomics investigation of copper-laden rat: a model of Wilson's disease.
Topics: Animals; Chelating Agents; Copper; Disease Models, Animal; Hepatolenticular Degeneration; Male; Meta | 2015 |
1H NMR-based metabolomics investigation of copper-laden rat: a model of Wilson's disease.
Topics: Animals; Chelating Agents; Copper; Disease Models, Animal; Hepatolenticular Degeneration; Male; Meta | 2015 |
MRI and oxidative stress markers in neurological worsening of Wilson disease following penicillamine.
Topics: Adult; Antidotes; Child; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Ne | 2015 |
MRI and oxidative stress markers in neurological worsening of Wilson disease following penicillamine.
Topics: Adult; Antidotes; Child; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Ne | 2015 |
Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy.
Topics: Adolescent; Adult; Antibodies, Antinuclear; Autoimmune Diseases; Chelating Agents; Child; Cross-Sect | 2016 |
Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy.
Topics: Adolescent; Adult; Antibodies, Antinuclear; Autoimmune Diseases; Chelating Agents; Child; Cross-Sect | 2016 |
Coagulation Parameters in Wilson Disease.
Topics: Adult; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Chelating Agents; Cross-Sectional S | 2015 |
Coagulation Parameters in Wilson Disease.
Topics: Adult; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Chelating Agents; Cross-Sectional S | 2015 |
Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy.
Topics: Adolescent; Adult; Antioxidants; Chelating Agents; Chelation Therapy; Child; Child, Preschool; Coppe | 2015 |
Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy.
Topics: Adolescent; Adult; Antioxidants; Chelating Agents; Chelation Therapy; Child; Child, Preschool; Coppe | 2015 |
Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Topics: Abdominal Pain; Adolescent; Chelating Agents; Child; Child, Preschool; Copper; Female; France; Healt | 2015 |
Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Topics: Abdominal Pain; Adolescent; Chelating Agents; Child; Child, Preschool; Copper; Female; France; Healt | 2015 |
Aberrance of Serum Zinc and Free Copper Level in Wilson Disease.
Topics: Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 2016 |
Aberrance of Serum Zinc and Free Copper Level in Wilson Disease.
Topics: Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 2016 |
D-penicillamine-induced ANA (+) ANCA (+) vasculitis in pediatric patients with Wilson's disease.
Topics: Adolescent; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil C | 2016 |
D-penicillamine-induced ANA (+) ANCA (+) vasculitis in pediatric patients with Wilson's disease.
Topics: Adolescent; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil C | 2016 |
Subclinical neurological involvement does not develop if Wilson's disease is treated early.
Topics: Adenosine Triphosphatases; Adolescent; Adult; Analysis of Variance; Brain; Cation Transport Proteins | 2016 |
Subclinical neurological involvement does not develop if Wilson's disease is treated early.
Topics: Adenosine Triphosphatases; Adolescent; Adult; Analysis of Variance; Brain; Cation Transport Proteins | 2016 |
Aberrance of Serum Zinc and Free Copper Level in Wilson Disease.
Topics: Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 2016 |
Aberrance of Serum Zinc and Free Copper Level in Wilson Disease.
Topics: Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 2016 |
Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.
Topics: Adenosine Triphosphatases; Apoptosis; Carcinoma, Hepatocellular; Cation Transport Proteins; Cell Sur | 2016 |
Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.
Topics: Adenosine Triphosphatases; Apoptosis; Carcinoma, Hepatocellular; Cation Transport Proteins; Cell Sur | 2016 |
[WILSON-KONOVALOV'S DISEASE IN TWO SISTERS: DIFFERENCES IN THE CLINICAL PICTURE AND SUCCESSFUL THERAPY].
Topics: Adenosine Triphosphatases; Adult; Brain; Cation Transport Proteins; Chelating Agents; Copper; Copper | 2016 |
[WILSON-KONOVALOV'S DISEASE IN TWO SISTERS: DIFFERENCES IN THE CLINICAL PICTURE AND SUCCESSFUL THERAPY].
Topics: Adenosine Triphosphatases; Adult; Brain; Cation Transport Proteins; Chelating Agents; Copper; Copper | 2016 |
50 Years Ago in TheJournal ofPediatrics: Hepatolenticular Degeneration: The Comparative Effectiveness of D-Penicillamine, Potassium Sulfide, and Diethyldithiocarbamate as Decoppering Agents.
Topics: Chelating Agents; Ditiocarb; Hepatolenticular Degeneration; History, 20th Century; Humans; Penicilla | 2016 |
50 Years Ago in TheJournal ofPediatrics: Hepatolenticular Degeneration: The Comparative Effectiveness of D-Penicillamine, Potassium Sulfide, and Diethyldithiocarbamate as Decoppering Agents.
Topics: Chelating Agents; Ditiocarb; Hepatolenticular Degeneration; History, 20th Century; Humans; Penicilla | 2016 |
Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database.
Topics: Adult; Chelating Agents; Chelation Therapy; Copper; Databases, Factual; Female; Germany; Hepatolenti | 2016 |
Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database.
Topics: Adult; Chelating Agents; Chelation Therapy; Copper; Databases, Factual; Female; Germany; Hepatolenti | 2016 |
Dermoscopy and direct immunofluorescence findings of elastosis perforans serpiginosa.
Topics: Adult; Chelating Agents; Dermoscopy; Elastic Tissue; Female; Fluorescent Antibody Technique, Direct; | 2016 |
Dermoscopy and direct immunofluorescence findings of elastosis perforans serpiginosa.
Topics: Adult; Chelating Agents; Dermoscopy; Elastic Tissue; Female; Fluorescent Antibody Technique, Direct; | 2016 |
Wilson Disease: Epigenetic effects of choline supplementation on phenotype and clinical course in a mouse model.
Topics: Animals; Choline; Copper; Dietary Supplements; Disease Models, Animal; DNA Methylation; Epigenomics; | 2016 |
Wilson Disease: Epigenetic effects of choline supplementation on phenotype and clinical course in a mouse model.
Topics: Animals; Choline; Copper; Dietary Supplements; Disease Models, Animal; DNA Methylation; Epigenomics; | 2016 |
Wilson's disease: the 60th anniversary of Walshe's article on treatment with penicillamine.
Topics: Biomedical Research; Boston; Hepatolenticular Degeneration; History, 20th Century; Penicillamine; Pe | 2017 |
Wilson's disease: the 60th anniversary of Walshe's article on treatment with penicillamine.
Topics: Biomedical Research; Boston; Hepatolenticular Degeneration; History, 20th Century; Penicillamine; Pe | 2017 |
A clinical study of bone mesenchymal stem cells for the treatment of hepatic fibrosis induced by hepatolenticular degeneration.
Topics: Adult; Biomarkers; Case-Control Studies; Cells, Cultured; Chelating Agents; Combined Modality Therap | 2017 |
A clinical study of bone mesenchymal stem cells for the treatment of hepatic fibrosis induced by hepatolenticular degeneration.
Topics: Adult; Biomarkers; Case-Control Studies; Cells, Cultured; Chelating Agents; Combined Modality Therap | 2017 |
Neurological deterioration during treatment in Wilson's disease: question.
Topics: Adult; Antirheumatic Agents; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imagi | 2008 |
Neurological deterioration during treatment in Wilson's disease: question.
Topics: Adult; Antirheumatic Agents; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imagi | 2008 |
Anesthesia for a patient with Wilson's disease--a case report.
Topics: Amides; Anesthesia; Anesthetics, Local; Chelating Agents; Copper; Female; Hepatolenticular Degenerat | 2008 |
Anesthesia for a patient with Wilson's disease--a case report.
Topics: Amides; Anesthesia; Anesthetics, Local; Chelating Agents; Copper; Female; Hepatolenticular Degenerat | 2008 |
Analysis of renal impairment in children with Wilson's disease.
Topics: Acetylglucosaminidase; Acidosis, Renal Tubular; Adolescent; Ceruloplasmin; Chelating Agents; Child; | 2008 |
Analysis of renal impairment in children with Wilson's disease.
Topics: Acetylglucosaminidase; Acidosis, Renal Tubular; Adolescent; Ceruloplasmin; Chelating Agents; Child; | 2008 |
'Face of the giant panda' sign in Wilson disease.
Topics: Adolescent; Arm; Brain; Chelating Agents; Dystonia; Follow-Up Studies; Hepatolenticular Degeneration | 2008 |
'Face of the giant panda' sign in Wilson disease.
Topics: Adolescent; Arm; Brain; Chelating Agents; Dystonia; Follow-Up Studies; Hepatolenticular Degeneration | 2008 |
Wilson disease as a cause of liver injury in cystic fibrosis.
Topics: Chelating Agents; Child; Child, Preschool; Cystic Fibrosis; Diagnosis, Differential; Genetic Testing | 2009 |
Wilson disease as a cause of liver injury in cystic fibrosis.
Topics: Chelating Agents; Child; Child, Preschool; Cystic Fibrosis; Diagnosis, Differential; Genetic Testing | 2009 |
Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Topics: Adolescent; Chelating Agents; Child; Female; Goiter; Hepatolenticular Degeneration; Humans; Hypothyr | 2008 |
Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Topics: Adolescent; Chelating Agents; Child; Female; Goiter; Hepatolenticular Degeneration; Humans; Hypothyr | 2008 |
Bullous pemphigoid induced by penicillamine in a patient with Wilson disease.
Topics: Chelating Agents; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; Male; Middle Aged; | 2009 |
Bullous pemphigoid induced by penicillamine in a patient with Wilson disease.
Topics: Chelating Agents; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; Male; Middle Aged; | 2009 |
Wilson disease in children: analysis of 57 cases.
Topics: Adenosine Triphosphatases; Adolescent; Biopsy; Cation Transport Proteins; Ceruloplasmin; Chelating A | 2009 |
Wilson disease in children: analysis of 57 cases.
Topics: Adenosine Triphosphatases; Adolescent; Biopsy; Cation Transport Proteins; Ceruloplasmin; Chelating A | 2009 |
[Clinical character and therapeutic effect of late-onset Wilson disease].
Topics: Adolescent; Adult; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Copper; Female; Hepatol | 2009 |
[Clinical character and therapeutic effect of late-onset Wilson disease].
Topics: Adolescent; Adult; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Copper; Female; Hepatol | 2009 |
[Wilson's disease in paediatric age: diagnosis and treatment. Recent advances].
Topics: Adenosine Triphosphatases; Astringents; Cation Transport Proteins; Ceruloplasmin; Chelating Agents; | 2008 |
[Wilson's disease in paediatric age: diagnosis and treatment. Recent advances].
Topics: Adenosine Triphosphatases; Astringents; Cation Transport Proteins; Ceruloplasmin; Chelating Agents; | 2008 |
[Acute recurrent hemolytic anemia as the first manifestation of Wilson's disease: Report of a case].
Topics: Acute Disease; Anemia, Hemolytic; Arrhythmias, Cardiac; Chelating Agents; Chelation Therapy; Child; | 2009 |
[Acute recurrent hemolytic anemia as the first manifestation of Wilson's disease: Report of a case].
Topics: Acute Disease; Anemia, Hemolytic; Arrhythmias, Cardiac; Chelating Agents; Chelation Therapy; Child; | 2009 |
Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
Topics: Adolescent; Adult; Chelating Agents; Child; Child, Preschool; Copper; Disease Progression; Female; H | 2008 |
Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
Topics: Adolescent; Adult; Chelating Agents; Child; Child, Preschool; Copper; Disease Progression; Female; H | 2008 |
Education and imaging. Hepatobiliary and pancreatic: hypersensitivity pneumonitis induced by penicillamine.
Topics: Alveolitis, Extrinsic Allergic; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Liv | 2009 |
Education and imaging. Hepatobiliary and pancreatic: hypersensitivity pneumonitis induced by penicillamine.
Topics: Alveolitis, Extrinsic Allergic; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Liv | 2009 |
A 15-year-old girl with severe hemolytic Wilson's crisis recovered without transplantation after extracorporeal circulation with the Prometheus system.
Topics: Acetylcysteine; Adolescent; Antidotes; Copper; Extracorporeal Circulation; Female; Free Radical Scav | 2009 |
A 15-year-old girl with severe hemolytic Wilson's crisis recovered without transplantation after extracorporeal circulation with the Prometheus system.
Topics: Acetylcysteine; Adolescent; Antidotes; Copper; Extracorporeal Circulation; Female; Free Radical Scav | 2009 |
Long-term outcome in Serbian patients with Wilson disease.
Topics: Age of Onset; Cause of Death; Chelating Agents; Cohort Studies; Female; Hepatolenticular Degeneratio | 2009 |
Long-term outcome in Serbian patients with Wilson disease.
Topics: Age of Onset; Cause of Death; Chelating Agents; Cohort Studies; Female; Hepatolenticular Degeneratio | 2009 |
Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI.
Topics: Adolescent; Adult; Brain; Central Nervous System Agents; Child; Female; Follow-Up Studies; Hepatolen | 2009 |
Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI.
Topics: Adolescent; Adult; Brain; Central Nervous System Agents; Child; Female; Follow-Up Studies; Hepatolen | 2009 |
"Acquired" hepatocerebral degeneration in a patient heterozygote carrier for a novel mutation in ATP7B gene.
Topics: Adenosine Triphosphatases; Adult; Amino Acid Substitution; Basal Ganglia; Cation Transport Proteins; | 2009 |
"Acquired" hepatocerebral degeneration in a patient heterozygote carrier for a novel mutation in ATP7B gene.
Topics: Adenosine Triphosphatases; Adult; Amino Acid Substitution; Basal Ganglia; Cation Transport Proteins; | 2009 |
Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc.
Topics: Adolescent; Adult; Case-Control Studies; Cohort Studies; Copper; Female; Hair; Hepatolenticular Dege | 2010 |
Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc.
Topics: Adolescent; Adult; Case-Control Studies; Cohort Studies; Copper; Female; Hair; Hepatolenticular Dege | 2010 |
Mutational analysis for Wilson's disease.
Topics: Adult; Alanine Transaminase; Ceruloplasmin; Chelating Agents; Copper; DNA Mutational Analysis; Frame | 2009 |
Mutational analysis for Wilson's disease.
Topics: Adult; Alanine Transaminase; Ceruloplasmin; Chelating Agents; Copper; DNA Mutational Analysis; Frame | 2009 |
Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
Topics: Adolescent; Adult; Bilirubin; Chelating Agents; Copper; Dose-Response Relationship, Drug; Female; Fo | 2009 |
Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
Topics: Adolescent; Adult; Bilirubin; Chelating Agents; Copper; Dose-Response Relationship, Drug; Female; Fo | 2009 |
Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
Topics: Chelating Agents; Copper; Dose-Response Relationship, Drug; Hepatolenticular Degeneration; Humans; L | 2009 |
Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
Topics: Chelating Agents; Copper; Dose-Response Relationship, Drug; Hepatolenticular Degeneration; Humans; L | 2009 |
Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Che | 2010 |
Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Che | 2010 |
[The reassessment of the diagnostic value of 24-hour urinary copper excretion in children with Wilson's disease].
Topics: Adolescent; Age Factors; Ceruloplasmin; Child; Child, Preschool; Copper; Female; Hepatitis; Hepatiti | 2010 |
[The reassessment of the diagnostic value of 24-hour urinary copper excretion in children with Wilson's disease].
Topics: Adolescent; Age Factors; Ceruloplasmin; Child; Child, Preschool; Copper; Female; Hepatitis; Hepatiti | 2010 |
Wilson disease: histopathological correlations with treatment on follow-up liver biopsies.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Biopsy; Chelating | 2010 |
Wilson disease: histopathological correlations with treatment on follow-up liver biopsies.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Biopsy; Chelating | 2010 |
Oral complications associated with D-penicillamine treatment for Wilson disease: a clinicopathologic report.
Topics: Adult; Candidiasis, Oral; Cheilitis; Chelating Agents; Elastic Tissue; Female; Follow-Up Studies; Gi | 2010 |
Oral complications associated with D-penicillamine treatment for Wilson disease: a clinicopathologic report.
Topics: Adult; Candidiasis, Oral; Cheilitis; Chelating Agents; Elastic Tissue; Female; Follow-Up Studies; Gi | 2010 |
Rippled hyperpigmentation in Wilson's disease.
Topics: Biopsy; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Hyperpigmentation; Melanins | 2010 |
Rippled hyperpigmentation in Wilson's disease.
Topics: Biopsy; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Hyperpigmentation; Melanins | 2010 |
[Follow-up study on the therapeutic efficacy in 80 children with Wilson disease].
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatolen | 2010 |
[Follow-up study on the therapeutic efficacy in 80 children with Wilson disease].
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatolen | 2010 |
Partial status epilepticus induced by hypocupremia in a patient with Wilson's disease.
Topics: Brain; Copper; Electroencephalography; Epilepsies, Partial; Hepatolenticular Degeneration; Humans; M | 2010 |
Partial status epilepticus induced by hypocupremia in a patient with Wilson's disease.
Topics: Brain; Copper; Electroencephalography; Epilepsies, Partial; Hepatolenticular Degeneration; Humans; M | 2010 |
Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation.
Topics: Adenosine Triphosphatases; Adolescent; Adult; Asymptomatic Diseases; Cation Transport Proteins; Chel | 2011 |
Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation.
Topics: Adenosine Triphosphatases; Adolescent; Adult; Asymptomatic Diseases; Cation Transport Proteins; Chel | 2011 |
Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease.
Topics: Adolescent; Ceruloplasmin; Child; Child, Preschool; Copper; Female; Hepatolenticular Degeneration; H | 2010 |
Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease.
Topics: Adolescent; Ceruloplasmin; Child; Child, Preschool; Copper; Female; Hepatolenticular Degeneration; H | 2010 |
Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Cell Count; Ceruloplasmi | 2010 |
Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Cell Count; Ceruloplasmi | 2010 |
D-penicillamine interferes with S-homocysteinylation and S-cysteinylation of LDL apolipoprotein B.
Topics: Apolipoproteins B; Cysteine; Hepatolenticular Degeneration; Homocysteine; Humans; Penicillamine; Sul | 2011 |
D-penicillamine interferes with S-homocysteinylation and S-cysteinylation of LDL apolipoprotein B.
Topics: Apolipoproteins B; Cysteine; Hepatolenticular Degeneration; Homocysteine; Humans; Penicillamine; Sul | 2011 |
Undetectable serum alkaline phosphatase activity in a patient with fulminant hepatic failure and hemolytic anemia.
Topics: Adult; Alkaline Phosphatase; Anemia, Hemolytic; Chelating Agents; Copper; Diagnosis, Differential; F | 2011 |
Undetectable serum alkaline phosphatase activity in a patient with fulminant hepatic failure and hemolytic anemia.
Topics: Adult; Alkaline Phosphatase; Anemia, Hemolytic; Chelating Agents; Copper; Diagnosis, Differential; F | 2011 |
Wilson's disease in southern Brazil: a 40-year follow-up study.
Topics: Adolescent; Adult; Age Distribution; Age Factors; Brazil; Chelating Agents; Child; Female; Follow-Up | 2011 |
Wilson's disease in southern Brazil: a 40-year follow-up study.
Topics: Adolescent; Adult; Age Distribution; Age Factors; Brazil; Chelating Agents; Child; Female; Follow-Up | 2011 |
The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
Topics: Adolescent; Adult; Chelating Agents; Chelation Therapy; Child; Child, Preschool; Copper; Disease Pro | 2011 |
The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
Topics: Adolescent; Adult; Chelating Agents; Chelation Therapy; Child; Child, Preschool; Copper; Disease Pro | 2011 |
Manifestations and evolution of Wilson disease in pediatric patients carrying ATP7B mutation L708P.
Topics: Adenosine Triphosphatases; Adolescent; Cation Transport Proteins; Ceruloplasmin; Chelating Agents; C | 2012 |
Manifestations and evolution of Wilson disease in pediatric patients carrying ATP7B mutation L708P.
Topics: Adenosine Triphosphatases; Adolescent; Cation Transport Proteins; Ceruloplasmin; Chelating Agents; C | 2012 |
Gross hematuria in a case of Wilson disease: answers.
Topics: Acidosis, Renal Tubular; Bicarbonates; Chelating Agents; Child; Hematuria; Hepatolenticular Degenera | 2012 |
Gross hematuria in a case of Wilson disease: answers.
Topics: Acidosis, Renal Tubular; Bicarbonates; Chelating Agents; Child; Hematuria; Hepatolenticular Degenera | 2012 |
Association of Wilson disease with neurofibromatosis.
Topics: Chelating Agents; Child, Preschool; Hepatolenticular Degeneration; Humans; Liver; Liver Diseases; Li | 2011 |
Association of Wilson disease with neurofibromatosis.
Topics: Chelating Agents; Child, Preschool; Hepatolenticular Degeneration; Humans; Liver; Liver Diseases; Li | 2011 |
A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
Topics: Adolescent; Biomarkers; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Copper; Diagnosis, | 2011 |
A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
Topics: Adolescent; Biomarkers; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Copper; Diagnosis, | 2011 |
Metal element excretion in 24-h urine in patients with Wilson disease under treatment of D-penicillamine.
Topics: Adolescent; Adult; Chelating Agents; Child; Child, Preschool; Female; Hepatolenticular Degeneration; | 2012 |
Metal element excretion in 24-h urine in patients with Wilson disease under treatment of D-penicillamine.
Topics: Adolescent; Adult; Chelating Agents; Child; Child, Preschool; Female; Hepatolenticular Degeneration; | 2012 |
Serum 'free' copper in Wilson disease.
Topics: Adolescent; Adult; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Copper; Hepatolenticula | 2012 |
Serum 'free' copper in Wilson disease.
Topics: Adolescent; Adult; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Copper; Hepatolenticula | 2012 |
Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
Topics: Ceruloplasmin; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Heterozygote; Humans | 2012 |
Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
Topics: Ceruloplasmin; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Heterozygote; Humans | 2012 |
[Diagnosis and care of Wilson disease with neurological revelation].
Topics: Adolescent; Brain; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Liver Transplant | 2012 |
[Diagnosis and care of Wilson disease with neurological revelation].
Topics: Adolescent; Brain; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Liver Transplant | 2012 |
Acute Gallbladder Hydrops and Arthritis: unusual initial manifestations of Wilson's Disease (WD): Case Report.
Topics: Adenosine Triphosphatases; Arthritis; Cation Transport Proteins; Ceruloplasmin; Chelating Agents; Ch | 2011 |
Acute Gallbladder Hydrops and Arthritis: unusual initial manifestations of Wilson's Disease (WD): Case Report.
Topics: Adenosine Triphosphatases; Arthritis; Cation Transport Proteins; Ceruloplasmin; Chelating Agents; Ch | 2011 |
Wilson's disease treated with penicillamine and lupus erythematosus: related or distinct entities?
Topics: Adolescent; Female; Hepatolenticular Degeneration; Humans; Lupus Erythematosus, Systemic; Penicillam | 2012 |
Wilson's disease treated with penicillamine and lupus erythematosus: related or distinct entities?
Topics: Adolescent; Female; Hepatolenticular Degeneration; Humans; Lupus Erythematosus, Systemic; Penicillam | 2012 |
Neurological Wilson disease in children: a three years experience from Multan.
Topics: Adolescent; Age Distribution; Age of Onset; Astringents; Chelating Agents; Child; Child, Preschool; | 2011 |
Neurological Wilson disease in children: a three years experience from Multan.
Topics: Adolescent; Age Distribution; Age of Onset; Astringents; Chelating Agents; Child; Child, Preschool; | 2011 |
Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
Topics: Ceruloplasmin; Chelating Agents; Chelation Therapy; Copper; Female; Gait Disorders, Neurologic; Hepa | 2012 |
Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
Topics: Ceruloplasmin; Chelating Agents; Chelation Therapy; Copper; Female; Gait Disorders, Neurologic; Hepa | 2012 |
Penicillamine increases free copper and enhances oxidative stress in the brain of toxic milk mice.
Topics: Adenosine Triphosphatases; Animals; Blood-Brain Barrier; Brain; Cation Transport Proteins; Cell Memb | 2012 |
Penicillamine increases free copper and enhances oxidative stress in the brain of toxic milk mice.
Topics: Adenosine Triphosphatases; Animals; Blood-Brain Barrier; Brain; Cation Transport Proteins; Cell Memb | 2012 |
Wilson disease: Canadian perspectives on presentation and outcomes from an adult ambulatory setting.
Topics: Adolescent; Adult; Ambulatory Care; Biopsy; Brain Diseases; Canada; Chelating Agents; Child; Female; | 2012 |
Wilson disease: Canadian perspectives on presentation and outcomes from an adult ambulatory setting.
Topics: Adolescent; Adult; Ambulatory Care; Biopsy; Brain Diseases; Canada; Chelating Agents; Child; Female; | 2012 |
Resolution of cranial MRI and SPECT abnormalities in a patient with Wilson's disease following oral zinc monotherapy.
Topics: Adult; Brain; Cerebellar Ataxia; Cerebrovascular Circulation; Female; Hepatolenticular Degeneration; | 2012 |
Resolution of cranial MRI and SPECT abnormalities in a patient with Wilson's disease following oral zinc monotherapy.
Topics: Adult; Brain; Cerebellar Ataxia; Cerebrovascular Circulation; Female; Hepatolenticular Degeneration; | 2012 |
Kayser-Fleischer ring in Wilson's disease: a cohort study.
Topics: Adolescent; Adult; Brain; Chelating Agents; Cohort Studies; Disease Progression; Female; Hepatolenti | 2012 |
Kayser-Fleischer ring in Wilson's disease: a cohort study.
Topics: Adolescent; Adult; Brain; Chelating Agents; Cohort Studies; Disease Progression; Female; Hepatolenti | 2012 |
A copper for your thoughts.
Topics: Adult; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Insurance, Life; Pen | 2012 |
A copper for your thoughts.
Topics: Adult; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Insurance, Life; Pen | 2012 |
Wilson's disease: changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease.
Topics: Adenosylhomocysteinase; Animals; Betaine; Copper; Disease Models, Animal; DNA (Cytosine-5-)-Methyltr | 2013 |
Wilson's disease: changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease.
Topics: Adenosylhomocysteinase; Animals; Betaine; Copper; Disease Models, Animal; DNA (Cytosine-5-)-Methyltr | 2013 |
Histologic evolution and long-term outcome of Wilson's disease: results of a single-center experience.
Topics: Adolescent; Adult; Biopsy; Chelating Agents; Chi-Square Distribution; Child; Child, Preschool; Disea | 2013 |
Histologic evolution and long-term outcome of Wilson's disease: results of a single-center experience.
Topics: Adolescent; Adult; Biopsy; Chelating Agents; Chi-Square Distribution; Child; Child, Preschool; Disea | 2013 |
Concurrent massive breast enlargement, myasthenia gravis and dermopathy as manifestations of penicillamine toxicity in a Wilson's disease patient.
Topics: Adolescent; Breast; Chelating Agents; Drug Eruptions; Female; Hepatolenticular Degeneration; Humans; | 2012 |
Concurrent massive breast enlargement, myasthenia gravis and dermopathy as manifestations of penicillamine toxicity in a Wilson's disease patient.
Topics: Adolescent; Breast; Chelating Agents; Drug Eruptions; Female; Hepatolenticular Degeneration; Humans; | 2012 |
Is blinking of the eyes affected in extrapyramidal disorders? An interesting observation in a patient with Wilson disease.
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Blinking; Carbidopa; Ceruloplasmin; Drug Therap | 2012 |
Is blinking of the eyes affected in extrapyramidal disorders? An interesting observation in a patient with Wilson disease.
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Blinking; Carbidopa; Ceruloplasmin; Drug Therap | 2012 |
A novel HPLC-electrochemical detection approach for the determination of D-penicillamine in skin specimens.
Topics: Case-Control Studies; Chromatography, High Pressure Liquid; Disulfides; Electrochemistry; Electrodes | 2013 |
A novel HPLC-electrochemical detection approach for the determination of D-penicillamine in skin specimens.
Topics: Case-Control Studies; Chromatography, High Pressure Liquid; Disulfides; Electrochemistry; Electrodes | 2013 |
[Appropriate administration schedule of D-penicillamine for pediatric Wilson's disease patients based on urinary copper excretion].
Topics: Biomarkers; Child; Copper; Drug Administration Schedule; Food-Drug Interactions; Hepatolenticular De | 2002 |
[Appropriate administration schedule of D-penicillamine for pediatric Wilson's disease patients based on urinary copper excretion].
Topics: Biomarkers; Child; Copper; Drug Administration Schedule; Food-Drug Interactions; Hepatolenticular De | 2002 |
Elastosis perforans serpiginosa secondary to D-penicillamine treatment in a Wilson's disease patient.
Topics: Adolescent; Antirheumatic Agents; Arm; Connective Tissue Diseases; Hepatolenticular Degeneration; Hu | 2002 |
Elastosis perforans serpiginosa secondary to D-penicillamine treatment in a Wilson's disease patient.
Topics: Adolescent; Antirheumatic Agents; Arm; Connective Tissue Diseases; Hepatolenticular Degeneration; Hu | 2002 |
[Late presentation of Wilson's disease].
Topics: Adult; Age Factors; Biopsy; Chelating Agents; Follow-Up Studies; Hepatolenticular Degeneration; Huma | 2002 |
[Late presentation of Wilson's disease].
Topics: Adult; Age Factors; Biopsy; Chelating Agents; Follow-Up Studies; Hepatolenticular Degeneration; Huma | 2002 |
D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease.
Topics: Adult; Anemia, Hemolytic; Biopsy; Ceruloplasmin; Chelating Agents; Copper; Female; Follow-Up Studies | 2003 |
D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease.
Topics: Adult; Anemia, Hemolytic; Biopsy; Ceruloplasmin; Chelating Agents; Copper; Female; Follow-Up Studies | 2003 |
Liver support--a task for nephrologists? Extracorporeal treatment of a patient with fulminant Wilson crisis.
Topics: Adolescent; Bilirubin; Copper; Female; Hepatic Encephalopathy; Hepatolenticular Degeneration; Humans | 2003 |
Liver support--a task for nephrologists? Extracorporeal treatment of a patient with fulminant Wilson crisis.
Topics: Adolescent; Bilirubin; Copper; Female; Hepatic Encephalopathy; Hepatolenticular Degeneration; Humans | 2003 |
The story of penicillamine: a difficult birth.
Topics: Adult; Antirheumatic Agents; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Histor | 2003 |
The story of penicillamine: a difficult birth.
Topics: Adult; Antirheumatic Agents; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Histor | 2003 |
[From gene to disease; Wilson disease: copper storage due to mutations in ATP7B].
Topics: Adenosine Triphosphatases; Chelating Agents; Copper; Hepatolenticular Degeneration; Mutation; Penici | 2003 |
[From gene to disease; Wilson disease: copper storage due to mutations in ATP7B].
Topics: Adenosine Triphosphatases; Chelating Agents; Copper; Hepatolenticular Degeneration; Mutation; Penici | 2003 |
A case report on Wilson's disease.
Topics: Adolescent; Ceruloplasmin; Chelating Agents; Hepatolenticular Degeneration; Humans; Male; Penicillam | 2003 |
A case report on Wilson's disease.
Topics: Adolescent; Ceruloplasmin; Chelating Agents; Hepatolenticular Degeneration; Humans; Male; Penicillam | 2003 |
[Nephrolithiasis as an initial clinical manifestation of Wilson-Konovalov disease].
Topics: Adolescent; Adult; Chelating Agents; Diagnosis, Differential; Female; Hepatolenticular Degeneration; | 2003 |
[Nephrolithiasis as an initial clinical manifestation of Wilson-Konovalov disease].
Topics: Adolescent; Adult; Chelating Agents; Diagnosis, Differential; Female; Hepatolenticular Degeneration; | 2003 |
The treatment of hepatolenticular degeneration with penicillamine; with report of two cases.
Topics: Cysteine; Hepatolenticular Degeneration; Humans; Penicillamine | 1958 |
The treatment of hepatolenticular degeneration with penicillamine; with report of two cases.
Topics: Cysteine; Hepatolenticular Degeneration; Humans; Penicillamine | 1958 |
Effects of penicillamine and dimercaprol on turnover of copper in patients with Wilson's disease.
Topics: Copper; Cysteine; Dimercaprol; Hepatolenticular Degeneration; Humans; Penicillamine | 1958 |
Effects of penicillamine and dimercaprol on turnover of copper in patients with Wilson's disease.
Topics: Copper; Cysteine; Dimercaprol; Hepatolenticular Degeneration; Humans; Penicillamine | 1958 |
Clinical studies with penicillamine in hepatolenticular degeneration.
Topics: Biomedical Research; Cysteine; Hepatolenticular Degeneration; Penicillamine | 1959 |
Clinical studies with penicillamine in hepatolenticular degeneration.
Topics: Biomedical Research; Cysteine; Hepatolenticular Degeneration; Penicillamine | 1959 |
[Essential hepatorenal form of Wilson's disease in a brother and a sister and its treatment with penicillamine].
Topics: Child; Female; Hepatolenticular Degeneration; Humans; Infant; Male; Penicillamine; Siblings; Valine | 1961 |
[Essential hepatorenal form of Wilson's disease in a brother and a sister and its treatment with penicillamine].
Topics: Child; Female; Hepatolenticular Degeneration; Humans; Infant; Male; Penicillamine; Siblings; Valine | 1961 |
Treatment of Wilson's disease with penicillamine.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Valine | 1960 |
Treatment of Wilson's disease with penicillamine.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Valine | 1960 |
[On Wilson's disease. Also a contribution on penicillamine therapy].
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Valine | 1960 |
[On Wilson's disease. Also a contribution on penicillamine therapy].
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Valine | 1960 |
[The use of penicillamine as a diagnostic aid in hepatolenticular degeneration (Wilson's disease)].
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Valine | 1961 |
[The use of penicillamine as a diagnostic aid in hepatolenticular degeneration (Wilson's disease)].
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Valine | 1961 |
Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Penicillins | 1961 |
Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Penicillins | 1961 |
Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Valine | 1962 |
Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Valine | 1962 |
[Ocular manifestations of Wilson's disease treated by penicillamine].
Topics: Chelating Agents; Copper; Eye Manifestations; Hepatolenticular Degeneration; Humans; Penicillamine | 1963 |
[Ocular manifestations of Wilson's disease treated by penicillamine].
Topics: Chelating Agents; Copper; Eye Manifestations; Hepatolenticular Degeneration; Humans; Penicillamine | 1963 |
[On 2 family lines with Wilson's pseudosclerosis. Clinical course and therapy, with special reference to combined therapy with BAL, penicillamine and vitamin E].
Topics: Chelating Agents; Dimercaprol; Hepatolenticular Degeneration; Humans; Penicillamine; Psychotherapy, | 1963 |
[On 2 family lines with Wilson's pseudosclerosis. Clinical course and therapy, with special reference to combined therapy with BAL, penicillamine and vitamin E].
Topics: Chelating Agents; Dimercaprol; Hepatolenticular Degeneration; Humans; Penicillamine; Psychotherapy, | 1963 |
[Method and surveillance of treatment by penicillamine during hepatolenticular degeneration and in poisonings. (Apropos of 3 cases)].
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Lead Poisoning; Penicillamine | 1963 |
[Method and surveillance of treatment by penicillamine during hepatolenticular degeneration and in poisonings. (Apropos of 3 cases)].
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Lead Poisoning; Penicillamine | 1963 |
[Treatment of Wilson's disease with penicillamine and guajacuran].
Topics: Chelating Agents; Guaifenesin; Hepatolenticular Degeneration; Humans; Penicillamine | 1963 |
[Treatment of Wilson's disease with penicillamine and guajacuran].
Topics: Chelating Agents; Guaifenesin; Hepatolenticular Degeneration; Humans; Penicillamine | 1963 |
PENICILLAMINE AND MIXED DISULPHIDE EXCRETION IN WILSON'S DISEASE.
Topics: Cysteine; Cystinuria; Disulfides; Hepatolenticular Degeneration; Humans; Penicillamine; Sulfides | 1963 |
PENICILLAMINE AND MIXED DISULPHIDE EXCRETION IN WILSON'S DISEASE.
Topics: Cysteine; Cystinuria; Disulfides; Hepatolenticular Degeneration; Humans; Penicillamine; Sulfides | 1963 |
MEDICAL GRAND ROUNDS FROM THE UNIVERSITY OF ALABAMA MEDICAL CENTER. CASE 9: WILSON'S DISEASE.
Topics: Chelating Agents; Drug Hypersensitivity; Hepatolenticular Degeneration; Humans; Penicillamine; Teach | 1963 |
MEDICAL GRAND ROUNDS FROM THE UNIVERSITY OF ALABAMA MEDICAL CENTER. CASE 9: WILSON'S DISEASE.
Topics: Chelating Agents; Drug Hypersensitivity; Hepatolenticular Degeneration; Humans; Penicillamine; Teach | 1963 |
STUDY OF WILSON'S DISEASE IN TAIWAN.
Topics: Asian People; China; Copper; Diet; Diet Therapy; Genetics, Medical; Hepatolenticular Degeneration; H | 1963 |
STUDY OF WILSON'S DISEASE IN TAIWAN.
Topics: Asian People; China; Copper; Diet; Diet Therapy; Genetics, Medical; Hepatolenticular Degeneration; H | 1963 |
HEPATOLENTICULAR DEGENERATION: OBSERVATIONS ON A CASE TREATED WITH D-PENICILLAMINE.
Topics: Blood Chemical Analysis; Ceruloplasmin; Child; Copper; Electrolytes; Hepatolenticular Degeneration; | 1963 |
HEPATOLENTICULAR DEGENERATION: OBSERVATIONS ON A CASE TREATED WITH D-PENICILLAMINE.
Topics: Blood Chemical Analysis; Ceruloplasmin; Child; Copper; Electrolytes; Hepatolenticular Degeneration; | 1963 |
CURRENT THERAPEUTICS. 192. PENICILLAMINE.
Topics: Chemical Phenomena; Chemistry; Child; Copper; Cystinosis; Cystinuria; Hepatolenticular Degeneration; | 1963 |
CURRENT THERAPEUTICS. 192. PENICILLAMINE.
Topics: Chemical Phenomena; Chemistry; Child; Copper; Cystinosis; Cystinuria; Hepatolenticular Degeneration; | 1963 |
[CONSIDERATIONS ON SPLENECTOMY AND ON PENICILLAMINIC THERAPY IN A CASE OF "ABDOMINAL FORM" OF HEPATOLENTICULAR DEGENERATION].
Topics: Abdomen; Hepatolenticular Degeneration; Penicillamine; Spleen; Splenectomy | 1963 |
[CONSIDERATIONS ON SPLENECTOMY AND ON PENICILLAMINIC THERAPY IN A CASE OF "ABDOMINAL FORM" OF HEPATOLENTICULAR DEGENERATION].
Topics: Abdomen; Hepatolenticular Degeneration; Penicillamine; Spleen; Splenectomy | 1963 |
[OUR EXPERIENCE IN THE TREATMENT OF WILSON'S DISEASE WITH PENICILLAMINE].
Topics: Adolescent; Copper; Dimercaprol; Edetic Acid; Hepatolenticular Degeneration; Humans; Neurologic Mani | 1963 |
[OUR EXPERIENCE IN THE TREATMENT OF WILSON'S DISEASE WITH PENICILLAMINE].
Topics: Adolescent; Copper; Dimercaprol; Edetic Acid; Hepatolenticular Degeneration; Humans; Neurologic Mani | 1963 |
FILTERABLE AND NON-FILTERABLE SERUM COPPER. 1. THE ACTION OF PENICILLAMINE.
Topics: Blood Chemical Analysis; Copper; Dialysis; Filtration; Fluid Therapy; Hepatolenticular Degeneration; | 1963 |
FILTERABLE AND NON-FILTERABLE SERUM COPPER. 1. THE ACTION OF PENICILLAMINE.
Topics: Blood Chemical Analysis; Copper; Dialysis; Filtration; Fluid Therapy; Hepatolenticular Degeneration; | 1963 |
NEPHROTIC SYNDROME ASSOCIATED WITH PENICILLAMINE THERAPY OF WILSON'S DISEASE.
Topics: Biopsy; Dermatology; Drug Hypersensitivity; Glomerulonephritis; Hepatolenticular Degeneration; Human | 1964 |
NEPHROTIC SYNDROME ASSOCIATED WITH PENICILLAMINE THERAPY OF WILSON'S DISEASE.
Topics: Biopsy; Dermatology; Drug Hypersensitivity; Glomerulonephritis; Hepatolenticular Degeneration; Human | 1964 |
HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE). TWO DIFFERENT COMPONENTS.
Topics: Adolescent; Chelating Agents; Child; Copper; Edetic Acid; Genetics, Medical; Hepatolenticular Degene | 1964 |
HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE). TWO DIFFERENT COMPONENTS.
Topics: Adolescent; Chelating Agents; Child; Copper; Edetic Acid; Genetics, Medical; Hepatolenticular Degene | 1964 |
[WILSON'S DISEASE (HEPATOCEREBRAL DEGENERATION) IN CHILDREN].
Topics: Child; Enzymes; Genetics, Medical; Hepatolenticular Degeneration; Humans; Penicillamine | 1964 |
[WILSON'S DISEASE (HEPATOCEREBRAL DEGENERATION) IN CHILDREN].
Topics: Child; Enzymes; Genetics, Medical; Hepatolenticular Degeneration; Humans; Penicillamine | 1964 |
[HEPATOCEREBRAL OR HEPATOLENTICULAR DEGENERATION].
Topics: Adolescent; Alkaline Phosphatase; Amino Acids; Bilirubin; Blood Coagulation Tests; Ceruloplasmin; Ch | 1964 |
[HEPATOCEREBRAL OR HEPATOLENTICULAR DEGENERATION].
Topics: Adolescent; Alkaline Phosphatase; Amino Acids; Bilirubin; Blood Coagulation Tests; Ceruloplasmin; Ch | 1964 |
D-PENICILLAMINE, WITH PARTICULAR RELATION TO WILSON'S DISEASE.
Topics: Body Fluids; Copper; Cystinosis; Edetic Acid; Hepatolenticular Degeneration; Humans; Immunologic Tes | 1964 |
D-PENICILLAMINE, WITH PARTICULAR RELATION TO WILSON'S DISEASE.
Topics: Body Fluids; Copper; Cystinosis; Edetic Acid; Hepatolenticular Degeneration; Humans; Immunologic Tes | 1964 |
WILSON'S DISEASE.
Topics: Child; Clinical Laboratory Techniques; Dimercaprol; Genetics, Medical; Hepatolenticular Degeneration | 1964 |
WILSON'S DISEASE.
Topics: Child; Clinical Laboratory Techniques; Dimercaprol; Genetics, Medical; Hepatolenticular Degeneration | 1964 |
WILSON'S DISEASE, AN INBORN ERROR OF METABOLISM AND A MODEL OF DEGENERATIVE CENTRAL NERVOUS SYSTEM DISEASE.
Topics: Central Nervous System Diseases; Chelating Agents; Copper; Dimercaprol; Hepatolenticular Degeneratio | 1964 |
WILSON'S DISEASE, AN INBORN ERROR OF METABOLISM AND A MODEL OF DEGENERATIVE CENTRAL NERVOUS SYSTEM DISEASE.
Topics: Central Nervous System Diseases; Chelating Agents; Copper; Dimercaprol; Hepatolenticular Degeneratio | 1964 |
FAMILIAL HEPATIC COPPER STORAGE DISEASE: A VARIANT OF WILSON'S DISEASE.
Topics: Adolescent; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Chemical Analysis; C | 1964 |
FAMILIAL HEPATIC COPPER STORAGE DISEASE: A VARIANT OF WILSON'S DISEASE.
Topics: Adolescent; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Chemical Analysis; C | 1964 |
FILTERABLE AND NON-FILTERABLE SERUM COPPER. (2). STUDIES WITH 64CU.
Topics: Blood Chemical Analysis; Ceruloplasmin; Copper; Filtration; Hepatolenticular Degeneration; Humans; M | 1964 |
FILTERABLE AND NON-FILTERABLE SERUM COPPER. (2). STUDIES WITH 64CU.
Topics: Blood Chemical Analysis; Ceruloplasmin; Copper; Filtration; Hepatolenticular Degeneration; Humans; M | 1964 |
BASAL COPPER EXCRETION IN WILSON'S DISEASE.
Topics: Adolescent; Child; Copper; Drug Therapy; Hepatolenticular Degeneration; Humans; Penicillamine; Urine | 1964 |
BASAL COPPER EXCRETION IN WILSON'S DISEASE.
Topics: Adolescent; Child; Copper; Drug Therapy; Hepatolenticular Degeneration; Humans; Penicillamine; Urine | 1964 |
PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION.
Topics: Amenorrhea; Avitaminosis; Bone and Bones; Copper; Desensitization, Immunologic; Diet; Drug Eruptions | 1964 |
PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION.
Topics: Amenorrhea; Avitaminosis; Bone and Bones; Copper; Desensitization, Immunologic; Diet; Drug Eruptions | 1964 |
ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE.
Topics: Adolescent; Blood; Body Fluids; Ceruloplasmin; Child; Copper; Hepatolenticular Degeneration; Humans; | 1964 |
ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE.
Topics: Adolescent; Blood; Body Fluids; Ceruloplasmin; Child; Copper; Hepatolenticular Degeneration; Humans; | 1964 |
WILSON'S DISEASE AS A GASTROENTEROLOGIC PROBLEM.
Topics: Copper; Diet; Diet Therapy; Dimercaprol; Gastroenterology; Genetics, Medical; Hepatolenticular Degen | 1964 |
WILSON'S DISEASE AS A GASTROENTEROLOGIC PROBLEM.
Topics: Copper; Diet; Diet Therapy; Dimercaprol; Gastroenterology; Genetics, Medical; Hepatolenticular Degen | 1964 |
[CURRENT ASPECTS OF WILSON'S DISEASE].
Topics: Carbamates; Ceruloplasmin; Diagnosis; Diet; Diet Therapy; Dimercaprol; Drug Therapy; Esters; Genetic | 1964 |
[CURRENT ASPECTS OF WILSON'S DISEASE].
Topics: Carbamates; Ceruloplasmin; Diagnosis; Diet; Diet Therapy; Dimercaprol; Drug Therapy; Esters; Genetic | 1964 |
[IMPROVEMENT IN WILSON'S DISEASE IN A 17-YEAR-OLD GIRL WITH CONTINUOUS PENICILLAMINE THERAPY].
Topics: Adolescent; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1964 |
[IMPROVEMENT IN WILSON'S DISEASE IN A 17-YEAR-OLD GIRL WITH CONTINUOUS PENICILLAMINE THERAPY].
Topics: Adolescent; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1964 |
[MODE OF ACTION OF CHELATOR AGENTS IN THE TREATMENT OF HEPATOLENTICULAR DEGENERATION].
Topics: Chelating Agents; Dimercaprol; Edetic Acid; Hepatolenticular Degeneration; Humans; Penicillamine | 1964 |
[MODE OF ACTION OF CHELATOR AGENTS IN THE TREATMENT OF HEPATOLENTICULAR DEGENERATION].
Topics: Chelating Agents; Dimercaprol; Edetic Acid; Hepatolenticular Degeneration; Humans; Penicillamine | 1964 |
[WILSON'S DISEASE AND ITS TREATMENT].
Topics: Drug Therapy; Hepatolenticular Degeneration; Humans; Penicillamine | 1964 |
[WILSON'S DISEASE AND ITS TREATMENT].
Topics: Drug Therapy; Hepatolenticular Degeneration; Humans; Penicillamine | 1964 |
HEPATO-LENTICULAR DEGENERATION (WILSON'S DISEASE) TREATED BY PENICILLAMINE.
Topics: Adolescent; Alkaline Phosphatase; Bilirubin; Blood Chemical Analysis; Blood Protein Electrophoresis; | 1964 |
HEPATO-LENTICULAR DEGENERATION (WILSON'S DISEASE) TREATED BY PENICILLAMINE.
Topics: Adolescent; Alkaline Phosphatase; Bilirubin; Blood Chemical Analysis; Blood Protein Electrophoresis; | 1964 |
STUDIES OF PYRIDOXAL-PENICILLAMINE ANTAGONISM IN THE HUMAN.
Topics: Hepatolenticular Degeneration; Humans; Metabolism; Penicillamine; Pharmacology; Pyridoxal; Pyridoxin | 1964 |
STUDIES OF PYRIDOXAL-PENICILLAMINE ANTAGONISM IN THE HUMAN.
Topics: Hepatolenticular Degeneration; Humans; Metabolism; Penicillamine; Pharmacology; Pyridoxal; Pyridoxin | 1964 |
EFFECT OF ADRENOCORTICAL STEROIDS ON THE HYPERCALCIURIA OF WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION).
Topics: Calcium; Calcium, Dietary; Cortisone; Feces; Fluids and Secretions; Hepatolenticular Degeneration; H | 1965 |
EFFECT OF ADRENOCORTICAL STEROIDS ON THE HYPERCALCIURIA OF WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION).
Topics: Calcium; Calcium, Dietary; Cortisone; Feces; Fluids and Secretions; Hepatolenticular Degeneration; H | 1965 |
[WILSON'S DISEASE IN THE FORM OF A PANHEMOCYTOPENIA].
Topics: Blood; Blood Coagulation Tests; Copper; Drug Therapy; Hemorrhagic Disorders; Hepatolenticular Degene | 1965 |
[WILSON'S DISEASE IN THE FORM OF A PANHEMOCYTOPENIA].
Topics: Blood; Blood Coagulation Tests; Copper; Drug Therapy; Hemorrhagic Disorders; Hepatolenticular Degene | 1965 |
COPPER BALANCE STUDIES IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION). OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBO-RESIN AND POTASSIUM SULFIDE.
Topics: Charcoal; Copper; Hepatolenticular Degeneration; Humans; Metabolism; Penicillamine; Pharmacology; Po | 1963 |
COPPER BALANCE STUDIES IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION). OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBO-RESIN AND POTASSIUM SULFIDE.
Topics: Charcoal; Copper; Hepatolenticular Degeneration; Humans; Metabolism; Penicillamine; Pharmacology; Po | 1963 |
TREATMENT OF HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE) IN THE ASYMPTOMATIC STAGE.
Topics: Asian People; Child; Copper; Diet; Diet Therapy; Drug Therapy; Electroencephalography; Feces; Hepato | 1965 |
TREATMENT OF HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE) IN THE ASYMPTOMATIC STAGE.
Topics: Asian People; Child; Copper; Diet; Diet Therapy; Drug Therapy; Electroencephalography; Feces; Hepato | 1965 |
COPPER BALANCE STUDIES IN WILSON'S DISEASE; OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBACRYLAMINE RESINS, AND POTASSIUM SULFIDE.
Topics: Copper; Drug Therapy; Feces; Fluids and Secretions; Hepatolenticular Degeneration; Humans; Ion Excha | 1965 |
COPPER BALANCE STUDIES IN WILSON'S DISEASE; OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBACRYLAMINE RESINS, AND POTASSIUM SULFIDE.
Topics: Copper; Drug Therapy; Feces; Fluids and Secretions; Hepatolenticular Degeneration; Humans; Ion Excha | 1965 |
COPPER BALANCE STUDIES DURING THE TREATMENT OF PATIENTS WITH WILSON'S DISEASE.
Topics: Adolescent; Asian People; Biological Transport; Copper; Drug Therapy; Electroencephalography; Feces; | 1965 |
COPPER BALANCE STUDIES DURING THE TREATMENT OF PATIENTS WITH WILSON'S DISEASE.
Topics: Adolescent; Asian People; Biological Transport; Copper; Drug Therapy; Electroencephalography; Feces; | 1965 |
THE NEPHROTIC SYNDROME AS A COMPLICATION OF PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE).
Topics: Drug Hypersensitivity; Drug Therapy; Hepatolenticular Degeneration; Humans; Hypersensitivity, Delaye | 1965 |
THE NEPHROTIC SYNDROME AS A COMPLICATION OF PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE).
Topics: Drug Hypersensitivity; Drug Therapy; Hepatolenticular Degeneration; Humans; Hypersensitivity, Delaye | 1965 |
[CONTROL OF THE COURSE IN FAMILIAL WILSON'S DISEASE (KAYSER-FLEISCHER RING, SUNFLOWER CATARACT, VITREOUS BODY PIGMENTATION)].
Topics: Adolescent; Cataract; Corneal Diseases; Helianthus; Hepatolenticular Degeneration; Humans; Penicilla | 1965 |
[CONTROL OF THE COURSE IN FAMILIAL WILSON'S DISEASE (KAYSER-FLEISCHER RING, SUNFLOWER CATARACT, VITREOUS BODY PIGMENTATION)].
Topics: Adolescent; Cataract; Corneal Diseases; Helianthus; Hepatolenticular Degeneration; Humans; Penicilla | 1965 |
CHEMICAL THERAPY OF WILSON'S DISEASE.
Topics: Dimercaprol; Drug Therapy; Edetic Acid; Hepatolenticular Degeneration; Humans; Penicillamine | 1965 |
CHEMICAL THERAPY OF WILSON'S DISEASE.
Topics: Dimercaprol; Drug Therapy; Edetic Acid; Hepatolenticular Degeneration; Humans; Penicillamine | 1965 |
WILSON'S DISEASE PRESENTING AS AN ACUTE HAEMOLYTIC ANAEMIA.
Topics: Anemia; Anemia, Hemolytic; Child; Copper; Diagnosis; Diet; Diet Therapy; Drug Therapy; Hepatolenticu | 1965 |
WILSON'S DISEASE PRESENTING AS AN ACUTE HAEMOLYTIC ANAEMIA.
Topics: Anemia; Anemia, Hemolytic; Child; Copper; Diagnosis; Diet; Diet Therapy; Drug Therapy; Hepatolenticu | 1965 |
Effect of D,L-penicillamine on the urinary excretion of copper and calcium in hepatolenticular degeneration (Wilson's disease).
Topics: Calcium; Copper; Hematologic Tests; Hepatolenticular Degeneration; Humans; Penicillamine; Valine | 1960 |
Effect of D,L-penicillamine on the urinary excretion of copper and calcium in hepatolenticular degeneration (Wilson's disease).
Topics: Calcium; Copper; Hematologic Tests; Hepatolenticular Degeneration; Humans; Penicillamine; Valine | 1960 |
[The effects of penicillamine and versenate in the treatment of Wilson's disease and lead poisoning].
Topics: Cysteine; Edetic Acid; Hepatolenticular Degeneration; Humans; Lead Poisoning; Penicillamine | 1959 |
[The effects of penicillamine and versenate in the treatment of Wilson's disease and lead poisoning].
Topics: Cysteine; Edetic Acid; Hepatolenticular Degeneration; Humans; Lead Poisoning; Penicillamine | 1959 |
[Late-onset Wilsońs disease].
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver; Liver Function Tests; Male; | 2003 |
[Late-onset Wilsońs disease].
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver; Liver Function Tests; Male; | 2003 |
Status epilepticus in a case with wilson's disease during D-pencillamine treatment.
Topics: Adult; Cerebral Cortex; Electroencephalography; Hepatolenticular Degeneration; Humans; Magnetic Reso | 2003 |
Status epilepticus in a case with wilson's disease during D-pencillamine treatment.
Topics: Adult; Cerebral Cortex; Electroencephalography; Hepatolenticular Degeneration; Humans; Magnetic Reso | 2003 |
Bridging use of plasma exchange and continuous hemodiafiltration before living donor liver transplantation in fulminant Wilson's disease.
Topics: Adolescent; Chelating Agents; Female; Hemodiafiltration; Hepatolenticular Degeneration; Humans; Live | 2003 |
Bridging use of plasma exchange and continuous hemodiafiltration before living donor liver transplantation in fulminant Wilson's disease.
Topics: Adolescent; Chelating Agents; Female; Hemodiafiltration; Hepatolenticular Degeneration; Humans; Live | 2003 |
A case of penicillamine-induced dermopathy.
Topics: Biopsy, Needle; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hepatolenticular Degene | 2003 |
A case of penicillamine-induced dermopathy.
Topics: Biopsy, Needle; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hepatolenticular Degene | 2003 |
Transient fetal myelosuppressive effect of D-penicillamine when used in pregnancy.
Topics: Chelating Agents; Female; Fetal Diseases; Hepatolenticular Degeneration; Humans; Infant, Newborn; Le | 2003 |
Transient fetal myelosuppressive effect of D-penicillamine when used in pregnancy.
Topics: Chelating Agents; Female; Fetal Diseases; Hepatolenticular Degeneration; Humans; Infant, Newborn; Le | 2003 |
Plasma D-penicillamine redox state evaluation by capillary electrophoresis with laser-induced fluorescence.
Topics: Fluorescence; Hepatolenticular Degeneration; Humans; Lasers; Oxidation-Reduction; Penicillamine; Rep | 2004 |
Plasma D-penicillamine redox state evaluation by capillary electrophoresis with laser-induced fluorescence.
Topics: Fluorescence; Hepatolenticular Degeneration; Humans; Lasers; Oxidation-Reduction; Penicillamine; Rep | 2004 |
Results of treatment of Wilson's disease--own observations.
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penicillamine | 2003 |
Results of treatment of Wilson's disease--own observations.
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penicillamine | 2003 |
Infant with severe penicillamine embryopathy born to a woman with Wilson disease.
Topics: Abnormalities, Drug-Induced; Agenesis of Corpus Callosum; Cutis Laxa; Female; Fetal Diseases; Fetus; | 2004 |
Infant with severe penicillamine embryopathy born to a woman with Wilson disease.
Topics: Abnormalities, Drug-Induced; Agenesis of Corpus Callosum; Cutis Laxa; Female; Fetal Diseases; Fetus; | 2004 |
[Pathogenesis and treatment of Wilson's disease].
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Intestinal Absorption; Penicillamin | 2003 |
[Pathogenesis and treatment of Wilson's disease].
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Intestinal Absorption; Penicillamin | 2003 |
Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease.
Topics: Adult; Aged; Aspartic Acid; Atrophy; Brain; Brain Chemistry; Chelation Therapy; Copper; Dipeptides; | 2004 |
Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease.
Topics: Adult; Aged; Aspartic Acid; Atrophy; Brain; Brain Chemistry; Chelation Therapy; Copper; Dipeptides; | 2004 |
Effect of D-penicillamine on neuromuscular junction in patients with Wilson disease.
Topics: Adolescent; Adult; Autoantibodies; Child; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; | 2004 |
Effect of D-penicillamine on neuromuscular junction in patients with Wilson disease.
Topics: Adolescent; Adult; Autoantibodies; Child; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; | 2004 |
[Wilson's disease and secondary copper hemochromatoses in hematological practice].
Topics: Adult; Chelating Agents; Copper; Diagnosis, Differential; Drug Administration Schedule; Hemochromato | 2004 |
[Wilson's disease and secondary copper hemochromatoses in hematological practice].
Topics: Adult; Chelating Agents; Copper; Diagnosis, Differential; Drug Administration Schedule; Hemochromato | 2004 |
Serum transaminases in children with Wilson's disease.
Topics: Adolescent; Alanine Transaminase; Child; Child, Preschool; Female; Hepatolenticular Degeneration; Hu | 2004 |
Serum transaminases in children with Wilson's disease.
Topics: Adolescent; Alanine Transaminase; Child; Child, Preschool; Female; Hepatolenticular Degeneration; Hu | 2004 |
Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson's disease with penicillamine.
Topics: Adult; Chelating Agents; Diagnosis, Differential; Facial Dermatoses; Female; Hepatolenticular Degene | 2005 |
Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson's disease with penicillamine.
Topics: Adult; Chelating Agents; Diagnosis, Differential; Facial Dermatoses; Female; Hepatolenticular Degene | 2005 |
Value of an enzymatic assay for the determination of serum ceruloplasmin.
Topics: Ceruloplasmin; Chelating Agents; Copper; Edetic Acid; Evaluation Studies as Topic; Female; Hepatolen | 2004 |
Value of an enzymatic assay for the determination of serum ceruloplasmin.
Topics: Ceruloplasmin; Chelating Agents; Copper; Edetic Acid; Evaluation Studies as Topic; Female; Hepatolen | 2004 |
Wilson's disease-cause of mortality in 164 patients during 1992-2003 observation period.
Topics: Adult; Brain; Confidence Intervals; Copper; Disease Progression; Female; Hepatolenticular Degenerati | 2005 |
Wilson's disease-cause of mortality in 164 patients during 1992-2003 observation period.
Topics: Adult; Brain; Confidence Intervals; Copper; Disease Progression; Female; Hepatolenticular Degenerati | 2005 |
Wilson's disease with depression and parkinsonism.
Topics: Adult; Antiparkinson Agents; Brain; Bromocriptine; Chelating Agents; Depressive Disorder; Female; He | 2005 |
Wilson's disease with depression and parkinsonism.
Topics: Adult; Antiparkinson Agents; Brain; Bromocriptine; Chelating Agents; Depressive Disorder; Female; He | 2005 |
An iatrogenic dermatosis with ulceration.
Topics: Adult; Chelating Agents; Drug Eruptions; Female; Hepatolenticular Degeneration; Humans; Penicillamin | 2005 |
An iatrogenic dermatosis with ulceration.
Topics: Adult; Chelating Agents; Drug Eruptions; Female; Hepatolenticular Degeneration; Humans; Penicillamin | 2005 |
Prognostic factors in patients presenting with severe neurological forms of Wilson's disease.
Topics: Adolescent; Adult; Chelating Agents; Child; Child, Preschool; Female; Hepatic Encephalopathy; Hepato | 2005 |
Prognostic factors in patients presenting with severe neurological forms of Wilson's disease.
Topics: Adolescent; Adult; Chelating Agents; Child; Child, Preschool; Female; Hepatic Encephalopathy; Hepato | 2005 |
D-Penicillamine improved laparoscopic and histological findings of the liver in a patient with Wilson's disease: 3-year follow-up after diagnosis of Coombs-negative hemolytic anemia of Wilson's disease.
Topics: Adolescent; Anemia, Hemolytic; Antidotes; Biopsy; Coombs Test; Copper; Female; Follow-Up Studies; He | 2005 |
D-Penicillamine improved laparoscopic and histological findings of the liver in a patient with Wilson's disease: 3-year follow-up after diagnosis of Coombs-negative hemolytic anemia of Wilson's disease.
Topics: Adolescent; Anemia, Hemolytic; Antidotes; Biopsy; Coombs Test; Copper; Female; Follow-Up Studies; He | 2005 |
Combination treatment with penicillamine and trientine in a patient with Wilson's disease.
Topics: Adult; Chelating Agents; Drug Therapy, Combination; Hepatolenticular Degeneration; Humans; Male; Pen | 2005 |
Combination treatment with penicillamine and trientine in a patient with Wilson's disease.
Topics: Adult; Chelating Agents; Drug Therapy, Combination; Hepatolenticular Degeneration; Humans; Male; Pen | 2005 |
Erythematous plaques on the flexural surfaces.
Topics: Adult; Antirheumatic Agents; Axilla; Diagnosis, Differential; Drug Eruptions; Female; Hepatolenticul | 2005 |
Erythematous plaques on the flexural surfaces.
Topics: Adult; Antirheumatic Agents; Axilla; Diagnosis, Differential; Drug Eruptions; Female; Hepatolenticul | 2005 |
Index of suspicion.
Topics: Chelating Agents; Child; Female; Gastric Outlet Obstruction; Hematuria; Hepatitis; Hepatolenticular | 2005 |
Index of suspicion.
Topics: Chelating Agents; Child; Female; Gastric Outlet Obstruction; Hematuria; Hepatitis; Hepatolenticular | 2005 |
Direct diagnosis of Wilson disease by molecular genetics.
Topics: Adenosine Triphosphatases; Adolescent; Antidotes; Cation Transport Proteins; Child; Copper-Transport | 2006 |
Direct diagnosis of Wilson disease by molecular genetics.
Topics: Adenosine Triphosphatases; Adolescent; Antidotes; Cation Transport Proteins; Child; Copper-Transport | 2006 |
Early diagnosis of Wilson Disease in a six-year-old child.
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Child, Preschool; Copper-Transporting ATPases; | 2006 |
Early diagnosis of Wilson Disease in a six-year-old child.
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Child, Preschool; Copper-Transporting ATPases; | 2006 |
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
Topics: Adenosine Triphosphatases; Adolescent; Adult; Cation Transport Proteins; Ceruloplasmin; Chelating Ag | 2007 |
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
Topics: Adenosine Triphosphatases; Adolescent; Adult; Cation Transport Proteins; Ceruloplasmin; Chelating Ag | 2007 |
Regression of nodular liver lesions in Wilson's disease.
Topics: Adult; Chelating Agents; Diagnosis, Differential; Female; Hepatolenticular Degeneration; Humans; Liv | 2006 |
Regression of nodular liver lesions in Wilson's disease.
Topics: Adult; Chelating Agents; Diagnosis, Differential; Female; Hepatolenticular Degeneration; Humans; Liv | 2006 |
Subcortical white matter abnormalities related to drug resistance in Wilson disease.
Topics: Adenosine Triphosphatases; Antidotes; Brain; Cation Transport Proteins; Child; Copper-Transporting A | 2006 |
Subcortical white matter abnormalities related to drug resistance in Wilson disease.
Topics: Adenosine Triphosphatases; Antidotes; Brain; Cation Transport Proteins; Child; Copper-Transporting A | 2006 |
Psychological presentations without hepatic involvement in Wilson disease.
Topics: Attention Deficit Disorder with Hyperactivity; Brain; Cerebral Cortex; Child; Copper; Diagnosis, Dif | 2006 |
Psychological presentations without hepatic involvement in Wilson disease.
Topics: Attention Deficit Disorder with Hyperactivity; Brain; Cerebral Cortex; Child; Copper; Diagnosis, Dif | 2006 |
Patient with late-onset Wilson's disease: deterioration with penicillamine.
Topics: Age Factors; Aged; Chelating Agents; Disease Progression; Fatal Outcome; Female; Hepatolenticular De | 2007 |
Patient with late-onset Wilson's disease: deterioration with penicillamine.
Topics: Age Factors; Aged; Chelating Agents; Disease Progression; Fatal Outcome; Female; Hepatolenticular De | 2007 |
[Wilson's disease: forms of presentation in childhood].
Topics: Chelating Agents; Child; Early Diagnosis; Hepatolenticular Degeneration; Humans; Penicillamine; Prog | 2006 |
[Wilson's disease: forms of presentation in childhood].
Topics: Chelating Agents; Child; Early Diagnosis; Hepatolenticular Degeneration; Humans; Penicillamine; Prog | 2006 |
Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Topics: Adult; Chelating Agents; Fatal Outcome; Female; Hepatolenticular Degeneration; Humans; Liver Cirrhos | 2007 |
Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Topics: Adult; Chelating Agents; Fatal Outcome; Female; Hepatolenticular Degeneration; Humans; Liver Cirrhos | 2007 |
Wilson's disease with hepatic presentation in childhood.
Topics: Adolescent; Age Factors; Bangladesh; Ceruloplasmin; Child; Child, Preschool; Copper; Developing Coun | 2007 |
Wilson's disease with hepatic presentation in childhood.
Topics: Adolescent; Age Factors; Bangladesh; Ceruloplasmin; Child; Child, Preschool; Copper; Developing Coun | 2007 |
Wilson's disease.
Topics: Chelating Agents; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Hepato | 2007 |
Wilson's disease.
Topics: Chelating Agents; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Hepato | 2007 |
Wilson disease: description of 282 patients evaluated over 3 decades.
Topics: Adolescent; Adult; Athetosis; Brain; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Chore | 2007 |
Wilson disease: description of 282 patients evaluated over 3 decades.
Topics: Adolescent; Adult; Athetosis; Brain; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Chore | 2007 |
Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children.
Topics: Adolescent; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Circadian Rhythm; Copper; Diag | 2007 |
Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children.
Topics: Adolescent; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Circadian Rhythm; Copper; Diag | 2007 |
Non-invasive testing for Wilson disease: revisiting the d-penicillamine challenge test.
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 2007 |
Non-invasive testing for Wilson disease: revisiting the d-penicillamine challenge test.
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 2007 |
Sequential MRI changes in Wilson's disease with de-coppering therapy: a study of 50 patients.
Topics: Adolescent; Adult; Astringents; Chelating Agents; Child; Disease Progression; Female; Health Status | 2007 |
Sequential MRI changes in Wilson's disease with de-coppering therapy: a study of 50 patients.
Topics: Adolescent; Adult; Astringents; Chelating Agents; Child; Disease Progression; Female; Health Status | 2007 |
Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Topics: Adolescent; Adult; Astringents; Chelating Agents; Chelation Therapy; Child; Child, Preschool; Copper | 2008 |
Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Topics: Adolescent; Adult; Astringents; Chelating Agents; Chelation Therapy; Child; Child, Preschool; Copper | 2008 |
Wilson disease with visceral leishmaniasis: an extremely uncommon presentation.
Topics: Adolescent; Chelating Agents; Hepatolenticular Degeneration; Humans; Leishmaniasis, Visceral; Male; | 2007 |
Wilson disease with visceral leishmaniasis: an extremely uncommon presentation.
Topics: Adolescent; Chelating Agents; Hepatolenticular Degeneration; Humans; Leishmaniasis, Visceral; Male; | 2007 |
Central pontine signal changes in Wilson's disease: distinct MRI morphology and sequential changes with de-coppering therapy.
Topics: Adolescent; Adult; Astringents; Chelating Agents; Chi-Square Distribution; Child; Disease Progressio | 2007 |
Central pontine signal changes in Wilson's disease: distinct MRI morphology and sequential changes with de-coppering therapy.
Topics: Adolescent; Adult; Astringents; Chelating Agents; Chi-Square Distribution; Child; Disease Progressio | 2007 |
Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge!
Topics: Adolescent; Adult; Chelating Agents; Cohort Studies; Copper; Depressive Disorder; Female; Follow-Up | 2008 |
Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge!
Topics: Adolescent; Adult; Chelating Agents; Cohort Studies; Copper; Depressive Disorder; Female; Follow-Up | 2008 |
D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Chelating Agents; Creatinine; Disease Progression; Fe | 2007 |
D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Chelating Agents; Creatinine; Disease Progression; Fe | 2007 |
Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
Topics: Adult; Age of Onset; Antirheumatic Agents; Chelating Agents; Drug Therapy, Combination; Female; Germ | 2008 |
Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
Topics: Adult; Age of Onset; Antirheumatic Agents; Chelating Agents; Drug Therapy, Combination; Female; Germ | 2008 |
Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Topics: Adolescent; Adult; Biopsy; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Iron; Ma | 2007 |
Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Topics: Adolescent; Adult; Biopsy; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Iron; Ma | 2007 |
Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy.
Topics: Adolescent; Bone Density; Bone Diseases, Metabolic; Chelating Agents; Child; Child, Preschool; Femal | 2008 |
Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy.
Topics: Adolescent; Bone Density; Bone Diseases, Metabolic; Chelating Agents; Child; Child, Preschool; Femal | 2008 |
Usefulness of penicillamine-stimulated urinary copper excretion in the diagnosis of adult Wilson's disease.
Topics: Adolescent; Adult; Biopsy, Needle; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Mal | 2008 |
Usefulness of penicillamine-stimulated urinary copper excretion in the diagnosis of adult Wilson's disease.
Topics: Adolescent; Adult; Biopsy, Needle; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Mal | 2008 |
[Nucleic acids in hepato-cerebral dystrophy].
Topics: Adolescent; Adult; Chelating Agents; DNA; Female; Glucose; Hepatolenticular Degeneration; Humans; Li | 1966 |
[Nucleic acids in hepato-cerebral dystrophy].
Topics: Adolescent; Adult; Chelating Agents; DNA; Female; Glucose; Hepatolenticular Degeneration; Humans; Li | 1966 |
Picture of the month. Wilson's disease (hepato-lenticular degeneration).
Topics: Child; Diet; Dimercaprol; Eye Manifestations; Facial Expression; Female; Hepatolenticular Degenerati | 1967 |
Picture of the month. Wilson's disease (hepato-lenticular degeneration).
Topics: Child; Diet; Dimercaprol; Eye Manifestations; Facial Expression; Female; Hepatolenticular Degenerati | 1967 |
Ceruloplasmin in Wilson's disease.
Topics: Adult; Amino Acids; Carbohydrates; Ceruloplasmin; Chromatography; Copper; Electrophoresis; Hepatolen | 1967 |
Ceruloplasmin in Wilson's disease.
Topics: Adult; Amino Acids; Carbohydrates; Ceruloplasmin; Chromatography; Copper; Electrophoresis; Hepatolen | 1967 |
[On the course and therapy of a juvenile Wilson's disease case].
Topics: Adolescent; Diet Therapy; Female; Hepatolenticular Degeneration; Humans; Neurologic Manifestations; | 1967 |
[On the course and therapy of a juvenile Wilson's disease case].
Topics: Adolescent; Diet Therapy; Female; Hepatolenticular Degeneration; Humans; Neurologic Manifestations; | 1967 |
Comparative metabolism of copper and zinc in patients with Wilson's disease (hepatolenticular degeneration).
Topics: Copper; Cystinuria; Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 1967 |
Comparative metabolism of copper and zinc in patients with Wilson's disease (hepatolenticular degeneration).
Topics: Copper; Cystinuria; Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 1967 |
Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilson's disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Copper; Female; Hepatolenticular Degeneration; Humans; M | 1967 |
Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilson's disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Copper; Female; Hepatolenticular Degeneration; Humans; M | 1967 |
Penicillamine.
Topics: Cystinuria; Gold; Hepatolenticular Degeneration; Humans; Lead Poisoning; Penicillamine | 1967 |
Penicillamine.
Topics: Cystinuria; Gold; Hepatolenticular Degeneration; Humans; Lead Poisoning; Penicillamine | 1967 |
Wilson's disease with aseptic meningitis and penicillamine-related cheilosis.
Topics: Adult; Blood Cell Count; Cerebrospinal Fluid Proteins; Ceruloplasmin; Cheilitis; Copper; Gingival Di | 1967 |
Wilson's disease with aseptic meningitis and penicillamine-related cheilosis.
Topics: Adult; Blood Cell Count; Cerebrospinal Fluid Proteins; Ceruloplasmin; Cheilitis; Copper; Gingival Di | 1967 |
[Kidney diseases caused by drugs].
Topics: Acute Kidney Injury; Adult; Anemia; Arthritis, Rheumatoid; Dextrans; Drug-Related Side Effects and A | 1967 |
[Kidney diseases caused by drugs].
Topics: Acute Kidney Injury; Adult; Anemia; Arthritis, Rheumatoid; Dextrans; Drug-Related Side Effects and A | 1967 |
[Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases].
Topics: Adolescent; Adult; Ceruloplasmin; Copper; Deficiency Diseases; Hepatolenticular Degeneration; Humans | 1967 |
[Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases].
Topics: Adolescent; Adult; Ceruloplasmin; Copper; Deficiency Diseases; Hepatolenticular Degeneration; Humans | 1967 |
Metabolic balances of copper in patients with hepatolenticular degeneration submitted to vegetarian and mixed diets.
Topics: Adult; Copper; Diet Therapy; Feces; Female; Hepatolenticular Degeneration; Humans; Male; Penicillami | 1967 |
Metabolic balances of copper in patients with hepatolenticular degeneration submitted to vegetarian and mixed diets.
Topics: Adult; Copper; Diet Therapy; Feces; Female; Hepatolenticular Degeneration; Humans; Male; Penicillami | 1967 |
Blue blood.
Topics: Ceruloplasmin; Hepatolenticular Degeneration; Humans; Penicillamine | 1967 |
Blue blood.
Topics: Ceruloplasmin; Hepatolenticular Degeneration; Humans; Penicillamine | 1967 |
[Mental disorders in Wilson's disease and the effect on them of penicillamine therapy].
Topics: Adolescent; Adult; Child; Female; Hepatolenticular Degeneration; Humans; Male; Mental Disorders; Pen | 1967 |
[Mental disorders in Wilson's disease and the effect on them of penicillamine therapy].
Topics: Adolescent; Adult; Child; Female; Hepatolenticular Degeneration; Humans; Male; Mental Disorders; Pen | 1967 |
[Hepatic changes in the neurological form of Wilson's disease].
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Male; Penicillami | 1967 |
[Hepatic changes in the neurological form of Wilson's disease].
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Male; Penicillami | 1967 |
Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride.
Topics: Adolescent; Adult; Brain; Ethylenediamines; Female; Hepatolenticular Degeneration; Humans; Male; Pen | 1982 |
Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride.
Topics: Adolescent; Adult; Brain; Ethylenediamines; Female; Hepatolenticular Degeneration; Humans; Male; Pen | 1982 |
Wilson's disease, an end to the search for new therapy?
Topics: Animals; Ethylenediamines; Hepatolenticular Degeneration; Humans; Penicillamine; Risk; Trientine | 1982 |
Wilson's disease, an end to the search for new therapy?
Topics: Animals; Ethylenediamines; Hepatolenticular Degeneration; Humans; Penicillamine; Risk; Trientine | 1982 |
Penicillamine in Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; United States | 1982 |
Penicillamine in Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; United States | 1982 |
Penicillamine in Wilson's disease.
Topics: Drug Evaluation; Hepatolenticular Degeneration; Humans; Penicillamine | 1982 |
Penicillamine in Wilson's disease.
Topics: Drug Evaluation; Hepatolenticular Degeneration; Humans; Penicillamine | 1982 |
Penicillamine in Wilson's disease.
Topics: Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 1982 |
Penicillamine in Wilson's disease.
Topics: Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 1982 |
Hudson memorial lecture: Wilson's disease: genetics and biochemistry--their relevance to therapy.
Topics: Adolescent; Adult; Ceruloplasmin; Child; Child, Preschool; Copper; Female; Hepatolenticular Degenera | 1983 |
Hudson memorial lecture: Wilson's disease: genetics and biochemistry--their relevance to therapy.
Topics: Adolescent; Adult; Ceruloplasmin; Child; Child, Preschool; Copper; Female; Hepatolenticular Degenera | 1983 |
Wilson's disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Hepatolenticular Degeneration; Humans; Middle Aged; Peni | 1984 |
Wilson's disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Hepatolenticular Degeneration; Humans; Middle Aged; Peni | 1984 |
[Wilson's disease in the German Democratic Republic. III. Diagnosis and therapy].
Topics: Adult; Ceruloplasmin; Child; Copper; Female; Genetic Carrier Screening; Hepatolenticular Degeneratio | 1980 |
[Wilson's disease in the German Democratic Republic. III. Diagnosis and therapy].
Topics: Adult; Ceruloplasmin; Child; Copper; Female; Genetic Carrier Screening; Hepatolenticular Degeneratio | 1980 |
Penicillamine-induced dermal fragility in Wilson's disease (hepato-lenticular degeneration).
Topics: Adult; Drug Eruptions; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Skin | 1981 |
Penicillamine-induced dermal fragility in Wilson's disease (hepato-lenticular degeneration).
Topics: Adult; Drug Eruptions; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Skin | 1981 |
[Computer tomographic studies in Wilson disease].
Topics: Adolescent; Adult; Brain Diseases, Metabolic; Female; Follow-Up Studies; Hepatolenticular Degenerati | 1984 |
[Computer tomographic studies in Wilson disease].
Topics: Adolescent; Adult; Brain Diseases, Metabolic; Female; Follow-Up Studies; Hepatolenticular Degenerati | 1984 |
Effective D-penicillamine treatment of an early diagnosed patient with Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Infant; Male; Penicillamine; Time Factors | 1984 |
Effective D-penicillamine treatment of an early diagnosed patient with Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Infant; Male; Penicillamine; Time Factors | 1984 |
Wilson's disease: a 1984 perspective.
Topics: Adolescent; Adult; Bone and Bones; Ceruloplasmin; Child; Child, Preschool; Copper; Diagnosis, Differ | 1984 |
Wilson's disease: a 1984 perspective.
Topics: Adolescent; Adult; Bone and Bones; Ceruloplasmin; Child; Child, Preschool; Copper; Diagnosis, Differ | 1984 |
Fulminant hepatic and renal failure complicating Wilson's disease.
Topics: Acute Kidney Injury; Adult; Hepatolenticular Degeneration; Humans; Liver; Liver Diseases; Male; Pati | 1984 |
Fulminant hepatic and renal failure complicating Wilson's disease.
Topics: Acute Kidney Injury; Adult; Hepatolenticular Degeneration; Humans; Liver; Liver Diseases; Male; Pati | 1984 |
Oral zinc therapy for Wilson's disease.
Topics: Acetates; Acetic Acid; Administration, Oral; Adult; Copper; Drug Administration Schedule; Feces; Fem | 1983 |
Oral zinc therapy for Wilson's disease.
Topics: Acetates; Acetic Acid; Administration, Oral; Adult; Copper; Drug Administration Schedule; Feces; Fem | 1983 |
Treatment of Wilson's disease.
Topics: Copper; Diagnostic Errors; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine; Zinc | 1983 |
Treatment of Wilson's disease.
Topics: Copper; Diagnostic Errors; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine; Zinc | 1983 |
Wilson's disease in childhood. Variability of clinical presentation.
Topics: Adolescent; Aspartate Aminotransferases; Bilirubin; Child; Female; Hemolysis; Hepatolenticular Degen | 1983 |
Wilson's disease in childhood. Variability of clinical presentation.
Topics: Adolescent; Aspartate Aminotransferases; Bilirubin; Child; Female; Hemolysis; Hepatolenticular Degen | 1983 |
Hepatolenticular degeneration: histological study of conjunctiva and observation of chalazii during D-penicillamine treatment.
Topics: Adolescent; Adult; Child, Preschool; Conjunctiva; Copper; Cysts; Descemet Membrane; Eyelid Diseases; | 1983 |
Hepatolenticular degeneration: histological study of conjunctiva and observation of chalazii during D-penicillamine treatment.
Topics: Adolescent; Adult; Child, Preschool; Conjunctiva; Copper; Cysts; Descemet Membrane; Eyelid Diseases; | 1983 |
Hypoparathyroidism in Wilson's disease.
Topics: Female; Hepatolenticular Degeneration; Humans; Hypoparathyroidism; Penicillamine | 1984 |
Hypoparathyroidism in Wilson's disease.
Topics: Female; Hepatolenticular Degeneration; Humans; Hypoparathyroidism; Penicillamine | 1984 |
[Changes in zinc metabolism during long-term D-penicillamine treatment of patients with Wilson-Konovalov disease].
Topics: Adolescent; Adult; Child; Dietary Proteins; Female; Hepatolenticular Degeneration; Humans; Male; Pen | 1984 |
[Changes in zinc metabolism during long-term D-penicillamine treatment of patients with Wilson-Konovalov disease].
Topics: Adolescent; Adult; Child; Dietary Proteins; Female; Hepatolenticular Degeneration; Humans; Male; Pen | 1984 |
Methods for assaying D-penicillamine in a clinical setting.
Topics: Arthritis, Rheumatoid; Chromatography, Gas; Chromatography, High Pressure Liquid; Cystinuria; Dose-R | 1984 |
Methods for assaying D-penicillamine in a clinical setting.
Topics: Arthritis, Rheumatoid; Chromatography, Gas; Chromatography, High Pressure Liquid; Cystinuria; Dose-R | 1984 |
Bio-inorganic effects of D-penicillamine in children and in the elderly.
Topics: Abnormalities, Drug-Induced; Aged; Arthritis, Juvenile; Arthritis, Rheumatoid; Child; Cystinuria; Fe | 1984 |
Bio-inorganic effects of D-penicillamine in children and in the elderly.
Topics: Abnormalities, Drug-Induced; Aged; Arthritis, Juvenile; Arthritis, Rheumatoid; Child; Cystinuria; Fe | 1984 |
Recurrent abdominal colic as the sole symptom of Wilson's Disease: case report.
Topics: Ceruloplasmin; Child; Colic; Copper; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; | 1981 |
Recurrent abdominal colic as the sole symptom of Wilson's Disease: case report.
Topics: Ceruloplasmin; Child; Colic; Copper; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; | 1981 |
The effect of chelation therapy on the amino aciduria and peptiduria of Wilson's disease.
Topics: Adolescent; Adult; Amino Acids; Chelating Agents; Child; Ethylenediamines; Female; Follow-Up Studies | 1983 |
The effect of chelation therapy on the amino aciduria and peptiduria of Wilson's disease.
Topics: Adolescent; Adult; Amino Acids; Chelating Agents; Child; Ethylenediamines; Female; Follow-Up Studies | 1983 |
Serial changes of cranial computerized tomographic findings in Wilson disease during D-penicillamine therapy.
Topics: Adolescent; Brain; Child; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Tomography, | 1983 |
Serial changes of cranial computerized tomographic findings in Wilson disease during D-penicillamine therapy.
Topics: Adolescent; Brain; Child; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Tomography, | 1983 |
Some therapeutic observations in Wilson's disease.
Topics: Adult; Brain; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penicillamin | 1983 |
Some therapeutic observations in Wilson's disease.
Topics: Adult; Brain; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penicillamin | 1983 |
Pemphigus-like mucosal lesions: a side effect of penicillamine therapy.
Topics: Adult; Diagnosis, Differential; Female; Hepatolenticular Degeneration; Humans; Mouth Diseases; Pemph | 1981 |
Pemphigus-like mucosal lesions: a side effect of penicillamine therapy.
Topics: Adult; Diagnosis, Differential; Female; Hepatolenticular Degeneration; Humans; Mouth Diseases; Pemph | 1981 |
Acute lymphoblastic leukemia in a patient receiving penicillamine for Wilson's disease.
Topics: Adolescent; Female; Hepatolenticular Degeneration; Humans; Immunity, Cellular; Immunoglobulin A; Leu | 1982 |
Acute lymphoblastic leukemia in a patient receiving penicillamine for Wilson's disease.
Topics: Adolescent; Female; Hepatolenticular Degeneration; Humans; Immunity, Cellular; Immunoglobulin A; Leu | 1982 |
Treatment of a presymptomatic 14-year-old girl with Wilson's disease.
Topics: Adolescent; Ceruloplasmin; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Rad | 1982 |
Treatment of a presymptomatic 14-year-old girl with Wilson's disease.
Topics: Adolescent; Ceruloplasmin; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Rad | 1982 |
[2 cases of verruciform elastoma after prolonged administration of D-penicillamine].
Topics: Adolescent; Adult; Child; Elastic Tissue; Female; Hepatolenticular Degeneration; Humans; Male; Penic | 1982 |
[2 cases of verruciform elastoma after prolonged administration of D-penicillamine].
Topics: Adolescent; Adult; Child; Elastic Tissue; Female; Hepatolenticular Degeneration; Humans; Male; Penic | 1982 |
D-penicillamine in Wilson's disease presenting as acute liver failure with hemolysis.
Topics: Acute Disease; Adolescent; Ceruloplasmin; Copper; Female; Glucocorticoids; Hemolysis; Hepatolenticul | 1982 |
D-penicillamine in Wilson's disease presenting as acute liver failure with hemolysis.
Topics: Acute Disease; Adolescent; Ceruloplasmin; Copper; Female; Glucocorticoids; Hemolysis; Hepatolenticul | 1982 |
[Hemolytic anemia associated with severe liver insufficiency as an initial symptom of Wilson's disease].
Topics: Adolescent; Anemia, Hemolytic; Ceruloplasmin; Copper; Female; Hepatolenticular Degeneration; Humans; | 1982 |
[Hemolytic anemia associated with severe liver insufficiency as an initial symptom of Wilson's disease].
Topics: Adolescent; Anemia, Hemolytic; Ceruloplasmin; Copper; Female; Hepatolenticular Degeneration; Humans; | 1982 |
The copper hypothesis of schizophrenia: a review.
Topics: Ceruloplasmin; Copper; Dopamine; Hepatolenticular Degeneration; Humans; Melanins; Penicillamine; Sch | 1982 |
The copper hypothesis of schizophrenia: a review.
Topics: Ceruloplasmin; Copper; Dopamine; Hepatolenticular Degeneration; Humans; Melanins; Penicillamine; Sch | 1982 |
Computed tomography in Wilson disease.
Topics: Adolescent; Adult; Brain; Diatrizoate Meglumine; Female; Hepatolenticular Degeneration; Humans; Male | 1981 |
Computed tomography in Wilson disease.
Topics: Adolescent; Adult; Brain; Diatrizoate Meglumine; Female; Hepatolenticular Degeneration; Humans; Male | 1981 |
Porphyria cutanea tarda complicating Wilson's disease.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Porphyrias; Skin Diseases | 1981 |
Porphyria cutanea tarda complicating Wilson's disease.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Porphyrias; Skin Diseases | 1981 |
[Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
Topics: Copper; Hepatolenticular Degeneration; Humans; Liver; Penicillamine | 1981 |
[Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
Topics: Copper; Hepatolenticular Degeneration; Humans; Liver; Penicillamine | 1981 |
Urinary copper excretion and hepatic copper concentrations in liver disease.
Topics: Adolescent; Adult; Aged; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Liver | 1981 |
Urinary copper excretion and hepatic copper concentrations in liver disease.
Topics: Adolescent; Adult; Aged; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Liver | 1981 |
[Main characteristics of the treatment of liver cirrhosis].
Topics: Adolescent; Adult; Ascites; Bed Rest; Bloodletting; Child; Child, Preschool; Cholestyramine Resin; D | 1981 |
[Main characteristics of the treatment of liver cirrhosis].
Topics: Adolescent; Adult; Ascites; Bed Rest; Bloodletting; Child; Child, Preschool; Cholestyramine Resin; D | 1981 |
The "lumpy-bumpy" elastic fiber. A marker for long-term administration of penicillamine.
Topics: Adult; Elastic Tissue; Female; Hepatolenticular Degeneration; Humans; Lung; Penicillamine; Skin | 1981 |
The "lumpy-bumpy" elastic fiber. A marker for long-term administration of penicillamine.
Topics: Adult; Elastic Tissue; Female; Hepatolenticular Degeneration; Humans; Lung; Penicillamine; Skin | 1981 |
Bilateral serous retinal detachment with thrombocytopenia during penicillamine therapy.
Topics: Adult; Female; Fluorescein Angiography; Fundus Oculi; Hepatolenticular Degeneration; Humans; Macula | 1981 |
Bilateral serous retinal detachment with thrombocytopenia during penicillamine therapy.
Topics: Adult; Female; Fluorescein Angiography; Fundus Oculi; Hepatolenticular Degeneration; Humans; Macula | 1981 |
[Plasma non-ceruloplasmin copper in hepatocerebral dystrophy (criterion for the diagnosis and evaluation of cuprogogue therapy)].
Topics: Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 1981 |
[Plasma non-ceruloplasmin copper in hepatocerebral dystrophy (criterion for the diagnosis and evaluation of cuprogogue therapy)].
Topics: Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 1981 |
D-penicillamine in pregnancy--to ban or not to ban?
Topics: Arthritis, Rheumatoid; Connective Tissue Diseases; Cystinuria; Female; Hepatolenticular Degeneration | 1981 |
D-penicillamine in pregnancy--to ban or not to ban?
Topics: Arthritis, Rheumatoid; Connective Tissue Diseases; Cystinuria; Female; Hepatolenticular Degeneration | 1981 |
[Penicillamine-induced dermolytic dermatosis in a patient with Wilson's disease (author's transl)].
Topics: Adult; Connective Tissue Diseases; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Ski | 1981 |
[Penicillamine-induced dermolytic dermatosis in a patient with Wilson's disease (author's transl)].
Topics: Adult; Connective Tissue Diseases; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Ski | 1981 |
[Treatment of hepatocerebral dystrophy (Wilson-Westphal-Konovalov's disease)].
Topics: Amino Acids; Ceruloplasmin; Diet Therapy; Drug Evaluation; Drug Therapy, Combination; Hepatolenticul | 1981 |
[Treatment of hepatocerebral dystrophy (Wilson-Westphal-Konovalov's disease)].
Topics: Amino Acids; Ceruloplasmin; Diet Therapy; Drug Evaluation; Drug Therapy, Combination; Hepatolenticul | 1981 |
[Penicillamine-induced elastosis perforans serpiginosa and pulmonary cyst in Wilson's disease (author's transl)].
Topics: Adult; Cysts; Elastic Tissue; Female; Hepatolenticular Degeneration; Humans; Lung; Lung Diseases; Pe | 1981 |
[Penicillamine-induced elastosis perforans serpiginosa and pulmonary cyst in Wilson's disease (author's transl)].
Topics: Adult; Cysts; Elastic Tissue; Female; Hepatolenticular Degeneration; Humans; Lung; Lung Diseases; Pe | 1981 |
[Copper metabolism: ultimate therapeutic implications in cholestasis].
Topics: Cholestasis; Copper; Hepatolenticular Degeneration; Humans; Liver; Liver Cirrhosis; Penicillamine | 1981 |
[Copper metabolism: ultimate therapeutic implications in cholestasis].
Topics: Cholestasis; Copper; Hepatolenticular Degeneration; Humans; Liver; Liver Cirrhosis; Penicillamine | 1981 |
Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents.
Topics: Adolescent; Adult; Atrophy; Brain; Cerebral Ventricles; Child; Dilatation, Pathologic; Ethylenediami | 1981 |
Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents.
Topics: Adolescent; Adult; Atrophy; Brain; Cerebral Ventricles; Child; Dilatation, Pathologic; Ethylenediami | 1981 |
[Wilson's disease: seven cases with hepatic onset (author's transl)].
Topics: Adolescent; Adult; Child; Copper; Female; Hepatitis; Hepatolenticular Degeneration; Humans; Liver; L | 1981 |
[Wilson's disease: seven cases with hepatic onset (author's transl)].
Topics: Adolescent; Adult; Child; Copper; Female; Hepatitis; Hepatolenticular Degeneration; Humans; Liver; L | 1981 |
Computerized cranial tomography in Wilson disease: report of a case before and after penicillamine therapy.
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Tomography, X-Ray Computed | 1981 |
Computerized cranial tomography in Wilson disease: report of a case before and after penicillamine therapy.
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Tomography, X-Ray Computed | 1981 |
Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine.
Topics: Animals; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Polyamines; | 1980 |
Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine.
Topics: Animals; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Polyamines; | 1980 |
[Use of penicillamine in Wilson-Konovalov disease].
Topics: Adolescent; Adult; Child; Copper; Hepatolenticular Degeneration; Humans; Liver; Penicillamine; Time | 1980 |
[Use of penicillamine in Wilson-Konovalov disease].
Topics: Adolescent; Adult; Child; Copper; Hepatolenticular Degeneration; Humans; Liver; Penicillamine; Time | 1980 |
Long-term penicillamine therapy for Wilson's disease.
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1980 |
Long-term penicillamine therapy for Wilson's disease.
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1980 |
Penicillamine: twenty-five years later.
Topics: Arthritis, Juvenile; Arthritis, Rheumatoid; Hepatolenticular Degeneration; Humans; Penicillamine | 1980 |
Penicillamine: twenty-five years later.
Topics: Arthritis, Juvenile; Arthritis, Rheumatoid; Hepatolenticular Degeneration; Humans; Penicillamine | 1980 |
[Regression of a Kayser-Fleischer ring in a case of Wilson's disease during penicillamine therapy (author's transl)].
Topics: Adult; Copper; Cornea; Corneal Diseases; Hepatolenticular Degeneration; Humans; Male; Penicillamine; | 1980 |
[Regression of a Kayser-Fleischer ring in a case of Wilson's disease during penicillamine therapy (author's transl)].
Topics: Adult; Copper; Cornea; Corneal Diseases; Hepatolenticular Degeneration; Humans; Male; Penicillamine; | 1980 |
[immunohistologic findings of kidney biopsies in Wilson's disease].
Topics: Biopsy; Complement C3; Hepatolenticular Degeneration; Humans; Immunoglobulin G; Kidney; Penicillamin | 1980 |
[immunohistologic findings of kidney biopsies in Wilson's disease].
Topics: Biopsy; Complement C3; Hepatolenticular Degeneration; Humans; Immunoglobulin G; Kidney; Penicillamin | 1980 |
Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
Topics: Adolescent; Copper; Ethylenediamines; Female; Hepatolenticular Degeneration; Humans; Penicillamine; | 1980 |
Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
Topics: Adolescent; Copper; Ethylenediamines; Female; Hepatolenticular Degeneration; Humans; Penicillamine; | 1980 |
Transient external ophthalmoplegia in Wilson's disease.
Topics: Adolescent; Female; Hepatolenticular Degeneration; Humans; Ophthalmoplegia; Penicillamine | 1980 |
Transient external ophthalmoplegia in Wilson's disease.
Topics: Adolescent; Female; Hepatolenticular Degeneration; Humans; Ophthalmoplegia; Penicillamine | 1980 |
[Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease].
Topics: Drug Hypersensitivity; Hepatolenticular Degeneration; Humans; Lymphocyte Activation; Penicillamine; | 1980 |
[Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease].
Topics: Drug Hypersensitivity; Hepatolenticular Degeneration; Humans; Lymphocyte Activation; Penicillamine; | 1980 |
Wilson's disease in pregnancy.
Topics: Adolescent; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Male; Penicillamine; Pregn | 1995 |
Wilson's disease in pregnancy.
Topics: Adolescent; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Male; Penicillamine; Pregn | 1995 |
Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
Topics: Adolescent; Adult; Biopsy; Chelating Agents; Child; Colon; Drug Administration Schedule; Duodenum; F | 1995 |
Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
Topics: Adolescent; Adult; Biopsy; Chelating Agents; Child; Colon; Drug Administration Schedule; Duodenum; F | 1995 |
Effect of growth hormone on IGF-I levels in a patient with growth hormone deficiency and Wilson disease.
Topics: Ceruloplasmin; Child, Preschool; Copper; Growth Hormone; Hepatolenticular Degeneration; Humans; Insu | 1995 |
Effect of growth hormone on IGF-I levels in a patient with growth hormone deficiency and Wilson disease.
Topics: Ceruloplasmin; Child, Preschool; Copper; Growth Hormone; Hepatolenticular Degeneration; Humans; Insu | 1995 |
Treatment of the neurologic manifestations of Wilson's disease.
Topics: Dimercaprol; Hepatolenticular Degeneration; Humans; Molybdenum; Nervous System Diseases; Penicillami | 1995 |
Treatment of the neurologic manifestations of Wilson's disease.
Topics: Dimercaprol; Hepatolenticular Degeneration; Humans; Molybdenum; Nervous System Diseases; Penicillami | 1995 |
[Wilson's disease--evolutive panorama of diagnosis and treatment in the last forty years].
Topics: Adult; Hepatolenticular Degeneration; History, 20th Century; Humans; Penicillamine; Trientine | 1995 |
[Wilson's disease--evolutive panorama of diagnosis and treatment in the last forty years].
Topics: Adult; Hepatolenticular Degeneration; History, 20th Century; Humans; Penicillamine; Trientine | 1995 |
Plasma copper and antioxidant status in Wilson's disease.
Topics: Allantoin; Antioxidants; Ascorbic Acid; Biomarkers; Ceruloplasmin; Child; Copper; Female; Free Radic | 1995 |
Plasma copper and antioxidant status in Wilson's disease.
Topics: Allantoin; Antioxidants; Ascorbic Acid; Biomarkers; Ceruloplasmin; Child; Copper; Female; Free Radic | 1995 |
The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Trientine; Zinc | 1995 |
The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Trientine; Zinc | 1995 |
Case report: concordant traumatic brainstem contusion delayed diagnosis in a young man with Wilson's disease.
Topics: Adolescent; Brain Concussion; Brain Stem; Combined Modality Therapy; Diagnosis, Differential; Hepato | 1995 |
Case report: concordant traumatic brainstem contusion delayed diagnosis in a young man with Wilson's disease.
Topics: Adolescent; Brain Concussion; Brain Stem; Combined Modality Therapy; Diagnosis, Differential; Hepato | 1995 |
Penicillamine as antioxidant.
Topics: Animals; Antioxidants; Copper; Erythrocyte Membrane; Free Radicals; Hepatolenticular Degeneration; H | 1994 |
Penicillamine as antioxidant.
Topics: Animals; Antioxidants; Copper; Erythrocyte Membrane; Free Radicals; Hepatolenticular Degeneration; H | 1994 |
Zinc-induced deterioration in Wilson's disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet.
Topics: Adult; Copper; Dimercaprol; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Sulfates; | 1995 |
Zinc-induced deterioration in Wilson's disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet.
Topics: Adult; Copper; Dimercaprol; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Sulfates; | 1995 |
Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease.
Topics: Adult; Basal Ganglia; Brain; Deoxyglucose; Dopamine Agents; Fluorine Radioisotopes; Glucose; Hepatol | 1994 |
Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease.
Topics: Adult; Basal Ganglia; Brain; Deoxyglucose; Dopamine Agents; Fluorine Radioisotopes; Glucose; Hepatol | 1994 |
[Wilson's disease: physiopathology, therapeutic approach and case report].
Topics: Adult; Copper; Hepatolenticular Degeneration; Humans; Liver; Male; Nephrotic Syndrome; Penicillamine | 1994 |
[Wilson's disease: physiopathology, therapeutic approach and case report].
Topics: Adult; Copper; Hepatolenticular Degeneration; Humans; Liver; Male; Nephrotic Syndrome; Penicillamine | 1994 |
Pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate. A case report and review of the literature.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Pregnancy Complicati | 1994 |
Pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate. A case report and review of the literature.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Pregnancy Complicati | 1994 |
Wilson's disease: unusual clinical and radiological features.
Topics: Adolescent; Brain; Hepatolenticular Degeneration; Humans; Knee Joint; Male; Penicillamine; Tomograph | 1994 |
Wilson's disease: unusual clinical and radiological features.
Topics: Adolescent; Brain; Hepatolenticular Degeneration; Humans; Knee Joint; Male; Penicillamine; Tomograph | 1994 |
Copper-induced acute rhabdomyolysis in Wilson's disease.
Topics: Acetates; Acetic Acid; Acute Disease; Adolescent; Biopsy; Copper; Hepatolenticular Degeneration; Hum | 1995 |
Copper-induced acute rhabdomyolysis in Wilson's disease.
Topics: Acetates; Acetic Acid; Acute Disease; Adolescent; Biopsy; Copper; Hepatolenticular Degeneration; Hum | 1995 |
[Cerebral magnetic resonance in Wilson's disease].
Topics: Adolescent; Adult; Basal Ganglia; Brain; Brain Stem; Cerebellar Nuclei; Female; Hepatolenticular Deg | 1994 |
[Cerebral magnetic resonance in Wilson's disease].
Topics: Adolescent; Adult; Basal Ganglia; Brain; Brain Stem; Cerebellar Nuclei; Female; Hepatolenticular Deg | 1994 |
[Dermatomyositis and Wilson disease].
Topics: Adolescent; Consanguinity; Dermatomyositis; Drug Therapy, Combination; Dysarthria; Female; Hepatolen | 1994 |
[Dermatomyositis and Wilson disease].
Topics: Adolescent; Consanguinity; Dermatomyositis; Drug Therapy, Combination; Dysarthria; Female; Hepatolen | 1994 |
Dangers of interrupting decoppering treatment in Wilson's disease.
Topics: Adult; Copper; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Sulfates; Zinc Compounds; | 1994 |
Dangers of interrupting decoppering treatment in Wilson's disease.
Topics: Adult; Copper; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Sulfates; Zinc Compounds; | 1994 |
Motor impairment in Wilson's disease. 3: The clinical impact of pyramidal tract involvement.
Topics: Adolescent; Adult; Brain; Chelation Therapy; Copper; Female; Hepatolenticular Degeneration; Humans; | 1994 |
Motor impairment in Wilson's disease. 3: The clinical impact of pyramidal tract involvement.
Topics: Adolescent; Adult; Brain; Chelation Therapy; Copper; Female; Hepatolenticular Degeneration; Humans; | 1994 |
Penicillamine-induced elastosis perforans serpiginosa treated successfully with isotretinoin.
Topics: Adult; Elastic Tissue; Female; Hepatolenticular Degeneration; Humans; Isotretinoin; Penicillamine; P | 1994 |
Penicillamine-induced elastosis perforans serpiginosa treated successfully with isotretinoin.
Topics: Adult; Elastic Tissue; Female; Hepatolenticular Degeneration; Humans; Isotretinoin; Penicillamine; P | 1994 |
Wilson's disease: contrast enhancement of cerebral lesions on MR images after penicillamine therapy.
Topics: Adolescent; Brain; Contrast Media; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance | 1994 |
Wilson's disease: contrast enhancement of cerebral lesions on MR images after penicillamine therapy.
Topics: Adolescent; Brain; Contrast Media; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance | 1994 |
D-penicillamine-induced elastosis perforans serpiginosa and localized cutis laxa in a patient with Wilson's disease.
Topics: Child; Connective Tissue Diseases; Cutis Laxa; Elastic Tissue; Female; Hepatolenticular Degeneration | 1994 |
D-penicillamine-induced elastosis perforans serpiginosa and localized cutis laxa in a patient with Wilson's disease.
Topics: Child; Connective Tissue Diseases; Cutis Laxa; Elastic Tissue; Female; Hepatolenticular Degeneration | 1994 |
Wilson's disease--a review of cases at University Hospital, Kuala Lumpur.
Topics: Adolescent; Adult; Child; Consanguinity; Female; Follow-Up Studies; Hepatolenticular Degeneration; H | 1994 |
Wilson's disease--a review of cases at University Hospital, Kuala Lumpur.
Topics: Adolescent; Adult; Child; Consanguinity; Female; Follow-Up Studies; Hepatolenticular Degeneration; H | 1994 |
Nontransplant options for the treatment of metabolic liver disease: saving livers while saving lives.
Topics: Genetic Therapy; Hepatolenticular Degeneration; Humans; Liver Diseases; Liver Transplantation; Metab | 1994 |
Nontransplant options for the treatment of metabolic liver disease: saving livers while saving lives.
Topics: Genetic Therapy; Hepatolenticular Degeneration; Humans; Liver Diseases; Liver Transplantation; Metab | 1994 |
Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease.
Topics: Adolescent; Drug Hypersensitivity; Female; Hepatolenticular Degeneration; Humans; Liver Transplantat | 1994 |
Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease.
Topics: Adolescent; Drug Hypersensitivity; Female; Hepatolenticular Degeneration; Humans; Liver Transplantat | 1994 |
Development of neurologic symptoms in a patient with asymptomatic Wilson's disease treated with penicillamine.
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Nervous System Diseases; Penicillamine | 1994 |
Development of neurologic symptoms in a patient with asymptomatic Wilson's disease treated with penicillamine.
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Nervous System Diseases; Penicillamine | 1994 |
Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.
Topics: Adolescent; Adult; Ceruloplasmin; Copper; Corpus Striatum; Deoxyglucose; Female; Fluorine Radioisoto | 1993 |
Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.
Topics: Adolescent; Adult; Ceruloplasmin; Copper; Corpus Striatum; Deoxyglucose; Female; Fluorine Radioisoto | 1993 |
Wilson's disease with cerebral manifestation: monitoring therapy by CSF copper concentration.
Topics: Adult; Brain; Ceruloplasmin; Chelation Therapy; Copper; Female; Hepatolenticular Degeneration; Human | 1993 |
Wilson's disease with cerebral manifestation: monitoring therapy by CSF copper concentration.
Topics: Adult; Brain; Ceruloplasmin; Chelation Therapy; Copper; Female; Hepatolenticular Degeneration; Human | 1993 |
[Penicillamine-induced elastosis perforans serpiginosa].
Topics: Adult; Darier Disease; Diagnosis, Differential; Drug Eruptions; Elastic Tissue; Hepatolenticular Deg | 1994 |
[Penicillamine-induced elastosis perforans serpiginosa].
Topics: Adult; Darier Disease; Diagnosis, Differential; Drug Eruptions; Elastic Tissue; Hepatolenticular Deg | 1994 |
Urinary copper excretion after penicillamine in the diagnosis of Wilson's disease in children.
Topics: Child; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Predictive Value of Tests | 1993 |
Urinary copper excretion after penicillamine in the diagnosis of Wilson's disease in children.
Topics: Child; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Predictive Value of Tests | 1993 |
Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson's disease.
Topics: Adolescent; Adult; Benzamides; Brain; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imag | 1994 |
Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson's disease.
Topics: Adolescent; Adult; Benzamides; Brain; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imag | 1994 |
Hemolytic episode in a patient with Wilson's disease treated with zinc.
Topics: Adult; Anemia, Hemolytic; Copper; Female; Hemolysis; Hepatolenticular Degeneration; Humans; Penicill | 1993 |
Hemolytic episode in a patient with Wilson's disease treated with zinc.
Topics: Adult; Anemia, Hemolytic; Copper; Female; Hemolysis; Hepatolenticular Degeneration; Humans; Penicill | 1993 |
[Nephrotic syndrome secondary to d-penicillamine in a patient with Wilson's disease].
Topics: Adolescent; Child; Female; Hepatolenticular Degeneration; Humans; Kidney Diseases; Male; Penicillami | 1993 |
[Nephrotic syndrome secondary to d-penicillamine in a patient with Wilson's disease].
Topics: Adolescent; Child; Female; Hepatolenticular Degeneration; Humans; Kidney Diseases; Male; Penicillami | 1993 |
Hypercalciuria and nephrocalcinosis, a feature of Wilson's disease.
Topics: Adolescent; Calcium; Hematuria; Hepatolenticular Degeneration; Humans; Kidney Calculi; Male; Nephroc | 1993 |
Hypercalciuria and nephrocalcinosis, a feature of Wilson's disease.
Topics: Adolescent; Calcium; Hematuria; Hepatolenticular Degeneration; Humans; Kidney Calculi; Male; Nephroc | 1993 |
[Treatment of Wilson's disease with zinc. 5 cases].
Topics: Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Zinc | 1993 |
[Treatment of Wilson's disease with zinc. 5 cases].
Topics: Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Zinc | 1993 |
Neurological Wilson's disease.
Topics: Child; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine | 1993 |
Neurological Wilson's disease.
Topics: Child; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine | 1993 |
Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease.
Topics: Adult; Ceruloplasmin; Copper; Female; Fetal Diseases; Fetus; Hepatolenticular Degeneration; Humans; | 1993 |
Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease.
Topics: Adult; Ceruloplasmin; Copper; Female; Fetal Diseases; Fetus; Hepatolenticular Degeneration; Humans; | 1993 |
Intractable neurological Wilson's disease treated with orthotopic liver transplantation.
Topics: Adult; Hepatolenticular Degeneration; Humans; Liver Transplantation; Male; Nervous System Diseases; | 1993 |
Intractable neurological Wilson's disease treated with orthotopic liver transplantation.
Topics: Adult; Hepatolenticular Degeneration; Humans; Liver Transplantation; Male; Nervous System Diseases; | 1993 |
Chelation treatment of neurological Wilson's disease.
Topics: Adolescent; Adult; Cause of Death; Chelation Therapy; Copper; Drug Administration Schedule; Female; | 1993 |
Chelation treatment of neurological Wilson's disease.
Topics: Adolescent; Adult; Cause of Death; Chelation Therapy; Copper; Drug Administration Schedule; Female; | 1993 |
[A study of trientine therapy in Wilson's disease with neurological symptoms].
Topics: Adolescent; Adult; Dysarthria; Dystonia; Female; Hepatolenticular Degeneration; Humans; Male; Penici | 1993 |
[A study of trientine therapy in Wilson's disease with neurological symptoms].
Topics: Adolescent; Adult; Dysarthria; Dystonia; Female; Hepatolenticular Degeneration; Humans; Male; Penici | 1993 |
Treatment of Wilson's disease with zinc: XI. Interaction with other anticopper agents.
Topics: Ascorbic Acid; Copper; Copper Radioisotopes; Drug Interactions; Drug Therapy, Combination; Hepatolen | 1993 |
Treatment of Wilson's disease with zinc: XI. Interaction with other anticopper agents.
Topics: Ascorbic Acid; Copper; Copper Radioisotopes; Drug Interactions; Drug Therapy, Combination; Hepatolen | 1993 |
Motor impairment in Wilson's disease, I: Slowness of voluntary limb movements.
Topics: Adolescent; Adult; Basal Ganglia; Female; Hepatolenticular Degeneration; Humans; Isometric Contracti | 1993 |
Motor impairment in Wilson's disease, I: Slowness of voluntary limb movements.
Topics: Adolescent; Adult; Basal Ganglia; Female; Hepatolenticular Degeneration; Humans; Isometric Contracti | 1993 |
Motor impairment in Wilson's disease, II: Slowness of speech.
Topics: Adolescent; Adult; Basal Ganglia; Female; Hepatolenticular Degeneration; Humans; Liver Transplantati | 1993 |
Motor impairment in Wilson's disease, II: Slowness of speech.
Topics: Adolescent; Adult; Basal Ganglia; Female; Hepatolenticular Degeneration; Humans; Liver Transplantati | 1993 |
Penicillamine-induced changes in elastic tissue of the upper respiratory tract.
Topics: Back; Elastic Tissue; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Neck; Penicillamine; | 1993 |
Penicillamine-induced changes in elastic tissue of the upper respiratory tract.
Topics: Back; Elastic Tissue; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Neck; Penicillamine; | 1993 |
[What is your diagnosis? Wilson's disease (hepatolenticular degeneration)].
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Neurocognitive Disorders; Penicillamine | 1993 |
[What is your diagnosis? Wilson's disease (hepatolenticular degeneration)].
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Neurocognitive Disorders; Penicillamine | 1993 |
Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease.
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penicillamine; | 1995 |
Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease.
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penicillamine; | 1995 |
Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers.
Topics: Adult; Anti-Bacterial Agents; Binding Sites; Brain; Caudate Nucleus; Ceruloplasmin; Copper; Corpus S | 1995 |
Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers.
Topics: Adult; Anti-Bacterial Agents; Binding Sites; Brain; Caudate Nucleus; Ceruloplasmin; Copper; Corpus S | 1995 |
Usefulness of Scheimpflug photography to follow up Wilson's disease.
Topics: Adult; Cataract; Chelating Agents; Corneal Diseases; Female; Follow-Up Studies; Hepatolenticular Deg | 1995 |
Usefulness of Scheimpflug photography to follow up Wilson's disease.
Topics: Adult; Cataract; Chelating Agents; Corneal Diseases; Female; Follow-Up Studies; Hepatolenticular Deg | 1995 |
Neuromuscular transmission and acetylcholine receptor antibodies in penicillamine-treated Wilson's disease patients.
Topics: Adolescent; Autoantibodies; Child; Female; Hepatolenticular Degeneration; Humans; Male; Muscles; Pen | 1996 |
Neuromuscular transmission and acetylcholine receptor antibodies in penicillamine-treated Wilson's disease patients.
Topics: Adolescent; Autoantibodies; Child; Female; Hepatolenticular Degeneration; Humans; Male; Muscles; Pen | 1996 |
Successful medical treatment of severely decompensated Wilson disease.
Topics: Adolescent; Anti-Bacterial Agents; Chelation Therapy; Child; Copper; Female; Hemolysis; Hepatolentic | 1996 |
Successful medical treatment of severely decompensated Wilson disease.
Topics: Adolescent; Anti-Bacterial Agents; Chelation Therapy; Child; Copper; Female; Hemolysis; Hepatolentic | 1996 |
[Aggressive behavior, increasing loss of independence in mentally retarded patient].
Topics: Adult; Behavior; Chelating Agents; Hepatolenticular Degeneration; Humans; Intellectual Disability; M | 1996 |
[Aggressive behavior, increasing loss of independence in mentally retarded patient].
Topics: Adult; Behavior; Chelating Agents; Hepatolenticular Degeneration; Humans; Intellectual Disability; M | 1996 |
[Visceral manifestations of Wilson-Konovalov disease (analysis of 22 cases)].
Topics: Adolescent; Adult; Chelating Agents; Diagnosis, Differential; Female; Hepatolenticular Degeneration; | 1995 |
[Visceral manifestations of Wilson-Konovalov disease (analysis of 22 cases)].
Topics: Adolescent; Adult; Chelating Agents; Diagnosis, Differential; Female; Hepatolenticular Degeneration; | 1995 |
[Wilson disease with HCV infections].
Topics: Adjuvants, Immunologic; Adolescent; Female; Hepatitis C; Hepatolenticular Degeneration; Humans; Inte | 1995 |
[Wilson disease with HCV infections].
Topics: Adjuvants, Immunologic; Adolescent; Female; Hepatitis C; Hepatolenticular Degeneration; Humans; Inte | 1995 |
Wilson's disease and mental disturbances.
Topics: Adult; Copper; Diagnosis, Differential; Female; Hepatolenticular Degeneration; Humans; Male; Neuroco | 1996 |
Wilson's disease and mental disturbances.
Topics: Adult; Copper; Diagnosis, Differential; Female; Hepatolenticular Degeneration; Humans; Male; Neuroco | 1996 |
[Wilson's disease: a review apropos of a clinical experience in 16 patients].
Topics: Adolescent; Adult; Central Nervous System Diseases; Ceruloplasmin; Child; Child, Preschool; Copper; | 1995 |
[Wilson's disease: a review apropos of a clinical experience in 16 patients].
Topics: Adolescent; Adult; Central Nervous System Diseases; Ceruloplasmin; Child; Child, Preschool; Copper; | 1995 |
[Prospective study on intelligence quotient of 28 hepatic lenticular degeneration patients with treatment combining traditional Chinese and Western medicine].
Topics: Adolescent; Adult; Chelating Agents; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hepat | 1996 |
[Prospective study on intelligence quotient of 28 hepatic lenticular degeneration patients with treatment combining traditional Chinese and Western medicine].
Topics: Adolescent; Adult; Chelating Agents; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hepat | 1996 |
Pleural effusion associated with D-penicillamine therapy: a case report.
Topics: Adult; Antidotes; Drainage; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pleural Ef | 1996 |
Pleural effusion associated with D-penicillamine therapy: a case report.
Topics: Adult; Antidotes; Drainage; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pleural Ef | 1996 |
Recurrent hypokalemic muscle weakness as an initial manifestation of Wilson's disease.
Topics: Acidosis, Renal Tubular; Adolescent; Atrophy; Brain; Chelating Agents; Hepatolenticular Degeneration | 1996 |
Recurrent hypokalemic muscle weakness as an initial manifestation of Wilson's disease.
Topics: Acidosis, Renal Tubular; Adolescent; Atrophy; Brain; Chelating Agents; Hepatolenticular Degeneration | 1996 |
Wilson disease: asymptomatic or late-onset type?
Topics: Chelating Agents; Drugs, Chinese Herbal; Female; Hepatolenticular Degeneration; Humans; Liver Functi | 1996 |
Wilson disease: asymptomatic or late-onset type?
Topics: Chelating Agents; Drugs, Chinese Herbal; Female; Hepatolenticular Degeneration; Humans; Liver Functi | 1996 |
Problems in diagnosis and management of Wilson's disease in India.
Topics: Hepatolenticular Degeneration; Humans; India; Penicillamine; Self-Help Groups | 1996 |
Problems in diagnosis and management of Wilson's disease in India.
Topics: Hepatolenticular Degeneration; Humans; India; Penicillamine; Self-Help Groups | 1996 |
Chronic internuclear ophthalmoplegia. A manifestation of D-penicillamine cerebral vasculitis.
Topics: Adult; Antirheumatic Agents; Biopsy; Brain Diseases; Chronic Disease; Female; Follow-Up Studies; Hep | 1997 |
Chronic internuclear ophthalmoplegia. A manifestation of D-penicillamine cerebral vasculitis.
Topics: Adult; Antirheumatic Agents; Biopsy; Brain Diseases; Chronic Disease; Female; Follow-Up Studies; Hep | 1997 |
[Wilson's disease].
Topics: Adolescent; Adult; Chelating Agents; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; | 1997 |
[Wilson's disease].
Topics: Adolescent; Adult; Chelating Agents; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; | 1997 |
Wilson's disease presenting as haemolytic anaemia and its successful treatment with penicillamine and zinc.
Topics: Adult; Anemia, Hemolytic; Diagnosis, Differential; Drug Therapy, Combination; Female; Hepatolenticul | 1996 |
Wilson's disease presenting as haemolytic anaemia and its successful treatment with penicillamine and zinc.
Topics: Adult; Anemia, Hemolytic; Diagnosis, Differential; Drug Therapy, Combination; Female; Hepatolenticul | 1996 |
[Acute hemolytic crisis as the initial manifestation of Wilson disease].
Topics: Acute Disease; Adult; Anemia, Hemolytic; Biopsy; Copper; Diagnosis, Differential; Female; Hepatolent | 1997 |
[Acute hemolytic crisis as the initial manifestation of Wilson disease].
Topics: Acute Disease; Adult; Anemia, Hemolytic; Biopsy; Copper; Diagnosis, Differential; Female; Hepatolent | 1997 |
Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.
Topics: Adolescent; Adult; Anemia, Hemolytic; Ataxia; Chelating Agents; Deglutition Disorders; Dysarthria; D | 1997 |
Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.
Topics: Adolescent; Adult; Anemia, Hemolytic; Ataxia; Chelating Agents; Deglutition Disorders; Dysarthria; D | 1997 |
Stereotypies in Wilson's disease.
Topics: Adult; Basal Ganglia; Chelating Agents; Female; Foot; Hepatolenticular Degeneration; Humans; Magneti | 1997 |
Stereotypies in Wilson's disease.
Topics: Adult; Basal Ganglia; Chelating Agents; Female; Foot; Hepatolenticular Degeneration; Humans; Magneti | 1997 |
Penicillamine-related neurologic syndrome in a child affected by Wilson disease with hepatic presentation.
Topics: Child; Hepatolenticular Degeneration; Humans; Liver Diseases; Male; Nervous System Diseases; Penicil | 1997 |
Penicillamine-related neurologic syndrome in a child affected by Wilson disease with hepatic presentation.
Topics: Child; Hepatolenticular Degeneration; Humans; Liver Diseases; Male; Nervous System Diseases; Penicil | 1997 |
Pretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson's disease.
Topics: Adult; Aged; Case-Control Studies; Cerebral Cortex; Chelating Agents; Corpus Striatum; Female; Gluco | 1998 |
Pretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson's disease.
Topics: Adult; Aged; Case-Control Studies; Cerebral Cortex; Chelating Agents; Corpus Striatum; Female; Gluco | 1998 |
Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.
Topics: Adolescent; Adult; Brain Stem; Dystonia; Female; Hepatolenticular Degeneration; Humans; Magnetic Res | 1998 |
Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.
Topics: Adolescent; Adult; Brain Stem; Dystonia; Female; Hepatolenticular Degeneration; Humans; Magnetic Res | 1998 |
Prenatal exposure to penicillamine and oral clefts: case report.
Topics: Adult; Chelating Agents; Cleft Lip; Cleft Palate; Female; Hepatolenticular Degeneration; Humans; Inf | 1998 |
Prenatal exposure to penicillamine and oral clefts: case report.
Topics: Adult; Chelating Agents; Cleft Lip; Cleft Palate; Female; Hepatolenticular Degeneration; Humans; Inf | 1998 |
[Schizophrenia-like symptoms in the Westphal-Strümpell variation of Wilson disease].
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Biperiden | 1998 |
[Schizophrenia-like symptoms in the Westphal-Strümpell variation of Wilson disease].
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Biperiden | 1998 |
A case of systemic pseudo-pseudoxanthoma elasticum with diverse symptomatology caused by long-term penicillamine use.
Topics: Chelating Agents; Drug Administration Schedule; Hepatolenticular Degeneration; Humans; Male; Middle | 1998 |
A case of systemic pseudo-pseudoxanthoma elasticum with diverse symptomatology caused by long-term penicillamine use.
Topics: Chelating Agents; Drug Administration Schedule; Hepatolenticular Degeneration; Humans; Male; Middle | 1998 |
[Neuroradiological findings in 2 cases of Wilson disease with neurological involvement].
Topics: Adolescent; Child; Female; Hepatolenticular Degeneration; Humans; Male; Nervous System Diseases; Pen | 1998 |
[Neuroradiological findings in 2 cases of Wilson disease with neurological involvement].
Topics: Adolescent; Child; Female; Hepatolenticular Degeneration; Humans; Male; Nervous System Diseases; Pen | 1998 |
Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
Topics: Adolescent; Chelating Agents; Child; Child, Preschool; Copper; Female; Hepatolenticular Degeneration | 1997 |
Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
Topics: Adolescent; Chelating Agents; Child; Child, Preschool; Copper; Female; Hepatolenticular Degeneration | 1997 |
Five successful deliveries following 9 consecutive spontaneous abortions in a patient with Wilson disease.
Topics: Abortion, Habitual; Adult; Ceruloplasmin; Chelating Agents; Copper; Delivery, Obstetric; Female; Hep | 1998 |
Five successful deliveries following 9 consecutive spontaneous abortions in a patient with Wilson disease.
Topics: Abortion, Habitual; Adult; Ceruloplasmin; Chelating Agents; Copper; Delivery, Obstetric; Female; Hep | 1998 |
Wilson's disease before and after 5 years of treatment with D-penicillamine.
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Radiography | 1998 |
Wilson's disease before and after 5 years of treatment with D-penicillamine.
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Radiography | 1998 |
[Contrast analysis of brainstem auditory evoked potential in untreated and treated hepatolenticular degeneration patients with treatment of combining traditional Chinese and Western medicine].
Topics: Adolescent; Adult; Chelating Agents; Child; Drugs, Chinese Herbal; Evoked Potentials, Auditory, Brai | 1997 |
[Contrast analysis of brainstem auditory evoked potential in untreated and treated hepatolenticular degeneration patients with treatment of combining traditional Chinese and Western medicine].
Topics: Adolescent; Adult; Chelating Agents; Child; Drugs, Chinese Herbal; Evoked Potentials, Auditory, Brai | 1997 |
D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: a lesson from patients with Wilson's disease.
Topics: Adolescent; Adult; Autoantibodies; Child; Diabetes Mellitus, Type 1; Female; Haplotypes; Hepatolenti | 1998 |
D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: a lesson from patients with Wilson's disease.
Topics: Adolescent; Adult; Autoantibodies; Child; Diabetes Mellitus, Type 1; Female; Haplotypes; Hepatolenti | 1998 |
Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
Topics: Chelating Agents; Child; Hepatolenticular Degeneration; Humans; Male; Nephrotic Syndrome; Penicillam | 1998 |
Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
Topics: Chelating Agents; Child; Hepatolenticular Degeneration; Humans; Male; Nephrotic Syndrome; Penicillam | 1998 |
A high index of suspicion: the key to an early diagnosis of Wilson's disease in childhood.
Topics: Adolescent; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Copper; Female; Hepatolenticul | 1999 |
A high index of suspicion: the key to an early diagnosis of Wilson's disease in childhood.
Topics: Adolescent; Ceruloplasmin; Chelating Agents; Child; Child, Preschool; Copper; Female; Hepatolenticul | 1999 |
[Long-term follow-up of combined therapy with large-dose zinc sulfate and low-dose penicillamine in children with hepatolenticular degeneration].
Topics: Adolescent; Chelating Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Hepatolent | 1999 |
[Long-term follow-up of combined therapy with large-dose zinc sulfate and low-dose penicillamine in children with hepatolenticular degeneration].
Topics: Adolescent; Chelating Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Hepatolent | 1999 |
Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Topics: Adult; Case-Control Studies; Chelating Agents; Copper; Duodenitis; Duodenum; Female; Hepatolenticula | 1999 |
Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Topics: Adult; Case-Control Studies; Chelating Agents; Copper; Duodenitis; Duodenum; Female; Hepatolenticula | 1999 |
[Acute hemolytic anemia associated with D-penicillamine absorption deficiency in Wilson's disease].
Topics: Acute Disease; Administration, Oral; Adult; Anemia, Hemolytic; Female; Hepatolenticular Degeneration | 1999 |
[Acute hemolytic anemia associated with D-penicillamine absorption deficiency in Wilson's disease].
Topics: Acute Disease; Administration, Oral; Adult; Anemia, Hemolytic; Female; Hepatolenticular Degeneration | 1999 |
Penicillamine: the treatment of first choice for patients with Wilson's disease.
Topics: Chelating Agents; Hepatolenticular Degeneration; Humans; Penicillamine | 1999 |
Penicillamine: the treatment of first choice for patients with Wilson's disease.
Topics: Chelating Agents; Hepatolenticular Degeneration; Humans; Penicillamine | 1999 |
Penicillamine should not be used as initial therapy in Wilson's disease.
Topics: Chelating Agents; Copper; Disease Progression; Hepatolenticular Degeneration; Humans; Penicillamine | 1999 |
Penicillamine should not be used as initial therapy in Wilson's disease.
Topics: Chelating Agents; Copper; Disease Progression; Hepatolenticular Degeneration; Humans; Penicillamine | 1999 |
Penicillamine as a controversial treatment for Wilson's disease.
Topics: Chelating Agents; Hepatolenticular Degeneration; Humans; Penicillamine | 1999 |
Penicillamine as a controversial treatment for Wilson's disease.
Topics: Chelating Agents; Hepatolenticular Degeneration; Humans; Penicillamine | 1999 |
[Short interval change of 99mTc-ethyl cysteinate dimer single photon emission computed tomography in Wilson's disease].
Topics: Adolescent; Brain; Cysteine; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imagi | 1999 |
[Short interval change of 99mTc-ethyl cysteinate dimer single photon emission computed tomography in Wilson's disease].
Topics: Adolescent; Brain; Cysteine; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imagi | 1999 |
Potential hepatotoxicity of penicillamine treatment in three patients with Wilson's disease.
Topics: Chelating Agents; Chemical and Drug Induced Liver Injury; Child; Hepatolenticular Degeneration; Huma | 1999 |
Potential hepatotoxicity of penicillamine treatment in three patients with Wilson's disease.
Topics: Chelating Agents; Chemical and Drug Induced Liver Injury; Child; Hepatolenticular Degeneration; Huma | 1999 |
[Pregnancy, labor and early puerperium in a patient with Wilson's disease].
Topics: Adult; Chelating Agents; Female; Foot Deformities, Congenital; Hepatolenticular Degeneration; Humans | 1999 |
[Pregnancy, labor and early puerperium in a patient with Wilson's disease].
Topics: Adult; Chelating Agents; Female; Foot Deformities, Congenital; Hepatolenticular Degeneration; Humans | 1999 |
Magnetic resonance imaging and proton MR spectroscopy in Wilson's disease.
Topics: Adult; Basal Ganglia; Case-Control Studies; Female; Follow-Up Studies; Hepatolenticular Degeneration | 1999 |
Magnetic resonance imaging and proton MR spectroscopy in Wilson's disease.
Topics: Adult; Basal Ganglia; Case-Control Studies; Female; Follow-Up Studies; Hepatolenticular Degeneration | 1999 |
Hypersomnia in Wilson's disease: an unusual symptom in an unusual case.
Topics: Adult; Ceruloplasmin; Copper; Diagnosis, Differential; Disorders of Excessive Somnolence; Fatigue; H | 2000 |
Hypersomnia in Wilson's disease: an unusual symptom in an unusual case.
Topics: Adult; Ceruloplasmin; Copper; Diagnosis, Differential; Disorders of Excessive Somnolence; Fatigue; H | 2000 |
Pencillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson's disease.
Topics: Adult; Chelating Agents; Cutis Laxa; Elastic Tissue; Hepatolenticular Degeneration; Humans; Male; Pe | 2000 |
Pencillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson's disease.
Topics: Adult; Chelating Agents; Cutis Laxa; Elastic Tissue; Hepatolenticular Degeneration; Humans; Male; Pe | 2000 |
Neuro/Images. Kayser-Fleischer corneal ring.
Topics: Adult; Corneal Diseases; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Male; Penicillami | 2000 |
Neuro/Images. Kayser-Fleischer corneal ring.
Topics: Adult; Corneal Diseases; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Male; Penicillami | 2000 |
[A case of delayed diagnosis of Wilson's disease].
Topics: Adult; Chelating Agents; Dementia; Dose-Response Relationship, Drug; Female; Hepatitis, Chronic; Hep | 2000 |
[A case of delayed diagnosis of Wilson's disease].
Topics: Adult; Chelating Agents; Dementia; Dose-Response Relationship, Drug; Female; Hepatitis, Chronic; Hep | 2000 |
CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease.
Topics: Adult; Blood-Brain Barrier; Brain; Cerebrovascular Circulation; Ceruloplasmin; Chelating Agents; Cop | 2000 |
CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease.
Topics: Adult; Blood-Brain Barrier; Brain; Cerebrovascular Circulation; Ceruloplasmin; Chelating Agents; Cop | 2000 |
Visual pathway abnormalities Wilson's disease: an electrophysiological study using electroretinography and visual evoked potentials.
Topics: Adolescent; Adult; Chelation Therapy; Child; Copper; Drug Therapy, Combination; Electroretinography; | 2000 |
Visual pathway abnormalities Wilson's disease: an electrophysiological study using electroretinography and visual evoked potentials.
Topics: Adolescent; Adult; Chelation Therapy; Child; Copper; Drug Therapy, Combination; Electroretinography; | 2000 |
[Two recovery cases of Wilson's disease initiated with severe hemolysis and acute hepatic failure].
Topics: Adolescent; Anemia, Hemolytic; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Live | 2000 |
[Two recovery cases of Wilson's disease initiated with severe hemolysis and acute hepatic failure].
Topics: Adolescent; Anemia, Hemolytic; Chelating Agents; Female; Hepatolenticular Degeneration; Humans; Live | 2000 |
Psychiatric symptoms as late onset of Wilson's disease: neuroradiological findings, clinical features and treatment.
Topics: Adult; Age of Onset; Antidepressive Agents; Basal Ganglia; Basal Ganglia Diseases; Biopsy; Bipolar D | 1999 |
Psychiatric symptoms as late onset of Wilson's disease: neuroradiological findings, clinical features and treatment.
Topics: Adult; Age of Onset; Antidepressive Agents; Basal Ganglia; Basal Ganglia Diseases; Biopsy; Bipolar D | 1999 |
Generalized myasthenia gravis following use of D-pencillamine in Wilson's disease.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Myasthenia Gravis; Penicillamine | 1999 |
Generalized myasthenia gravis following use of D-pencillamine in Wilson's disease.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Myasthenia Gravis; Penicillamine | 1999 |
Acute hepatitis after starting zinc therapy in a patient with presymptomatic Wilson's disease.
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Female; Hepatolenticular Degeneration; | 2000 |
Acute hepatitis after starting zinc therapy in a patient with presymptomatic Wilson's disease.
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Female; Hepatolenticular Degeneration; | 2000 |
The level of serum lipids, vitamin E and low density lipoprotein oxidation in Wilson's disease patients.
Topics: Adult; Cholesterol; Copper; Hepatolenticular Degeneration; Humans; Lipid Peroxidation; Lipoproteins, | 2000 |
The level of serum lipids, vitamin E and low density lipoprotein oxidation in Wilson's disease patients.
Topics: Adult; Cholesterol; Copper; Hepatolenticular Degeneration; Humans; Lipid Peroxidation; Lipoproteins, | 2000 |
Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine.
Topics: Acute Kidney Injury; Adolescent; Adult; Chelating Agents; Child; Female; Hepatic Encephalopathy; Hep | 2001 |
Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine.
Topics: Acute Kidney Injury; Adolescent; Adult; Chelating Agents; Child; Female; Hepatic Encephalopathy; Hep | 2001 |
Wilson's disease in pregnancy: five successful consecutive pregnancies of the same woman.
Topics: Alanine Transaminase; Apgar Score; Aspartate Aminotransferases; Chelating Agents; Female; Gestationa | 2001 |
Wilson's disease in pregnancy: five successful consecutive pregnancies of the same woman.
Topics: Alanine Transaminase; Apgar Score; Aspartate Aminotransferases; Chelating Agents; Female; Gestationa | 2001 |
Penicillamine-induced lethal status dystonicus in a patient with Wilson's disease.
Topics: Acute Kidney Injury; Adult; Chelating Agents; Dystonia; Fatal Outcome; Hepatolenticular Degeneration | 2001 |
Penicillamine-induced lethal status dystonicus in a patient with Wilson's disease.
Topics: Acute Kidney Injury; Adult; Chelating Agents; Dystonia; Fatal Outcome; Hepatolenticular Degeneration | 2001 |
Generalised oedema, lethargy, personality disturbance, and recurring nightmares in a young girl.
Topics: Adolescent; Biopsy; Ceruloplasmin; Chelating Agents; Copper; Edema; Female; Hepatolenticular Degener | 2001 |
Generalised oedema, lethargy, personality disturbance, and recurring nightmares in a young girl.
Topics: Adolescent; Biopsy; Ceruloplasmin; Chelating Agents; Copper; Edema; Female; Hepatolenticular Degener | 2001 |
Iron accumulation in the liver of male patients with Wilson's disease.
Topics: Adolescent; Adult; Chelating Agents; Hepatolenticular Degeneration; Humans; Iron; Liver; Male; Penic | 2001 |
Iron accumulation in the liver of male patients with Wilson's disease.
Topics: Adolescent; Adult; Chelating Agents; Hepatolenticular Degeneration; Humans; Iron; Liver; Male; Penic | 2001 |
Wilson's disease in Eastern India.
Topics: Adolescent; Adult; Age Distribution; Age of Onset; Child; Female; Hepatolenticular Degeneration; Hum | 2001 |
Wilson's disease in Eastern India.
Topics: Adolescent; Adult; Age Distribution; Age of Onset; Child; Female; Hepatolenticular Degeneration; Hum | 2001 |
Disturbed copper transport in humans. Part 2: mutations of the ATP7B gene lead to Wilson disease (WD).
Topics: Adenosine Triphosphatases; Adolescent; Base Sequence; Cation Transport Proteins; Copper; Copper-Tran | 2001 |
Disturbed copper transport in humans. Part 2: mutations of the ATP7B gene lead to Wilson disease (WD).
Topics: Adenosine Triphosphatases; Adolescent; Base Sequence; Cation Transport Proteins; Copper; Copper-Tran | 2001 |
Proton MR spectroscopy of basal ganglia in Wilson's disease: case report and review of literature.
Topics: Adolescent; Basal Ganglia; Chelating Agents; Child; Choline; Creatine; Drug Therapy, Combination; Fa | 2002 |
Proton MR spectroscopy of basal ganglia in Wilson's disease: case report and review of literature.
Topics: Adolescent; Basal Ganglia; Chelating Agents; Child; Choline; Creatine; Drug Therapy, Combination; Fa | 2002 |
[Wilson's disease. Clinical presentation, treatment and evolution in 21 cases].
Topics: Adolescent; Adult; Antirheumatic Agents; Copper; Disease Progression; Female; Hepatolenticular Degen | 2002 |
[Wilson's disease. Clinical presentation, treatment and evolution in 21 cases].
Topics: Adolescent; Adult; Antirheumatic Agents; Copper; Disease Progression; Female; Hepatolenticular Degen | 2002 |
Letter: Mannosidosis and maternal penicillamine therapy.
Topics: Carbohydrate Metabolism, Inborn Errors; Disaccharidases; Female; Hepatolenticular Degeneration; Huma | 1976 |
Letter: Mannosidosis and maternal penicillamine therapy.
Topics: Carbohydrate Metabolism, Inborn Errors; Disaccharidases; Female; Hepatolenticular Degeneration; Huma | 1976 |
Letter: D-penicillamine and haemolytic anaemia.
Topics: Anemia, Hemolytic; Child; Hepatolenticular Degeneration; Humans; Penicillamine | 1976 |
Letter: D-penicillamine and haemolytic anaemia.
Topics: Anemia, Hemolytic; Child; Hepatolenticular Degeneration; Humans; Penicillamine | 1976 |
D-penicillamine-induced IgA deficiency in Wilson's disease.
Topics: Adolescent; Dysgammaglobulinemia; Female; Hepatolenticular Degeneration; Humans; Immunoglobulin A; I | 1976 |
D-penicillamine-induced IgA deficiency in Wilson's disease.
Topics: Adolescent; Dysgammaglobulinemia; Female; Hepatolenticular Degeneration; Humans; Immunoglobulin A; I | 1976 |
Reversible cutis laxa due to maternal D-penicillamine treatment.
Topics: Cutis Laxa; Female; Fetus; Hepatolenticular Degeneration; Humans; Infant, Newborn; Infant, Newborn, | 1979 |
Reversible cutis laxa due to maternal D-penicillamine treatment.
Topics: Cutis Laxa; Female; Fetus; Hepatolenticular Degeneration; Humans; Infant, Newborn; Infant, Newborn, | 1979 |
[Wilson's disease or liver cirrhosis of a different etiology].
Topics: Adolescent; Ceruloplasmin; Copper; Corneal Diseases; Diagnosis, Differential; Female; Hepatolenticul | 1979 |
[Wilson's disease or liver cirrhosis of a different etiology].
Topics: Adolescent; Ceruloplasmin; Copper; Corneal Diseases; Diagnosis, Differential; Female; Hepatolenticul | 1979 |
Preparation of and clinical experiences with trien for the treatment of Wilson's disease in absolute intolerance of D-penicillamine.
Topics: Adult; Drug Tolerance; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine | 1977 |
Preparation of and clinical experiences with trien for the treatment of Wilson's disease in absolute intolerance of D-penicillamine.
Topics: Adult; Drug Tolerance; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine | 1977 |
[Serious side effects with D-penicillamine therapy for Wilson's disease].
Topics: Basement Membrane; Complement C3; Glomerulonephritis; Hepatolenticular Degeneration; Humans; Immune | 1979 |
[Serious side effects with D-penicillamine therapy for Wilson's disease].
Topics: Basement Membrane; Complement C3; Glomerulonephritis; Hepatolenticular Degeneration; Humans; Immune | 1979 |
Drugs: distamine.
Topics: Adult; Arthritis, Rheumatoid; Child; Hepatolenticular Degeneration; Humans; Lead Poisoning; Penicill | 1979 |
Drugs: distamine.
Topics: Adult; Arthritis, Rheumatoid; Child; Hepatolenticular Degeneration; Humans; Lead Poisoning; Penicill | 1979 |
Ocular manifestations of Wilson's disease in Iran.
Topics: Adolescent; Adult; Child; Child, Preschool; Cornea; Descemet Membrane; Female; Hepatolenticular Dege | 1977 |
Ocular manifestations of Wilson's disease in Iran.
Topics: Adolescent; Adult; Child; Child, Preschool; Cornea; Descemet Membrane; Female; Hepatolenticular Dege | 1977 |
[Unusual and different clinical aspects of Wilson's disease in 2 sisters].
Topics: Acute Kidney Injury; Anemia, Hemolytic; Chelating Agents; Child; Copper; Disseminated Intravascular | 1979 |
[Unusual and different clinical aspects of Wilson's disease in 2 sisters].
Topics: Acute Kidney Injury; Anemia, Hemolytic; Chelating Agents; Child; Copper; Disseminated Intravascular | 1979 |
Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Hypertension, Portal; Penicillamine; Portacaval Shunt, Surgic | 1979 |
Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Hypertension, Portal; Penicillamine; Portacaval Shunt, Surgic | 1979 |
[The effect of penicillamine on the mental disorders associated with wilson's disease (author's transl)].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Male; Mental Disorders; Penicillamine; Psychol | 1979 |
[The effect of penicillamine on the mental disorders associated with wilson's disease (author's transl)].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Male; Mental Disorders; Penicillamine; Psychol | 1979 |
Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children.
Topics: Adolescent; Adult; Azathioprine; Ceruloplasmin; Child; Child, Preschool; Chronic Disease; Copper; Di | 1979 |
Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children.
Topics: Adolescent; Adult; Azathioprine; Ceruloplasmin; Child; Child, Preschool; Chronic Disease; Copper; Di | 1979 |
[The therapeutic use of D-penicyllamine in the light of most recent pharmacokinetic and clinical observations (author's transl)].
Topics: Chelating Agents; Copper; Cystinuria; Hepatolenticular Degeneration; Humans; Metal Metabolism, Inbor | 1979 |
[The therapeutic use of D-penicyllamine in the light of most recent pharmacokinetic and clinical observations (author's transl)].
Topics: Chelating Agents; Copper; Cystinuria; Hepatolenticular Degeneration; Humans; Metal Metabolism, Inbor | 1979 |
Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration).
Topics: Administration, Oral; Adult; Ceruloplasmin; Copper; Drug Evaluation; Hepatolenticular Degeneration; | 1979 |
Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration).
Topics: Administration, Oral; Adult; Ceruloplasmin; Copper; Drug Evaluation; Hepatolenticular Degeneration; | 1979 |
[Hepatolenticular degeneration. Clinical course in 2 siblings during penicillamine therapy].
Topics: Adolescent; Child; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; Male; Penicillami | 1979 |
[Hepatolenticular degeneration. Clinical course in 2 siblings during penicillamine therapy].
Topics: Adolescent; Child; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; Male; Penicillami | 1979 |
[D-Penacillamine. From constituent of penicillins to significant drug].
Topics: Arthritis, Rheumatoid; Cystinuria; Hepatitis; Hepatolenticular Degeneration; Humans; Multiple Sclero | 1979 |
[D-Penacillamine. From constituent of penicillins to significant drug].
Topics: Arthritis, Rheumatoid; Cystinuria; Hepatitis; Hepatolenticular Degeneration; Humans; Multiple Sclero | 1979 |
2,3,2-tetramine--a potent cupruretic agent.
Topics: Animals; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Polyamines; | 1979 |
2,3,2-tetramine--a potent cupruretic agent.
Topics: Animals; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Polyamines; | 1979 |
The formation and nature of the mixed valence copper-D-penicillamine-chloride cluster in aqueous solution and its relevance to the treatment of Wilson's disease.
Topics: Chemical Phenomena; Chemistry; Copper; Hepatolenticular Degeneration; Humans; Kinetics; Penicillamin | 1979 |
The formation and nature of the mixed valence copper-D-penicillamine-chloride cluster in aqueous solution and its relevance to the treatment of Wilson's disease.
Topics: Chemical Phenomena; Chemistry; Copper; Hepatolenticular Degeneration; Humans; Kinetics; Penicillamin | 1979 |
The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1).
Topics: Drug Hypersensitivity; Ethylenediamines; Female; Hepatolenticular Degeneration; Humans; Male; Penici | 1979 |
The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1).
Topics: Drug Hypersensitivity; Ethylenediamines; Female; Hepatolenticular Degeneration; Humans; Male; Penici | 1979 |
[Some problems of Wilson's disease].
Topics: Adolescent; Adult; Child; Genetic Carrier Screening; Germany, East; Hepatolenticular Degeneration; H | 1979 |
[Some problems of Wilson's disease].
Topics: Adolescent; Adult; Child; Genetic Carrier Screening; Germany, East; Hepatolenticular Degeneration; H | 1979 |
[Treatment of liver cirrhosis and its complications].
Topics: Ascites; Azathioprine; Barbiturates; Hemochromatosis; Hepatic Encephalopathy; Hepatolenticular Degen | 1979 |
[Treatment of liver cirrhosis and its complications].
Topics: Ascites; Azathioprine; Barbiturates; Hemochromatosis; Hepatic Encephalopathy; Hepatolenticular Degen | 1979 |
[Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
Topics: Adolescent; Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Spectrophot | 1979 |
[Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
Topics: Adolescent; Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Spectrophot | 1979 |
[Evolution of nocturnal sleep in a case of Wilson's disease].
Topics: Adolescent; Basal Ganglia; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Sleep Stage | 1979 |
[Evolution of nocturnal sleep in a case of Wilson's disease].
Topics: Adolescent; Basal Ganglia; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Sleep Stage | 1979 |
[Wilson's disease].
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1977 |
[Wilson's disease].
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1977 |
Computerized cranial tomography in Wilson disease.
Topics: Adult; Basal Ganglia; Ceruloplasmin; Female; Hepatolenticular Degeneration; Humans; Male; Neurocogni | 1979 |
Computerized cranial tomography in Wilson disease.
Topics: Adult; Basal Ganglia; Ceruloplasmin; Female; Hepatolenticular Degeneration; Humans; Male; Neurocogni | 1979 |
Hemolytic anemia in Wilson's disease. A report of three cases with transient increase in hemoglobin A2.
Topics: Acute Disease; Adolescent; Anemia, Hemolytic; Ascites; Copper; Female; Hemoglobin A; Hemoglobins; He | 1977 |
Hemolytic anemia in Wilson's disease. A report of three cases with transient increase in hemoglobin A2.
Topics: Acute Disease; Adolescent; Anemia, Hemolytic; Ascites; Copper; Female; Hemoglobin A; Hemoglobins; He | 1977 |
The influence of prolonged treatment with D-penicillamine on the immune response in Wilson's disease.
Topics: Adult; Cell Migration Inhibition; Hepatolenticular Degeneration; Humans; Immunity; Immunity, Cellula | 1977 |
The influence of prolonged treatment with D-penicillamine on the immune response in Wilson's disease.
Topics: Adult; Cell Migration Inhibition; Hepatolenticular Degeneration; Humans; Immunity; Immunity, Cellula | 1977 |
[Management of hepatocerebral degeneration].
Topics: Copper; Cornea; Diet; Hepatolenticular Degeneration; Humans; Penicillamine | 1977 |
[Management of hepatocerebral degeneration].
Topics: Copper; Cornea; Diet; Hepatolenticular Degeneration; Humans; Penicillamine | 1977 |
[Morbus Wilson--pathogenesis, diagnosis, therapy, and course (author's transl)].
Topics: Age Factors; Ceruloplasmin; Child; Copper; Hemolysis; Hepatolenticular Degeneration; Humans; Liver C | 1977 |
[Morbus Wilson--pathogenesis, diagnosis, therapy, and course (author's transl)].
Topics: Age Factors; Ceruloplasmin; Child; Copper; Hemolysis; Hepatolenticular Degeneration; Humans; Liver C | 1977 |
[Morbus wilson--progressive fatal course of the hepatic form with apoplexy and abscess of the brain (author's transl)].
Topics: Adult; Brain Abscess; Cerebrovascular Disorders; Child; Female; Hemolysis; Hepatolenticular Degenera | 1977 |
[Morbus wilson--progressive fatal course of the hepatic form with apoplexy and abscess of the brain (author's transl)].
Topics: Adult; Brain Abscess; Cerebrovascular Disorders; Child; Female; Hemolysis; Hepatolenticular Degenera | 1977 |
[Immune deficiency during D-penicillamine treatment ].
Topics: Child; Dysgammaglobulinemia; Female; Hepatolenticular Degeneration; Humans; Immunoglobulin A; Penici | 1977 |
[Immune deficiency during D-penicillamine treatment ].
Topics: Child; Dysgammaglobulinemia; Female; Hepatolenticular Degeneration; Humans; Immunoglobulin A; Penici | 1977 |
Pregnancy and delivery in penicillamine treated patients with Wilson's disease.
Topics: Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Labor, Obstetric; Liver; Maternal-Feta | 1977 |
Pregnancy and delivery in penicillamine treated patients with Wilson's disease.
Topics: Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Labor, Obstetric; Liver; Maternal-Feta | 1977 |
Diagnostic dilemmas of Wilson's disease: diagnosis and treatment.
Topics: Adolescent; Adult; Copper; Diagnosis, Differential; Female; Hemolysis; Hepatolenticular Degeneration | 1978 |
Diagnostic dilemmas of Wilson's disease: diagnosis and treatment.
Topics: Adolescent; Adult; Copper; Diagnosis, Differential; Female; Hemolysis; Hepatolenticular Degeneration | 1978 |
Wilson's disease and monoamines.
Topics: Adult; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Pen | 1978 |
Wilson's disease and monoamines.
Topics: Adult; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Pen | 1978 |
[Monocytic neck lymphadenitis with morbileiform exanthema as side effect of penicillamine therapy of infantile Wilson's diseases].
Topics: Child; Drug Hypersensitivity; Exanthema; Female; Hepatolenticular Degeneration; Humans; Lymphadeniti | 1978 |
[Monocytic neck lymphadenitis with morbileiform exanthema as side effect of penicillamine therapy of infantile Wilson's diseases].
Topics: Child; Drug Hypersensitivity; Exanthema; Female; Hepatolenticular Degeneration; Humans; Lymphadeniti | 1978 |
The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
Topics: Adolescent; Adult; Child; Copper; Female; Hepatolenticular Degeneration; Heterozygote; Humans; Male; | 1978 |
The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
Topics: Adolescent; Adult; Child; Copper; Female; Hepatolenticular Degeneration; Heterozygote; Humans; Male; | 1978 |
Don't forget Wilson's disease.
Topics: Diagnosis, Differential; Hepatolenticular Degeneration; Humans; Liver Diseases; Middle Aged; Penicil | 1978 |
Don't forget Wilson's disease.
Topics: Diagnosis, Differential; Hepatolenticular Degeneration; Humans; Liver Diseases; Middle Aged; Penicil | 1978 |
Ophthalmoscopic changes in a patient with Wilson's disease during long-term penicillamine therapy.
Topics: Adult; Copper; Female; Fundus Oculi; Hepatolenticular Degeneration; Humans; Penicillamine; Pigment E | 1978 |
Ophthalmoscopic changes in a patient with Wilson's disease during long-term penicillamine therapy.
Topics: Adult; Copper; Female; Fundus Oculi; Hepatolenticular Degeneration; Humans; Penicillamine; Pigment E | 1978 |
[Wilson's disease: description of various cases].
Topics: Adolescent; Adult; Child; Chromosome Aberrations; Chromosome Disorders; Female; Genes, Recessive; He | 1978 |
[Wilson's disease: description of various cases].
Topics: Adolescent; Adult; Child; Chromosome Aberrations; Chromosome Disorders; Female; Genes, Recessive; He | 1978 |
Clinical spectrum of Wilson's disease (hepatolenticular degeneration).
Topics: Adolescent; Adult; Brain Diseases; Child; Copper; Cornea; Dimercaprol; Female; Hepatolenticular Dege | 1979 |
Clinical spectrum of Wilson's disease (hepatolenticular degeneration).
Topics: Adolescent; Adult; Brain Diseases; Child; Copper; Cornea; Dimercaprol; Female; Hepatolenticular Dege | 1979 |
[Wilson's disease (hepatocerebral degeneration)].
Topics: Adolescent; Adult; Ceruloplasmin; Child; Female; Hepatolenticular Degeneration; Humans; Liver; Male; | 1976 |
[Wilson's disease (hepatocerebral degeneration)].
Topics: Adolescent; Adult; Ceruloplasmin; Child; Female; Hepatolenticular Degeneration; Humans; Liver; Male; | 1976 |
[Experiences with penicillamine in Wilson's disease].
Topics: Adolescent; Adult; Child; Copper; Female; Follow-Up Studies; Hepatolenticular Degeneration; Humans; | 1975 |
[Experiences with penicillamine in Wilson's disease].
Topics: Adolescent; Adult; Child; Copper; Female; Follow-Up Studies; Hepatolenticular Degeneration; Humans; | 1975 |
[Liver cirrhosis caused by genetic defects].
Topics: Adult; Bloodletting; Hemochromatosis; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Male; | 1977 |
[Liver cirrhosis caused by genetic defects].
Topics: Adult; Bloodletting; Hemochromatosis; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Male; | 1977 |
IgA deficiency during D-penicillamine treatment.
Topics: Child; Dysgammaglobulinemia; Female; Hepatolenticular Degeneration; Humans; Immunoglobulin A; Immuno | 1977 |
IgA deficiency during D-penicillamine treatment.
Topics: Child; Dysgammaglobulinemia; Female; Hepatolenticular Degeneration; Humans; Immunoglobulin A; Immuno | 1977 |
[Changes in the bioelectrical activity of the brain in hepato-cerebral dystrophy (Wilson--Konovalov disease)].
Topics: Adult; Brain; Child; Diagnosis, Differential; Electroencephalography; Hepatolenticular Degeneration; | 1977 |
[Changes in the bioelectrical activity of the brain in hepato-cerebral dystrophy (Wilson--Konovalov disease)].
Topics: Adult; Brain; Child; Diagnosis, Differential; Electroencephalography; Hepatolenticular Degeneration; | 1977 |
Elastosis perforans serpiginosa induced by penicillamine.
Topics: Adult; Elastic Tissue; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Skin; Skin Diseas | 1977 |
Elastosis perforans serpiginosa induced by penicillamine.
Topics: Adult; Elastic Tissue; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Skin; Skin Diseas | 1977 |
Wilson's disease: a common liver disorder?
Topics: Adolescent; Adult; Aspartate Aminotransferases; Blood Sedimentation; Ceruloplasmin; Child; Copper; E | 1977 |
Wilson's disease: a common liver disorder?
Topics: Adolescent; Adult; Aspartate Aminotransferases; Blood Sedimentation; Ceruloplasmin; Child; Copper; E | 1977 |
Pregnancy in Wilson's disease.
Topics: Ceruloplasmin; Copper; Female; Fetal Blood; Hepatolenticular Degeneration; Humans; Penicillamine; Pr | 1977 |
Pregnancy in Wilson's disease.
Topics: Ceruloplasmin; Copper; Female; Fetal Blood; Hepatolenticular Degeneration; Humans; Penicillamine; Pr | 1977 |
The ophthalmologic manifestations of Wilson's disease.
Topics: Adolescent; Adult; Child; Cornea; Eye Manifestations; Female; Hepatolenticular Degeneration; Humans; | 1977 |
The ophthalmologic manifestations of Wilson's disease.
Topics: Adolescent; Adult; Child; Cornea; Eye Manifestations; Female; Hepatolenticular Degeneration; Humans; | 1977 |
Fulminant Wilson's disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens.
Topics: Acute Kidney Injury; Adolescent; Child; Copper; Female; Hemolysis; Hepatolenticular Degeneration; Hu | 1977 |
Fulminant Wilson's disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens.
Topics: Acute Kidney Injury; Adolescent; Child; Copper; Female; Hemolysis; Hepatolenticular Degeneration; Hu | 1977 |
Structure, properties, and function of a copper(I)-copper(II) complex of D-penicillamine: pentathallium(I) mu8-chloro-dodeca (D-penicillaminato)-octacuprate(I)hexacuprate(II) n-hydrate.
Topics: Chelating Agents; Chemical Phenomena; Chemistry; Copper; Crystallography; Hepatolenticular Degenerat | 1977 |
Structure, properties, and function of a copper(I)-copper(II) complex of D-penicillamine: pentathallium(I) mu8-chloro-dodeca (D-penicillaminato)-octacuprate(I)hexacuprate(II) n-hydrate.
Topics: Chelating Agents; Chemical Phenomena; Chemistry; Copper; Crystallography; Hepatolenticular Degenerat | 1977 |
The effect of certain chelating compounds on the urinary excretion of copper by the rat: observations on their clinical significance.
Topics: Animals; Chelating Agents; Copper; Drug Evaluation, Preclinical; Ethylenediamines; Hepatolenticular | 1977 |
The effect of certain chelating compounds on the urinary excretion of copper by the rat: observations on their clinical significance.
Topics: Animals; Chelating Agents; Copper; Drug Evaluation, Preclinical; Ethylenediamines; Hepatolenticular | 1977 |
Prognosis of Wilson's disease in childhood.
Topics: Adolescent; Age Factors; Ascites; Child; Child, Preschool; Hepatolenticular Degeneration; Hepatomega | 1977 |
Prognosis of Wilson's disease in childhood.
Topics: Adolescent; Age Factors; Ascites; Child; Child, Preschool; Hepatolenticular Degeneration; Hepatomega | 1977 |
[Effects and adverse effects in D-penicillamine therapy].
Topics: Arthritis, Rheumatoid; Blood Coagulation Disorders; Female; Hepatolenticular Degeneration; Humans; M | 1977 |
[Effects and adverse effects in D-penicillamine therapy].
Topics: Arthritis, Rheumatoid; Blood Coagulation Disorders; Female; Hepatolenticular Degeneration; Humans; M | 1977 |
Failure of L-dopa to relieve activated rigidity in Parkinson's disease.
Topics: Adult; Amantadine; Extrapyramidal Tracts; Hepatolenticular Degeneration; Humans; Levodopa; Male; Mid | 1977 |
Failure of L-dopa to relieve activated rigidity in Parkinson's disease.
Topics: Adult; Amantadine; Extrapyramidal Tracts; Hepatolenticular Degeneration; Humans; Levodopa; Male; Mid | 1977 |
Effects of anticopper therapy on hepatocellular mitochondria in patients with Wilson's disease: an ultrastructural and stereological study.
Topics: Adolescent; Child; Copper; Hepatolenticular Degeneration; Humans; Liver; Liver Function Tests; Mitoc | 1976 |
Effects of anticopper therapy on hepatocellular mitochondria in patients with Wilson's disease: an ultrastructural and stereological study.
Topics: Adolescent; Child; Copper; Hepatolenticular Degeneration; Humans; Liver; Liver Function Tests; Mitoc | 1976 |
Letter: Pregnancy in penicillamine-treated patients with Wilson's disease.
Topics: Female; Hepatolenticular Degeneration; Humans; Maternal-Fetal Exchange; Penicillamine; Pregnancy; Pr | 1976 |
Letter: Pregnancy in penicillamine-treated patients with Wilson's disease.
Topics: Female; Hepatolenticular Degeneration; Humans; Maternal-Fetal Exchange; Penicillamine; Pregnancy; Pr | 1976 |
[Nephrotic syndrome after treatment with penicillamine in Wilson's disease].
Topics: Adult; Furosemide; Hepatolenticular Degeneration; Humans; Male; Nephrotic Syndrome; Penicillamine; P | 1976 |
[Nephrotic syndrome after treatment with penicillamine in Wilson's disease].
Topics: Adult; Furosemide; Hepatolenticular Degeneration; Humans; Male; Nephrotic Syndrome; Penicillamine; P | 1976 |
[Insufficiency of the exocrine pancreas in Wilson's disease (author's transl)].
Topics: Adult; Ceruloplasmin; Child; Chymotrypsin; Copper; Hepatolenticular Degeneration; Humans; Lysosomes; | 1976 |
[Insufficiency of the exocrine pancreas in Wilson's disease (author's transl)].
Topics: Adult; Ceruloplasmin; Child; Chymotrypsin; Copper; Hepatolenticular Degeneration; Humans; Lysosomes; | 1976 |
Reactions of D-penicillamine with copper in Wilson's disease.
Topics: Binding Sites; Copper; Hepatolenticular Degeneration; Humans; Mathematics; Molecular Conformation; P | 1976 |
Reactions of D-penicillamine with copper in Wilson's disease.
Topics: Binding Sites; Copper; Hepatolenticular Degeneration; Humans; Mathematics; Molecular Conformation; P | 1976 |
[Electrophysiological changes of the brain in Wilson's disease under D-penicillamine treatment].
Topics: Child; Electroencephalography; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1976 |
[Electrophysiological changes of the brain in Wilson's disease under D-penicillamine treatment].
Topics: Child; Electroencephalography; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1976 |
[Wilson's disease treated with penicillamine (author's transl)].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1976 |
[Wilson's disease treated with penicillamine (author's transl)].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1976 |
[Hepatolemticular degeneration (Wison's disease): prolonged treatment with D-penicillamine in 3 cases].
Topics: Adolescent; Adult; Child; Drug Evaluation; Female; Hepatolenticular Degeneration; Humans; Penicillam | 1976 |
[Hepatolemticular degeneration (Wison's disease): prolonged treatment with D-penicillamine in 3 cases].
Topics: Adolescent; Adult; Child; Drug Evaluation; Female; Hepatolenticular Degeneration; Humans; Penicillam | 1976 |
Wilson's disease (hepatolenticular degeneration).
Topics: Adolescent; Adult; Cataract; Ceruloplasmin; Copper; Descemet Membrane; Female; Hepatolenticular Dege | 1976 |
Wilson's disease (hepatolenticular degeneration).
Topics: Adolescent; Adult; Cataract; Ceruloplasmin; Copper; Descemet Membrane; Female; Hepatolenticular Dege | 1976 |
My battle against Wilson's disease.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1976 |
My battle against Wilson's disease.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1976 |
Wilson's disease: a rare genetic disorder.
Topics: Diagnosis, Differential; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1976 |
Wilson's disease: a rare genetic disorder.
Topics: Diagnosis, Differential; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1976 |
D-penicillamine induced Goodpasture's syndrome in Wilson's disease.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Child; Female; Fluorescent Antibody Technique; Glo | 1975 |
D-penicillamine induced Goodpasture's syndrome in Wilson's disease.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Child; Female; Fluorescent Antibody Technique; Glo | 1975 |
Wilson's disease. Clinical and laboratory maniestations in 40 patients.
Topics: Adolescent; Adult; Blood Cell Count; Blood Platelets; Ceruloplasmin; Child; Copper; Cornea; Female; | 1975 |
Wilson's disease. Clinical and laboratory maniestations in 40 patients.
Topics: Adolescent; Adult; Blood Cell Count; Blood Platelets; Ceruloplasmin; Child; Copper; Cornea; Female; | 1975 |
Letter: Uses and usefulness of penicillamine.
Topics: Drug Tolerance; Ethylenediamines; Hepatolenticular Degeneration; Humans; Penicillamine; United State | 1975 |
Letter: Uses and usefulness of penicillamine.
Topics: Drug Tolerance; Ethylenediamines; Hepatolenticular Degeneration; Humans; Penicillamine; United State | 1975 |
Copper toxicity, rats and Wilson's disease.
Topics: Animals; Brain; Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Liver; Penicillamine; | 1975 |
Copper toxicity, rats and Wilson's disease.
Topics: Animals; Brain; Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Liver; Penicillamine; | 1975 |
Myasthenia syndrome during penicillamine treatment.
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Myasthenia Gravis; Penicillamine; Time Fact | 1975 |
Myasthenia syndrome during penicillamine treatment.
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Myasthenia Gravis; Penicillamine; Time Fact | 1975 |
Lipolysosomes in human hepatocytes. Ultrastructural and cytochemical studies of patients with Wilson's disease.
Topics: Acid Phosphatase; Adolescent; Adult; Biopsy, Needle; Child; Child, Preschool; Female; Hepatolenticul | 1975 |
Lipolysosomes in human hepatocytes. Ultrastructural and cytochemical studies of patients with Wilson's disease.
Topics: Acid Phosphatase; Adolescent; Adult; Biopsy, Needle; Child; Child, Preschool; Female; Hepatolenticul | 1975 |
[On the therapeutic combination of S-adenosylmethionine with D-penicillamine in Wilson's disease].
Topics: Adolescent; Adult; Blood Proteins; Child; Drug Therapy, Combination; Female; Hepatolenticular Degene | 1975 |
[On the therapeutic combination of S-adenosylmethionine with D-penicillamine in Wilson's disease].
Topics: Adolescent; Adult; Blood Proteins; Child; Drug Therapy, Combination; Female; Hepatolenticular Degene | 1975 |
Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case.
Topics: Ceruloplasmin; Copper; Feces; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penicillamin | 1975 |
Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case.
Topics: Ceruloplasmin; Copper; Feces; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penicillamin | 1975 |
Penicillamine in prevention of symptomatic Wilson's disease: 8 year follow up in two sibs.
Topics: Adolescent; Child; Child, Preschool; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Male; | 1975 |
Penicillamine in prevention of symptomatic Wilson's disease: 8 year follow up in two sibs.
Topics: Adolescent; Child; Child, Preschool; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Male; | 1975 |
Juvenile Wilson disease: histologic and functional studies during penicillamine therapy.
Topics: Adolescent; Adult; Cell Nucleus; Ceruloplasmin; Connective Tissue; Copper; Fatty Liver; Female; Hepa | 1975 |
Juvenile Wilson disease: histologic and functional studies during penicillamine therapy.
Topics: Adolescent; Adult; Cell Nucleus; Ceruloplasmin; Connective Tissue; Copper; Fatty Liver; Female; Hepa | 1975 |
Pregnancy in penicillamine-treated patients with Wilson's disease.
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Infant, Newborn; Male; Penicillami | 1975 |
Pregnancy in penicillamine-treated patients with Wilson's disease.
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Infant, Newborn; Male; Penicillami | 1975 |
[Pigment cirrhosis of the liver. I. Wilson's disease--hepatolenticular degeneration].
Topics: Copper; Feces; Hepatolenticular Degeneration; Heterozygote; Homozygote; Humans; Liver; Microscopy, E | 1975 |
[Pigment cirrhosis of the liver. I. Wilson's disease--hepatolenticular degeneration].
Topics: Copper; Feces; Hepatolenticular Degeneration; Heterozygote; Homozygote; Humans; Liver; Microscopy, E | 1975 |
The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
Topics: Adolescent; Adult; Ceruloplasmin; Copper; Female; Follow-Up Studies; Hepatolenticular Degeneration; | 1975 |
The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
Topics: Adolescent; Adult; Ceruloplasmin; Copper; Female; Follow-Up Studies; Hepatolenticular Degeneration; | 1975 |
Letter: Treatment of Wilson's disease.
Topics: Copper; Hepatolenticular Degeneration; Humans; Metronidazole; Penicillamine | 1975 |
Letter: Treatment of Wilson's disease.
Topics: Copper; Hepatolenticular Degeneration; Humans; Metronidazole; Penicillamine | 1975 |
[Hepato-cerebral dystrophy in children].
Topics: Adolescent; Child; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Unithiol | 1975 |
[Hepato-cerebral dystrophy in children].
Topics: Adolescent; Child; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Unithiol | 1975 |
[Recent findings in the therapy of Wilson's disease].
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1975 |
[Recent findings in the therapy of Wilson's disease].
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1975 |
[The portal circulation in liver parenchymal lesions, due to Wilson's disease and treated for a long time with D-penicillamine].
Topics: Esophageal and Gastric Varices; Hepatolenticular Degeneration; Humans; Liver; Liver Circulation; Liv | 1975 |
[The portal circulation in liver parenchymal lesions, due to Wilson's disease and treated for a long time with D-penicillamine].
Topics: Esophageal and Gastric Varices; Hepatolenticular Degeneration; Humans; Liver; Liver Circulation; Liv | 1975 |
[Results of electroencephalographic and familial studies in Wilson's disease].
Topics: Adolescent; Adult; Alpha Rhythm; Child; Electroencephalography; Female; Hepatolenticular Degeneratio | 1975 |
[Results of electroencephalographic and familial studies in Wilson's disease].
Topics: Adolescent; Adult; Alpha Rhythm; Child; Electroencephalography; Female; Hepatolenticular Degeneratio | 1975 |
Letter: The pregnant woman with Wilson's disease.
Topics: Female; Fetus; Hepatolenticular Degeneration; Humans; Maternal-Fetal Exchange; Penicillamine; Pregna | 1976 |
Letter: The pregnant woman with Wilson's disease.
Topics: Female; Fetus; Hepatolenticular Degeneration; Humans; Maternal-Fetal Exchange; Penicillamine; Pregna | 1976 |
Platelet function and coagulation in patients with Wilson disease.
Topics: Adolescent; Adult; Blood Coagulation; Blood Platelets; Child; Female; Hemorrhage; Hepatolenticular D | 1976 |
Platelet function and coagulation in patients with Wilson disease.
Topics: Adolescent; Adult; Blood Coagulation; Blood Platelets; Child; Female; Hemorrhage; Hepatolenticular D | 1976 |
Studies on D-penicillamine metabolism in cystinuria and rheumatoid arthritis: isolation of S-methyl-D-penicillamine.
Topics: Arthritis, Rheumatoid; Cystinuria; Feces; Hepatolenticular Degeneration; Humans; Oxidation-Reduction | 1976 |
Studies on D-penicillamine metabolism in cystinuria and rheumatoid arthritis: isolation of S-methyl-D-penicillamine.
Topics: Arthritis, Rheumatoid; Cystinuria; Feces; Hepatolenticular Degeneration; Humans; Oxidation-Reduction | 1976 |
[Wilson's disease. A case history].
Topics: Adolescent; Affective Symptoms; Age Factors; Ceruloplasmin; Child Behavior Disorders; Copper; Diet T | 1976 |
[Wilson's disease. A case history].
Topics: Adolescent; Affective Symptoms; Age Factors; Ceruloplasmin; Child Behavior Disorders; Copper; Diet T | 1976 |
Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Chelating Agents; Copper; Fema | 1992 |
Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Chelating Agents; Copper; Fema | 1992 |
[Zinc in the treatment of hepatolenticular degeneration: report of 3 cases].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penicillamine; Sulfates; Zi | 1992 |
[Zinc in the treatment of hepatolenticular degeneration: report of 3 cases].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penicillamine; Sulfates; Zi | 1992 |
Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson's disease: report of a case.
Topics: Adult; Brain; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Tomography, X-Ray Computed | 1992 |
Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson's disease: report of a case.
Topics: Adult; Brain; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Tomography, X-Ray Computed | 1992 |
Wilson's disease: initial worsening of neurologic syndrome with penicillamine therapy.
Topics: Child; Female; Hepatolenticular Degeneration; Humans; Nervous System Diseases; Penicillamine; Syndro | 1992 |
Wilson's disease: initial worsening of neurologic syndrome with penicillamine therapy.
Topics: Child; Female; Hepatolenticular Degeneration; Humans; Nervous System Diseases; Penicillamine; Syndro | 1992 |
[Diagnostic difficulties and therapeutic success in Wilson-Konovalov disease].
Topics: Adolescent; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Female; Hepatolenticular Deg | 1992 |
[Diagnostic difficulties and therapeutic success in Wilson-Konovalov disease].
Topics: Adolescent; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Female; Hepatolenticular Deg | 1992 |
Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease.
Topics: Adolescent; Ceruloplasmin; Child; Child, Preschool; Copper; Female; Hepatolenticular Degeneration; H | 1992 |
Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease.
Topics: Adolescent; Ceruloplasmin; Child; Child, Preschool; Copper; Female; Hepatolenticular Degeneration; H | 1992 |
Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease.
Topics: Adult; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hepatol | 1992 |
Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease.
Topics: Adult; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hepatol | 1992 |
Treatment of Wilson's disease: penicillamine or triene?
Topics: Copper; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Penicillamine; Trientine; | 1992 |
Treatment of Wilson's disease: penicillamine or triene?
Topics: Copper; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Penicillamine; Trientine; | 1992 |
[Wilson's disease. A retrospective analysis of 12 cases].
Topics: Age Factors; Ceruloplasmin; Copper; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Penici | 1992 |
[Wilson's disease. A retrospective analysis of 12 cases].
Topics: Age Factors; Ceruloplasmin; Copper; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Penici | 1992 |
The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy.
Topics: Animals; Arthritis; Copper; Cytosol; Hepatolenticular Degeneration; Humans; Injections, Intramuscula | 1992 |
The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy.
Topics: Animals; Arthritis; Copper; Cytosol; Hepatolenticular Degeneration; Humans; Injections, Intramuscula | 1992 |
Diagnosing Wilson disease.
Topics: Drug Monitoring; Hepatolenticular Degeneration; Humans; Penicillamine | 1992 |
Diagnosing Wilson disease.
Topics: Drug Monitoring; Hepatolenticular Degeneration; Humans; Penicillamine | 1992 |
Screening for Wilson's disease in the investigation of hematuria.
Topics: Ceruloplasmin; Child; Child, Preschool; Hematuria; Hepatolenticular Degeneration; Humans; Male; Peni | 1992 |
Screening for Wilson's disease in the investigation of hematuria.
Topics: Ceruloplasmin; Child; Child, Preschool; Hematuria; Hepatolenticular Degeneration; Humans; Male; Peni | 1992 |
Penicillamine hepatotoxicity in the treatment of Wilson's disease.
Topics: Child; Child, Preschool; Copper; Hepatolenticular Degeneration; Humans; Liver; Male; Penicillamine; | 1992 |
Penicillamine hepatotoxicity in the treatment of Wilson's disease.
Topics: Child; Child, Preschool; Copper; Hepatolenticular Degeneration; Humans; Liver; Male; Penicillamine; | 1992 |
Abnormal conduction in corticospinal pathways in Wilson's disease: investigation of nine cases with magnetic brain stimulation.
Topics: Adult; Electromagnetic Fields; Electromyography; Follow-Up Studies; Hepatolenticular Degeneration; H | 1991 |
Abnormal conduction in corticospinal pathways in Wilson's disease: investigation of nine cases with magnetic brain stimulation.
Topics: Adult; Electromagnetic Fields; Electromyography; Follow-Up Studies; Hepatolenticular Degeneration; H | 1991 |
Successful pregnancy after D-penicillamine therapy in a patient with Wilson's disease.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Infant, Newborn; Penicillamine; Pregnancy | 1991 |
Successful pregnancy after D-penicillamine therapy in a patient with Wilson's disease.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Infant, Newborn; Penicillamine; Pregnancy | 1991 |
Wilson disease--penicillamine therapy and late presentation.
Topics: Drug Monitoring; Hepatolenticular Degeneration; Humans; Penicillamine | 1992 |
Wilson disease--penicillamine therapy and late presentation.
Topics: Drug Monitoring; Hepatolenticular Degeneration; Humans; Penicillamine | 1992 |
Wilson's disease in Scotland.
Topics: Adolescent; Child; Female; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Male; Penicilla | 1991 |
Wilson's disease in Scotland.
Topics: Adolescent; Child; Female; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Male; Penicilla | 1991 |
Case update--progressive skin laxity secondary to penicillamine treatment.
Topics: Female; Hepatolenticular Degeneration; Humans; Middle Aged; Penicillamine; Skin Aging | 1991 |
Case update--progressive skin laxity secondary to penicillamine treatment.
Topics: Female; Hepatolenticular Degeneration; Humans; Middle Aged; Penicillamine; Skin Aging | 1991 |
[Hepatolenticular degeneration: evaluation of neurological course in 76 treated cases].
Topics: Female; Food, Fortified; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Prognosis; Retr | 1991 |
[Hepatolenticular degeneration: evaluation of neurological course in 76 treated cases].
Topics: Female; Food, Fortified; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Prognosis; Retr | 1991 |
Pregnancy and Wilson's disease.
Topics: Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Pregnancy Complications; Su | 1991 |
Pregnancy and Wilson's disease.
Topics: Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Pregnancy Complications; Su | 1991 |
Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
Topics: Adult; Copper; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatolenticular Deg | 1991 |
Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
Topics: Adult; Copper; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatolenticular Deg | 1991 |
Triethylene-tetramine (trien) therapy for Wilson's disease.
Topics: Adolescent; Adult; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Pe | 1991 |
Triethylene-tetramine (trien) therapy for Wilson's disease.
Topics: Adolescent; Adult; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Pe | 1991 |
Wilson disease: clinical presentation, treatment, and survival.
Topics: Adolescent; Female; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Liver Transplantation; | 1991 |
Wilson disease: clinical presentation, treatment, and survival.
Topics: Adolescent; Female; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Liver Transplantation; | 1991 |
Penicillamine treatment of Wilson's disease and optic neuropathy.
Topics: Adult; Color Perception; Dose-Response Relationship, Drug; Female; Hepatolenticular Degeneration; Hu | 1991 |
Penicillamine treatment of Wilson's disease and optic neuropathy.
Topics: Adult; Color Perception; Dose-Response Relationship, Drug; Female; Hepatolenticular Degeneration; Hu | 1991 |
Wilson's disease: normalisation of cortically evoked motor responses with treatment.
Topics: Adolescent; Electromyography; Evoked Potentials, Auditory; Evoked Potentials, Somatosensory; Globus | 1991 |
Wilson's disease: normalisation of cortically evoked motor responses with treatment.
Topics: Adolescent; Electromyography; Evoked Potentials, Auditory; Evoked Potentials, Somatosensory; Globus | 1991 |
[Abnormal hepatic copper accumulation and its significance in LEC rats developing spontaneous hepatitis and hepatoma].
Topics: Alanine Transaminase; Animals; Ceruloplasmin; Copper; Disease Models, Animal; Female; Hepatitis, Ani | 1991 |
[Abnormal hepatic copper accumulation and its significance in LEC rats developing spontaneous hepatitis and hepatoma].
Topics: Alanine Transaminase; Animals; Ceruloplasmin; Copper; Disease Models, Animal; Female; Hepatitis, Ani | 1991 |
Excellent prognosis in Wilsonian chronic active hepatitis: new data or an article of faith?
Topics: Hepatitis, Chronic; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Penicillamine; Prognosis | 1991 |
Excellent prognosis in Wilsonian chronic active hepatitis: new data or an article of faith?
Topics: Hepatitis, Chronic; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Penicillamine; Prognosis | 1991 |
Evoked potentials in assessment and follow-up of patients with Wilson's disease.
Topics: Administration, Oral; Adult; Brain Chemistry; Child; Copper; Evaluation Studies as Topic; Evoked Pot | 1990 |
Evoked potentials in assessment and follow-up of patients with Wilson's disease.
Topics: Administration, Oral; Adult; Brain Chemistry; Child; Copper; Evaluation Studies as Topic; Evoked Pot | 1990 |
Prognosis of Wilsonian chronic active hepatitis.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Child; Copper; Fema | 1991 |
Prognosis of Wilsonian chronic active hepatitis.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Child; Copper; Fema | 1991 |
[Early diagnosis is crucial for the prognosis of Wilson's disease].
Topics: Adolescent; Adult; Ceruloplasmin; Female; Hepatolenticular Degeneration; Humans; Liver Transplantati | 1991 |
[Early diagnosis is crucial for the prognosis of Wilson's disease].
Topics: Adolescent; Adult; Ceruloplasmin; Female; Hepatolenticular Degeneration; Humans; Liver Transplantati | 1991 |
Fulminant hepatic failure during perinatal period in a pregnant woman with Wilson's disease.
Topics: Adult; Anemia, Hemolytic; Female; Hepatolenticular Degeneration; Humans; Liver; Liver Diseases; Peni | 1991 |
Fulminant hepatic failure during perinatal period in a pregnant woman with Wilson's disease.
Topics: Adult; Anemia, Hemolytic; Female; Hepatolenticular Degeneration; Humans; Liver; Liver Diseases; Peni | 1991 |
A comparison of the effects of penicillamine, trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson's disease therapy.
Topics: Animals; Copper; Cytosol; Hepatolenticular Degeneration; Liver; Male; Metallothionein; Molybdenum; P | 1991 |
A comparison of the effects of penicillamine, trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson's disease therapy.
Topics: Animals; Copper; Cytosol; Hepatolenticular Degeneration; Liver; Male; Metallothionein; Molybdenum; P | 1991 |
Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine.
Topics: Adult; Brain Diseases; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Sulfate | 1991 |
Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine.
Topics: Adult; Brain Diseases; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Sulfate | 1991 |
[Successful treatment of a patient with hepatolenticular degeneration with the terminal stage of liver disease].
Topics: Adult; Combined Modality Therapy; Critical Care; Hepatic Encephalopathy; Hepatolenticular Degenerati | 1991 |
[Successful treatment of a patient with hepatolenticular degeneration with the terminal stage of liver disease].
Topics: Adult; Combined Modality Therapy; Critical Care; Hepatic Encephalopathy; Hepatolenticular Degenerati | 1991 |
[Clinical analysis of 418 patients with Wilson's disease in traditional Chinese medicine and Western medicine therapy].
Topics: Adolescent; Adult; Child; Child, Preschool; Combined Modality Therapy; Drugs, Chinese Herbal; Female | 1990 |
[Clinical analysis of 418 patients with Wilson's disease in traditional Chinese medicine and Western medicine therapy].
Topics: Adolescent; Adult; Child; Child, Preschool; Combined Modality Therapy; Drugs, Chinese Herbal; Female | 1990 |
Pregnancy in a patient with treated Wilson's disease: a case report.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Pregnancy Complicati | 1990 |
Pregnancy in a patient with treated Wilson's disease: a case report.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Pregnancy Complicati | 1990 |
Involvement of corticospinal tract in Wilson's disease. A study of three cases with transcranial stimulation.
Topics: Adolescent; Adult; Electric Stimulation; Female; Hepatolenticular Degeneration; Humans; Male; Muscle | 1990 |
Involvement of corticospinal tract in Wilson's disease. A study of three cases with transcranial stimulation.
Topics: Adolescent; Adult; Electric Stimulation; Female; Hepatolenticular Degeneration; Humans; Male; Muscle | 1990 |
Low-dose zinc therapy for maintenance treatment of Wilson's disease.
Topics: Administration, Oral; Adult; Alanine Transaminase; Aspartate Aminotransferases; Copper; Hepatolentic | 1990 |
Low-dose zinc therapy for maintenance treatment of Wilson's disease.
Topics: Administration, Oral; Adult; Alanine Transaminase; Aspartate Aminotransferases; Copper; Hepatolentic | 1990 |
[Wilson's disease--critical deterioration under high-dose parenteral penicillamine therapy].
Topics: Adult; Chronic Disease; Copper; Hepatolenticular Degeneration; Humans; Infusions, Parenteral; Male; | 1990 |
[Wilson's disease--critical deterioration under high-dose parenteral penicillamine therapy].
Topics: Adult; Chronic Disease; Copper; Hepatolenticular Degeneration; Humans; Infusions, Parenteral; Male; | 1990 |
Macromastia in a woman treated with penicillamine and oral contraceptives. A case report.
Topics: Adult; Breast; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; E | 1990 |
Macromastia in a woman treated with penicillamine and oral contraceptives. A case report.
Topics: Adult; Breast; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; E | 1990 |
Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine).
Topics: Administration, Oral; Adolescent; Adult; Drug Evaluation; Ethylenediamines; Female; Hepatolenticular | 1990 |
Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine).
Topics: Administration, Oral; Adolescent; Adult; Drug Evaluation; Ethylenediamines; Female; Hepatolenticular | 1990 |
Wilson's disease. Development of neurological disease after beginning penicillamine therapy.
Topics: Adult; Behavior; Brain; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Ner | 1990 |
Wilson's disease. Development of neurological disease after beginning penicillamine therapy.
Topics: Adult; Behavior; Brain; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Ner | 1990 |
[Therapeutic approaches to Wilson's disease].
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 1990 |
[Therapeutic approaches to Wilson's disease].
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 1990 |
Zinc therapy in Wilson's disease: observations in five patients.
Topics: Adolescent; Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Liver Function Test | 1990 |
Zinc therapy in Wilson's disease: observations in five patients.
Topics: Adolescent; Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Liver Function Test | 1990 |
Nuclear magnetic resonance brain study in a case of Wilson disease.
Topics: Adolescent; Brain; Hepatolenticular Degeneration; Humans; Magnetic Resonance Spectroscopy; Male; Pen | 1989 |
Nuclear magnetic resonance brain study in a case of Wilson disease.
Topics: Adolescent; Brain; Hepatolenticular Degeneration; Humans; Magnetic Resonance Spectroscopy; Male; Pen | 1989 |
Sulphasalazine in rheumatoid arthritis: haematological problems.
Topics: Arthritis, Rheumatoid; Hepatolenticular Degeneration; Humans; Penicillamine; Sulfasalazine | 1989 |
Sulphasalazine in rheumatoid arthritis: haematological problems.
Topics: Arthritis, Rheumatoid; Hepatolenticular Degeneration; Humans; Penicillamine; Sulfasalazine | 1989 |
Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients.
Topics: Adolescent; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Liver Function Tests; Male | 1989 |
Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients.
Topics: Adolescent; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Liver Function Tests; Male | 1989 |
Long-term care and management of Wilson's disease in the GDR.
Topics: Adaptation, Psychological; Copper; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Penicil | 1989 |
Long-term care and management of Wilson's disease in the GDR.
Topics: Adaptation, Psychological; Copper; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Penicil | 1989 |
Penicillamine dermatopathy with lymphangiectases. A clinical, immunohistologic, and ultrastructural study.
Topics: Adult; Biopsy; Collagen; Connective Tissue; Elastin; Hepatolenticular Degeneration; Humans; Immunoen | 1989 |
Penicillamine dermatopathy with lymphangiectases. A clinical, immunohistologic, and ultrastructural study.
Topics: Adult; Biopsy; Collagen; Connective Tissue; Elastin; Hepatolenticular Degeneration; Humans; Immunoen | 1989 |
[Indications for liver transplantation in Wilson's disease with a fulminant course].
Topics: Adult; Alkaline Phosphatase; Bilirubin; Cholinesterases; Female; Hepatolenticular Degeneration; Huma | 1989 |
[Indications for liver transplantation in Wilson's disease with a fulminant course].
Topics: Adult; Alkaline Phosphatase; Bilirubin; Cholinesterases; Female; Hepatolenticular Degeneration; Huma | 1989 |
Dermal alterations in patients with Wilson's disease treated with D-penicillamine.
Topics: Adolescent; Adult; Aged; Biopsy; Collagen; Elastin; Female; Glycosaminoglycans; Hepatolenticular Deg | 1989 |
Dermal alterations in patients with Wilson's disease treated with D-penicillamine.
Topics: Adolescent; Adult; Aged; Biopsy; Collagen; Elastin; Female; Glycosaminoglycans; Hepatolenticular Deg | 1989 |
Deterioration of Wilson's disease following the start of penicillamine therapy.
Topics: Copper; Hepatolenticular Degeneration; Humans; Nervous System; Penicillamine; Zinc | 1989 |
Deterioration of Wilson's disease following the start of penicillamine therapy.
Topics: Copper; Hepatolenticular Degeneration; Humans; Nervous System; Penicillamine; Zinc | 1989 |
[A case of Wilson's disease who developed status epilepticus during D-penicillamine therapy].
Topics: Adolescent; Cerebral Cortex; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Status Ep | 1989 |
[A case of Wilson's disease who developed status epilepticus during D-penicillamine therapy].
Topics: Adolescent; Cerebral Cortex; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Status Ep | 1989 |
[A case of Wilson's disease recovering from severe brain damage--special reference to trientine and D-penicillamine therapy].
Topics: Adolescent; Ethylenediamines; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Trientin | 1989 |
[A case of Wilson's disease recovering from severe brain damage--special reference to trientine and D-penicillamine therapy].
Topics: Adolescent; Ethylenediamines; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Trientin | 1989 |
Is Wilson's disease a dementing condition?
Topics: Dementia; Hepatolenticular Degeneration; Humans; Neuropsychological Tests; Penicillamine; Wechsler S | 1989 |
Is Wilson's disease a dementing condition?
Topics: Dementia; Hepatolenticular Degeneration; Humans; Neuropsychological Tests; Penicillamine; Wechsler S | 1989 |
[Characteristics of visceral manifestations of Wilson-Konovalov disease].
Topics: Adult; Diagnosis, Differential; Female; Hepatitis; Hepatolenticular Degeneration; Humans; Jaundice; | 1989 |
[Characteristics of visceral manifestations of Wilson-Konovalov disease].
Topics: Adult; Diagnosis, Differential; Female; Hepatitis; Hepatolenticular Degeneration; Humans; Jaundice; | 1989 |
Dangers of non-compliance in Wilson's disease.
Topics: Acute Disease; Adolescent; Ascites; Brain Chemistry; Copper; Female; Follow-Up Studies; Hepatolentic | 1986 |
Dangers of non-compliance in Wilson's disease.
Topics: Acute Disease; Adolescent; Ascites; Brain Chemistry; Copper; Female; Follow-Up Studies; Hepatolentic | 1986 |
Compliance and Wilson's disease.
Topics: Adolescent; Attitude of Health Personnel; Dementia; Female; Hepatolenticular Degeneration; Humans; P | 1986 |
Compliance and Wilson's disease.
Topics: Adolescent; Attitude of Health Personnel; Dementia; Female; Hepatolenticular Degeneration; Humans; P | 1986 |
Compliance in Wilson's disease and in copper toxicosis of Bedlington terriers.
Topics: Animals; Copper; Disease Models, Animal; Dogs; Hepatolenticular Degeneration; Humans; Patient Compli | 1986 |
Compliance in Wilson's disease and in copper toxicosis of Bedlington terriers.
Topics: Animals; Copper; Disease Models, Animal; Dogs; Hepatolenticular Degeneration; Humans; Patient Compli | 1986 |
Penicillamine may detoxify copper in Wilson's disease.
Topics: Copper; Hepatolenticular Degeneration; Humans; Inactivation, Metabolic; Penicillamine | 1987 |
Penicillamine may detoxify copper in Wilson's disease.
Topics: Copper; Hepatolenticular Degeneration; Humans; Inactivation, Metabolic; Penicillamine | 1987 |
Diagnosis and treatment of presymptomatic Wilson's disease.
Topics: Adolescent; Adult; Chelating Agents; Child; Copper; Female; Hepatolenticular Degeneration; Humans; L | 1988 |
Diagnosis and treatment of presymptomatic Wilson's disease.
Topics: Adolescent; Adult; Chelating Agents; Child; Copper; Female; Hepatolenticular Degeneration; Humans; L | 1988 |
[An unusual cutaneous reaction pattern as a side effect of penicillamine: elastosis perforans serpiginosa].
Topics: Adult; Cystinuria; Drug Eruptions; Elastic Tissue; Female; Hepatolenticular Degeneration; Humans; Ma | 1988 |
[An unusual cutaneous reaction pattern as a side effect of penicillamine: elastosis perforans serpiginosa].
Topics: Adult; Cystinuria; Drug Eruptions; Elastic Tissue; Female; Hepatolenticular Degeneration; Humans; Ma | 1988 |
Lid-opening apraxia in Wilson's disease.
Topics: Adult; Apraxias; Atrophy; Brain; Cerebellum; Eyelid Diseases; Hepatolenticular Degeneration; Humans; | 1988 |
Lid-opening apraxia in Wilson's disease.
Topics: Adult; Apraxias; Atrophy; Brain; Cerebellum; Eyelid Diseases; Hepatolenticular Degeneration; Humans; | 1988 |
[Vitamin-resistant rickets preceding Wilson's disease].
Topics: Child; Ergocalciferols; Female; Hepatolenticular Degeneration; Humans; Hypophosphatemia, Familial; P | 1986 |
[Vitamin-resistant rickets preceding Wilson's disease].
Topics: Child; Ergocalciferols; Female; Hepatolenticular Degeneration; Humans; Hypophosphatemia, Familial; P | 1986 |
Hemolytic anemia with jaundice and ascites.
Topics: Adult; Anemia, Hemolytic; Ascites; Copper; Diagnosis, Differential; Female; Hepatolenticular Degener | 1987 |
Hemolytic anemia with jaundice and ascites.
Topics: Adult; Anemia, Hemolytic; Ascites; Copper; Diagnosis, Differential; Female; Hepatolenticular Degener | 1987 |
[The topography of P300 in neuropsychiatric pharmacotherapy. III. Cognitive P300 fields in an organic psychosyndrome (Wilson's disease) before and during treatment with D-penicillamine].
Topics: Adult; Brain; Cognition; Electroencephalography; Hepatolenticular Degeneration; Humans; Male; Penici | 1988 |
[The topography of P300 in neuropsychiatric pharmacotherapy. III. Cognitive P300 fields in an organic psychosyndrome (Wilson's disease) before and during treatment with D-penicillamine].
Topics: Adult; Brain; Cognition; Electroencephalography; Hepatolenticular Degeneration; Humans; Male; Penici | 1988 |
[Current experiences and problems with long-term management of patients with Wilson's disease in East Germany].
Topics: Adolescent; Adult; Combined Modality Therapy; Diagnosis, Differential; Follow-Up Studies; Germany, E | 1988 |
[Current experiences and problems with long-term management of patients with Wilson's disease in East Germany].
Topics: Adolescent; Adult; Combined Modality Therapy; Diagnosis, Differential; Follow-Up Studies; Germany, E | 1988 |
[Hepatocerebral dystrophy in pregnancy].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Pregnancy Complicati | 1988 |
[Hepatocerebral dystrophy in pregnancy].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Pregnancy Complicati | 1988 |
[Fibrinolytic activity in patients with hepatolenticular degeneration: the effect of penicillamine].
Topics: Adolescent; Adult; Child; Female; Fibrinolysis; Hepatolenticular Degeneration; Humans; Male; Penicil | 1988 |
[Fibrinolytic activity in patients with hepatolenticular degeneration: the effect of penicillamine].
Topics: Adolescent; Adult; Child; Female; Fibrinolysis; Hepatolenticular Degeneration; Humans; Male; Penicil | 1988 |
Effect of D-penicillamine treatment on brain metabolism in Wilson's disease: a case study.
Topics: Adult; Blood Glucose; Brain; Brain Diseases, Metabolic; Female; Hepatolenticular Degeneration; Human | 1988 |
Effect of D-penicillamine treatment on brain metabolism in Wilson's disease: a case study.
Topics: Adult; Blood Glucose; Brain; Brain Diseases, Metabolic; Female; Hepatolenticular Degeneration; Human | 1988 |
The efficacy of oral zinc therapy as an alternative to penicillamine for Wilson's disease.
Topics: Administration, Oral; Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 1988 |
The efficacy of oral zinc therapy as an alternative to penicillamine for Wilson's disease.
Topics: Administration, Oral; Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 1988 |
Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 1988 |
Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 1988 |
Zinc therapy as the initial treatment for Wilson's disease.
Topics: Administration, Oral; Drug Administration Schedule; Hepatolenticular Degeneration; Humans; Penicilla | 1988 |
Zinc therapy as the initial treatment for Wilson's disease.
Topics: Administration, Oral; Drug Administration Schedule; Hepatolenticular Degeneration; Humans; Penicilla | 1988 |
Wilson's disease in The Merck Manual: corrections.
Topics: Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Zinc | 1988 |
Wilson's disease in The Merck Manual: corrections.
Topics: Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pregnancy; Zinc | 1988 |
[Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
Topics: Copper Radioisotopes; Ethylenediamines; Hepatolenticular Degeneration; Humans; Liver; Penicillamine; | 1988 |
[Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
Topics: Copper Radioisotopes; Ethylenediamines; Hepatolenticular Degeneration; Humans; Liver; Penicillamine; | 1988 |
Successful long term oral zinc in florid Wilson's disease: a case report.
Topics: Administration, Oral; Adolescent; Copper; Hepatolenticular Degeneration; Humans; India; Male; Penici | 1988 |
Successful long term oral zinc in florid Wilson's disease: a case report.
Topics: Administration, Oral; Adolescent; Copper; Hepatolenticular Degeneration; Humans; India; Male; Penici | 1988 |
[New possibilities in the treatment of Wilson-Konovalov disease (hepatolenticular degeneration)].
Topics: Adolescent; Adult; Drug Evaluation; Drug Tolerance; Female; Hepatolenticular Degeneration; Humans; P | 1987 |
[New possibilities in the treatment of Wilson-Konovalov disease (hepatolenticular degeneration)].
Topics: Adolescent; Adult; Drug Evaluation; Drug Tolerance; Female; Hepatolenticular Degeneration; Humans; P | 1987 |
Wilson's disease: varied manifestations and consequences of non-compliance with treatment.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Male; Patient Compliance; Penicillamine | 1987 |
Wilson's disease: varied manifestations and consequences of non-compliance with treatment.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Male; Patient Compliance; Penicillamine | 1987 |
[The detection of antibodies against D-penicillamine. 3. Detection of antibodies against D-penicillamine in the serum of patients with Wilson's disease treated with D-penicillamine--preliminary results].
Topics: Antibodies; Fluorescent Antibody Technique; Hepatolenticular Degeneration; Humans; Immunoglobulin G; | 1986 |
[The detection of antibodies against D-penicillamine. 3. Detection of antibodies against D-penicillamine in the serum of patients with Wilson's disease treated with D-penicillamine--preliminary results].
Topics: Antibodies; Fluorescent Antibody Technique; Hepatolenticular Degeneration; Humans; Immunoglobulin G; | 1986 |
Neurological abnormalities in Wilson's disease are reversible.
Topics: Adolescent; Child; Child Behavior Disorders; Ethylenediamines; Female; Hepatolenticular Degeneration | 1987 |
Neurological abnormalities in Wilson's disease are reversible.
Topics: Adolescent; Child; Child Behavior Disorders; Ethylenediamines; Female; Hepatolenticular Degeneration | 1987 |
The treatment of Wilson's disease with zinc. IV. Efficacy monitoring using urine and plasma copper.
Topics: Ceruloplasmin; Copper; Follow-Up Studies; Hepatolenticular Degeneration; In Vitro Techniques; Penici | 1987 |
The treatment of Wilson's disease with zinc. IV. Efficacy monitoring using urine and plasma copper.
Topics: Ceruloplasmin; Copper; Follow-Up Studies; Hepatolenticular Degeneration; In Vitro Techniques; Penici | 1987 |
A copper-sulfur complex in the liver of a patient with Wilson's disease.
Topics: Adolescent; Biopsy; Calcium; Copper; Electron Probe Microanalysis; Hepatolenticular Degeneration; Hu | 1986 |
A copper-sulfur complex in the liver of a patient with Wilson's disease.
Topics: Adolescent; Biopsy; Calcium; Copper; Electron Probe Microanalysis; Hepatolenticular Degeneration; Hu | 1986 |
Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy.
Topics: Adolescent; Adult; Basal Ganglia; Female; Frontal Lobe; Hepatolenticular Degeneration; Humans; Magne | 1987 |
Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy.
Topics: Adolescent; Adult; Basal Ganglia; Female; Frontal Lobe; Hepatolenticular Degeneration; Humans; Magne | 1987 |
[Treatment of Wilson's disease].
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Sulfates; Zinc; Zinc Sulfate | 1987 |
[Treatment of Wilson's disease].
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Sulfates; Zinc; Zinc Sulfate | 1987 |
[Systemic lupus erythematosus induced by d-penicillamine in Wilson's disease: apropos of a case].
Topics: Adult; Hepatolenticular Degeneration; Humans; Lupus Erythematosus, Systemic; Male; Penicillamine | 1987 |
[Systemic lupus erythematosus induced by d-penicillamine in Wilson's disease: apropos of a case].
Topics: Adult; Hepatolenticular Degeneration; Humans; Lupus Erythematosus, Systemic; Male; Penicillamine | 1987 |
Wilson's disease, a reversible dementia: case report.
Topics: Adult; Dementia; Female; Hepatolenticular Degeneration; Humans; Neuropsychological Tests; Penicillam | 1987 |
Wilson's disease, a reversible dementia: case report.
Topics: Adult; Dementia; Female; Hepatolenticular Degeneration; Humans; Neuropsychological Tests; Penicillam | 1987 |
The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease.
Topics: Ethylenediamines; Female; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Patient Complian | 1987 |
The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease.
Topics: Ethylenediamines; Female; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Patient Complian | 1987 |
CSF copper concentration: a new parameter for diagnosis and monitoring therapy of Wilson's disease with cerebral manifestation.
Topics: Adult; Brain Diseases, Metabolic; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Middl | 1987 |
CSF copper concentration: a new parameter for diagnosis and monitoring therapy of Wilson's disease with cerebral manifestation.
Topics: Adult; Brain Diseases, Metabolic; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Middl | 1987 |
Factors modifying the prognosis of Wilson's disease in childhood.
Topics: Adolescent; Child; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Prognosis | 1987 |
Factors modifying the prognosis of Wilson's disease in childhood.
Topics: Adolescent; Child; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Prognosis | 1987 |
D-penicillamine induced dermopathy in Wilson's disease.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Skin Diseases | 1987 |
D-penicillamine induced dermopathy in Wilson's disease.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Skin Diseases | 1987 |
[Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
Topics: Adult; Drug Hypersensitivity; Ethylenediamines; Hepatolenticular Degeneration; Humans; Male; Penicil | 1987 |
[Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
Topics: Adult; Drug Hypersensitivity; Ethylenediamines; Hepatolenticular Degeneration; Humans; Male; Penicil | 1987 |
[Westphal-Strumpell disease. Description of a clinical case].
Topics: Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1987 |
[Westphal-Strumpell disease. Description of a clinical case].
Topics: Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1987 |
Pregnancy and penicillamine treatment in a patient with Wilson's disease.
Topics: Adult; Ceruloplasmin; Female; Hepatolenticular Degeneration; Humans; Infant, Newborn; Male; Penicill | 1986 |
Pregnancy and penicillamine treatment in a patient with Wilson's disease.
Topics: Adult; Ceruloplasmin; Female; Hepatolenticular Degeneration; Humans; Infant, Newborn; Male; Penicill | 1986 |
[Triethylene tetramine in Wilson's disease].
Topics: Adult; Ethylenediamines; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Trientine | 1986 |
[Triethylene tetramine in Wilson's disease].
Topics: Adult; Ethylenediamines; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Trientine | 1986 |
Trientine for Wilson's disease.
Topics: Ethylenediamines; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine | 1986 |
Trientine for Wilson's disease.
Topics: Ethylenediamines; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine | 1986 |
Teratogen update: penicillamine.
Topics: Abnormalities, Drug-Induced; Animals; Collagen; Copper; Cutis Laxa; Female; Hepatolenticular Degener | 1986 |
Teratogen update: penicillamine.
Topics: Abnormalities, Drug-Induced; Animals; Collagen; Copper; Cutis Laxa; Female; Hepatolenticular Degener | 1986 |
Wilson's disease revisited in the tropics.
Topics: Adolescent; Adult; Central Nervous System Diseases; Ceruloplasmin; Child; Copper; Female; Hepatolent | 1986 |
Wilson's disease revisited in the tropics.
Topics: Adolescent; Adult; Central Nervous System Diseases; Ceruloplasmin; Child; Copper; Female; Hepatolent | 1986 |
Wilson's disease in childhood. A plea for increased awareness.
Topics: Child; Diagnosis, Differential; Female; Hepatolenticular Degeneration; Humans; Liver; Male; Penicill | 1986 |
Wilson's disease in childhood. A plea for increased awareness.
Topics: Child; Diagnosis, Differential; Female; Hepatolenticular Degeneration; Humans; Liver; Male; Penicill | 1986 |
Wilsons disease in childhood. Surviving severe haemolytic crisis with coma.
Topics: Bilirubin; Coma; Copper; Hemolysis; Hepatolenticular Degeneration; Humans; Penicillamine | 1986 |
Wilsons disease in childhood. Surviving severe haemolytic crisis with coma.
Topics: Bilirubin; Coma; Copper; Hemolysis; Hepatolenticular Degeneration; Humans; Penicillamine | 1986 |
Wilson's disease and liver failure in childhood.
Topics: Adolescent; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Liver Diseases; Male; Peni | 1986 |
Wilson's disease and liver failure in childhood.
Topics: Adolescent; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Liver Diseases; Male; Peni | 1986 |
The treatment of Wilson's disease in paediatrics: oral zinc therapy versus penicillamine.
Topics: Adult; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Zinc | 1986 |
The treatment of Wilson's disease in paediatrics: oral zinc therapy versus penicillamine.
Topics: Adult; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Zinc | 1986 |
Oral zinc therapy normalizes serum uric acid level in Wilson's disease patients.
Topics: Administration, Oral; Child; Drug Hypersensitivity; Female; Hepatolenticular Degeneration; Humans; L | 1986 |
Oral zinc therapy normalizes serum uric acid level in Wilson's disease patients.
Topics: Administration, Oral; Child; Drug Hypersensitivity; Female; Hepatolenticular Degeneration; Humans; L | 1986 |
[Effect of sera from patients with hepatolenticular degeneration treated with D-penicillamine on the development of Wilsonian gliopathy in vitro].
Topics: Adolescent; Adult; Animals; Astrocytes; Cerebellum; Female; Hepatolenticular Degeneration; Humans; H | 1986 |
[Effect of sera from patients with hepatolenticular degeneration treated with D-penicillamine on the development of Wilsonian gliopathy in vitro].
Topics: Adolescent; Adult; Animals; Astrocytes; Cerebellum; Female; Hepatolenticular Degeneration; Humans; H | 1986 |
Systemic sclerosis-like lesions during long-term penicillamine therapy for Wilson's disease.
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Scleroderma, Systemic | 1987 |
Systemic sclerosis-like lesions during long-term penicillamine therapy for Wilson's disease.
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Scleroderma, Systemic | 1987 |
Endocrine studies of the ovulatory disturbances in Wilson's disease (hepatolenticular degeneration).
Topics: Adolescent; Adult; Amenorrhea; Androstenedione; Estradiol; Female; Hepatolenticular Degeneration; Hu | 1987 |
Endocrine studies of the ovulatory disturbances in Wilson's disease (hepatolenticular degeneration).
Topics: Adolescent; Adult; Amenorrhea; Androstenedione; Estradiol; Female; Hepatolenticular Degeneration; Hu | 1987 |
Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients.
Topics: Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Sulfates; Zinc; Zinc Sulfate | 1987 |
Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients.
Topics: Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Sulfates; Zinc; Zinc Sulfate | 1987 |
Penicillamine associated pulmonary hemorrhage.
Topics: Adult; Antigen-Antibody Complex; Hemorrhage; Hepatolenticular Degeneration; Humans; Lung Diseases; M | 1986 |
Penicillamine associated pulmonary hemorrhage.
Topics: Adult; Antigen-Antibody Complex; Hemorrhage; Hepatolenticular Degeneration; Humans; Lung Diseases; M | 1986 |
Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging.
Topics: Adolescent; Adult; Brain; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance Spectros | 1987 |
Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging.
Topics: Adolescent; Adult; Brain; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance Spectros | 1987 |
[Long-term follow-up study of seventeen cases with Wilson's disease].
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Male; Pe | 1985 |
[Long-term follow-up study of seventeen cases with Wilson's disease].
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Male; Pe | 1985 |
Unithiol in Wilson's disease.
Topics: Adolescent; Copper; Dimercaprol; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Unithio | 1985 |
Unithiol in Wilson's disease.
Topics: Adolescent; Copper; Dimercaprol; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Unithio | 1985 |
Detection of Wilson's disease in sibs of a patient with Wilson's disease.
Topics: Copper; Hepatolenticular Degeneration; Humans; Liver; Penicillamine | 1986 |
Detection of Wilson's disease in sibs of a patient with Wilson's disease.
Topics: Copper; Hepatolenticular Degeneration; Humans; Liver; Penicillamine | 1986 |
Wilson's disease in the Commonwealth of Dominica, a case report.
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Pedigree; Penicillamine; West Indies | 1986 |
Wilson's disease in the Commonwealth of Dominica, a case report.
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Pedigree; Penicillamine; West Indies | 1986 |
Unusual digestive lesions in a patient with Wilson's disease treated with long-term penicillamine.
Topics: Hepatolenticular Degeneration; Humans; Ileal Diseases; Male; Middle Aged; Penicillamine; Sarcoma, Ka | 1985 |
Unusual digestive lesions in a patient with Wilson's disease treated with long-term penicillamine.
Topics: Hepatolenticular Degeneration; Humans; Ileal Diseases; Male; Middle Aged; Penicillamine; Sarcoma, Ka | 1985 |
[Visually evoked potentials in Wilson's disease].
Topics: Adolescent; Adult; Evoked Potentials, Visual; Female; Hepatolenticular Degeneration; Humans; Male; M | 1985 |
[Visually evoked potentials in Wilson's disease].
Topics: Adolescent; Adult; Evoked Potentials, Visual; Female; Hepatolenticular Degeneration; Humans; Male; M | 1985 |
Neuropsychological and electrophysiological examination of a patient with Wilson's disease.
Topics: Adult; Brain Stem; Copper; Drug Therapy, Combination; Electrodiagnosis; Electroencephalography; Evok | 1985 |
Neuropsychological and electrophysiological examination of a patient with Wilson's disease.
Topics: Adult; Brain Stem; Copper; Drug Therapy, Combination; Electrodiagnosis; Electroencephalography; Evok | 1985 |
Oral zinc sulphate for Wilson's disease.
Topics: Administration, Oral; Child, Preschool; Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 1985 |
Oral zinc sulphate for Wilson's disease.
Topics: Administration, Oral; Child, Preschool; Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 1985 |
Wilson's disease: assessment of D-penicillamine treatment.
Topics: Child; Child, Preschool; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 1985 |
Wilson's disease: assessment of D-penicillamine treatment.
Topics: Child; Child, Preschool; Copper; Hepatolenticular Degeneration; Humans; Penicillamine; Zinc | 1985 |
[A syndrome similar to systemic lupus erythematosus caused by penicillamine in patients with Wilson's disease].
Topics: Adult; Hepatolenticular Degeneration; Humans; Lupus Erythematosus, Systemic; Male; Penicillamine; Sy | 1985 |
[A syndrome similar to systemic lupus erythematosus caused by penicillamine in patients with Wilson's disease].
Topics: Adult; Hepatolenticular Degeneration; Humans; Lupus Erythematosus, Systemic; Male; Penicillamine; Sy | 1985 |
Peritoneal dialysis with D-penicillamine in Wilson disease.
Topics: Albumins; Child; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Peritoneal Dialysis; | 1985 |
Peritoneal dialysis with D-penicillamine in Wilson disease.
Topics: Albumins; Child; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Peritoneal Dialysis; | 1985 |
Pseudoxanthoma elasticum-like skin changes induced by penicillamine.
Topics: Adolescent; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pseudoxanthoma Elasticum | 1985 |
Pseudoxanthoma elasticum-like skin changes induced by penicillamine.
Topics: Adolescent; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pseudoxanthoma Elasticum | 1985 |
Successful pregnancy in Wilson's disease: a case report and review of the literature.
Topics: Adult; Ceruloplasmin; Copper; Diet; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pr | 1985 |
Successful pregnancy in Wilson's disease: a case report and review of the literature.
Topics: Adult; Ceruloplasmin; Copper; Diet; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Pr | 1985 |
[Teratogenic risk during treatment of Wilson disease].
Topics: Adult; Congenital Abnormalities; Copper; Female; Fetus; Hepatolenticular Degeneration; Humans; Infan | 1985 |
[Teratogenic risk during treatment of Wilson disease].
Topics: Adult; Congenital Abnormalities; Copper; Female; Fetus; Hepatolenticular Degeneration; Humans; Infan | 1985 |
Penicillamine therapy for schizophreniform psychosis in Wilson's disease.
Topics: Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Psychiatric Status Rati | 1985 |
Penicillamine therapy for schizophreniform psychosis in Wilson's disease.
Topics: Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Psychiatric Status Rati | 1985 |
[Oral zinc in Wilson disease--an alternative to D-penicillamine].
Topics: Administration, Oral; Adult; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Liver Function | 1985 |
[Oral zinc in Wilson disease--an alternative to D-penicillamine].
Topics: Administration, Oral; Adult; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Liver Function | 1985 |
D-penicillamine and neutrophilic agranulocytosis.
Topics: Agranulocytosis; Child; Female; Hepatolenticular Degeneration; Humans; Neutropenia; Penicillamine | 1985 |
D-penicillamine and neutrophilic agranulocytosis.
Topics: Agranulocytosis; Child; Female; Hepatolenticular Degeneration; Humans; Neutropenia; Penicillamine | 1985 |
[Wilson's hepatolenticular degeneration. Apropos of a case report].
Topics: Adult; Ceruloplasmin; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1985 |
[Wilson's hepatolenticular degeneration. Apropos of a case report].
Topics: Adult; Ceruloplasmin; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1985 |
[Early diagnosis and treatment of hepatolenticular degeneration: clinical analysis of 92 cases].
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Dimercaprol; Female; Hepatolenticular Degeneratio | 1985 |
[Early diagnosis and treatment of hepatolenticular degeneration: clinical analysis of 92 cases].
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Dimercaprol; Female; Hepatolenticular Degeneratio | 1985 |
Lupus-like syndrome induced by D-penicillamine in Wilson's disease.
Topics: Adult; Antigen-Antibody Reactions; Arthritis, Rheumatoid; Autoantibodies; Cystinuria; Female; Hapten | 1971 |
Lupus-like syndrome induced by D-penicillamine in Wilson's disease.
Topics: Adult; Antigen-Antibody Reactions; Arthritis, Rheumatoid; Autoantibodies; Cystinuria; Female; Hapten | 1971 |
Inborn errors of metabolism in neurology (Wilson's disease, Refsum's disease and lipidoses).
Topics: Adolescent; Adult; Cerebral Cortex; Ceruloplasmin; Cholesterol; Copper; Dimercaprol; Fatty Acids; Fe | 1971 |
Inborn errors of metabolism in neurology (Wilson's disease, Refsum's disease and lipidoses).
Topics: Adolescent; Adult; Cerebral Cortex; Ceruloplasmin; Cholesterol; Copper; Dimercaprol; Fatty Acids; Fe | 1971 |
Chelating agents in medicine.
Topics: Chelating Agents; Chemistry, Pharmaceutical; Deferoxamine; Dicumarol; Edetic Acid; Hemochromatosis; | 1971 |
Chelating agents in medicine.
Topics: Chelating Agents; Chemistry, Pharmaceutical; Deferoxamine; Dicumarol; Edetic Acid; Hemochromatosis; | 1971 |
Polymyositis and penicillamine.
Topics: Adult; Autoimmune Diseases; Diagnosis, Differential; Female; Hepatolenticular Degeneration; Homozygo | 1972 |
Polymyositis and penicillamine.
Topics: Adult; Autoimmune Diseases; Diagnosis, Differential; Female; Hepatolenticular Degeneration; Homozygo | 1972 |
[Verruciform perforating elastoma in a patient treated by penicillamine for Wilson's disease].
Topics: Adult; Biopsy; Collagen; Darier Disease; Elastic Tissue; Female; Hepatolenticular Degeneration; Hist | 1972 |
[Verruciform perforating elastoma in a patient treated by penicillamine for Wilson's disease].
Topics: Adult; Biopsy; Collagen; Darier Disease; Elastic Tissue; Female; Hepatolenticular Degeneration; Hist | 1972 |
[Presymptomatic Wilson's disease. Diagnosis, therapy and family examination].
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Ceruloplasmin; Child; | 1973 |
[Presymptomatic Wilson's disease. Diagnosis, therapy and family examination].
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Ceruloplasmin; Child; | 1973 |
Letter: Peptic ulceration and D-penicillamine.
Topics: Arthritis, Rheumatoid; Hepatolenticular Degeneration; Humans; Penicillamine; Peptic Ulcer; Peptic Ul | 1974 |
Letter: Peptic ulceration and D-penicillamine.
Topics: Arthritis, Rheumatoid; Hepatolenticular Degeneration; Humans; Penicillamine; Peptic Ulcer; Peptic Ul | 1974 |
Penicillamine and pyridoxine requirements in man.
Topics: Adult; Animals; Child; Chromatography, Paper; Epilepsies, Partial; Female; Hepatolenticular Degenera | 1966 |
Penicillamine and pyridoxine requirements in man.
Topics: Adult; Animals; Child; Chromatography, Paper; Epilepsies, Partial; Female; Hepatolenticular Degenera | 1966 |
Effect of penicillamine on human collagen and its possible application to treatment of scleroderma.
Topics: Adult; Aged; Arthritis, Rheumatoid; Collagen; Cystinuria; Female; Hepatolenticular Degeneration; Hum | 1966 |
Effect of penicillamine on human collagen and its possible application to treatment of scleroderma.
Topics: Adult; Aged; Arthritis, Rheumatoid; Collagen; Cystinuria; Female; Hepatolenticular Degeneration; Hum | 1966 |
Studies with radioactive copper (64Cu and 67Cu) in relation to the natural history of Wilson's disease.
Topics: Adolescent; Adult; Child; Copper; Hepatolenticular Degeneration; Humans; Liver; Middle Aged; Penicil | 1967 |
Studies with radioactive copper (64Cu and 67Cu) in relation to the natural history of Wilson's disease.
Topics: Adolescent; Adult; Child; Copper; Hepatolenticular Degeneration; Humans; Liver; Middle Aged; Penicil | 1967 |
Presymptomatic Wilson's disease.
Topics: Adolescent; Adult; Biopsy; Ceruloplasmin; Child; Child, Preschool; Copper; Fatty Liver; Hepatolentic | 1967 |
Presymptomatic Wilson's disease.
Topics: Adolescent; Adult; Biopsy; Ceruloplasmin; Child; Child, Preschool; Copper; Fatty Liver; Hepatolentic | 1967 |
Decreased taste sensitivity after D-penicillamine reversed by copper administration.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Ceruloplasmin; Child; Copper; Cystinuria; Female; He | 1967 |
Decreased taste sensitivity after D-penicillamine reversed by copper administration.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Ceruloplasmin; Child; Copper; Cystinuria; Female; He | 1967 |
Nephrotic syndrome after treatment with D-penicillamine.
Topics: Adult; Creatinine; Cystinuria; Female; Hepatolenticular Degeneration; Humans; Nephrotic Syndrome; Pe | 1968 |
Nephrotic syndrome after treatment with D-penicillamine.
Topics: Adult; Creatinine; Cystinuria; Female; Hepatolenticular Degeneration; Humans; Nephrotic Syndrome; Pe | 1968 |
Effect of penicillamine on failure of renal acidification in Wilson's disease.
Topics: Adolescent; Adult; Ammonia; Ammonium Chloride; Ceruloplasmin; Child; Copper; Female; Hepatolenticula | 1968 |
Effect of penicillamine on failure of renal acidification in Wilson's disease.
Topics: Adolescent; Adult; Ammonia; Ammonium Chloride; Ceruloplasmin; Child; Copper; Female; Hepatolenticula | 1968 |
Penicillamine for tubular dysfunction in Wilson's disease.
Topics: Acute Kidney Injury; Amino Acids; Child; Hepatolenticular Degeneration; Humans; Kidney Function Test | 1968 |
Penicillamine for tubular dysfunction in Wilson's disease.
Topics: Acute Kidney Injury; Amino Acids; Child; Hepatolenticular Degeneration; Humans; Kidney Function Test | 1968 |
Prevention of Wilson's disease by penicillamine?
Topics: Ceruloplasmin; Child, Preschool; Copper; Hepatolenticular Degeneration; Homozygote; Humans; Liver; P | 1968 |
Prevention of Wilson's disease by penicillamine?
Topics: Ceruloplasmin; Child, Preschool; Copper; Hepatolenticular Degeneration; Homozygote; Humans; Liver; P | 1968 |
Liver-copper levels in liver disease: studies using neutron activation analysis.
Topics: Activation Analysis; Biliary Tract Diseases; Biopsy; Chemical and Drug Induced Liver Injury; Cholest | 1968 |
Liver-copper levels in liver disease: studies using neutron activation analysis.
Topics: Activation Analysis; Biliary Tract Diseases; Biopsy; Chemical and Drug Induced Liver Injury; Cholest | 1968 |
Diagnosis of Wilson's disease in children with liver disease. A report of two families.
Topics: Adolescent; Adult; Brain; Ceruloplasmin; Child; Copper; Diagnosis, Differential; Eye Manifestations; | 1969 |
Diagnosis of Wilson's disease in children with liver disease. A report of two families.
Topics: Adolescent; Adult; Brain; Ceruloplasmin; Child; Copper; Diagnosis, Differential; Eye Manifestations; | 1969 |
Uncommon EEG findings in hepato-lenticular degeneration.
Topics: Cerebral Cortex; Child; Dimercaprol; Electroencephalography; Epilepsy; Female; Hepatolenticular Dege | 1969 |
Uncommon EEG findings in hepato-lenticular degeneration.
Topics: Cerebral Cortex; Child; Dimercaprol; Electroencephalography; Epilepsy; Female; Hepatolenticular Dege | 1969 |
Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.
Topics: Adolescent; Chelating Agents; Chlorides; Copper; Ethylenediamines; Hepatolenticular Degeneration; Hu | 1969 |
Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.
Topics: Adolescent; Chelating Agents; Chlorides; Copper; Ethylenediamines; Hepatolenticular Degeneration; Hu | 1969 |
Bleeding oesophageal varices in patients with Wilson's disease.
Topics: Adolescent; Adult; Azygos Vein; Child; Esophageal and Gastric Varices; Esophageal Diseases; Female; | 1970 |
Bleeding oesophageal varices in patients with Wilson's disease.
Topics: Adolescent; Adult; Azygos Vein; Child; Esophageal and Gastric Varices; Esophageal Diseases; Female; | 1970 |
Treatment of Wilson's disease with L-dopa after failure with penicillamine.
Topics: Adolescent; Carboxy-Lyases; Dihydroxyphenylalanine; Female; Hepatolenticular Degeneration; Humans; P | 1970 |
Treatment of Wilson's disease with L-dopa after failure with penicillamine.
Topics: Adolescent; Carboxy-Lyases; Dihydroxyphenylalanine; Female; Hepatolenticular Degeneration; Humans; P | 1970 |
Ineffectiveness of L-dopa as supplement to penicillamine in a case of Wilson's disease.
Topics: Adult; Carbon Isotopes; Dihydroxyphenylalanine; Female; Hepatolenticular Degeneration; Humans; Penic | 1970 |
Ineffectiveness of L-dopa as supplement to penicillamine in a case of Wilson's disease.
Topics: Adult; Carbon Isotopes; Dihydroxyphenylalanine; Female; Hepatolenticular Degeneration; Humans; Penic | 1970 |
Wilson's disease in the United Kingdom and Taiwan. I. General characteristics of 142 cases and prognosis. II. A genetic analysis of 88 cases.
Topics: Adolescent; Adult; Age Factors; Child; Female; Hepatolenticular Degeneration; Humans; Long-Term Care | 1973 |
Wilson's disease in the United Kingdom and Taiwan. I. General characteristics of 142 cases and prognosis. II. A genetic analysis of 88 cases.
Topics: Adolescent; Adult; Age Factors; Child; Female; Hepatolenticular Degeneration; Humans; Long-Term Care | 1973 |
[Diagnostic and therapeutic aspects of Wilson's disease in the preclinical stage].
Topics: Adult; Ceruloplasmin; Child; Child, Preschool; Copper; Female; Hepatolenticular Degeneration; Humans | 1973 |
[Diagnostic and therapeutic aspects of Wilson's disease in the preclinical stage].
Topics: Adult; Ceruloplasmin; Child; Child, Preschool; Copper; Female; Hepatolenticular Degeneration; Humans | 1973 |
[Wilson's disease (experience of long-term treatment with penicillamine---con penicilamina].
Topics: Adult; Drug Evaluation; Female; Hepatolenticular Degeneration; Humans; Long-Term Care; Penicillamine | 1974 |
[Wilson's disease (experience of long-term treatment with penicillamine---con penicilamina].
Topics: Adult; Drug Evaluation; Female; Hepatolenticular Degeneration; Humans; Long-Term Care; Penicillamine | 1974 |
Penicillamine-induced skin lesions. A possible example of human lathyrism.
Topics: Adult; Cysts; Drug Eruptions; Hepatolenticular Degeneration; Humans; Lathyrism; Male; Penicillamine | 1967 |
Penicillamine-induced skin lesions. A possible example of human lathyrism.
Topics: Adult; Cysts; Drug Eruptions; Hepatolenticular Degeneration; Humans; Lathyrism; Male; Penicillamine | 1967 |
[Late cutaneous lesions due to penicillamine in a patient with Wilson's disease].
Topics: Adolescent; Drug Eruptions; Exanthema; Hepatolenticular Degeneration; Humans; Leg Dermatoses; Male; | 1969 |
[Late cutaneous lesions due to penicillamine in a patient with Wilson's disease].
Topics: Adolescent; Drug Eruptions; Exanthema; Hepatolenticular Degeneration; Humans; Leg Dermatoses; Male; | 1969 |
[Clinical, therapeutic and isotopic study of familial Wilson's disease: desensitization to penicillamine D].
Topics: Adult; Child; Child, Preschool; Copper; Desensitization, Immunologic; Drug Eruptions; Female; Hepato | 1969 |
[Clinical, therapeutic and isotopic study of familial Wilson's disease: desensitization to penicillamine D].
Topics: Adult; Child; Child, Preschool; Copper; Desensitization, Immunologic; Drug Eruptions; Female; Hepato | 1969 |
[Lupoid syndrome due to D-penicillamine associated with Wilson's disease: immunologic study by leukocyte migration test (L.M.T.)].
Topics: Cell Movement; Drug Eruptions; Female; Hepatolenticular Degeneration; Humans; Leukocytes; Lupus Vulg | 1971 |
[Lupoid syndrome due to D-penicillamine associated with Wilson's disease: immunologic study by leukocyte migration test (L.M.T.)].
Topics: Cell Movement; Drug Eruptions; Female; Hepatolenticular Degeneration; Humans; Leukocytes; Lupus Vulg | 1971 |
Febrile penicillamine eruption.
Topics: Antigen-Antibody Complex; Asian People; Drug Eruptions; Hepatolenticular Degeneration; Humans; Penic | 1972 |
Febrile penicillamine eruption.
Topics: Antigen-Antibody Complex; Asian People; Drug Eruptions; Hepatolenticular Degeneration; Humans; Penic | 1972 |
[Dermatological complications during treatment of Wilsons disease with D-penicillamine].
Topics: Adolescent; Adult; Agammaglobulinemia; Drug Eruptions; Female; Hepatolenticular Degeneration; Humans | 1973 |
[Dermatological complications during treatment of Wilsons disease with D-penicillamine].
Topics: Adolescent; Adult; Agammaglobulinemia; Drug Eruptions; Female; Hepatolenticular Degeneration; Humans | 1973 |
A mechanism for the action of penicillamine in the treatment of Wilson's disease.
Topics: Chelating Agents; Copper; Cysteine; Edetic Acid; Electron Spin Resonance Spectroscopy; Hepatolenticu | 1969 |
A mechanism for the action of penicillamine in the treatment of Wilson's disease.
Topics: Chelating Agents; Copper; Cysteine; Edetic Acid; Electron Spin Resonance Spectroscopy; Hepatolenticu | 1969 |
Unusual problems tend to appear in crops.
Topics: Adult; Biopsy; Ceruloplasmin; Child; Diagnosis, Differential; Diet; Dimercaprol; Eye Manifestations; | 1971 |
Unusual problems tend to appear in crops.
Topics: Adult; Biopsy; Ceruloplasmin; Child; Diagnosis, Differential; Diet; Dimercaprol; Eye Manifestations; | 1971 |
[The organic psycho-syndrome in Wilson's disease (longterm follow-up with psychologic testing in 4 patients during d-penicillamin-therapy) (author's transl)].
Topics: Adolescent; Adult; Aftercare; Child; Female; Hepatolenticular Degeneration; Humans; Intelligence Tes | 1973 |
[The organic psycho-syndrome in Wilson's disease (longterm follow-up with psychologic testing in 4 patients during d-penicillamin-therapy) (author's transl)].
Topics: Adolescent; Adult; Aftercare; Child; Female; Hepatolenticular Degeneration; Humans; Intelligence Tes | 1973 |
Psychiatric aspects of Wilson's disease (hepatolenticular degeneration): results of psychometric tests during long-term therapy.
Topics: Adolescent; Adult; Child; Child, Preschool; Diet Therapy; Educational Status; Female; Hepatolenticul | 1968 |
Psychiatric aspects of Wilson's disease (hepatolenticular degeneration): results of psychometric tests during long-term therapy.
Topics: Adolescent; Adult; Child; Child, Preschool; Diet Therapy; Educational Status; Female; Hepatolenticul | 1968 |
[Therapy and rehabilitation of Wilson's disease (author's transl)].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1974 |
[Therapy and rehabilitation of Wilson's disease (author's transl)].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1974 |
[Acute hemolysis in morbus Wilson (author's transl)].
Topics: Adolescent; Adult; Anemia, Hemolytic; Ascites; Bilirubin; Blood Coagulation Tests; Blood Protein Ele | 1974 |
[Acute hemolysis in morbus Wilson (author's transl)].
Topics: Adolescent; Adult; Anemia, Hemolytic; Ascites; Bilirubin; Blood Coagulation Tests; Blood Protein Ele | 1974 |
[Nature of course and rehabilitation in the clinical stage of Wilson's disease].
Topics: Adolescent; Adult; Age Factors; Basal Ganglia Diseases; Child; Child, Preschool; Diagnosis, Differen | 1974 |
[Nature of course and rehabilitation in the clinical stage of Wilson's disease].
Topics: Adolescent; Adult; Age Factors; Basal Ganglia Diseases; Child; Child, Preschool; Diagnosis, Differen | 1974 |
Use of the 198Au liver scan in assessing the therapeutic effect of penicillamine in Wilson's disease.
Topics: Adolescent; Female; Gold Radioisotopes; Hepatolenticular Degeneration; Humans; Liver; Penicillamine; | 1974 |
Use of the 198Au liver scan in assessing the therapeutic effect of penicillamine in Wilson's disease.
Topics: Adolescent; Female; Gold Radioisotopes; Hepatolenticular Degeneration; Humans; Liver; Penicillamine; | 1974 |
Trade names or approved names. Part III. Special cases. Drugs for rare diseases.
Topics: Costs and Cost Analysis; Drug Evaluation; Drug Evaluation, Preclinical; Drug Industry; Hepatolenticu | 1974 |
Trade names or approved names. Part III. Special cases. Drugs for rare diseases.
Topics: Costs and Cost Analysis; Drug Evaluation; Drug Evaluation, Preclinical; Drug Industry; Hepatolenticu | 1974 |
[Stomatitis caused by D-penicillamine].
Topics: Arthritis, Rheumatoid; Drug Hypersensitivity; Epidermolysis Bullosa; Female; Hepatolenticular Degene | 1973 |
[Stomatitis caused by D-penicillamine].
Topics: Arthritis, Rheumatoid; Drug Hypersensitivity; Epidermolysis Bullosa; Female; Hepatolenticular Degene | 1973 |
[Possible accidents due to penicillamine during treatment of Wilson's disease].
Topics: Acute Kidney Injury; Adolescent; Adult; Child; Epilepsy; Female; Hepatolenticular Degeneration; Huma | 1972 |
[Possible accidents due to penicillamine during treatment of Wilson's disease].
Topics: Acute Kidney Injury; Adolescent; Adult; Child; Epilepsy; Female; Hepatolenticular Degeneration; Huma | 1972 |
Diagnosis of allergic drug reaction.
Topics: Antibodies, Antinuclear; Antibody Formation; Antigen-Antibody Complex; Coombs Test; Dextrans; Drug H | 1973 |
Diagnosis of allergic drug reaction.
Topics: Antibodies, Antinuclear; Antibody Formation; Antigen-Antibody Complex; Coombs Test; Dextrans; Drug H | 1973 |
[Optic neuritis in a child with Wilson's disease].
Topics: Adolescent; Copper; Hepatolenticular Degeneration; Humans; Long-Term Care; Male; Optic Atrophy; Opti | 1972 |
[Optic neuritis in a child with Wilson's disease].
Topics: Adolescent; Copper; Hepatolenticular Degeneration; Humans; Long-Term Care; Male; Optic Atrophy; Opti | 1972 |
[Current treatment of hepatolenticular degenerescence].
Topics: Adrenal Cortex Hormones; Cysteine; Diet Therapy; Dimercaprol; Edetic Acid; Folic Acid; Hepatolenticu | 1972 |
[Current treatment of hepatolenticular degenerescence].
Topics: Adrenal Cortex Hormones; Cysteine; Diet Therapy; Dimercaprol; Edetic Acid; Folic Acid; Hepatolenticu | 1972 |
[Long-term D-penicillamine therapy of Wilson's disease in childhood. Changes in blood coagulation and effects on the haematopoetic system].
Topics: Adolescent; Blood Coagulation; Child; Female; Hematopoiesis; Hepatolenticular Degeneration; Humans; | 1973 |
[Long-term D-penicillamine therapy of Wilson's disease in childhood. Changes in blood coagulation and effects on the haematopoetic system].
Topics: Adolescent; Blood Coagulation; Child; Female; Hematopoiesis; Hepatolenticular Degeneration; Humans; | 1973 |
Renal abnormalities in heterozygotes for Wilson's disease: genes or copper?
Topics: Ceruloplasmin; Copper; Genes; Hepatolenticular Degeneration; Heterozygote; Humans; Kidney; Penicilla | 1972 |
Renal abnormalities in heterozygotes for Wilson's disease: genes or copper?
Topics: Ceruloplasmin; Copper; Genes; Hepatolenticular Degeneration; Heterozygote; Humans; Kidney; Penicilla | 1972 |
[Cutis hyperelastica following prolonged administration of penicillamine in a patient with Wilson's disease].
Topics: Adolescent; Biopsy; Copper; Ehlers-Danlos Syndrome; Female; Hepatolenticular Degeneration; Humans; P | 1972 |
[Cutis hyperelastica following prolonged administration of penicillamine in a patient with Wilson's disease].
Topics: Adolescent; Biopsy; Copper; Ehlers-Danlos Syndrome; Female; Hepatolenticular Degeneration; Humans; P | 1972 |
[Pregnancy in a case of Wilson's copper metabolism disorder].
Topics: Amenorrhea; Female; Hepatolenticular Degeneration; Humans; Infertility; Male; Penicillamine; Pregnan | 1972 |
[Pregnancy in a case of Wilson's copper metabolism disorder].
Topics: Amenorrhea; Female; Hepatolenticular Degeneration; Humans; Infertility; Male; Penicillamine; Pregnan | 1972 |
Penicillamine-induced cupriuria in normal subjects and in patients with active liver disease.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aspartate Aminotransferases; Bilirubin; Cerulo | 1973 |
Penicillamine-induced cupriuria in normal subjects and in patients with active liver disease.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aspartate Aminotransferases; Bilirubin; Cerulo | 1973 |
[Wilson's disease in Switzerland. Clinical, genetic and biochemical studies].
Topics: Copper; Female; Hepatolenticular Degeneration; Histocytochemistry; Humans; Liver; Male; Penicillamin | 1973 |
[Wilson's disease in Switzerland. Clinical, genetic and biochemical studies].
Topics: Copper; Female; Hepatolenticular Degeneration; Histocytochemistry; Humans; Liver; Male; Penicillamin | 1973 |
[Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
Topics: Adolescent; Adult; Atropine; Basal Ganglia Diseases; Chelating Agents; Chronic Disease; Dihydroxyphe | 1973 |
[Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
Topics: Adolescent; Adult; Atropine; Basal Ganglia Diseases; Chelating Agents; Chronic Disease; Dihydroxyphe | 1973 |
Wilson's disease and pregnancy. A case report.
Topics: Abortion, Spontaneous; Adult; Ascites; Autopsy; Ceruloplasmin; Copper; Diet Therapy; Female; Fetus; | 1973 |
Wilson's disease and pregnancy. A case report.
Topics: Abortion, Spontaneous; Adult; Ascites; Autopsy; Ceruloplasmin; Copper; Diet Therapy; Female; Fetus; | 1973 |
Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
Topics: Adolescent; Adult; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Me | 1973 |
Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
Topics: Adolescent; Adult; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Me | 1973 |
[D-penicillamine].
Topics: Arthritis, Rheumatoid; Cystinuria; Hepatolenticular Degeneration; Humans; Penicillamine | 1973 |
[D-penicillamine].
Topics: Arthritis, Rheumatoid; Cystinuria; Hepatolenticular Degeneration; Humans; Penicillamine | 1973 |
[Favorable results with an association of L-dopa and amantadine added to penicillamine in the treatment of Wilson's disease].
Topics: Adolescent; Amantadine; Dihydroxyphenylalanine; Drug Synergism; Female; Hepatolenticular Degeneratio | 1973 |
[Favorable results with an association of L-dopa and amantadine added to penicillamine in the treatment of Wilson's disease].
Topics: Adolescent; Amantadine; Dihydroxyphenylalanine; Drug Synergism; Female; Hepatolenticular Degeneratio | 1973 |
[Hepatocerebral degeneration (Wilson's disease). Demonstration of the clinical picture and demonstration of own case].
Topics: Adolescent; Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1973 |
[Hepatocerebral degeneration (Wilson's disease). Demonstration of the clinical picture and demonstration of own case].
Topics: Adolescent; Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1973 |
Elastosis perforans serpiginosa during penicillamine therapy for Wilson disease.
Topics: Adult; Biopsy; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Skin Diseases | 1973 |
Elastosis perforans serpiginosa during penicillamine therapy for Wilson disease.
Topics: Adult; Biopsy; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Skin Diseases | 1973 |
[Hemorrhagic diathesis in Wilson's disease. Plasmatic or thrombocytic etiology?].
Topics: Blood Platelets; Child; Cold Temperature; Female; Hemorrhagic Disorders; Hepatolenticular Degenerati | 1973 |
[Hemorrhagic diathesis in Wilson's disease. Plasmatic or thrombocytic etiology?].
Topics: Blood Platelets; Child; Cold Temperature; Female; Hemorrhagic Disorders; Hepatolenticular Degenerati | 1973 |
Renal urate excretion in patients with Wilson's disease.
Topics: Arginine; Depression, Chemical; Glomerular Filtration Rate; Glutamine; Hepatolenticular Degeneration | 1973 |
Renal urate excretion in patients with Wilson's disease.
Topics: Arginine; Depression, Chemical; Glomerular Filtration Rate; Glutamine; Hepatolenticular Degeneration | 1973 |
Ophthalmologic and genetic aspects of Wilson's disease (hepatolenticular degeneration).
Topics: Adult; Biopsy; Ceruloplasmin; Copper; Eye Manifestations; Female; Finland; Hepatolenticular Degenera | 1973 |
Ophthalmologic and genetic aspects of Wilson's disease (hepatolenticular degeneration).
Topics: Adult; Biopsy; Ceruloplasmin; Copper; Eye Manifestations; Female; Finland; Hepatolenticular Degenera | 1973 |
Wilson's disease: modification by L-DOPA.
Topics: Adolescent; Chelating Agents; Copper; Dihydroxyphenylalanine; Evaluation Studies as Topic; Hepatolen | 1973 |
Wilson's disease: modification by L-DOPA.
Topics: Adolescent; Chelating Agents; Copper; Dihydroxyphenylalanine; Evaluation Studies as Topic; Hepatolen | 1973 |
Evidence for a urate reabsorptive defect in patients with Wilson's disease.
Topics: Arginine; Follow-Up Studies; Glomerular Filtration Rate; Glutamine; Hepatolenticular Degeneration; H | 1974 |
Evidence for a urate reabsorptive defect in patients with Wilson's disease.
Topics: Arginine; Follow-Up Studies; Glomerular Filtration Rate; Glutamine; Hepatolenticular Degeneration; H | 1974 |
Psychologic investigation of Wilson's disease.
Topics: Auditory Perception; Diet Therapy; Hepatolenticular Degeneration; Humans; Intelligence; Intelligence | 1974 |
Psychologic investigation of Wilson's disease.
Topics: Auditory Perception; Diet Therapy; Hepatolenticular Degeneration; Humans; Intelligence; Intelligence | 1974 |
Effects of penicillamine therapy and low-copper diet on dysarthria in Wilson's disease (hepatolenticular degeneration).
Topics: Copper; Diet Therapy; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Speech Dis | 1974 |
Effects of penicillamine therapy and low-copper diet on dysarthria in Wilson's disease (hepatolenticular degeneration).
Topics: Copper; Diet Therapy; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Speech Dis | 1974 |
Dysarthria in Wilson's disease.
Topics: Adolescent; Adult; Ataxia; Athetosis; Chorea; Evaluation Studies as Topic; Female; Hepatolenticular | 1974 |
Dysarthria in Wilson's disease.
Topics: Adolescent; Adult; Ataxia; Athetosis; Chorea; Evaluation Studies as Topic; Female; Hepatolenticular | 1974 |
Hemolytic anemia of Wilson's disease.
Topics: Adult; Anemia, Hemolytic; Bilirubin; Ceruloplasmin; Copper; Erythrocyte Count; Female; Hemoglobins; | 1974 |
Hemolytic anemia of Wilson's disease.
Topics: Adult; Anemia, Hemolytic; Bilirubin; Ceruloplasmin; Copper; Erythrocyte Count; Female; Hemoglobins; | 1974 |
Hemolytic anemia associated with Wilson's disease.
Topics: Adult; Anemia, Hemolytic; Ascites; Child; Copper; Cornea; Diet Therapy; Dimercaprol; Edetic Acid; Fe | 1967 |
Hemolytic anemia associated with Wilson's disease.
Topics: Adult; Anemia, Hemolytic; Ascites; Child; Copper; Cornea; Diet Therapy; Dimercaprol; Edetic Acid; Fe | 1967 |
Wilson's disease: the role of penicillamine.
Topics: Copper; Diet Therapy; Hepatolenticular Degeneration; Humans; Penicillamine | 1969 |
Wilson's disease: the role of penicillamine.
Topics: Copper; Diet Therapy; Hepatolenticular Degeneration; Humans; Penicillamine | 1969 |
[Use of neutron activation analysis in the diagnosis and follow-up studies of Wilson's disease].
Topics: Activation Analysis; Adolescent; Biopsy; Copper; Follow-Up Studies; Hepatolenticular Degeneration; H | 1971 |
[Use of neutron activation analysis in the diagnosis and follow-up studies of Wilson's disease].
Topics: Activation Analysis; Adolescent; Biopsy; Copper; Follow-Up Studies; Hepatolenticular Degeneration; H | 1971 |
Long-term therapy of Wilson's disease.
Topics: Adolescent; Adult; Blood Cell Count; Central Nervous System; Child; Copper; Cornea; Female; Follow-U | 1971 |
Long-term therapy of Wilson's disease.
Topics: Adolescent; Adult; Blood Cell Count; Central Nervous System; Child; Copper; Cornea; Female; Follow-U | 1971 |
The binding of copper by bile and serum.
Topics: Adolescent; Adult; Animals; Bile; Bile Acids and Salts; Child; Copper; Dialysis; Edetic Acid; Female | 1971 |
The binding of copper by bile and serum.
Topics: Adolescent; Adult; Animals; Bile; Bile Acids and Salts; Child; Copper; Dialysis; Edetic Acid; Female | 1971 |
[Wilson's disease].
Topics: Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1972 |
[Wilson's disease].
Topics: Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1972 |
[Wilson's disease. Etiopathogenetic, morphologic, clinical and therapeutic considerations, Case report].
Topics: Adolescent; Brain; Hepatolenticular Degeneration; Humans; Liver; Male; Penicillamine | 1972 |
[Wilson's disease. Etiopathogenetic, morphologic, clinical and therapeutic considerations, Case report].
Topics: Adolescent; Brain; Hepatolenticular Degeneration; Humans; Liver; Male; Penicillamine | 1972 |
Glucose intolerance in Wilson's disease. Normalization after treatment with penicillamine.
Topics: Adolescent; Biopsy; Blood Glucose; Copper; Female; Glucose Tolerance Test; Growth Hormone; Hepatolen | 1972 |
Glucose intolerance in Wilson's disease. Normalization after treatment with penicillamine.
Topics: Adolescent; Biopsy; Blood Glucose; Copper; Female; Glucose Tolerance Test; Growth Hormone; Hepatolen | 1972 |
Chronic hepatitis as a first manifestation of Wilson's disease.
Topics: Adolescent; Adult; Biopsy; Ceruloplasmin; Child; Chronic Disease; Copper; Eye Manifestations; Female | 1972 |
Chronic hepatitis as a first manifestation of Wilson's disease.
Topics: Adolescent; Adult; Biopsy; Ceruloplasmin; Child; Chronic Disease; Copper; Eye Manifestations; Female | 1972 |
[EEG changes under sodium diethyldithiocarbamate therapy in 2 cases of Wilson's disease].
Topics: Adult; Chelating Agents; Cognition Disorders; Copper; Electroencephalography; Female; Hepatolenticul | 1972 |
[EEG changes under sodium diethyldithiocarbamate therapy in 2 cases of Wilson's disease].
Topics: Adult; Chelating Agents; Cognition Disorders; Copper; Electroencephalography; Female; Hepatolenticul | 1972 |
Evidence for a ternary complex containing albumin, copper, and penicillamine.
Topics: Animals; Cattle; Chelating Agents; Chemical Phenomena; Chemistry; Chromatography, Gel; Copper; Hepat | 1972 |
Evidence for a ternary complex containing albumin, copper, and penicillamine.
Topics: Animals; Cattle; Chelating Agents; Chemical Phenomena; Chemistry; Chromatography, Gel; Copper; Hepat | 1972 |
'Torsion dystony' and abnormal copper metabolism.
Topics: Adult; Ceruloplasmin; Copper; Diagnosis, Differential; Diazepam; Dihydroxyphenylalanine; Dystonia Mu | 1972 |
'Torsion dystony' and abnormal copper metabolism.
Topics: Adult; Ceruloplasmin; Copper; Diagnosis, Differential; Diazepam; Dihydroxyphenylalanine; Dystonia Mu | 1972 |
Studies with 35S-labelled DL-penicillamine in patients with Wilson's disease.
Topics: Administration, Oral; Adolescent; Adult; Autoradiography; Blood Protein Electrophoresis; Body Fluids | 1971 |
Studies with 35S-labelled DL-penicillamine in patients with Wilson's disease.
Topics: Administration, Oral; Adolescent; Adult; Autoradiography; Blood Protein Electrophoresis; Body Fluids | 1971 |
Renal clearances of different amino acids in Wilson's disease before and after treatment with penicillamine.
Topics: Adolescent; Albuminuria; Amino Acids; Aminohippuric Acids; Copper; Female; Glomerular Filtration Rat | 1971 |
Renal clearances of different amino acids in Wilson's disease before and after treatment with penicillamine.
Topics: Adolescent; Albuminuria; Amino Acids; Aminohippuric Acids; Copper; Female; Glomerular Filtration Rat | 1971 |
Interruption of the tryptophan-nicotinic acid pathway by penicillamine-induced pyridoxine deficiency in patients with Wilson's disease and in experimental animals.
Topics: Animals; Carbon Isotopes; Chromatography; Female; Hepatolenticular Degeneration; Humans; Kynurenine; | 1969 |
Interruption of the tryptophan-nicotinic acid pathway by penicillamine-induced pyridoxine deficiency in patients with Wilson's disease and in experimental animals.
Topics: Animals; Carbon Isotopes; Chromatography; Female; Hepatolenticular Degeneration; Humans; Kynurenine; | 1969 |
Effect of treatment on renal function in severe osteomalacia due to Wilson's disease.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Ergocalciferols; Fanconi Syndrome; Hepatolenticular Degene | 1970 |
Effect of treatment on renal function in severe osteomalacia due to Wilson's disease.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Ergocalciferols; Fanconi Syndrome; Hepatolenticular Degene | 1970 |
Wilson's disease with reversible renal tubular dysfunction. Correlation with proximal tubular ultrastructure.
Topics: Acute Kidney Injury; Adolescent; Antibodies, Antinuclear; Biopsy; Copper; Creatinine; Female; Glomer | 1971 |
Wilson's disease with reversible renal tubular dysfunction. Correlation with proximal tubular ultrastructure.
Topics: Acute Kidney Injury; Adolescent; Antibodies, Antinuclear; Biopsy; Copper; Creatinine; Female; Glomer | 1971 |
Disappearance of Kayser-Fleischer rings. Effects of penicillamine.
Topics: Adult; Color; Cornea; Descemet Membrane; Female; Hepatolenticular Degeneration; Humans; Male; Penici | 1969 |
Disappearance of Kayser-Fleischer rings. Effects of penicillamine.
Topics: Adult; Color; Cornea; Descemet Membrane; Female; Hepatolenticular Degeneration; Humans; Male; Penici | 1969 |
Studies with radioactive copper (64Cu and 67Cu): abdominal scintiscans in patients with Wilson's disease.
Topics: Adolescent; Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Radio | 1969 |
Studies with radioactive copper (64Cu and 67Cu): abdominal scintiscans in patients with Wilson's disease.
Topics: Adolescent; Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Radio | 1969 |
[Current problems of Wilson's disease (hepatolenticular degeneration)].
Topics: Adolescent; Copper; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1969 |
[Current problems of Wilson's disease (hepatolenticular degeneration)].
Topics: Adolescent; Copper; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1969 |
Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
Topics: Copper; Diet Therapy; Hepatolenticular Degeneration; Humans; Penicillamine | 1969 |
Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
Topics: Copper; Diet Therapy; Hepatolenticular Degeneration; Humans; Penicillamine | 1969 |
[Motometric studies in the diagnosis and observation of the course of Wilson's disease].
Topics: Child; Hepatolenticular Degeneration; Humans; Male; Motor Skills; Neurologic Examination; Penicillam | 1969 |
[Motometric studies in the diagnosis and observation of the course of Wilson's disease].
Topics: Child; Hepatolenticular Degeneration; Humans; Male; Motor Skills; Neurologic Examination; Penicillam | 1969 |
[Wilson's disease: hepatocerebral degeneration. 2. Clinical findings and therapy].
Topics: Adult; Dimercaprol; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Prognosis | 1969 |
[Wilson's disease: hepatocerebral degeneration. 2. Clinical findings and therapy].
Topics: Adult; Dimercaprol; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Prognosis | 1969 |
[Pemphigus in a patient treated with penicillamine for Wilson's disease].
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Pemphigus; Penicillamine | 1969 |
[Pemphigus in a patient treated with penicillamine for Wilson's disease].
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Pemphigus; Penicillamine | 1969 |
[2 cases of Wilson's disease with hepatic precession in biliary lithiasis].
Topics: Adolescent; Adult; Cholelithiasis; Female; Hepatolenticular Degeneration; Humans; Jaundice; Penicill | 1969 |
[2 cases of Wilson's disease with hepatic precession in biliary lithiasis].
Topics: Adolescent; Adult; Cholelithiasis; Female; Hepatolenticular Degeneration; Humans; Jaundice; Penicill | 1969 |
Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
Topics: Ceruloplasmin; Child; Copper; Female; Hepatolenticular Degeneration; Histocytochemistry; Humans; Liv | 1970 |
Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
Topics: Ceruloplasmin; Child; Copper; Female; Hepatolenticular Degeneration; Histocytochemistry; Humans; Liv | 1970 |
[Therapy of neurologic manifestations of Wilson's disease using penicillamine].
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Male; Neurologic Manifestations; P | 1970 |
[Therapy of neurologic manifestations of Wilson's disease using penicillamine].
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Male; Neurologic Manifestations; P | 1970 |
[Penicillamine in the treatment of Wilson's disease. Clinical picture].
Topics: Adolescent; Adult; Child; Female; Handwriting; Hepatolenticular Degeneration; Humans; Male; Neurolog | 1970 |
[Penicillamine in the treatment of Wilson's disease. Clinical picture].
Topics: Adolescent; Adult; Child; Female; Handwriting; Hepatolenticular Degeneration; Humans; Male; Neurolog | 1970 |
Hepatolenticular degeneration (Wilson's disease).
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1970 |
Hepatolenticular degeneration (Wilson's disease).
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1970 |
[Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
Topics: Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Iron; Penicillamine; Time Factors; Uri | 1970 |
[Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
Topics: Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Iron; Penicillamine; Time Factors; Uri | 1970 |
Hemolytic anemia in Wilson's disease.
Topics: Adult; Anemia, Hemolytic; Copper; Erythrocytes; Female; Glucosephosphate Dehydrogenase; Glutathione; | 1970 |
Hemolytic anemia in Wilson's disease.
Topics: Adult; Anemia, Hemolytic; Copper; Erythrocytes; Female; Glucosephosphate Dehydrogenase; Glutathione; | 1970 |
[Penicillin allergy--penicillamine allergy. A successful desensitization of a penicillamine allergy with penicillin G in mobus Wilson].
Topics: Adolescent; Desensitization, Immunologic; Drug Hypersensitivity; Exanthema; Hepatolenticular Degener | 1970 |
[Penicillin allergy--penicillamine allergy. A successful desensitization of a penicillamine allergy with penicillin G in mobus Wilson].
Topics: Adolescent; Desensitization, Immunologic; Drug Hypersensitivity; Exanthema; Hepatolenticular Degener | 1970 |
Heptolenticular degeneration (Wilson's disease) in an Australian Aboriginal.
Topics: Adult; Australia; Hepatolenticular Degeneration; Humans; Male; Mutation; Native Hawaiian or Other Pa | 1970 |
Heptolenticular degeneration (Wilson's disease) in an Australian Aboriginal.
Topics: Adult; Australia; Hepatolenticular Degeneration; Humans; Male; Mutation; Native Hawaiian or Other Pa | 1970 |
[Studies of the hepatolenticular degeneration and results of its continuous therapy].
Topics: Acid Phosphatase; Adolescent; Adult; Alkaline Phosphatase; Blood Proteins; Chronic Disease; Depressi | 1970 |
[Studies of the hepatolenticular degeneration and results of its continuous therapy].
Topics: Acid Phosphatase; Adolescent; Adult; Alkaline Phosphatase; Blood Proteins; Chronic Disease; Depressi | 1970 |
Renal function in Wilson's disease: response to penicillamine therapy.
Topics: Adolescent; Adult; Aminohippuric Acids; Ammonium Chloride; Calcium; Dehydration; Female; Follow-Up S | 1970 |
Renal function in Wilson's disease: response to penicillamine therapy.
Topics: Adolescent; Adult; Aminohippuric Acids; Ammonium Chloride; Calcium; Dehydration; Female; Follow-Up S | 1970 |
Prevention of Wilson's disease--a long term follow-up.
Topics: Adolescent; Adult; Child; Child, Preschool; Copper; Diet Therapy; Female; Follow-Up Studies; Hepatol | 1970 |
Prevention of Wilson's disease--a long term follow-up.
Topics: Adolescent; Adult; Child; Child, Preschool; Copper; Diet Therapy; Female; Follow-Up Studies; Hepatol | 1970 |
The varied manifestations of Wilson's disease.
Topics: Adolescent; Anemia, Hemolytic; Ascites; Ceruloplasmin; Child; Copper; Diseases in Twins; Eye Manifes | 1971 |
The varied manifestations of Wilson's disease.
Topics: Adolescent; Anemia, Hemolytic; Ascites; Ceruloplasmin; Child; Copper; Diseases in Twins; Eye Manifes | 1971 |
[Diagnosis of asymptomatic forms of hepatolenticular degeneration].
Topics: Adolescent; Biopsy; Ceruloplasmin; Copper; Dermatoglyphics; Female; Hepatolenticular Degeneration; H | 1971 |
[Diagnosis of asymptomatic forms of hepatolenticular degeneration].
Topics: Adolescent; Biopsy; Ceruloplasmin; Copper; Dermatoglyphics; Female; Hepatolenticular Degeneration; H | 1971 |
Tissue copper, zinc, and manganese levels in Wilson's disease: studies with the use of neutron activation analysis.
Topics: Activation Analysis; Adolescent; Adrenal Glands; Adult; Autopsy; Brain Chemistry; Ceruloplasmin; Cop | 1971 |
Tissue copper, zinc, and manganese levels in Wilson's disease: studies with the use of neutron activation analysis.
Topics: Activation Analysis; Adolescent; Adrenal Glands; Adult; Autopsy; Brain Chemistry; Ceruloplasmin; Cop | 1971 |
Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper.
Topics: Adolescent; Adult; Ascites; California; Ceruloplasmin; Child; Copper; Female; Hepatolenticular Degen | 1971 |
Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper.
Topics: Adolescent; Adult; Ascites; California; Ceruloplasmin; Child; Copper; Female; Hepatolenticular Degen | 1971 |
Wilson's disease (hepatolenticular degeneration). Treatment with penicillamine and changes in hepatic trapping of radioactive copper.
Topics: Adolescent; Adult; Child; Child, Preschool; Copper; Diet Therapy; Dimercaprol; Female; Hepatolenticu | 1971 |
Wilson's disease (hepatolenticular degeneration). Treatment with penicillamine and changes in hepatic trapping of radioactive copper.
Topics: Adolescent; Adult; Child; Child, Preschool; Copper; Diet Therapy; Dimercaprol; Female; Hepatolenticu | 1971 |
[Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine].
Topics: Adolescent; Copper; Female; Hepatolenticular Degeneration; Humans; Kidney Tubules; Liver; Male; Peni | 1971 |
[Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine].
Topics: Adolescent; Copper; Female; Hepatolenticular Degeneration; Humans; Kidney Tubules; Liver; Male; Peni | 1971 |
Metabolic studies in Wilson's disease. Evaluation of efficacy of chelation therapy in respect to copper balance.
Topics: Adolescent; Adult; Chelating Agents; Child; Copper; Diet Therapy; Evaluation Studies as Topic; Femal | 1971 |
Metabolic studies in Wilson's disease. Evaluation of efficacy of chelation therapy in respect to copper balance.
Topics: Adolescent; Adult; Chelating Agents; Child; Copper; Diet Therapy; Evaluation Studies as Topic; Femal | 1971 |
[Lupoid syndrome due to D-penicillamine associated with Wilson's disease: clinical study of a case].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Lupus Vulgaris; Penicillamine | 1971 |
[Lupoid syndrome due to D-penicillamine associated with Wilson's disease: clinical study of a case].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Lupus Vulgaris; Penicillamine | 1971 |
[Lupus erythematosus due to penicillamine associated with Wilson's disease].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Lupus Erythematosus, Systemic; Penicillamine | 1971 |
[Lupus erythematosus due to penicillamine associated with Wilson's disease].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Lupus Erythematosus, Systemic; Penicillamine | 1971 |
[Wilson's disease. Introduction to current problems (early diagnosis and therapy)].
Topics: Adolescent; Adult; Agranulocytosis; Ceruloplasmin; Child; Copper; Female; Hepatolenticular Degenerat | 1967 |
[Wilson's disease. Introduction to current problems (early diagnosis and therapy)].
Topics: Adolescent; Adult; Agranulocytosis; Ceruloplasmin; Child; Copper; Female; Hepatolenticular Degenerat | 1967 |
[Experiences with long-term therapy of Wilson's disease].
Topics: Adolescent; Ceruloplasmin; Diet Therapy; Female; Hepatolenticular Degeneration; Humans; Penicillamin | 1967 |
[Experiences with long-term therapy of Wilson's disease].
Topics: Adolescent; Ceruloplasmin; Diet Therapy; Female; Hepatolenticular Degeneration; Humans; Penicillamin | 1967 |
[Urine copper determination in Wilson's disease during therapy].
Topics: Adult; Blood Cell Count; Child; Copper; Hepatolenticular Degeneration; Humans; Male; Neurologic Mani | 1967 |
[Urine copper determination in Wilson's disease during therapy].
Topics: Adult; Blood Cell Count; Child; Copper; Hepatolenticular Degeneration; Humans; Male; Neurologic Mani | 1967 |
[Contribution to the clarification of the pathogenesis of osteopathies in Wilson's disease. (Hepatolenticular degeneration)].
Topics: Adolescent; Calcium; Hepatolenticular Degeneration; Humans; Male; Osteopathic Medicine; Penicillamin | 1967 |
[Contribution to the clarification of the pathogenesis of osteopathies in Wilson's disease. (Hepatolenticular degeneration)].
Topics: Adolescent; Calcium; Hepatolenticular Degeneration; Humans; Male; Osteopathic Medicine; Penicillamin | 1967 |
The renal clearance of amino acids in a patient with Wilson's disease during penicillamine treatment.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Amino Acids; Copper; Creatinine; Hepatolenticular | 1968 |
The renal clearance of amino acids in a patient with Wilson's disease during penicillamine treatment.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Amino Acids; Copper; Creatinine; Hepatolenticular | 1968 |
Prevention of Wilson's disease in asymptomatic patients.
Topics: Adolescent; Adult; Biopsy; Ceruloplasmin; Child; Child, Preschool; Copper; Female; Hepatolenticular | 1968 |
Prevention of Wilson's disease in asymptomatic patients.
Topics: Adolescent; Adult; Biopsy; Ceruloplasmin; Child; Child, Preschool; Copper; Female; Hepatolenticular | 1968 |
Editor's choice: Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
Editor's choice: Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
Prophylactic use of penicillamine.
Topics: Adolescent; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1968 |
Prophylactic use of penicillamine.
Topics: Adolescent; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1968 |
Prophylactic treatment of Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
Prophylactic treatment of Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
Wilson's disease presenting with rickets.
Topics: Child; Copper; Diagnosis, Differential; Diet Therapy; Eye Manifestations; Hepatolenticular Degenerat | 1968 |
Wilson's disease presenting with rickets.
Topics: Child; Copper; Diagnosis, Differential; Diet Therapy; Eye Manifestations; Hepatolenticular Degenerat | 1968 |
Defective urinary acidification in Wilson's disease.
Topics: Acidosis, Renal Tubular; Adolescent; Adult; Ammonium Chloride; Blood Chemical Analysis; Female; Hepa | 1968 |
Defective urinary acidification in Wilson's disease.
Topics: Acidosis, Renal Tubular; Adolescent; Adult; Ammonium Chloride; Blood Chemical Analysis; Female; Hepa | 1968 |
Treatment of Wilson's disease.
Topics: Adult; Anticonvulsants; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Prognosis | 1968 |
Treatment of Wilson's disease.
Topics: Adult; Anticonvulsants; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Prognosis | 1968 |
Controversy in Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
Controversy in Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
Prophylaxis for Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Statistics as Topic | 1968 |
Prophylaxis for Wilson's disease.
Topics: Hepatolenticular Degeneration; Humans; Penicillamine; Statistics as Topic | 1968 |
[Glossitis, stomatitis and onychopathy caused by penicillinamine].
Topics: Child; Drug Hypersensitivity; Female; Glossitis; Hepatolenticular Degeneration; Humans; Nails; Penic | 1968 |
[Glossitis, stomatitis and onychopathy caused by penicillinamine].
Topics: Child; Drug Hypersensitivity; Female; Glossitis; Hepatolenticular Degeneration; Humans; Nails; Penic | 1968 |
Changes in Kayser-Fleischer ring during treatment of hepatolenticular degeneration.
Topics: Adult; Copper; Cornea; Diet Therapy; Dimercaprol; Female; Hepatolenticular Degeneration; Humans; Mal | 1968 |
Changes in Kayser-Fleischer ring during treatment of hepatolenticular degeneration.
Topics: Adult; Copper; Cornea; Diet Therapy; Dimercaprol; Female; Hepatolenticular Degeneration; Humans; Mal | 1968 |
[Effects of the combined administration of glutathione and D-penicillamine on the urinary copper excretion in Wilson's disease].
Topics: Adolescent; Buffers; Ceruloplasmin; Copper; Drug Synergism; Female; Glutathione; Hepatolenticular De | 1968 |
[Effects of the combined administration of glutathione and D-penicillamine on the urinary copper excretion in Wilson's disease].
Topics: Adolescent; Buffers; Ceruloplasmin; Copper; Drug Synergism; Female; Glutathione; Hepatolenticular De | 1968 |
Neutron activation analysis ofr copper in biological material applied to Wilson's disease.
Topics: Activation Analysis; Adolescent; Child; Child, Preschool; Colorimetry; Copper; Female; Hair; Hepatol | 1968 |
Neutron activation analysis ofr copper in biological material applied to Wilson's disease.
Topics: Activation Analysis; Adolescent; Child; Child, Preschool; Colorimetry; Copper; Female; Hair; Hepatol | 1968 |
Use of whole-body counter to study body retention of radiocopper in Wilson's disease.
Topics: Carrier State; Copper; Hepatolenticular Degeneration; Heterozygote; Homozygote; Humans; Injections, | 1968 |
Use of whole-body counter to study body retention of radiocopper in Wilson's disease.
Topics: Carrier State; Copper; Hepatolenticular Degeneration; Heterozygote; Homozygote; Humans; Injections, | 1968 |
[Anatomo-clinical study of a case of Wilson's disease treated with chelating agents for 5 years].
Topics: Acute Kidney Injury; Adult; Basal Ganglia; Chelating Agents; Female; Globus Pallidus; Hepatolenticul | 1968 |
[Anatomo-clinical study of a case of Wilson's disease treated with chelating agents for 5 years].
Topics: Acute Kidney Injury; Adult; Basal Ganglia; Chelating Agents; Female; Globus Pallidus; Hepatolenticul | 1968 |
[Functional disorders of the renal tubules in Wilson's disease].
Topics: Child; Copper; Hepatolenticular Degeneration; Humans; Kidney Diseases; Kidney Tubules; Male; Penicil | 1968 |
[Functional disorders of the renal tubules in Wilson's disease].
Topics: Child; Copper; Hepatolenticular Degeneration; Humans; Kidney Diseases; Kidney Tubules; Male; Penicil | 1968 |
Toxicity of penicillamine.
Topics: Adult; Drug Hypersensitivity; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
Toxicity of penicillamine.
Topics: Adult; Drug Hypersensitivity; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
Nephrotic syndrome from penicillamine.
Topics: Antibodies; Child; Hepatolenticular Degeneration; Humans; Male; Nephrotic Syndrome; Penicillamine | 1968 |
Nephrotic syndrome from penicillamine.
Topics: Antibodies; Child; Hepatolenticular Degeneration; Humans; Male; Nephrotic Syndrome; Penicillamine | 1968 |
Toxic reactions to penicillamine in patients with Wilson's disease.
Topics: Adolescent; Antibody Formation; Child; Female; Hepatolenticular Degeneration; Humans; Male; Penicill | 1968 |
Toxic reactions to penicillamine in patients with Wilson's disease.
Topics: Adolescent; Antibody Formation; Child; Female; Hepatolenticular Degeneration; Humans; Male; Penicill | 1968 |
Prevention of Wilson's disease in asymptomatic patients.
Topics: Child; Child, Preschool; Copper; Diet Therapy; Female; Follow-Up Studies; Hepatolenticular Degenerat | 1968 |
Prevention of Wilson's disease in asymptomatic patients.
Topics: Child; Child, Preschool; Copper; Diet Therapy; Female; Follow-Up Studies; Hepatolenticular Degenerat | 1968 |
[Wilson's disease treated by penicillamine: favorable effect].
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
[Wilson's disease treated by penicillamine: favorable effect].
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
[Wilson's disease (hepatolenticular degeneration)].
Topics: Adolescent; Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
[Wilson's disease (hepatolenticular degeneration)].
Topics: Adolescent; Adult; Copper; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
What Wilson's disease and its treatment have taught us about the metabolism of copper. Observations in 27 cases.
Topics: Adolescent; Adult; Biological Transport; Ceruloplasmin; Child; Child, Preschool; Copper; Diet Therap | 1968 |
What Wilson's disease and its treatment have taught us about the metabolism of copper. Observations in 27 cases.
Topics: Adolescent; Adult; Biological Transport; Ceruloplasmin; Child; Child, Preschool; Copper; Diet Therap | 1968 |
[Treatment of Wilson's disease].
Topics: Chelating Agents; Drug Synergism; Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
[Treatment of Wilson's disease].
Topics: Chelating Agents; Drug Synergism; Hepatolenticular Degeneration; Humans; Penicillamine | 1968 |
[Presymptomatic and hepatic forms of Wilson's disease in childhood. Long-term therapy with D-penicillamine].
Topics: Ceruloplasmin; Child; Child, Preschool; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1968 |
[Presymptomatic and hepatic forms of Wilson's disease in childhood. Long-term therapy with D-penicillamine].
Topics: Ceruloplasmin; Child; Child, Preschool; Hepatolenticular Degeneration; Humans; Male; Penicillamine | 1968 |
[Therapy of Wilson's disease].
Topics: Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 1969 |
[Therapy of Wilson's disease].
Topics: Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Penicillamine | 1969 |
Wilson's disease.
Topics: Adolescent; Adult; Animals; Brain; Child; Columbidae; Copper; Hepatolenticular Degeneration; Humans; | 1969 |
Wilson's disease.
Topics: Adolescent; Adult; Animals; Brain; Child; Columbidae; Copper; Hepatolenticular Degeneration; Humans; | 1969 |
Tremor induction in mice and its modification.
Topics: Alcohols; Amides; Animals; Brain Chemistry; Carbon Tetrachloride; Copper; Cysteamine; Female; Hepato | 1969 |
Tremor induction in mice and its modification.
Topics: Alcohols; Amides; Animals; Brain Chemistry; Carbon Tetrachloride; Copper; Cysteamine; Female; Hepato | 1969 |
"Sunflower cataract" in Wilson's disease.
Topics: Cataract; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Lens, Crystalline; Penicilla | 1969 |
"Sunflower cataract" in Wilson's disease.
Topics: Cataract; Child; Copper; Female; Hepatolenticular Degeneration; Humans; Lens, Crystalline; Penicilla | 1969 |
[Penicillamine treatment of Wilson's disease].
Topics: Child; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Penicillamine | 1969 |
[Penicillamine treatment of Wilson's disease].
Topics: Child; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Penicillamine | 1969 |
Gastrointestinal absorption of copper: studies with 64Cu, 95Zr, a whole-body counter and the scintillation camera.
Topics: Adolescent; Adult; Aged; Copper; Duodenum; Feces; Female; Gastric Mucosa; Hepatolenticular Degenerat | 1969 |
Gastrointestinal absorption of copper: studies with 64Cu, 95Zr, a whole-body counter and the scintillation camera.
Topics: Adolescent; Adult; Aged; Copper; Duodenum; Feces; Female; Gastric Mucosa; Hepatolenticular Degenerat | 1969 |
[On methods of copper determination in body fluids in disorders of copper metabolism].
Topics: Chemistry, Clinical; Copper; Hepatolenticular Degeneration; Humans; Methods; Penicillamine; Photomet | 1969 |
[On methods of copper determination in body fluids in disorders of copper metabolism].
Topics: Chemistry, Clinical; Copper; Hepatolenticular Degeneration; Humans; Methods; Penicillamine; Photomet | 1969 |
[Iron and copper metabolism in hemochromatosis and Wilson's disease. Studies on relatives of patients].
Topics: Adolescent; Adult; Biopsy; Copper; Female; Hemochromatosis; Hepatolenticular Degeneration; Humans; I | 1969 |
[Iron and copper metabolism in hemochromatosis and Wilson's disease. Studies on relatives of patients].
Topics: Adolescent; Adult; Biopsy; Copper; Female; Hemochromatosis; Hepatolenticular Degeneration; Humans; I | 1969 |
Coagulation abnormalities in Wilson's disease.
Topics: Adolescent; Blood Coagulation Disorders; Blood Platelets; Child; Child, Preschool; Female; Fibrinoly | 1969 |
Coagulation abnormalities in Wilson's disease.
Topics: Adolescent; Blood Coagulation Disorders; Blood Platelets; Child; Child, Preschool; Female; Fibrinoly | 1969 |
[Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy].
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Penicillamine; Ti | 1969 |
[Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy].
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Penicillamine; Ti | 1969 |
[Renal accidents in 2 cases of Wilson's disease treated with penicillamine].
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Kidney Diseases; Penicillamine | 1965 |
[Renal accidents in 2 cases of Wilson's disease treated with penicillamine].
Topics: Adolescent; Adult; Female; Hepatolenticular Degeneration; Humans; Kidney Diseases; Penicillamine | 1965 |
[Early detection and treatment of Wilson's disease].
Topics: Hepatolenticular Degeneration; Humans; Penicillamine | 1965 |
[Early detection and treatment of Wilson's disease].
Topics: Hepatolenticular Degeneration; Humans; Penicillamine | 1965 |
Effect of penicillamine on serum iron.
Topics: Adolescent; Adult; Blood; Child; Copper; Evaluation Studies as Topic; Female; Hemoglobinometry; Hepa | 1965 |
Effect of penicillamine on serum iron.
Topics: Adolescent; Adult; Blood; Child; Copper; Evaluation Studies as Topic; Female; Hemoglobinometry; Hepa | 1965 |
[Splenomegalic cirrhosis in a 26-year old man: hepatolenticular degeneration with only splanchnic manifestations].
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Splenomegaly | 1965 |
[Splenomegalic cirrhosis in a 26-year old man: hepatolenticular degeneration with only splanchnic manifestations].
Topics: Adult; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Splenomegaly | 1965 |
Changes of some clotting factors in hepatolenticular degeneration (Wilson's disease).
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Hepatolenticular Degeneration; Humans; Liver F | 1965 |
Changes of some clotting factors in hepatolenticular degeneration (Wilson's disease).
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Hepatolenticular Degeneration; Humans; Liver F | 1965 |
[On the early diagnosis of Wilson's disease].
Topics: Child; Child, Preschool; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1965 |
[On the early diagnosis of Wilson's disease].
Topics: Child; Child, Preschool; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1965 |
[Hepatocerebral degeneration (Wilson's disease). 2. Therapy].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1965 |
[Hepatocerebral degeneration (Wilson's disease). 2. Therapy].
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Penicillamine | 1965 |
[Therapeutic effects of penicillamine on Wilson's disease].
Topics: Adult; Child; Hepatolenticular Degeneration; Humans; In Vitro Techniques; Male; Penicillamine | 1965 |
[Therapeutic effects of penicillamine on Wilson's disease].
Topics: Adult; Child; Hepatolenticular Degeneration; Humans; In Vitro Techniques; Male; Penicillamine | 1965 |
Radiocopper studies in patients with Wilson's disease and their relatives.
Topics: Copper; Feces; Hepatolenticular Degeneration; Humans; Liver; Penicillamine; Radioisotopes | 1966 |
Radiocopper studies in patients with Wilson's disease and their relatives.
Topics: Copper; Feces; Hepatolenticular Degeneration; Humans; Liver; Penicillamine; Radioisotopes | 1966 |
Influence of penicillamine on the turnover of I-131-labeled ceruloplasmin in Wilson's disease.
Topics: Adult; Aged; Ceruloplasmin; Female; Hepatolenticular Degeneration; Humans; Iodine Isotopes; Kinetics | 1966 |
Influence of penicillamine on the turnover of I-131-labeled ceruloplasmin in Wilson's disease.
Topics: Adult; Aged; Ceruloplasmin; Female; Hepatolenticular Degeneration; Humans; Iodine Isotopes; Kinetics | 1966 |
Copper content of saliva of normal subjects and treated Wilson's disease patients.
Topics: Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Saliva; Spectrophotometr | 1966 |
Copper content of saliva of normal subjects and treated Wilson's disease patients.
Topics: Copper; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Saliva; Spectrophotometr | 1966 |
[Penicillamine].
Topics: Adolescent; Adult; Hepatolenticular Degeneration; Humans; Lead Poisoning; Male; Penicillamine | 1966 |
[Penicillamine].
Topics: Adolescent; Adult; Hepatolenticular Degeneration; Humans; Lead Poisoning; Male; Penicillamine | 1966 |
Nephrotic syndrome in the course of treatment of Wilson's disease with DL-penicillamine.
Topics: Child; Female; Hepatolenticular Degeneration; Humans; Kidney Glomerulus; Kidney Tubules; Liver; Neph | 1966 |
Nephrotic syndrome in the course of treatment of Wilson's disease with DL-penicillamine.
Topics: Child; Female; Hepatolenticular Degeneration; Humans; Kidney Glomerulus; Kidney Tubules; Liver; Neph | 1966 |
Some problems of the penicillamine action in hepatolenticular degeneration.
Topics: Adult; Copper; Dialysis; Female; Hepatolenticular Degeneration; Humans; In Vitro Techniques; Macrogl | 1966 |
Some problems of the penicillamine action in hepatolenticular degeneration.
Topics: Adult; Copper; Dialysis; Female; Hepatolenticular Degeneration; Humans; In Vitro Techniques; Macrogl | 1966 |
Penicillamine and the nephrotic syndrome.
Topics: Adolescent; Adult; Child; Hepatolenticular Degeneration; Humans; Nephrotic Syndrome; Penicillamine | 1966 |
Penicillamine and the nephrotic syndrome.
Topics: Adolescent; Adult; Child; Hepatolenticular Degeneration; Humans; Nephrotic Syndrome; Penicillamine | 1966 |
The effects of penicillamine therapy on uric acid metabolism in Wilson's disease.
Topics: Body Weight; Carbon Isotopes; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Ur | 1966 |
The effects of penicillamine therapy on uric acid metabolism in Wilson's disease.
Topics: Body Weight; Carbon Isotopes; Female; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Ur | 1966 |
[Clinical, bioptic, biochemical and therapeutic study of a case of hepatolenticular degeneration of K. Wilson with pseudotumoral onset].
Topics: Biopsy; Blood Protein Electrophoresis; Cerebral Angiography; Ceruloplasmin; Child; Eye Manifestation | 1966 |
[Clinical, bioptic, biochemical and therapeutic study of a case of hepatolenticular degeneration of K. Wilson with pseudotumoral onset].
Topics: Biopsy; Blood Protein Electrophoresis; Cerebral Angiography; Ceruloplasmin; Child; Eye Manifestation | 1966 |
[Therapeutic considerations on Wilson's disease].
Topics: Adult; Dimercaprol; Hepatolenticular Degeneration; Humans; Male; Mental Disorders; Movement Disorder | 1966 |
[Therapeutic considerations on Wilson's disease].
Topics: Adult; Dimercaprol; Hepatolenticular Degeneration; Humans; Male; Mental Disorders; Movement Disorder | 1966 |